6-K

Use these links to rapidly review the document
TABLE OF CONTENTS

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16 OF THE
SECURITIES EXCHANGE ACT OF 1934

For the month of July 2013

FRESENIUS MEDICAL CARE AG & Co. KGaA
(Translation of registrant's name into English)

Else-Kröner Strasse 1
61346 Bad Homburg
Germany
(Address of principal executive offices)

        Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

        Form 20-F ý                    Form 40-F o

        Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

        Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

        Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

        Yes o                                 No ý

        If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-            .

FRESENIUS MEDICAL CARE AG & Co. KGaA

	Page
Interim Report of Financial Condition and Results of Operations for the three and six months ended June 30, 2013 and 2012
Financial Condition and Results of Operations	1
Balance Sheet Structure	18
Outlook	18
Financial Statements
Consolidated Statements of Income	20
Consolidated Statements of Comprehensive Income	21
Consolidated Balance Sheets	22
Consolidated Statements of Cash Flows	23
Consolidated Statement of Shareholders' Equity	24
Notes to Consolidated Financial Statements	25
Quantitative and Qualitative Disclosures About Market Risk	52
Controls and Procedures	53
OTHER INFORMATION
Legal and Regulatory Matters	54
Exhibits	56
Signatures	57

i

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

Financial Condition and Results of Operations

        You should read the following discussion and analysis of the results of operations of Fresenius Medical Care AG & Co. KGaA ("FMC-AG & Co. KGaA," or the "Company") and its subsidiaries in conjunction with our unaudited consolidated financial statements and related notes contained elsewhere in this report and our disclosures and discussions in our Annual Report on Form 20-F for the year ended December 31, 2012. In this report, "FMC-AG & Co. KGaA," or the "Company," "we," "us" or "our" refers to the Company or the Company and its subsidiaries on a consolidated basis, as the context requires. The term "North America Segment" refers to our North America operating segment and the term "International Segment" refers to the combination of our "EMEALA" (Europe, Middle East, Africa and Latin America) operating segment and our Asia-Pacific operating segment.

Forward-looking Statements

        This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this report, the words "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions are generally intended to identify forward looking statements. Although we believe that the expectations reflected in such forward-looking statements are reasonable, forward-looking statements are inherently subject to risks and uncertainties, many of which cannot be predicted with accuracy and some of which might not even be anticipated, and future events and actual results, financial and otherwise, could differ materially from those set forth in or contemplated by the forward-looking statements contained elsewhere in this report. We have based these forward-looking statements on current estimates and assumptions made to the best of our knowledge. By their nature, such forward-looking statements involve risks, uncertainties, assumptions and other factors which could cause actual results, including our financial condition and profitability, to differ materially and be more negative than the results expressly or implicitly described in or suggested by these statements. Moreover, forward-looking estimates or predictions derived from third parties' studies or information may prove to be inaccurate. Consequently, we cannot give any assurance regarding the future accuracy of the opinions set forth in this report or the actual occurrence of the developments described herein. In addition, even if our future results meet the expectations expressed here, those results may not be indicative of our performance in future periods.

        These risks, uncertainties, assumptions, and other factors that could cause actual results to differ from our projected results include, among others, the following:

•

changes in governmental and commercial insurer reimbursement for our complete products and services portfolio, including the expanded United States ("U.S.") Medicare reimbursement system for dialysis services;

•

changes in utilization patterns for pharmaceuticals and in our costs of purchasing pharmaceuticals;

•

the outcome of ongoing government and internal investigations;

•

risks relating to compliance with the myriad government regulations applicable to our business including, in the U.S., the Anti-Kickback Statute, the False Claims Act, the Stark Law and the Foreign Corrupt Practices Act, and comparable regulatory regimes in many of the 120 countries in which we supply dialysis services and/ or products;

•

the influence of private insurers and managed care organizations;

•

the impact of recently enacted and possible future health care reforms;

•

product liability risks;

•

the outcome of ongoing potentially material litigation;

•

risks relating to the integration of acquisitions and our dependence on additional acquisitions;

•

the impact of currency fluctuations;

1

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

•

introduction of generic or new pharmaceuticals that compete with our pharmaceutical products;

•

changes in raw material and energy costs or the ability to procure raw materials; as well as

•

the financial stability and liquidity of our governmental and commercial payors.

        Important factors that could contribute to such differences are noted in the "Overview" section below and in Note 11 of the Notes to Consolidated Financial Statements (Unaudited), "Commitments and Contingencies" included in this report and in our Annual Report on Form 20-F for the year ended December 31, 2012, under "Risk Factors" and elsewhere in that report.

        Our business is also subject to other risks and uncertainties that we describe from time to time in our public filings. Developments in any of these areas could cause our results to differ materially from the results that we or others have projected or may project.

        Our reported financial condition and results of operations are sensitive to accounting methods, assumptions and estimates that are the basis of our financial statements. The actual accounting policies, the judgments made in the selection and application of these policies and the sensitivities of reported results to changes in accounting policies, assumptions and estimates, are factors to be considered along with our financial statements and the discussion under "Results of Operations" below. For a discussion of our critical accounting policies, see Item 5, "Operating and Financial Review and Prospects—Critical Accounting Policies" in our Annual Report on Form 20-F for the year ended December 31, 2012.

Overview

        We are engaged primarily in providing dialysis services including pharmacy services and vascular access surgery services (together, the "Expanded Services") and manufacturing and distributing products and equipment for the treatment of End-Stage Renal Disease ("ESRD"). Fresenius Medical Care Holdings, Inc. ("FMCH"), located in the United States and our largest subsidiary, also provides laboratory testing services, and inpatient dialysis services as well as other services under contract to hospitals. We estimate that providing dialysis services and distributing dialysis products and equipment represents a worldwide market of approximately $75 billion with expected annual worldwide market growth of around 4%, adjusted for currency. Patient growth results from factors such as the aging population and increased life expectancies; shortage of donor organs for kidney transplants; increasing incidence and better treatment of and survival of patients with diabetes and hypertension, which frequently precede the onset of ESRD; improvements in treatment quality, which prolong patient life; and improving standards of living in developing countries, which make life-saving dialysis treatment available. Key to continued growth in revenue is our ability to attract new patients in order to increase the number of treatments performed each year. For that reason, we believe the number of treatments performed each year is a strong indicator of continued revenue growth and success. In addition, the reimbursement and ancillary services utilization environment significantly influences our business. With the exception of the implementation of the ESRD prospective payment system ("ESRD PPS") in the U.S. in January 2011, the U.S. federal government sequestration cuts and the current proposal to reduce reimbursement under the ESRD PPS effective January 1, 2014 to account for the decline in utilization of certain drugs and biologicals associated with dialysis, we experienced and also expect in the future to experience generally stable reimbursements for dialysis services. See discussion of the American Taxpayer Relief Act of 2012 below. This includes the balancing of unfavorable reimbursement changes in certain countries with favorable changes in other countries. The majority of treatments are paid for by governmental institutions such as Medicare in the United States. As a consequence of the pressure to decrease healthcare costs, reimbursement rate increases have historically been limited. Our ability to influence the pricing of our services is limited.

        With the enactment in the U.S. of the Medicare Improvements for Patients and Providers Act of 2008 ("MIPPA") in 2008, Congress mandated the development of an expanded ESRD PPS for services furnished on or after January 1, 2011. On July 26, 2010, the U.S. Centers for Medicare & Medicaid Services ("CMS") published a final rule implementing the ESRD PPS for ESRD dialysis facilities in accordance with MIPPA. Under the ESRD PPS, CMS reimburses dialysis facilities with a single payment for each dialysis treatment, inclusive of (i) all items and services included in the former composite rate, (ii) oral vitamin D analogues, oral levocarnitine (an amino acid derivative) and all erythropoietin

2

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

stimulating agents ("ESAs") and other pharmaceuticals (other than vaccines and certain other oral drugs) furnished to ESRD patients that were previously reimbursed separately under Part B of the Medicare program, (iii) most diagnostic laboratory tests and (iv) certain other items and services furnished to individuals for the treatment of ESRD. ESRD-related drugs with only an oral form, including our phosphate binder PhosLo®, are expected to be reimbursed under the ESRD PPS starting in January 2016 with an adjusted payment amount to be determined by the Secretary of Health and Human Services to reflect the additional cost to dialysis facilities of providing these medications. The base ESRD PPS payment is subject to case mix adjustments that take into account individual patient characteristics (e.g., age, body surface area, body mass, time on dialysis) and certain co-morbidities. The base payment is also adjusted for (i) certain high cost patient outliers due to unusual variations in medically necessary care, (ii) disparately high costs incurred by low volume facilities relative to other facilities, (iii) provision of home dialysis training and (iv) wage-related costs in the geographic area in which the provider is located.

        The ESRD PPS payment amount is subject to annual adjustment based on increases in the costs of a "market basket" of certain healthcare items and services less a productivity adjustment. The 2013 ESRD PPS base rate is $240.36 per treatment. This amount reflects a productivity adjusted market basket update of 2.3%, which was based on a market basket update over 2012 reimbursement rates of 2.9% less a productivity adjustment of 0.6%, and a wage index budget-neutrality adjustment factor of 1.000613 applied to the 2012 ESRD PPS base rate of $234.81 per treatment.

        The initial ESRD PPS resulted in a lower reimbursement rate on average at our U.S. dialysis facilities. We mitigated the impact of the ESRD PPS with two broad measures. First, we worked with medical directors and treating physicians to find efficiencies consistent with the ESRD PPS's quality incentive program ("QIP") and good clinical practices, and we negotiated pharmaceutical acquisition cost savings. In addition, we achieved greater efficiencies and better patient outcomes by introducing new initiatives to improve patient care upon initiation of dialysis, increase the percentage of patients using home therapies and achieve additional cost reductions in our clinics.

        The ESRD PPS's QIP began affecting payments starting January 1, 2012. Dialysis facilities that fail to achieve the established quality standards now have payments reduced by up to 2%. Performance on specified measures in 2010 affected payments in 2012. Based on our performance in 2010, the QIP's impact on our 2012 results was immaterial. In 2013, payments will be affected by performance with respect to measures in 2011. The initial QIP measures for 2010 and 2011 focused on anemia management and dialysis adequacy (Urea Reduction Ratio or URR). For 2012 reporting (affecting payments in 2014), CMS adopted four additional measures: prevalence of catheter and A/V fistula use, reporting of infections to the Centers for Disease Control and Prevention, administration of patient satisfaction surveys and monthly monitoring of phosphorus and calcium levels. For payment year 2015, CMS has continued all of the 2014 QIP measures except URR dialysis adequacy, expanded the scope of infection reporting and mineral metabolism reporting, and added four new measures. The new payment year 2015 measures consist of three new clinical measures (hemodialysis adequacy (adult patients), hemodialysis adequacy (pediatric patients) and peritoneal dialysis adequacy), and one new reporting measure (anemia management reporting). For payment year 2016, CMS has proposed continuing the payment year 2015 QIP measures, revising the mineral metabolism reporting and anemia management reporting measures, expanding the scope of patient satisfaction surveys, and adding five new measures for a total of fourteen. The proposed new measures consist of three new clinical measures (patient-informed consent for anemia treatment, proportion of patients with hypercalcemia, and bloodstream infection in hemodialysis outpatients), and two new reporting measures (pediatric iron therapy and patient comorbidity). A final QIP rule for 2016 is expected later this year.

        The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2011 (collectively, "ACA") implements broad healthcare system reforms, including (i) provisions to facilitate access to affordable health insurance for all Americans, (ii) expansion of the Medicaid program, (iii) an industry fee on pharmaceutical companies that began in 2011 based on sales of brand name pharmaceuticals to government healthcare programs, (iv) a 2.3% excise tax on manufacturers' medical device sales starting in 2013, (v) increases in Medicaid prescription drug rebates effective January 1, 2010, (vi) commercial insurance market reforms that protect consumers, such as bans on

3

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

lifetime and annual limits, coverage of pre-existing conditions, limits on administrative costs, and limits on waiting periods, (vii) provisions encouraging integrated care, efficiency and coordination among providers and (viii) provisions for reduction of healthcare program waste and fraud. ACA does not modify the dialysis reimbursement provisions of MIPPA, except to change the annual update provision by substituting a productivity adjustment to the market basket rate of increase for a MIPPA provision that specified a one percentage point reduction in the market basket rate of increase. ACA's medical device excise tax, Medicaid drug rebate increases and annual pharmaceutical industry fees will adversely impact our product business earnings and cash flows. We expect modest favorable impact from ACA's integrated care and commercial insurance consumer protection provisions.

        On August 2, 2011, the Budget Control Act ("BCA") was enacted, raising the U.S.'s debt ceiling and putting into effect a series of actions for deficit reduction. Pursuant to the American Taxpayer Relief Act of 2012 (``ATRA"), the automatic across-the-board spending cuts over nine fiscal years (2013-2021), projected to total $1.2 trillion for all U.S. Federal government programs required under the BCA became effective as of March 1, 2013 and were implemented on April 1, 2013 for CMS reimbursement to providers. The reduction in Medicare payments to providers and suppliers is limited to one adjustment of no more than 2% through 2021 (the "Sequestration"). The Medicare reimbursement reduction is independent of annual inflation update mechanisms, such as the market basket update pursuant to the ESRD PPS.

        ATRA also directed CMS to reduce the ESRD PPS payment rate, effective January 1, 2014, to account for changes in the utilization of certain drugs and biologicals that are included in the ESRD PPS. In making such reduction, the law requires CMS to use the most recently available pricing data for such drugs and biologicals. On July 1, 2013, CMS released a proposal to reduce the ESRD PPS payment rate by 12% ($29.52 per treatment) effective January 1, 2014 which would be partially offset by a proposed 2.5% ($6) increase due to the productivity adjusted market basket update for 2014 and a proposed wage index budget factor of 1.000411 for 2014. If finalized later this year, the net effect of the proposal and the market basket update would reduce the ESRD PPS base rate from $240.36 per treatment in 2013 to $216.95 per treatment in 2014. If implemented as proposed the expected net effect of the reductions would result in a material adverse impact on our consolidated operating income and cash flows. CMS is seeking comment on, among other things, the proposed methodology for the reduction to the ESRD PPS base rate and a potential transition or phase-in period of the reduction amount over more than one year. The Company intends to work with our provider, patient and physician partners to develop our comments to submit during the public comment period which expires August 30, 2013, and to work with CMS to maintain the stability of the ESRD PPS to help ensure continued access to quality care for ESRD patients.

        On February 4, 2013, CMS announced plans to test a new Comprehensive ESRD Care Model and issued a solicitation for applications. As currently proposed, CMS will work with up to 15 healthcare provider groups, known as ESRD Seamless Care Organizations ("ESCOs"), to test a new system of payment and care delivery that seeks to deliver better health outcomes for ESRD patients while lowering CMS's costs. ESCOs that achieve the program's minimum quality thresholds and generate reductions in CMS's cost of care above certain thresholds for the ESRD patients covered by the ESCO will receive a share of the cost savings. ESCOs that include dialysis chains with more than 200 facilities are required to share in the risk of cost increases and reimburse CMS a share of any such increases. Organizations must apply and be approved by CMS to participate in the program. The application deadline has been extended to August 30, 2013. We are reviewing the details of the proposed program to determine whether to participate in this program.

        Any significant decreases in Medicare reimbursement rates could have material adverse effects on our provider business and, because the demand for products is affected by Medicare reimbursement, on our products business. To the extent that increases in operating costs that are affected by inflation, such as labor and supply costs, are not fully reflected in a compensating increase in reimbursement rates, our business and results of operations may be adversely affected.

        We have identified three operating segments, North America, EMEALA, and Asia-Pacific, which were determined based upon how we manage our businesses. All segments are primarily engaged in providing dialysis care services and the distribution of products and equipment for the treatment of ESRD. For reporting purposes, we have aggregated EMEALA and Asia-Pacific operating segments as the

4

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

"International Segment." We aggregated these operating segments due to their similar economic characteristics. These characteristics include same services provided and same products sold, same type patient population, similar methods of distribution of products and services and similar economic environments. Our General Partner's management board member responsible for the profitability and cash flow of each segment's various businesses supervises the management of each operating segment. The accounting policies of the segments are the same as those we apply in preparing our consolidated financial statements under accounting principles generally accepted in the U.S. ("U.S. GAAP").

        Our management evaluates each segment using a measure that reflects all of the segment's controllable revenues and expenses. With respect to the performance of our business operations, our management believes the most appropriate measure in this regard is operating income which measures our source of earnings. We do not include the investment gain resulting from our 2012 acquisition of Liberty Dialysis Holdings, Inc. (the "Liberty Acquisition") nor income taxes as we believe these items to be outside the segments' control. Financing is a corporate function which our segments do not control. Therefore, we do not include interest expense relating to financing as a segment measurement. Similarly, we do not allocate "corporate costs," which relate primarily to certain headquarters overhead charges, including accounting and finance, global research and development, etc., because we believe that these costs are also not within the control of the individual segments. Production of products, production asset management, quality management and procurement are centrally managed in corporate by our Global Manufacturing Operations division. These corporate activities do not fulfill the definition of a segment. Products are transferred to the segments at cost; therefore no internal profit is generated. The associated internal revenues for the product transfers and their elimination are recorded as corporate activities (See Note 14 of the Notes to Consolidated Financial Statements (unaudited) "Segment Information" found elsewhere in this report). Capital expenditures for production are based on the expected demand of the segments and consolidated profitability considerations. In addition, certain revenues, investments and intangible assets, as well as any related expenses, are not allocated to a segment but are accounted for as "Corporate." Accordingly, all of these items are excluded from our analysis of segment results and are discussed below in the discussion of our consolidated results of operations.

5

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

Results of Operations

        The following tables summarize our financial performance and certain operating results by principal reporting segment and Corporate for the periods indicated. Inter-segment sales primarily reflect sales of medical equipment and supplies. We prepared the information using a management approach, consistent with the basis and manner in which our management internally disaggregates financial information to assist in making internal operating decisions and evaluating management performance.

	For the three months ended June 30,						For the six months ended June 30,
	2013			2012			2013			2012
	(in millions)						(in millions)
Total revenue
North America	$	2,377		$	2,252		$	4,665		$	4,360
International		1,228			1,171			2,397			2,307
Corporate		10			8			17			17
Totals		3,615			3,431			7,079			6,684
Inter-segment revenue
North America		2			3			3			7
International		—			—			—			—
Totals		2			3			3			7
Total net revenue
North America		2,375			2,249			4,662			4,353
International		1,228			1,171			2,397			2,307
Corporate		10			8			17			17
Totals		3,613			3,428			7,076			6,677
Amortization and depreciation
North America		81			79			161			151
International		46			43			91			86
Corporate		32			29			63			57
Totals		159			151			315			294
Operating income
North America		394			431			763			779
International		209			207			393			402
Corporate		(59	)		(49	)		(118	)		(89	)
Totals		544			589			1,038			1,092
Investment gain		—			13			—			140
Interest income		7			13			17			33
Interest expense		(110	)		(117	)		(224	)		(236	)
Income tax expense		(144	)		(172	)		(273	)		(309	)
Net Income		297			326			558			720
Less: Net Income attributable to Noncontrolling interests		(34	)		(37	)		(70	)		(60	)
Net Income attributable to shareholders of FMC-AG & Co. KGaA	$	263		$	289		$	488		$	660

6

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

Three months ended June 30, 2013 compared to three months ended June 30, 2012

Consolidated Financials

Key Indicators for Consolidated Financial Statements

	For the three months ended June 30,						Change in %
							as reported			at constant exchange rates(1)
	2013			2012
Number of treatments		10,066,397			9,672,567			4	%
Same market treatment growth in %		3.9	%		3.7	%
Net revenue in $ million		3,613			3,428			5	%		6	%
Gross profit as a % of revenue		32.1	%		32.9	%
Selling, general and administrative costs as a % of revenue		16.5	%		15.7	%
Net income attributable to shareholders of FMC-AG & Co. KGaA in $ million		263			289			(9	%)

(1)

For further information on "at constant exchange rates," see "Non-U.S. GAAP Measures—Constant currency" below.

        Treatments increased by 4% for the second quarter of 2013 as compared to the same period in 2012. The increase is due to same market treatment growth (4%) and acquisitions (2%), partially offset by the effect of closed or sold clinics (2%).

        At June 30, 2013, we owned, operated or managed (excluding those managed but not consolidated in the U.S.) 3,212 clinics compared to 3,123 clinics at June 30, 2012. During the second quarter of 2013, we acquired 15 clinics, opened 20 clinics and combined or closed 3 clinics. The number of patients treated in clinics that we own, operate or manage (excluding patients of clinics managed but not consolidated in the U.S.) increased by 3% to 264,290 at June 30, 2013 from 256,456 at June 30, 2012.

        Net dialysis care revenue increased by 5% (6% at constant exchange rates) to $2,743 million for the second quarter of 2013 from $2,605 million in the same period of 2012, mainly due to growth in same market treatments (4%), increases in organic revenue per treatment (1%) and contributions from acquisitions (1%), partially offset by the negative effect of exchange rate fluctuations (1%).

        Dialysis product revenue increased by 6% (an increase of 5% at constant exchange rates) to $870 million from $823 million in the same period of 2012. The increase at constant currency was driven by increased sales of hemodialysis products, especially of dialyzers, solutions and concentrates and bloodlines as well as products for acute care, partially offset by lower sales of renal pharmaceuticals.

        Net revenue increased by 5% (6% at constant exchange rates) for the second quarter of 2013 over the comparable period in 2012, due to growth in dialysis care and product revenues as discussed above.

        The decrease in gross profit margin is mainly the result of a decrease in the North America Segment. The decrease in the North America Segment was due to a lower commercial payor mix coupled with price reductions from commercial contracting and the impact from U.S. sequestration. Further, the margin was impacted by higher personnel expense, largely offset by modest reductions in pharmaceutical costs and increased revenue in the Expanded Services, however, at lower than average margins.

        Selling, general and administrative ("SG&A") expenses increased to $595 million in the second quarter of 2013 from $540 million in the same period of 2012. SG&A expenses as a percentage of revenues increased to 16.5% for the second quarter of 2013 in comparison with 15.7% during the same period of 2012 due to increased Corporate expenses as well as increases in the North America and International Segments. The percentage of revenue increase at Corporate was mainly due to increased legal and consulting expenses. The percentage of revenue increase in the North America Segment was largely driven by higher personnel expense, an unfavorable impact from U.S. sequestration and higher bad debt expense, partially offset by increased revenue from our Expanded Services. The percentage of revenue increase in the International Segment was due to unfavorable foreign exchange effects including the devaluation of the Venezuelan Bolivar driven by a hyperinflationary economy, partially offset by sales growth in EMEALA.

7

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

At June 30, 2013, we had a $8 million gain from the sale of FMC-AG & Co. KGaA dialysis clinics as compared to a $25 million gain in the same period of 2012 mainly in connection with divestitures required for regulatory clearance of the Liberty Acquisition, which occurred in the first quarter of 2012. (See Note 2 of the Notes to Consolidated Financial Statements (unaudited) "Acquisition of Liberty Dialysis Holdings—Divestitures" included in this Report).

        Operating income decreased to $544 million in the second quarter of 2013 from $589 million for the same period in 2012. Operating income margin decreased to 15.1% for the second quarter of 2013 from 17.2% for the same period in 2012 as a result of a decrease in gross profit margin, higher SG&A as a percentage of revenue and a lower gain on the sale of FMC-AG & Co. KGaA clinics, all as discussed above.

        The non-taxable investment gain of $127 million due to our acquisition of LD Holdings recorded in the first quarter of 2012 increased by $13 million in the second quarter of 2012 to a total of $140 million for the six months ended June 30, 2012. This increase is due to fair value re-measurements related to developments in the finalization of our acquisition accounting.

        Interest expense decreased by 6% to $110 million for the second quarter of 2013 from $117 million for the same period in 2012 mainly due to decreased debt. Interest income decreased to $7 million for the second quarter of 2013 from $13 million for the same period of 2012 due to the retirement of the loan receivable from Renal Advantage Partners LLC as part of the Liberty Acquisition on February 28, 2012.

        Income tax expense decreased to $144 million for the second quarter of 2013 from $172 million for the same period in 2012. The effective tax rate decreased to 32.6% from 34.6% for the same period of 2012 as a result of higher tax benefits related to internal financing, a lower tax expense on the gain from the sale of FMC-AG & Co. KGaA dialysis clinics in connection with the Liberty Acquisition and higher noncontrolling interest in North America.

        Net income attributable to shareholders of FMC-AG & Co. KGaA for the second quarter of 2013 decreased to $263 million from $289 million for the same period in 2012 as a result of the items discussed above.

        We employed 87,944 people (full-time equivalents) at June 30, 2013 compared to 84,194 at June 30, 2012, an increase of 4.5%, primarily due to overall growth in our business and acquisitions.

        The following discussions pertain to the North America Segment and the International Segment and the measures we use to manage these segments.

North America Segment

Key Indicators for North America Segment

	For the three months ended June 30,
							Change in %
	2013			2012
Number of treatments		6,383,556			6,141,414			4	%
Same market treatment growth in %		3.8	%		3.6	%
Net revenue in $ million		2,375			2,249			6	%
Depreciation and amortization in $ million		81			79			3	%
Operating income in $ million		394			431			(9	%)
Operating income margin in %		16.6	%		19.2	%

Revenue

        Treatments increased by 4% for the second quarter of 2013 as compared to the same period in 2012 mostly due to same market treatment growth (4%) and contributions from acquisitions (1%), partially offset by the effect of closed or sold clinics (1%). At June 30, 2013, 168,160 patients (a 3% increase over June 30, 2012) were being treated in the 2,104 clinics that we own or operate in the North America Segment, compared to 164,058 patients treated in 2,046 clinics at June 30, 2012. Average North America

8

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

revenue per treatment, which includes Canada and Mexico, before bad debt expense, was $347 for the second quarter of 2013 and $344 for the same period in 2012. In the U.S., the average revenue per treatment was $355 for the second quarter of 2013 in comparison to $351 for the same period in 2012. The increase was mainly attributable to increased revenue driven by further development of our Expanded Services and the updated Medicare reimbursement rate which came into effect in 2013, partially offset by the unfavorable impact from U.S. sequestration, an unfavorable commercial payor mix coupled price reductions from commercial contracting and reduced pharmaceutical utilization in non-bundled commercial treatments.

        The dialysis care revenue increase was driven by same market treatment growth (4%), increases in organic revenue per treatment (1%) and contributions from acquisitions (1%).

        The dialysis product revenue increase was driven by higher sales of dialyzers.

        Net revenue for the North America Segment for the second quarter of 2013 increased as a result of an increase in dialysis care revenue by 6% to $2,157 million from $2,043 million in the same period of 2012 and an increase in dialysis product revenue to $218 million from $206 million.

Operating Income

        Operating income decreased to $394 million for the second quarter of 2013 from $431 million for the same period in 2012. Operating income margin decreased to 16.6% for the second quarter of 2013 from 19.2% for the same period in 2012. The decrease in the North America Segment was due to a lower commercial payor mix coupled with price reductions from commercial contracting, the impact from U.S. sequestration and higher personnel expense, which was largely offset by modest reductions in pharmaceutical costs and increased revenue in the Expanded Services, however, at lower than average margins. Further, the margin was impacted by a lower gain on the sale of FMC-AG & Co. KGaA clinics related to the Liberty Acquisition. Cost per treatment for North America increased to $286 for the quarter ended June 30, 2013 from $275 in 2012. Cost per treatment in the U.S. increased to $291 for the quarter ended June 30, 2013 from $280 in the same period of 2012.

International Segment

Key Indicators for International Segment

	For the three months ended June 30,						Change in %
							as reported			at constant exchange rates(1)
	2013			2012
Number of treatments		3,682,841			3,531,153			4	%
Same market treatment growth in %		4.0	%		3.9	%
Net revenue in $ million		1,228			1,171			5	%		6	%
Depreciation and amortization in $ million		46			43			6	%
Operating income in $ million		209			207			1	%
Operating income margin in %		17.0	%		17.7	%

(1)

For further information on "at constant exchange rates," see "Non-U.S. GAAP Measures—Constant currency" below.

Revenue

        Treatments increased by 4% for the second quarter of 2013 over the same period in 2012 mainly due to same market treatment growth (4%) and contributions from acquisitions (2%), partially offset by the effect of closed or sold clinics (2%). At June 30, 2013, we had 96,130 patients (a 4% increase over June 30, 2012) being treated at the 1,108 clinics that we own, operate or manage in the International Segment compared to 92,398 patients treated at 1,077 clinics at June 30, 2012. Average revenue per treatment for the second quarter of 2013 remained constant at $159 as compared to the same period in 2012 due to increased reimbursement rates and changes in country mix ($4), offset by the weakening of local currencies against the U.S. dollar ($4).

9

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

        Including the effects of acquisitions, European region revenue increased 4% (3% increase at constant exchange rates), Latin America region revenue increased 11% (18% at constant exchange rates), and Asia-Pacific region revenue increased 3% (4% at constant exchange rates).

        Total dialysis care revenue for the International Segment increased during the second quarter of 2013 by 4% (7% increase at constant exchange rates) to $586 million from $562 million in the same period of 2012. This increase is a result of same market treatment growth (4%), contributions from acquisitions (4%) and increases in organic revenue per treatment (1%), partially offset by the negative effect of exchange rate fluctuations (3%) and the effect of closed or sold clinics (2%).

        Total dialysis product revenue for the second quarter of 2013 increased by 5% (5% increase at constant exchange rates) to $642 million from $609 million in the same period of 2012. This increase at constant currency was due to increased sales of hemodialysis products, especially of solutions and concentrates, bloodlines and dialyzers as well as products for acute care and peritoneal dialysis, partially offset by lower sales of renal pharmaceuticals.

        Net revenues for the International Segment for the second quarter of 2013 increased by 5% (6% increase at constant exchange rates) as compared to the same period in 2012 mainly as a result of increases in both dialysis care and dialysis product revenues. Organic growth during the period was 5% and acquisitions during the period contributed 2%, partially offset by the negative effect of exchange rate fluctuations (1%) and the effect of closed or sold clinics (1%).

Operating Income

        Operating income increased to $209 million for the second quarter of 2013 from $207 million for the same period in 2012. Operating income margin decreased to 17.0% for the second quarter of 2013 from 17.7% for the same period in 2012 mainly due to unfavorable foreign exchange effects including the devaluation of the Venezuelan Bolivar driven by a hyperinflationary economy.

Six months ended June 30, 2013 compared to six months ended June 30, 2012

Consolidated Financials

Key Indicators for Consolidated Financial Statements

	For the six months ended June 30,						Change in %
							as reported			at constant exchange rates(1)
	2013			2012
Number of treatments		19,747,907			18,885,213			5	%
Same market treatment growth in %		3.6	%		3.8	%
Net revenue in $ million		7,076			6,677			6	%		6	%
Gross profit as a % of revenue		32.0	%		32.9	%
Selling, general and administrative costs as a % of revenue		16.8	%		16.4	%
Net income attributable to shareholders of FMC-AG & Co. KGaA in $ million		488			660			(26	%)

(1)

For further information on "at constant exchange rates," see "Non-U.S. GAAP Measures—Constant currency" below.

        Treatments increased by 5% for the six months ended June 30, 2013 as compared to the same period in 2012. The increase is due to same market treatment growth (4%), the Liberty Acquisition, net of the divestitures (2%) and other acquisitions (2%), partially offset by the effect of closed or sold clinics (2%) and a decrease in dialysis treatment days (1%).

        Dialysis care revenue increased by 7% to $5,422 million (7% at constant exchange rates) for the six-months ended June 30, 2013 from $5,082 million in the same period of 2012, mainly due to growth in same market treatments (4%), contributions from acquisitions (4%), and increases in organic revenue per

10

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

treatment (1%), partially offset by a decrease in dialysis treatment days (1%) and the effect of closed or sold clinics (1%).

        Dialysis product revenue increased by 4% (4% increase at constant exchange rates) to $1,654 million compared to $1,595 million in the same period of 2012. The increase at constant currency was driven by increased sales of hemodialysis products, especially of dialyzers, solutions and concentrates and bloodlines as well as products for acute care, partially offset by lower sales of renal pharmaceuticals.

        Net revenue increased by 6% (6% at constant exchange rates) for the six months ended June 30, 2013 over the comparable period in 2012 due to growth in both dialysis care revenues and dialysis product revenues as discussed above.

        The decrease in gross profit margin mostly reflects decreases in both the North America Segment and the International Segment. The decrease in the North America Segment was due to a lower commercial payor mix coupled with price reductions from commercial contracting and the impact from U.S. sequestration. Further, the margin was impacted by higher personnel expense, which was largely offset by modest reductions in pharmaceutical costs and increased revenue in the Expanded Services, however, at lower than average margins. The decrease in the International Segment was due to cost increases in various countries and an unfavorable impact from lower business growth in Asia-Pacific.

        SG&A expenses increased to $1,187 million in the six-months ended June 30, 2013 from $1,092 million in the same period of 2012. SG&A expenses as a percentage of sales increased to 16.8% for the first six months of 2013 in comparison with 16.4% in the same period of 2012 due to an unfavorable impact from Corporate and an increase in the International Segment. The percentage of revenue increase at Corporate was due to increased legal and consulting expenses. The percentage of revenue increase in the International Segment was driven by unfavorable foreign exchange effects including devaluation of the Venezuelan Bolivar due to a hyperinflationary economy, partially offset by sales growth in EMEALA.

        For the six months ended 2013, we had an $8 million gain from the sale of FMC-AG & Co. KGaA dialysis clinics in our North America Segment as well as a $1 million gain in the International Segment as compared to a $34 million gain in the same period of the prior year mainly in connection with divestitures required for regulatory clearance of the Liberty Acquisition, which occurred in the first quarter of 2012. (See Note 2 of the Notes to Consolidated Financial Statements (unaudited) "Acquisition of Liberty Dialysis Holdings—Divestitures" included in this Report).

        Operating income decreased to $1,038 million for the six-months ended June 30, 2013 from $1,092 million for the same period in 2012. Operating income margin decreased to 14.7% for the six-month ended June 30, 2013 as compared to 16.4% for the same period in 2012 as a result of the decrease in gross profit margin, a lower gain on the sale of FMC-AG & Co. KGaA clinics and higher SG&A as a percentage of revenue, all as discussed above.

        The investment gain in the first six months of 2012 of $140 million, which was non-taxable, was due to the fair valuation of our investment in Renal Advantage Partners, LLC at the time of the Liberty Acquisition. This gain was finalized at December 31, 2012.

        Interest expense decreased by 5% to $224 million for the six months ended June 30, 2013 from $236 million for the same period in 2012 due to decreased debt and lower interest rates due to the expiration of interest rates swaps at the end of the first quarter of 2012. Interest income decreased to $17 million for the six months ended June 30, 2013 from $33 million for the same period in 2012 mainly as a result of the retirement of the loan receivable from Renal Advantage Partners LLC as part of the Liberty Acquisition on February 28, 2012.

        Income tax expense decreased to $273 million for the six-months ended June 30, 2013 from $309 million for the same period in 2012. The effective tax rate increased to 32.8% from 30.1% for the same period of 2012, as a result of the non-taxable investment gain in 2012, partially offset by a lower tax expense on the gain from the sale of FMC-AG & Co. KGaA dialysis clinics in connection with the Liberty Acquisition and higher noncontrolling interest in North America.

11

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

        Net income attributable to noncontrolling interests for the second quarter of 2013 increased to $70 million from $60 million for the same period of 2012 primarily due to losses attributable to noncontrolling interests in the International Segment in 2012 and the non-controlling interest associated with the Liberty Acquisition which closed on February 28, 2012.

        Net income attributable to FMC-AG & Co. KGaA for the six months ended June 30, 2013 decreased to $488 million from $660 million for the same period in 2012 as a result of the combined effects of the items discussed above.

        The following discussions pertain to the North America Segment and the International Segment and the measures we use to manage these segments.

North America Segment

Key Indicators for North America Segment

	For the six months ended June 30,
							Change in %
	2013			2012
Number of treatments		12,532,406			11,887,400			5	%
Same market treatment growth in %		3.7	%		3.5	%
Net revenue in $ million		4,662			4,353			7	%
Depreciation and amortization in $ million		161			151			7	%
Operating income in $ million		763			779			(2	%)
Operating income margin in %		16.4	%		17.9	%

Revenue

        Treatments increased by 5% for the six months ended June 30, 2013 as compared to the same period in 2012 mostly due to same market treatment growth (4%), the Liberty Acquisition, net of divestitures (3%) and contributions from other acquisitions (1%), partially offset by a decrease in dialysis treatment days (2%) and the effect of closed or sold clinics (1%). Average North America revenue per treatment, which includes Canada and Mexico, before bad debt expense, was $349 for the six months ended June 30, 2013 and $345 in the same period in 2012. In the U.S., the average revenue per treatment was $357 for the six months ended June 30, 2013 and $352 for the same period in 2012. The increase was mainly attributable to further development of our Expanded Services and the updated Medicare reimbursement rate which came into effect in 2013, partially offset by reduced pharmaceutical utilization in non-bundled commercial treatments reimbursed by commercial payors, the unfavorable impact from U.S. sequestration and an unfavorable commercial payor mix coupled price reductions from commercial contracting.

        The dialysis care revenue increase was driven by same market treatment growth (4%), contributions from acquisitions (4%), and increases in organic revenue per treatment (1%), partially offset by the effect of closed or sold clinics (1%).

        The dialysis product revenue increase was driven by higher sales of dialyzers, partially offset by lower sales of renal pharmaceuticals.

        Net revenue for the North America segment for the first six months of 2013 increased as a result of an increase in dialysis care revenue by 8% to $4,261 million from $3,960 million in the same period of 2012 as well as an increase in dialysis product revenue by 2% to $401 million from $393 million in the first six months of 2012.

Operating Income

        Operating income decreased to $763 million for the six-months ended June 30, 2013 from $779 million for the same period in 2012. Operating income margin decreased to 16.4% for the six months ended June 30, 2013 from 17.9% for the same period in 2012, due to a lower commercial payor mix coupled with price reductions from commercial contracting, the impact from U.S. sequestration and higher personnel expense, largely offset by modest reductions in pharmaceutical costs and increased revenue in the

12

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

expanded services, however, at lower than average margins. The margin was further impacted by a lower gain on the sale of FMC-AG & Co. KGaA clinics related to the Liberty Acquisition and increased legal expenses, partially offset by, one-time costs related to the Liberty Acquisition in 2012 as well as the overall impact from the Liberty Acquisition. Cost per treatment for North America increased to $287 for the first six months of 2013 as compared to $277 the same period of 2012. Cost per treatment in the U.S. increased to $293 for the first six months of 2013 from $283 in the same period of 2012.

International Segment

Key Indicators for International Segment

	For the six months ended June 30,						Change in %
							as reported			at constant exchange rates(1)
	2013			2012
Number of treatments		7,215,501			6,997,813			3	%
Same market treatment growth in %		3.5	%		4.3	%
Net revenue in $ million		2,397			2,307			4	%		5	%
Depreciation and amortization in $ million		91			86			6	%
Operating income in $ million		393			402			(2	%)
Operating income margin in %		16.4	%		17.4	%

(1)

For further information on "at constant exchange rates," see "Non-U.S. GAAP Measures—Constant currency" below.

Revenue

        Treatments increased by 3% for the six months ended June 30, 2013 over the same period in 2012 mainly due to same market treatment growth (4%) and contributions from acquisitions (2%), partially offset by the effect of closed or sold clinics (2%) and a decrease in dialysis treatment days (1%). Average revenue per treatment for the six months ended June 30, 2013 increased to $161 in comparison with $160 for the same period of 2012 due to increased reimbursement rates and changes in country mix ($5), partially offset by weakening of local currencies against the U.S. dollar ($4).

        Including the effects of acquisitions, European region revenue increased 3% (2% increase at constant exchange rates), Latin America region revenue increased 7% (15% at constant exchange rates), and Asia-Pacific region revenue increased 4% (5% at constant exchange rates).

        Total dialysis care revenue for the International Segment increased during the six months ended June 30, 2013 by 3% (6% increase at constant exchange rates) to $1,161 million from $1,122 million in the same period of 2012. This increase is a result of same market treatment growth (4%), contributions from acquisitions (3%) and increases in organic revenue per treatment (2%), partially offset by the negative effect of exchange rate fluctuations (3%), the effect of closed or sold clinics (2%) and a decrease in dialysis treatment days (1%).

        Total dialysis product revenue for the six months ended June 30, 2013 increased by 4% (4% increase at constant exchange rates) to $1,236 million compared to $1,185 million in the same period of 2012. The 4% increase in product revenue at constant currency was driven by increased sales of hemodialysis products, especially of solutions and concentrates, dialyzers, bloodlines and products for acute care treatments, partially offset by lower sales of renal pharmaceuticals and machines.

        Net revenues for the International Segment for the six months ended June 30, 2013 increased by 4% (5% at constant exchange rates) as compared to the same period in 2012 mainly as a result of increases in both dialysis care and dialysis product revenues, as discussed above. Organic growth during the period was 5% and acquisitions during the period contributed 1%, partially offset by the negative effect of exchange rate fluctuations (1%), and the effect of closed or sold clinics (1%).

13

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

Operating Income

        Operating income decreased to $393 million for the six months ended June 30, 2013 from $402 million for the same period in 2012. Operating income margin decreased to 16.4% for the six months ended June 30, 2013 from 17.4% for the same period in 2012 due to unfavorable foreign exchange effects including the devaluation of the Venezuelan Bolivar as a result of a hyperinflationary economy and various cost increases.

Inflationary Accounting

        As we are subject to foreign exchange risk, we monitor the economic conditions of the countries in which we operate. Venezuela has been considered a hyperinflationary economy since 2010. In November 2012, the SEC Regulations Committee reaffirmed this status. Effective January 1, 2013 our operations in Venezuela are still considered to be operating in a hyperinflationary economy, as the Venezuelan economy exceeded the three-year cumulative inflation rate of 100% during the fourth quarter of 2012. We use a blend of the National Consumer Price Index and the Consumer Price Index to determine whether Venezuela is a hyperinflationary economy. As a result, our financial statements of our subsidiaries operating in Venezuela continue to use the U.S dollar as their functional currency. However, in 2013, the Venezuelan government revalued the Bolivar. Consequently, we recorded a pre-tax loss of $11.5 million for the first half of 2013.

Liquidity and Capital Resources

Six months ended June 30, 2013 compared to six months ended June 30, 2012

Liquidity

        Our primary sources of liquidity are typically cash from operations, cash from borrowings from third parties and related parties, as well as cash from issuance of debt and equity securities. We require this capital primarily to finance working capital needs, to fund acquisitions and joint ventures, to develop free-standing renal dialysis centers, to purchase equipment for existing or new renal dialysis centers and production sites, to repay debt and to pay dividends as well as the repurchasing of shares.

        At June 30, 2013, we had cash and cash equivalents of $586 million. For information regarding utilization and availability under our principal credit facility (the "2012 Credit Agreement"), see Note 6 of the Notes to Consolidated Financial Statements (unaudited), "Long-term Debt and Capital Lease Obligations," included in this report.

Operations

        In the first six months of 2013 and 2012, we generated net cash from operations of $841 million and $932 million, respectively. Cash from operations is impacted by the profitability of our business, the development of our working capital, principally receivables, and cash outflows that occur due to a number of specific items as discussed below. The decrease in 2013 versus 2012 was mainly a result of a $100 million payment, partially offset by repayments received, both of which were associated with the amendment to the license agreement relating to our iron product Venofer^® (see Item 5, "Operating and Financial Review and Prospects—Results of Operations—Year ended December 31, 2012 compared to the year ended December 31, 2011" in our Annual Report on Form 20-F for the year ended December 31, 2012) and unchanged days sales outstanding ("DSO") as compared to a 3 day decrease of DSO in the same period of 2012, partially offset by a favorable development of other working capital items.

        The profitability of our business depends significantly on reimbursement rates. Approximately 77% of our revenues are generated by providing dialysis services, a major portion of which is reimbursed by either public health care organizations or private insurers. For the six months ended June 30, 2013, approximately 32% of our consolidated revenues were attributable to U.S. federal health care benefit programs, such as Medicare and Medicaid reimbursement. Legislative changes could affect Medicare reimbursement rates for a significant portion of the services we provide, as well as the scope of Medicare coverage. A decrease in reimbursement rates or the scope of coverage could have a material adverse effect on our business,

14

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

financial condition and results of operations and thus on our capacity to generate cash flow. With the exception of the implementation of the ESRD PPS in the U.S. in January 2011, the U.S. federal government sequestration cuts and the current proposal to reduce reimbursement under the ESRD PPS effective January 1, 2014 to account for the decline in utilization of certain drugs and biologicals associated with dialysis, we have experienced and also expect in the future to experience generally stable reimbursements for dialysis services. This includes the balancing of unfavorable reimbursement changes in certain countries with favorable changes in other countries.

        Our working capital, which is defined as current assets less current liabilities, was $2,744 million at June 30, 2013 which decreased from $2,957 million at December 31, 2012. The change is primarily the result of reclassifications of the payments relating the maturity of two of our European Investment Bank ("EIB") Agreements, quarterly repayments of our term loan facility under the 2012 Credit Agreement from long-term debt to the current portion of long-term debt, a decrease in cash and a reclassification of a loan with a related party from long-term debt to short-term borrowings, partially offset by a reduction in accounts payable driven by the payment of the $100 million Venofer® agreement amendment fee incurred in 2012. Our ratio of current assets to current liabilities was 1.8 at June 30, 2013.

        We intend to continue to address our current cash and financing requirements by the generation of cash from operations, our existing and future credit agreements, and the issuance of debt securities. In addition, when funds are required for acquisitions or to meet other needs, we expect to successfully complete long-term financing arrangements, such as the issuance of senior notes, see "Financing" below. We aim to preserve financial resources with a minimum of $300 to $500 million of committed and unutilized credit facilities.

        Cash from operations depends on the collection of accounts receivable. Commercial customers and governments generally have different payment cycles. A lengthening of their payment cycles could have a material adverse effect on our capacity to generate cash flow. In addition, we could face difficulties in enforcing and collecting accounts receivable under some countries' legal systems and due to the economic conditions in some countries. Accounts receivable balances, net of valuation allowances, represented DSO of approximately 76 at both June 30, 2013 and December 31, 2012.

        DSO by segment is calculated by dividing the segment's accounts receivable, as converted to U.S. dollars using the average exchange rate for the period presented, less any value added tax included in the receivables, by the average daily sales for the last twelve months of that segment, as converted to U.S. dollars using the average exchange rate for the period. Receivables and sales are adjusted for amounts related to significant acquisitions made during the periods presented. The development of DSO by reporting segment is shown in the table below:

	June 30, 2013		December 31, 2012
North America days sales outstanding		54		55
International days sales outstanding		116		115
FMC-AG & Co. KGaA average days sales outstanding		76		76

        DSO remained stable. The slight decrease in the North America Segment was offset by a slight increase in the International Segment between December 31, 2012 and June 30, 2013. The decrease in North America is due to continued strong cash performance across all payor groups. The International Segment's DSO slight increase reflects slight payment delays, particularly in countries with budget deficits. Due to the fact that a large portion of our reimbursement is provided by public health care organizations and private insurers, we expect that most of our accounts receivable will be collectible, albeit slightly more slowly in the International Segment in the immediate future.

        Tax or other items we have identified that will or could impact our financial results and cash flows from operations in the future are as follows:

        We filed claims for refunds contesting the Internal Revenue Service's ("IRS") disallowance of FMCH's civil settlement payment deductions taken by FMCH in prior year tax returns. As a result of a

15

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

settlement agreement with the IRS, we received a partial refund in September 2008 of $37 million, inclusive of interest and preserved our right to pursue claims in the United States Courts for refunds of all other disallowed deductions, which totaled approximately $126 million. On December 22, 2008, we filed a complaint for complete refund in the United States District Court for the District of Massachusetts, styled as Fresenius Medical Care Holdings, Inc. v. United States. On August 15, 2012, a jury entered a verdict for FMCH granting additional deductions of $95 million. On May 31, 2013, the District Court entered final judgment for FMCH in the amount of $50.4 million. On July 18, 2013, the District Court denied the IRS's post trial motion seeking to set aside the verdict and judgment and closed the file. The IRS may appeal to the Court of Appeals for the First Circuit (Boston).

Investing

        We used net cash of $403 million and $1,794 million in investing activities in the six-month periods ended June 30, 2013 and 2012, respectively.

        Capital expenditures for property, plant and equipment, net of disposals were $319 million and $274 million in the first six months of 2013 and 2012, respectively. In the first six months of 2013, capital expenditures were $174 million in the North America Segment, $80 million for the International Segment and $65 million at Corporate. Capital expenditures in the first six months of 2012 were $132 million in the North America Segment, $80 million for the International Segment and $62 million at Corporate. The majority of our capital expenditures was used for maintaining existing clinics, equipping new clinics, maintenance and expansion of production facilities, primarily in Germany, North America and France and capitalization of machines provided to our customers, primarily in the International Segment. Capital expenditures were approximately 5% of total revenue in the first six months of 2013 as compared to 4% for the same period in 2012.

        We invested approximately $102 million cash in the first six months of 2013, $45 million in the North America Segment and $57 million in the International Segment. We received approximately $18 million for divestitures in 2013 largely due to the sale of the final clinic for regulatory clearance of the Liberty Acquisition. In the first six months of 2012, we invested approximately $1,748 million cash primarily through the $1,455 million acquisition of Liberty, net of divestitures ($1,730 million in the North America Segment and $17 million in the International Segment and $1 million at Corporate).

        We anticipate capital expenditures of approximately $0.7 billion and expect to make acquisitions of approximately $0.5 billion in 2013. See "Outlook" below.

Financing

        Net cash used in financing was $524 million in the first six months of 2013 compared to net cash provided by financing of $1,089 million in the first six months of 2012, respectively.

        In the six-month period ended June 30, 2013, cash was used in the payment of dividends, the purchase of our shares through the share buyback program, distributions to noncontrolling interests as well as the repayment of portions of long-term debt and short-term borrowings, partially offset by proceeds from long-term and short-term borrowings as well as drawings on the accounts receivable facility. In the first six months of 2012, cash was provided by the issuance of senior notes and short-term borrowings, partially offset by, repayment of long-term debt, the accounts receivable facility, borrowings from related parties as well as the payment of dividends.

        On May 17, 2013, we paid a dividend with respect to 2012 of €.75 per ordinary share (for 2011 paid in 2012 €.69) and €.77 per preference share (for 2011 paid in 2012: €.71). The total dividend payment was €230 million ($296 million) as compared with €210 million ($272 million) in the prior year.

        On May 16, 2013, we held the Annual General Meeting and the separate Preference Shareholder Meeting during which resolutions on the conversion of the preference shares to ordinary shares were passed. The preference share conversion was affected on June 28, 2013 with 3,975,533 preference shares in the amount of €3.9 million ($4.5 million) converted on a 1:1 basis to ordinary shares. In addition, 32,006 options associated with the preference shares were converted for options associated with ordinary shares.

16

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

        On July 5, 2013, we received a €27 million ($35 million) premium from the largest preference shareholder for the conversion of their preference shares to ordinary shares. At June 30, 2013, this amount was recorded as a short-term receivable with a corresponding increase recorded in equity.

        Additionally, we announced the share buy-back program. We intend to repurchase ordinary shares in an aggregate value of up to €385 million (approximately $500 million). This program is expected to run into the third quarter of 2013. At June 30, 2013, 3,580,807 shares were repurchased in the amount of €190 million ($249 million). These shares are restricted treasury stock which means there are no associated dividends or voting rights. These treasury shares will be used to serve the sole purposes of either reducing our registered share capital by cancellation of the acquired shares, or fulfilling our employee participation programs.

Non-U.S. GAAP Measures

Constant currency

        Changes in revenue include the impact of changes in foreign currency exchange rates. We use the non-GAAP financial measure "at constant exchange rates" in our filings to show changes in our revenue without giving effect to period-to-period currency fluctuations. Under U.S. GAAP, revenues received in local (non-U.S. dollar) currency are translated into U.S. dollars at the average exchange rate for the period presented. When we use the term "constant currency," it means that we have translated local currency revenues for the current reporting period into U.S. dollars using the same average foreign currency exchange rates for the conversion of revenues into U.S. dollars that we used to translate local currency revenues for the comparable reporting period of the prior year. We then calculate the change, as a percentage, of the current period revenues using the prior period exchange rates versus the prior period revenues. This resulting percentage is a non-GAAP measure referring to a change as a percentage "at constant exchange rates."

        We believe that revenue growth is a key indication of how a company is progressing from period to period and that the non-GAAP financial measure constant currency is useful to investors, lenders, and other creditors because such information enables them to gauge the impact of currency fluctuations on a company's revenue from period to period. However, we also believe that the usefulness of data on constant currency period-over-period changes is subject to limitations, particularly if the currency effects that are eliminated constitute a significant element of our revenue and significantly impact our performance. We therefore limit our use of constant currency period-over-period changes to a measure for the impact of currency fluctuations on the translation of local currency revenue into U.S. dollars. We do not evaluate our results and performance without considering both constant currency period-over-period changes in non-U.S. GAAP revenue on the one hand and changes in revenue prepared in accordance with U.S. GAAP on the other. We caution the readers of this report to follow a similar approach by considering data on constant currency period-over-period changes only in addition to, and not as a substitute for or superior to, changes in revenue prepared in accordance with U.S. GAAP. We present the fluctuation derived from U.S. GAAP revenue next to the fluctuation derived from non-GAAP revenue. Because the reconciliation is inherent in the disclosure, we believe that a separate reconciliation would not provide any additional benefit.

Debt covenant disclosure—EBITDA

        EBITDA (earnings before interest, tax, depreciation and amortization expenses) was approximately $1,353 million, 19.1% of revenues for the six-month period ended June 30, 2013, and $1,386 million, 20.8% of revenues for the same period of 2012. EBITDA is the basis for determining compliance with certain covenants contained in our 2012 Credit Agreement, euro-denominated notes, EIB agreements, and the indentures relating to our senior notes. You should not consider EBITDA to be an alternative to net earnings determined in accordance with U.S. GAAP or to cash flow from operations, investing activities or financing activities. In addition, not all funds depicted by EBITDA are available for management's discretionary use. For example, a substantial portion of such funds are subject to contractual restrictions and functional requirements for debt service, to fund necessary capital expenditures and to meet other

17

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

commitments from time to time as described in more detail elsewhere in this report. EBITDA, as calculated, may not be comparable to similarly titled measures reported by other companies.

Reconciliation of EBITDA to net cash provided by (used in) operating activities

        A reconciliation of EBITDA to net cash provided by (used in) operating activities, which we believe to be the most directly comparable U.S GAAP financial measure, is calculated as follows:

	For the six months ended June 30,
	2013			2012
	($ in millions)
Total EBITDA	$	1,353		$	1,386
Interest expense (net of interest income)		(207	)		(203	)
Income tax expense, net		(273	)		(309	)
Change in deferred taxes, net		(7	)		65
Changes in operating assets and liabilities		(43	)		(2	)
Stock compensation expense		13			13
Other items, net		5			(18	)
Net cash provided by (used in) operating activities	$	841		$	932

Balance Sheet Structure

        Total assets as of June 30, 2013 remained constant at $22.3 billion as compared to December 31, 2012. Current assets as a percent of total assets increased by 1% to 28% at June 30, 2013 as compared to 27% at December 31, 2012. The equity ratio, the ratio of our equity divided by total liabilities and shareholders' equity, remained constant at 41% at June 30, 2013 as compared to December 31, 2012.

Outlook

        Below is a table showing our growth outlook for 2013:

	2013
Revenue	> $14.6 billion
Revenue growth	> 6%
Operating Income	$2.3 - $2.4 billion
Net Income attributable to shareholders of FMC-AG & Co. KGaA	$1.1 - $1.15 billion
Capital Expenditures	~$0.7 billion
Acquisitions	~$0.5 billion
Debt/EBITDA Ratio	£ 3.0

        The Outlook above is confirmed and has been substantiated for the potential impact of the U.S. Sequestration on our business performance. Net income attributable to shareholders of FMC-AG & Co. KGaA represents an increase of between 5% and 10% if compared to the net income attributable to shareholders of FMC-AG & Co. KGaA for 2012 excluding an investment gain in the amount of $140 million.

Recently Adopted Accounting Pronouncements

        On January 31, 2013, FASB issued Accounting Standards Update 2013-01 ("ASU 2013-01") an update to Balance Sheet (Topic 210), Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities

18

FRESENIUS MEDICAL CARE AG & Co. KGaA

Interim Report of Financial Condition and Results of Operations
for the three and six months ended June 30, 2013 and 2012

("Topic 210"). The main purpose of ASU 2013-01 is to clarify the scope of balance sheet offsetting under Topic 210 to include derivatives, repurchase agreements and reverse repurchase agreements, and securities borrowing and securities lending transactions that are offset or subject to master netting agreements. The disclosures required under Topic 210 would apply to these transactions and other types of financial assets or liabilities will no longer be subject to Topic 210. The update is effective for periods beginning on or after January 1, 2013. The Company does not utilize balance sheet offsetting for their derivative transactions. See Note 12, "Financial Instruments" in our Consolidated Financial Statements included in this report for more information.

Recently Issued Accounting Pronouncements

        On February 28, 2013 FASB issued Accounting Standards Update 2013-04 ("ASU 2013-04") Liabilities (Topic 405), Obligations Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligations is Fixed at the Reporting Date." ASU 2013-04's objective is to provide guidance and clarification on the recognition, measurement and disclosure of obligations resulting from joint and several liability arrangements such as debt arrangements, other contractual obligations and settled litigation and judicial rulings. The update is effective for periods beginning on or after December 15, 2013. We are currently evaluating the impact of ASU 2013-04 on our Consolidated Financial Statements.

        On March 4, 2013 FASB issued Accounting Standards Update 2013-05 ("ASU 2013-05") Foreign Currency Matters (Topic 830), Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity. The purpose of 2013-05 is to provide clarification and further refinement regarding the treatment of the release of a cumulative translation adjustment into net income. This occurs in instances where the parent either sells a part or all of its investment in a foreign entity. Another possibility is if a company no longer holds a controlling interest in a subsidiary or group of assets that is a nonprofit activity or business within a foreign entity. The update is effective for periods beginning on or after December 15, 2013. We are currently evaluating the impact of ASU 2013-05 on our Consolidated Financial Statements.

        On July 17, 2013, FASB issued Accounting Standards Update 2013-10 ("ASU 2013-10") Derivatives and Hedging (Topic 815), Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes. The purpose of 2013-10 is to provide the inclusion of the Fed Funds Effective Swap Rate as a U.S. benchmark interest rate for hedge accounting purposes. This rate will now be available to use along with the U.S. government interest rates and the London Interbank Offered Rate. This update is effective prospectively for new or designated hedging relationships entered into on or after July 17, 2013. Currently, we do not intend to utilize the newly available Fed Funds Effective Swap Rate for our hedge accounting.

        On July 18, 2013, FASB issued Accounting Standards Update 2013-11 ("ASU 2013-11") Income Taxes (Topic 740) Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists. The purpose of ASU 2013-11 is to align the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists. In most cases, the unrecognized tax benefit should be presented as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward. The update is effective for periods beginning on or after December 15, 2013. We are currently evaluating the impact of ASU 2013-11 on our Consolidated Financial Statements.

19

FRESENIUS MEDICAL CARE AG & Co. KGaA

Consolidated Statements of Income

(unaudited)

(in thousands, except share data)

	For the three months ended June 30,						For the six months ended June 30,
	2013			2012			2013			2012
Revenue:
Dialysis Care	$	2,811,244		$	2,675,422		$	5,553,179		$	5,219,481
Less: Patient service bad debt provision		67,798			70,303			131,547			137,162
Net Dialysis Care		2,743,446			2,605,119			5,421,632			5,082,319
Dialysis Products		869,069			822,854			1,654,804			1,594,409
		3,612,515			3,427,973			7,076,436			6,676,728
Costs of revenue:
Dialysis Care		2,057,342			1,913,947			4,041,566			3,745,073
Dialysis Products		396,800			387,152			766,979			735,272
		2,454,142			2,301,099			4,808,545			4,480,345
Gross profit		1,158,373			1,126,874			2,267,891			2,196,383
Operating (income) expenses:
Selling, general and administrative		595,356			539,616			1,187,070			1,092,448
Gain on sale of dialysis clinics		(7,727	)		(24,647	)		(8,800	)		(33,961	)
Research and development		30,921			26,938			61,293			55,460
Income from equity method investees		(4,416	)		(3,858	)		(9,224	)		(9,355	)
Operating income		544,239			588,825			1,037,552			1,091,791
Other (income) expense:
Investment gain		—			(12,915	)		—			(139,600	)
Interest income		(6,653	)		(12,496	)		(17,242	)		(32,802	)
Interest expense		109,704			116,691			224,522			235,877
Income before income taxes		441,188			497,545			830,272			1,028,316
Income tax expense		143,613			172,241			272,614			309,318
Net income		297,575			325,304			557,658			718,998
Less: Net income attributable to noncontrolling interests		35,051			35,967			69,635			59,163
Net income attributable to shareholders of FMC-AG & Co. KGaA	$	262,524		$	289,337		$	488,023		$	659,835
Basic income per ordinary share	$	0.86		$	0.95		$	1.59		$	2.17
Fully diluted income per ordinary share	$	0.85		$	0.94		$	1.59		$	2.15

See accompanying notes to unaudited consolidated financial statements.

20

FRESENIUS MEDICAL CARE AG & Co. KGaA

Consolidated Statements of Comprehensive Income

(unaudited)

(in thousands, except share data)

	For the three months ended June 30,						For the six months ended June 30,
	2013			2012			2013			2012
Net Income	$	297,575		$	325,304		$	557,658		$	718,998
Gain (loss) related to cash flow hedges		3,993			12,525			19,890			8,242
Actuarial gain (loss) on defined benefit pension plans		6,385			4,370			12,777			8,743
Gain (loss) related to foreign currency translation		(59,174	)		(168,412	)		(127,362	)		(47,616	)
Income tax (expense) benefit related to components of other comprehensive income		(3,232	)		(4,977	)		(9,914	)		(23,958	)
Other comprehensive income (loss), net of tax		(52,028	)		(156,494	)		(104,609	)		(54,589	)
Total comprehensive income	$	245,547		$	168,810		$	453,049		$	664,409
Comprehensive income attributable to noncontrolling interests		34,715			35,212			67,317			59,249
Comprehensive income attributable to shareholders of FMC-AG & Co. KGaA	$	210,832		$	133,598		$	385,732		$	605,160

See accompanying notes to unaudited consolidated financial statements.

21

FRESENIUS MEDICAL CARE AG & Co. KGaA

Consolidated Balance Sheets

At June 30, 2013 and December 31, 2012

(in thousands, except share data)

	June 30, 2013			December 31, 2012
	(unaudited)			(audited)
Assets
Current assets:
Cash and cash equivalents	$	585,857		$	688,040
Trade accounts receivable less allowance for doubtful accounts of $329,762 in 2013 and $328,893 in 2012		3,031,167			3,019,424
Accounts receivable from related parties		190,868			137,809
Inventories		1,055,099			1,036,809
Prepaid expenses and other current assets		994,777			937,761
Deferred taxes		292,033			307,613
Total current assets		6,149,801			6,127,456
Property, plant and equipment, net		2,935,140			2,940,603
Intangible assets		681,264			710,116
Goodwill		11,468,599			11,421,889
Deferred taxes		135,631			133,753
Investment in equity method investees		617,430			637,373
Other assets and notes receivables		340,482			354,808
Total assets	$	22,328,347		$	22,325,998
Liabilities and shareholders' equity
Current liabilities:
Accounts payable	$	493,947		$	622,294
Accounts payable to related parties		199,285			123,350
Accrued expenses and other current liabilities		1,831,164			1,787,471
Short-term borrowings		115,322			117,850
Short-term borrowings from related parties		59,364			3,973
Current portion of long-term debt and capital lease obligations		514,118			334,747
Income tax payable		154,938			150,003
Deferred taxes		37,409			30,303
Total current liabilities		3,405,547			3,169,991
Long-term debt and capital lease obligations, less current portion		7,657,012			7,785,740
Long-term debt from related parties		—			56,174
Other liabilities		324,338			294,569
Pension liabilities		432,060			423,361
Income tax payable		205,438			201,642
Deferred taxes		652,612			664,001
Total liabilities		12,677,007			12,595,478
Noncontrolling interests subject to put provisions		541,347			523,260
Shareholders' equity:
Preference shares, no par value, €1.00 nominal value, 7,066,522 shares authorized, 3,973,333 issued and outstanding as of December 31, 2012 (see Note 7)		—			4,462
Ordinary shares, no par value, €1.00 nominal value, 392,462,972 shares authorized, 307,579,315 issued and 303,998,508 outstanding		380,510			374,915
Treasury stock, at cost		(248,889	)		—
Additional paid-in capital		3,548,973			3,491,581
Retained earnings		5,755,550			5,563,661
Accumulated other comprehensive (loss) income		(594,404	)		(492,113	)
Total FMC-AG & Co. KGaA shareholders' equity		8,841,740			8,942,506
Noncontrolling interests not subject to put provisions		268,253			264,754
Total equity		9,109,993			9,207,260
Total liabilities and equity	$	22,328,347		$	22,325,998

See accompanying notes to unaudited consolidated financial statements.

22

FRESENIUS MEDICAL CARE AG & Co. KGaA

Consolidated Statements of Cash Flows

For the six months ended June 30, 2013 and 2012

(unaudited)

(in thousands)

	For the six months ended June 30,
	2013			2012
Operating Activities:
Net income	$	557,658		$	718,998
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		315,154			294,251
Change in deferred taxes, net		(6,570	)		64,934
(Gain) loss on sale of investments		(8,800	)		(33,978	)
(Gain) loss on sale of fixed assets		2,546			1,004
Investment (gain)		—			(139,600	)
Compensation expense related to stock options		12,777			12,949
Cash inflow (outflow) from hedging		(4,028	)		(14,074	)
Investments in equity method investees, net		14,751			28,979
Changes in assets and liabilities, net of amounts from businesses acquired:
Trade accounts receivable, net		(62,574	)		(12,498	)
Inventories		(34,265	)		(64,821	)
Prepaid expenses, other current and non-current assets		28,776			124,258
Accounts receivable from related parties		(56,774	)		(101,405	)
Accounts payable to related parties		78,094			82,647
Accounts payable, accrued expenses and other current and non-current liabilities		(9,009	)		17,328
Income tax payable		12,801			(47,012	)
Net cash provided by (used in) operating activities		840,537			931,960
Investing Activities:
Purchases of property, plant and equipment		(333,642	)		(277,423	)
Proceeds from sale of property, plant and equipment		14,796			3,664
Acquisitions and investments, net of cash acquired, and purchases of intangible assets		(101,809	)		(1,748,179	)
Proceeds from divestitures		17,824			228,206
Net cash provided by (used in) investing activities		(402,831	)		(1,793,732	)
Financing Activities:
Proceeds from short-term borrowings		64,703			57,332
Repayments of short-term borrowings		(62,148	)		(67,162	)
Proceeds from short-term borrowings from related parties		4,203			38,907
Repayments of short-term borrowings from related parties		(5,819	)		(13,743	)
Proceeds from long-term debt and capital lease obligations (net of debt issuance costs and other hedging costs of $156,406 in 2012)		203,080			2,028,913
Repayments of long-term debt and capital lease obligations		(169,796	)		(555,746	)
Increase (decrease) of accounts receivable securitization program		23,000			(82,500	)
Proceeds from exercise of stock options		36,142			22,748
Purchase of treasury stock		(230,654	)		—
Dividends paid		(296,134	)		(271,733	)
Distributions to noncontrolling interests		(117,855	)		(79,334	)
Contributions from noncontrolling interests		27,157			11,763
Net cash provided by (used in) financing activities		(524,121	)		1,089,445
Effect of exchange rate changes on cash and cash equivalents		(15,768	)		(7,587	)
Cash and Cash Equivalents:
Net increase (decrease) in cash and cash equivalents		(102,183	)		220,086
Cash and cash equivalents at beginning of period		688,040			457,292
Cash and cash equivalents at end of period	$	585,857		$	677,378

See accompanying notes to unaudited consolidated financial statements.

23

FRESENIUS MEDICAL CARE AG & Co. KGaA
Consolidated Statement of Shareholders' Equity
For the six months ended June 30, 2013 (unaudited) and
year ended December 31, 2012 (audited)
(in thousands, except share data)

	Preference Shares						Ordinary Shares				Treasury Stock															Total FMC-AG & Co. KGaA shareholders' equity
																							Accumulated Other comprehensive income (loss)						Noncontrolling interests not subject to put provisions
	Number of shares			No par value			Number of shares		No par value		Number of shares			Amount			Additional paid in capital			Retained earnings												Total Equity
Balance at December 31, 2011		3,965,691		$	4,452			300,164,922	$	371,649		—		$	—		$	3,362,633		$	4,648,585		$	(485,767	)	$	7,901,552		$	159,465		$	8,061,017
Proceeds from exercise of options and related tax effects		7,642			10			2,574,836		3,266		—			—			110,510			—			—			113,786			—			113,786
Compensation expense related to stock options		—			—			—		—		—			—			26,476			—			—			26,476			—			26,476
Dividends paid		—			—			—		—		—			—			—			(271,733	)		—			(271,733	)		—			(271,733	)
Purchase/ sale of noncontrolling interests		—			—			—		—		—			—			(26,918	)		—			—			(26,918	)		86,705			59,787
Contributions from/ to noncontrolling interests		—			—			—		—		—			—			—			—			—			—			(26,428	)		(26,428	)
Changes in fair value of noncontrolling interests subject to put provisions		—			—			—		—		—			—			18,880			—			—			18,880			—			18,880
Net income		—			—			—		—		—			—			—			1,186,809			—			1,186,809			45,450			1,232,259
Other comprehensive income (loss)		—			—			—		—		—			—			—			—			(6,346	)		(6,346	)		(438	)		(6,784	)
Comprehensive income		—			—			—		—		—			—			—			—			—			1,180,463			45,012			1,225,475
Balance at December 31, 2012		3,973,333		$	4,462			302,739,758	$	374,915		—		$	—		$	3,491,581		$	5,563,661		$	(492,113	)	$	8,942,506		$	264,754		$	9,207,260
Proceeds from exercise of options and related tax effects		2,200			3			864,024		1,130		—			—			34,706			—			—			35,839			—			35,839
Proceeds from conversion of preference shares into ordinary shares		(3,975,533	)		(4,465	)		3,975,533		4,465		—			—			35,316			—			—			35,316			—			35,316
Compensation expense related to stock options		—			—			—		—		—			—			12,777			—			—			12,777			—			12,777
Purchase of treasury stock		—			—			—		—		(3,580,807	)		(248,889	)		—			—			—			(248,889	)		—			(248,889	)
Dividends paid		—			—			—		—		—			—			—			(296,134	)		—			(296,134	)		—			(296,134	)
Purchase/ sale of noncontrolling interests		—			—			—		—		—			—			(15,074	)		—			—			(15,074	)		4,963			(10,111	)
Contributions from/ to noncontrolling interests		—			—			—		—		—			—			—			—			—			—			(20,121	)		(20,121	)
Changes in fair value of noncontrolling interests subject to put provisions		—			—			—		—		—			—			(10,333	)		—			—			(10,333	)		—			(10,333	)
Net income		—			—			—		—		—			—			—			488,023			—			488,023			20,823			508,846
Other comprehensive income (loss)		—			—			—		—		—			—			—			—			(102,291	)		(102,291	)		(2,166	)		(104,457	)
Comprehensive income		—			—			—		—		—			—			—			—			—			385,732			18,657			404,389
Balance at June 30, 2013		—		$	—			307,579,315	$	380,510		(3,580,807	)	$	(248,889	)	$	3,548,973		$	5,755,550		$	(594,404	)	$	8,841,740		$	268,253		$	9,109,993

See accompanying notes to unaudited consolidated financial statements.

24

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements

(unaudited)

(in thousands, except share and per share data)

1.     The Company and Basis of Presentation

The Company

        Fresenius Medical Care AG & Co. KGaA ("FMC-AG & Co. KGaA" or the "Company"), a German partnership limited by shares (Kommanditgesellschaft auf Aktien), is the world's largest kidney dialysis company, operating in both the field of dialysis care and the field of dialysis products for the treatment of end-stage renal disease ("ESRD"). The Company's dialysis care business, in addition to providing dialysis treatments, includes pharmacy services and vascular access surgery services (together, the "Expanded Services"). The Company's dialysis products business includes manufacturing and distributing products and equipment for the treatment of ESRD. The Company's dialysis business is vertically integrated, providing dialysis treatment at dialysis clinics it owns or operates and supplying these clinics with a broad range of products. In addition, the Company sells dialysis products to other dialysis service providers. Fresenius Medical Care Holdings, Inc. ("FMCH"), located in the United States and our largest subsidiary also provides laboratory testing services, and inpatient dialysis services as well as other services under contract to hospitals.

        In these unaudited consolidated financial statements, "FMC-AG & Co. KGaA," or the "Company," "we," "us" or "our" refers to the Company or the Company and its subsidiaries on a consolidated basis, as the context requires. The term "North America Segment" refers to the North America operating segment. The term "International Segment" refers to the combined Europe, Middle East, Africa and Latin America ("EMEALA") operating segment and Asia-Pacific operating segment.

Basis of Presentation

        The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").

        The consolidated financial statements at June 30, 2013 and for the three and six months ended June 30, 2013 and 2012 contained in this report are unaudited and should be read in conjunction with the consolidated financial statements contained in the Company's 2012 Annual Report on Form 20-F. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Such financial statements reflect all adjustments that, in the opinion of management, are necessary for a fair presentation of the results of the periods presented. All such adjustments are of a normal recurring nature.

        The accounting policies applied in the accompanying consolidated financial statements are the same as those applied in the consolidated financial statements at and for the year ended December 31, 2012, contained in the Company's 2012 Annual Report on Form 20-F.

        The results of operations for the three and six-month periods ended June 30, 2013 are not necessarily indicative of the results of operations for the year ending December 31, 2013.

2.     Acquisition of Liberty Dialysis Holdings, Inc.

        On February 28, 2012, the Company acquired 100% of the equity of Liberty Dialysis Holdings, Inc. ("LD Holdings"), the owner of Liberty Dialysis and owner of a 51% stake in Renal Advantage Partners, LLC (the "Liberty Acquisition"). The Company accounted for this transaction as a business combination and finalized the acquisition accounting on February 28, 2013.

        Total consideration for the Liberty Acquisition was $2,181,358, consisting of $1,696,659 cash, net of cash acquired and $484,699 non-cash consideration. Accounting standards for business combinations require previously held equity interests to be fair valued at the time of the acquisition with the difference

25

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

to book value to be recognized as a gain or loss in income. Prior to the Liberty Acquisition, the Company had a 49% equity investment in Renal Advantage Partners, LLC, the fair value of which, $201,915, was included as part of the non-cash consideration. The fair value was determined based on the discounted cash flow method, utilizing a discount rate of approximately 13%. In addition to the Company's investment, it also had a loan receivable from Renal Advantage Partners, LLC of $279,793, at a fair value of $282,784, which was retired as part of the transaction.

        The following table summarizes the final fair values of assets acquired and liabilities assumed at the date of the acquisition. Any adjustments to acquisition accounting from December 31, 2012 until finalization, net of related income tax effects, were recorded with a corresponding adjustment to goodwill:

Assets held for sale	$	164,068
Trade accounts receivable		149,219
Other current assets		17,458
Deferred tax assets		14,932
Property, plant and equipment		168,335
Intangible assets and other assets		84,556
Goodwill		2,003,465
Accounts payable, accrued expenses and other current liabilities		(105,403	)
Income tax payable and deferred taxes		(33,597	)
Short-term borrowings, other financial liabilities, long-term debt and capital lease obligations		(72,101	)
Other liabilities		(39,923	)
Noncontrolling interests (subject and not subject to put provisions)		(169,651	)
Total acquisition cost	$	2,181,358
Less non-cash contributions at fair value
Investment at acquisition date		(201,915	)
Long-term Notes Receivable		(282,784	)
Total non-cash items	$	(484,699	)
Net Cash paid	$	1,696,659

        The amortizable intangible assets acquired in this acquisition have weighted average useful lives of 6-8 years.

        Goodwill in the amount of $2,003,465 was acquired as part of the Liberty Acquisition and was allocated to the North America Segment. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Goodwill arises principally due to the fair value placed on an estimated stream of future cash flows versus building a similar franchise. Of the goodwill recognized in this acquisition, approximately $436,000 is expected to be deductible for tax purposes and amortized over a 15 year period.

        The noncontrolling interests acquired as part of the acquisition are stated at fair value based upon contractual multiples typically utilized by the Company for such arrangements as well as the Company's overall experience.

        The fair valuation of the Company's investment at the time of the Liberty Acquisition resulted in a non-taxable gain of $139,600. The retirement of the loan receivable resulted in a benefit of $8,501.

Divestitures

        In connection with the Federal Trade Commission's consent order relating to the Liberty Acquisition, the Company agreed to divest a total of 62 renal dialysis centers. 61 clinics were sold by the end of the second quarter of 2012, 24 of which were FMC-AG & Co. KGaA clinics which generated a gain of $33,490. This gain was subsequently finalized in the amount of $33,455 during the period ended December 31, 2012

26

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

and included in the Consolidated Statements of Income. In the second quarter of 2013, the remaining clinic was sold for a gain of $7,705. The 38 clinics acquired and subsequently sold were categorized as Assets held for sale in the table above at the time of the Liberty Acquisition.

Pro Forma Financial Information

        The following financial information, on a pro forma basis, reflects the consolidated results of operations as if the Liberty Acquisition and the divestitures described above had been consummated on January 1, 2011. The pro forma information includes adjustments primarily for elimination of the investment gain and the gain from the retirement of debt. The pro-forma financial information is not necessarily indicative of the results of operations as it would have been had the transactions been consummated on January 1, 2011.

	For the three months ended June 30, 2012		For the six months ended June 30, 2012
Net revenue	$	3,420,560	$	6,782,198
Net income attributable to shareholders of FMC-AG & Co. KGaA		266,093		529,400
Income per ordinary share
Basic	$	0.87	$	1.74
Fully diluted	$	0.87	$	1.73

3.     Related Party Transactions

        The Company's parent, Fresenius SE & Co. KGaA ("Fresenius SE"), a German partnership limited by shares, owns 100% of the share capital of Fresenius Medical Care Management AG, the Company's general partner ("General Partner"). Fresenius SE, the Company's largest shareholder, owns approximately 31.0% of the Company's voting shares at June 30, 2013, excluding the shares purchased through the share buyback program as they are not considered to be outstanding, voting shares (see Note 7, Earnings Per Share).

a)

Service and Lease Agreements

        The Company is party to service agreements with Fresenius SE and certain of its affiliates (collectively the "Fresenius SE Companies") to receive services, including, but not limited to: administrative services, management information services, employee benefit administration, insurance, information technology services, tax services and treasury management services. In 2013, the Company entered into a new information technology services agreement for the next five years, expiring in 2018, which has an automatic continuation for an additional 5 year period with short-term continuations thereafter unless either party terminates the agreement as of the end of the then-current term. The Company has complied with all corporate governance procedures for this agreement (for information on corporate governance, see Item 16G, "Corporate Governance" in our Annual Report on Form 20-F for the year ended December 31, 2012). During the six-month ended June 30, 2013 and 2012, amounts charged by Fresenius SE to the Company under the terms of these agreements were $57,253 and $38,418, respectively. The Company also provides certain services to the Fresenius SE Companies, including research and development, central purchasing and warehousing. The Company charged $3,387 and $3,184 for services rendered to the Fresenius SE Companies during the first six months of 2013 and 2012 respectively.

        Under real estate operating lease agreements entered into with the Fresenius SE Companies, which are leases for the corporate headquarters in Bad Homburg, Germany and production sites in Schweinfurt and St. Wendel, Germany, the Company paid the Fresenius SE Companies $13,317 and $12,660 during the six months ended June 30, 2013 and 2012, respectively. The majority of the leases expire in 2016 and contain renewal options.

27

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

        The Company's Articles of Association provide that the General Partner shall be reimbursed for any and all expenses in connection with management of the Company's business, including remuneration of the members of the General Partner's supervisory board and the General Partner's management board. The aggregate amount reimbursed to the General Partner was $9,136 and $6,453, respectively, for its management services during the six months ended June 30, 2013 and 2012.

b)

Products

        For the first six months of 2013 and 2012, the Company sold products to the Fresenius SE Companies for $15,598 and $12,646, respectively. During the same periods, the Company made purchases from the Fresenius SE Companies in the amount of $22,066 and $24,488, respectively.

        In addition to the purchases noted above, the Company currently purchases heparin supplied by Fresenius Kabi USA, Inc. ("Kabi USA"), through an independent group purchasing organization ("GPO"). Kabi USA is wholly-owned by Fresenius Kabi AG, a wholly-owned subsidiary of Fresenius SE. The Company has no direct supply agreement with Kabi USA and does not submit purchase orders directly to Kabi USA. During the six-month ended June 30, 2013 and 2012, FMCH, a 100% owned subsidiary of the Company and its principal North American subsidiary, acquired approximately $8,864 and $8,565, respectively, of heparin from Kabi USA, through the GPO contract, which was negotiated by the GPO at arm's length on behalf of all members of the GPO.

c)

Financing Provided by and to Fresenius SE and the General Partner

        The Company receives short-term financing from and provides short-term financing to Fresenius SE. The Company also utilizes Fresenius SE's cash management system for the settlement of certain intercompany receivables and payables with its subsidiaries and other related parties.

        At June 30, 2013, the Company provided a loan to Fresenius SE of €22,600 ($29,561 at June 30, 2013) at an interest rate of 1.371%, due and paid on July 2, 2013.

        On August 19, 2009, the Company borrowed €1,500 ($1,962 at June 30, 2013) from the General Partner at 1.335%. The loan repayment has been extended periodically and is currently due August 20, 2013 at an interest rate of 2.132%.

        At June 30, 2013, the Company had a Chinese Yuan Renminbi ("CNY") loan of 352,313 ($57,402 at June 30, 2013) outstanding with a subsidiary of Fresenius SE at an interest rate of 6.1% and a maturity date of May 23, 2014.

d)

Other

        The Company, at June 30, 2013, had a receivable from Fresenius SE in the amount of €4,791 ($6,267 at June 30, 2013) resulting from being a party to a German trade tax group agreement with Fresenius SE for the fiscal years 1997-2001.

4.     Inventories

        At June 30, 2013 and December 31, 2012, inventories consisted of the following:

	June 30, 2013		December 31, 2012
Finished goods	$	644,376	$	627,338
Raw materials and purchased components		179,242		171,373
Health care supplies		143,233		154,840
Work in process		88,248		83,258
Inventories	$	1,055,099	$	1,036,809

28

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

5.     Short-Term Borrowings and Short-Term Borrowings from Related Parties

        At June 30, 2013 and December 31, 2012, short-term borrowings and short-term borrowings from related parties consisted of the following:

	June 30, 2013		December 31, 2012
Borrowings under lines of credit	$	115,322	$	117,850
Short-term borrowings from related parties (see Note 3.c.)		59,364		3,973
Short-term borrowings and Short-term borrowings from related parties	$	174,686	$	121,823

6.     Long-Term Debt and Capital Lease Obligations and Long-Term Debt from Related Parties

        At June 30, 2013 and December 31, 2012, long-term debt and capital lease obligations and long-term debt from related parties consisted of the following:

	June 30, 2013			December 31, 2012
2012 Credit Agreement	$	2,832,312		$	2,659,340
Senior Notes		4,730,687			4,743,442
Euro Notes		44,145			51,951
European Investment Bank Agreements		231,926			324,334
Accounts receivable facility		185,000			162,000
Capital lease obligations		13,772			15,618
Other		133,288			163,802
Long-term debt and capital lease obligations		8,171,130			8,120,487
Less current maturities		(514,118	)		(334,747	)
Long-term debt and capital lease obligations, less current portion		7,657,012			7,785,740
Long-term debt from related parties		—			56,174
Long-term debt and capital lease obligations and long-term debt from related parties	$	7,657,012		$	7,841,914

2012 Credit Agreement

        The following table shows the available and outstanding amounts under the 2012 Credit Agreement at June 30, 2013 and at December 31, 2012:

	Maximum Amount Available June 30, 2013				Balance Outstanding June 30, 2013
Revolving Credit USD	$	600,000	$	600,000	$	101,512	$	101,512
Revolving Credit EUR	€	500,000	$	654,000	€	100,000	$	130,800
Term Loan A	$	2,600,000	$	2,600,000	$	2,600,000	$	2,600,000
			$	3,854,000			$	2,832,312

	Maximum Amount Available December 31, 2012				Balance Outstanding December 31, 2012
Revolving Credit USD	$	600,000	$	600,000	$	59,340	$	59,340
Revolving Credit EUR	€	500,000	$	659,700	€	—	$	—
Term Loan A	$	2,600,000	$	2,600,000	$	2,600,000	$	2,600,000
			$	3,859,700			$	2,659,340

29

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

        In addition, at June 30, 2013 and December 31, 2012, the Company had letters of credit outstanding in the amount of $ 11,065 and $ 77,188 , respectively, under the revolving credit facility, which are not included above as part of the balance outstanding, but reduce the available borrowings under the revolving credit facility.

Accounts Receivable Facility Letters of Credit

        The Company also had letters of credit outstanding under the accounts receivable facility in the amount of $65,622 as of June 30, 2013. These letters of credit are not included above as part of the balance outstanding at June 30, 2013; however, they reduce available borrowings under the accounts receivable facility.

7.     Earnings Per Ordinary Share

        The following table contains reconciliations of the numerators and denominators of the basic and diluted earnings per ordinary share computations for the three- and six-month ended June 30, 2013 and 2012:

	For the three months ended June 30,				For the six months ended June 30,
	2013		2012		2013		2012
Numerators:
Net income attributable to shareholders of FMC-AG & Co. KGaA	$	262,524	$	289,337	$	488,023	$	659,835
less:
Dividend preference on Preference shares		—		25		—		51
Income available to all classes of shares	$	262,524	$	289,312	$	488,023	$	659,784
Denominators:
Weighted average number of:
Ordinary shares outstanding		302,409,369		300,415,725		302,590,288		300,310,425
Preference shares outstanding		3,842,900		3,966,600		3,907,756		3,966,301
Total weighted average shares outstanding		306,252,269		304,382,325		306,498,044		304,276,726
Potentially dilutive Ordinary shares		1,362,863		2,405,628		1,247,741		2,372,829
Potentially dilutive Preference shares		—		18,019		—		18,145
Total weighted average Ordinary shares outstanding assuming dilution		303,772,232		302,821,353		303,838,029		302,683,254
Total weighted average Preference shares outstanding assuming dilution		3,842,900		3,984,619		3,907,756		3,984,446
Basic income per Ordinary share	$	0.86	$	0.95	$	1.59	$	2.17
Fully diluted income per Ordinary share	$	0.85	$	0.94	$	1.59	$	2.15

        On May 16, 2013, the Company held its Annual General Meeting and a separate Preference Shareholder Meeting during which resolutions on the conversion of the preference shares to ordinary shares were passed. The preference share conversion was affected on June 28, 2013 with 3,975,533 preference shares in the amount of €3,976 ($4,465) converted on a 1:1 basis to ordinary shares. In addition, 32,006 options associated with the preference shares were converted for options associated with ordinary shares.

        On July 5, 2013, the Company received a €27,000 ($35,316) premium from the largest preference shareholder for the conversion of their preference shares to ordinary shares. At June 30, 2013, this amount was recorded as a short-term receivable with a corresponding increase recorded in equity.

30

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

        Additionally, the Company announced the share buy-back program. The Company intends to repurchase ordinary shares in an aggregate value of up to €385,000 (approximately $500,000). This program is expected to run into the third quarter of 2013. At June 30, 2013, 3,580,807 shares were repurchased in the amount of €189,876 ($248,889). These shares are restricted treasury stock which means there are no associated dividends or voting rights. These treasury shares will be used to serve the sole purposes of either reducing the registered share capital of the Company by cancellation of the acquired shares, or fulfilling employee participation programs of the Company.

        The following tabular disclosure provides the shares repurchased during the second quarter of 2013:

Period	Average price paid per share		Average price paid per share(1)		Total number of shares purchased as part of publicly announced plans or programs		Total Value of Shares Repurchased(4)		Total Value of Shares Repurchased(2)(4)		Maximum value of shares that may yet be purchased under plans or programs as of the end of the period(3)
	in €		in $				in €		in $		in €		in $
							in thousands
May 2013	€	52.96	$	68.48		1,078,255	€	57,107	$	73,842	€	327,910	$	426,480
June 2013	€	53.05	$	69.95		2,502,552	€	132,769	$	175,047	€	195,165	$	255,276
Total	€	53.03	$	69.51		3,580,807	€	189,876	$	248,889

(1)

The dollar value is calculated using the daily exchange rate for the share repurchases made during the month.

(2)

The value of the shares repurchased in Dollar is calculated using the total value of the shares purchased in Euro converted using the daily exchange rate for the transactions.

(3)

The maximum Dollar value of the shares remaining is calculated using the maximum Euro value of shares that may yet be repurchased converted at the end of the month spot rate.

(4)

This amount is inclusive of fees paid in the amount of approximately $53 (€41) for services rendered.

8.     Employee Benefit Plans

        The Company currently has two principal pension plans, one for German employees, the other covering employees in the United States, the latter of which was curtailed in 2002. Plan benefits are generally based on years of service and final salary. As there is no legal requirement in Germany to fund defined benefit plans, the Company's pension obligations in Germany are unfunded. Each year FMCH contributes to the plan covering United States employees at least the minimum required by the Employee Retirement Income Security Act of 1974, as amended.

        The following table provides the calculations of net periodic benefit cost for the three- and six-months ended June 30, 2013 and 2012, respectively.

	Three months ended June 30,						Six months ended June 30,
	2013			2012			2013			2012
Components of net periodic benefit cost:
Service cost	$	3,818		$	2,645		$	7,669		$	5,337
Interest cost		6,735			6,446			13,495			12,938
Expected return on plan assets		(3,400	)		(3,825	)		(6,800	)		(7,650	)
Amortization of unrealized losses		6,385			4,370			12,777			8,743
Net periodic benefit costs	$	13,538		$	9,636		$	27,141		$	19,368

31

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

9.     Noncontrolling Interests Subject to Put Provisions

        The Company has potential obligations to purchase the noncontrolling interests held by third parties in certain of its consolidated subsidiaries. These obligations are in the form of put provisions and are exercisable at the third-party owners' discretion within specified periods as outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase all or part of third-party owners' noncontrolling interests at the appraised fair value at the time of exercise. The methodology the Company uses to estimate the fair values of the noncontrolling interest subject to put provisions assumes the greater of net book value or a multiple of earnings, based on historical earnings, the development stage of the underlying business and other factors. The estimated fair values of the noncontrolling interests subject to these put provisions can also fluctuate and the implicit multiple of earnings at which these noncontrolling interest obligations may ultimately be settled could vary significantly from our current estimates depending upon market conditions.

        At June 30, 2013 and December 31, 2012, the Company's potential obligations under these put options were $541,347 and $523,260, respectively, of which, at June 30, 2013, $208,239 were exercisable. No put options were exercised during the first six months of 2013.

        Following is a roll forward of noncontrolling interests subject to put provisions for the six months ended June 30, 2013 and the year ended December 31, 2012:

	June 30, 2013			December 31, 2012
Beginning balance as of January 1,	$	523,260		$	410,491
Contributions to noncontrolling interests		(56,330	)		(114,536	)
Purchase/ sale of noncontrolling interests		10,515			134,643
Contributions from noncontrolling interests		4,909			16,565
Changes in fair value of noncontrolling interests		10,333			(18,880	)
Net income		48,812			94,718
Other comprehensive income (loss)		(152	)		259
Ending balance as of June 30, 2013 and December 31, 2012	$	541,347		$	523,260

10.   Sources of Revenue

        Below is a table showing the sources of our U.S. patient service revenue (net of contractual allowance and discounts but before patient service bad debt provision), included in the Company's dialysis care revenue, for the six months ended June 30, 2013 and 2012. Outside of the U.S., the Company does not recognize patient service revenue at the time the services are rendered without assessing the patient's ability to pay. Accordingly, the additional disclosure requirements introduced with ASU 2011-07 only apply to the U.S. patient service revenue.

	For the six months ended June 30,
	2013		2012
Medicare ESRD program	$	2,131,095	$	1,926,433
Private/alternative payors		1,865,556		1,775,378
Medicaid and other government sources		186,059		194,154
Hospitals		209,517		201,709
Total patient service revenue	$	4,392,227	$	4,097,674

32

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

11.   Commitments and Contingencies

Legal and Regulatory Matters

        The Company is routinely involved in numerous claims, lawsuits, regulatory and tax audits, investigations and other legal matters arising, for the most part, in the ordinary course of its business of providing healthcare services and products. Legal matters that the Company currently deems to be material are described below. For the matters described below in which the Company believes a loss is both reasonably possible and estimable, an estimate of the loss or range of loss exposure is provided. For the other matters described below, the Company believes that the loss probability is remote and/or the loss or range of possible losses cannot be reasonably estimated at this time. The outcome of litigation and other legal matters is always difficult to predict accurately and outcomes that are not consistent with the Company's view of the merits can occur. The Company believes that it has valid defenses to the legal matters pending against it and is defending itself vigorously. Nevertheless, it is possible that the resolution of one or more of the legal matters currently pending or threatened could have a material adverse effect on its business, results of operations and financial condition.

Commercial Litigation

        The Company was originally formed as a result of a series of transactions it completed pursuant to the Agreement and Plan of Reorganization dated as of February 4, 1996, by and between W.R. Grace & Co. and Fresenius SE (the "Merger"). At the time of the Merger, a W.R. Grace & Co. subsidiary known as W.R. Grace & Co.-Conn. had, and continues to have, significant liabilities arising out of product-liability related litigation (including asbestos-related actions), pre-Merger tax claims and other claims unrelated to National Medical Care, Inc. ("NMC"), which was W.R. Grace & Co.'s dialysis business prior to the Merger. In connection with the Merger, W.R. Grace & Co.-Conn. agreed to indemnify the Company, FMCH, and NMC against all liabilities of W.R. Grace & Co., whether relating to events occurring before or after the Merger, other than liabilities arising from or relating to NMC's operations. W.R. Grace & Co. and certain of its subsidiaries filed for reorganization under Chapter 11 of the U.S. Bankruptcy Code (the "Grace Chapter 11 Proceedings") on April 2, 2001.

        Prior to and after the commencement of the Grace Chapter 11 Proceedings, class action complaints were filed against W.R. Grace & Co. and FMCH by plaintiffs claiming to be creditors of W.R. Grace & Co.-Conn., and by the asbestos creditors' committees on behalf of the W.R. Grace & Co. bankruptcy estate in the Grace Chapter 11 Proceedings, alleging, among other things that the Merger was a fraudulent conveyance, violated the uniform fraudulent transfer act and constituted a conspiracy. All such cases have been stayed and transferred to or are pending before the U.S. District Court as part of the Grace Chapter 11 Proceedings.

        In 2003, the Company reached agreement with the asbestos creditors' committees on behalf of the W.R. Grace & Co. bankruptcy estate and W.R. Grace & Co. in the matters pending in the Grace Chapter 11 Proceedings for the settlement of all fraudulent conveyance and tax claims against it and other claims related to the Company that arise out of the bankruptcy of W.R. Grace & Co. Under the terms of the settlement agreement as amended (the "Settlement Agreement"), fraudulent conveyance and other claims raised on behalf of asbestos claimants will be dismissed with prejudice and the Company will receive protection against existing and potential future W.R. Grace & Co. related claims, including fraudulent conveyance and asbestos claims, and indemnification against income tax claims related to the non-NMC members of the W.R. Grace & Co. consolidated tax group upon confirmation of a W.R. Grace & Co. bankruptcy reorganization plan that contains such provisions. Under the Settlement Agreement, the Company will pay a total of $115,000 without interest, which has previously been accrued and is included on the Company's Consolidated Balance Sheets, to the W.R. Grace & Co. bankruptcy estate, or as otherwise directed by the Court, upon plan confirmation. No admission of liability has been or will be made. While the Company believes this accrual reasonably estimates its currently anticipated costs related to the continued defense and resolution of this matter, no assurances can be given that its actual costs incurred will not exceed the amount of this accrual. The Settlement Agreement has been approved by the

33

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

U.S. District Court. In January and February 2011, the U.S. Bankruptcy Court entered orders confirming the plan of reorganization and the confirmation orders were affirmed by the U.S. District Court on January 31, 2012. Multiple parties have appealed to the Third Circuit Court of Appeals and the plan of reorganization will not be implemented until the appeals are finally resolved.

        Subsequent to the Merger, W.R. Grace & Co. was involved in a multi-step transaction involving Sealed Air Corporation ("Sealed Air," formerly known as Grace Holding, Inc.). The Company is engaged in litigation with Sealed Air to confirm its entitlement to indemnification from Sealed Air for all losses and expenses incurred by the Company relating to pre-Merger tax liabilities and Merger-related claims. Under the Settlement Agreement, upon final confirmation of a plan of reorganization that satisfies the conditions of the Company's payment obligation, this litigation will be dismissed with prejudice.

        On April 4, 2003, FMCH filed a suit in the U. S. District Court for the Northern District of California, styled Fresenius USA, Inc., et al., v. Baxter International Inc., et al., Case No. C 03-1431, seeking a declaratory judgment that FMCH does not infringe patents held by Baxter International Inc. and its subsidiaries and affiliates ("Baxter"), that the patents are invalid, and that Baxter is without right or authority to threaten or maintain suit against FMCH for alleged infringement of Baxter's patents. In general, the asserted patents concern the use of touch screen interfaces for hemodialysis machines. Baxter filed counterclaims against FMCH seeking more than $140,000 in monetary damages and injunctive relief, and alleging that FMCH willfully infringed on Baxter's patents. On July 17, 2006, the court entered judgment on a jury verdict in favor of FMCH finding all asserted claims of Baxter patents invalid as obvious and/or anticipated in light of prior art.

        On February 13, 2007, the court granted Baxter's motion to set aside the jury's verdict in favor of FMCH and reinstated the patents and entered judgment of infringement. Following a trial on damages, the court entered judgment on November 6, 2007 in favor of Baxter on a jury award of $14,300. On April 4, 2008, the court denied Baxter's motion for a new trial, established a royalty payable to Baxter of 10% of the sales price for continuing sales of FMCH's 2008K hemodialysis machines and 7% of the sales price of related disposables, parts and service beginning November 7, 2007, and enjoined sales of the touchscreen-equipped 2008K machine effective January 1, 2009. The Company appealed the court's rulings to the United States Court of Appeals for the Federal Circuit ("Federal Circuit"). On September 10, 2009, the Federal Circuit reversed the district court's decision and determined that the asserted claims in two of the three patents at issue are invalid. As to the third patent, the Federal Circuit affirmed the district court's decision; however, the Court also vacated the injunction and award of damages. These issues were remanded to the District Court for reconsideration in light of the invalidity ruling on most of the claims. As a result, FMCH is no longer required to fund the court-approved escrow account set up to hold the royalty payments ordered by the district court. Funds of $70,000 were contributed to the escrow fund. Upon remand, the district court reduced the post verdict damages award to $10,000 and $61,000 of the escrowed funds was returned to FMCH. In the parallel reexamination of the last surviving patent, the U.S. Patent and Trademark Office ("USPTO") and the Board of Patent Appeals and Interferences ruled that the remaining Baxter patent is invalid. On May 17, 2012 the Federal Circuit affirmed the USPTO's ruling and invalidated the final remaining Baxter patent. The Federal Circuit issued a mandate to the USPTO to cancel the claims of the last remaining asserted Baxter HD patent. Baxter appealed to the Federal Circuit claiming that approximately $20,000 of damages awarded to it by the District Court before the Federal Circuit affirmed the USPTO ruling constitutes a final judgment that may be collected. On July 2, 2013, the Federal Circuit denied Baxter's appeal and ordered the District Court to dismiss the case.

        On August 27, 2012, Baxter filed suit in the U.S. District Court for the Northern District of Illinois, styled Baxter International Inc., et al., v. Fresenius Medical Care Holdings, Inc., Case No. 12-cv-06890, alleging that the Company's Liberty^TM cycler infringes certain U.S. patents that were issued to Baxter between October 2010 and June 2012. The Company believes it has valid defenses to these claims, and will defend this litigation vigorously.

        On April 5, 2013, the U.S. Judicial Panel on Multidistrict Litigation ordered that lawsuits filed in various federal courts alleging wrongful death and personal injury claims against FMCH and certain of its

34

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

affiliates relating to FMCH's dialysate concentrate products NaturaLyte® and Granuflo® be transferred and consolidated for pretrial management purposes into a consolidated multidistrict litigation in the United States District Court for the District of Massachusetts, styled In Re: Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation, Case No. 2013-md-02428. These lawsuits allege generally that inadequate labeling and warnings for these products caused harm to patients. In addition, similar cases have been filed in other courts that will not be formally consolidated with the federal multidistrict litigation. FMCH believes that these lawsuits are without merit, and will defend them vigorously.

Other Litigation and Potential Exposures

        On February 15, 2011, a qui tam relator's complaint under the False Claims Act against FMCH was unsealed by order of the United States District Court for the District of Massachusetts and served by the relator. The United States has not intervened in the case United States ex rel. Chris Drennen v. Fresenius Medical Care Holdings, Inc., 2009 Civ. 10179 (D. Mass.). The relator's complaint, which was first filed under seal in February 2009, alleges that the Company seeks and receives reimbursement from government payors for serum ferritin and hepatitis B laboratory tests that are medically unnecessary or not properly ordered by a physician. On March 6, 2011, the United States Attorney for the District of Massachusetts issued a Civil Investigative Demand seeking the production of documents related to the same laboratory tests that are the subject of the relator's complaint. FMCH has cooperated fully in responding to the Civil Investigative Demand, and will vigorously contest the relator's complaint.

        On June 29, 2011, FMCH received a subpoena from the United States Attorney for the Eastern District of New York ("E.D.N.Y."). On December 6, 2011, a single Company facility in New York received a subpoena from the Office of the Inspector General of the Department of Health and Human Services that was substantially similar to the one issued by the U.S. Attorney for the E.D.N.Y. These subpoenas are part of a criminal and civil investigation into relationships between retail pharmacies and outpatient dialysis facilities in the State of New York and into the reimbursement under government payor programs in New York for medications provided to patients with ESRD. Among the issues encompassed by the investigation is whether retail pharmacies may have provided or received compensation from the New York Medicaid program for pharmaceutical products that should be provided by the dialysis facilities in exchange for the New York Medicaid payment to the dialysis facilities. The Company has cooperated in the investigation.

        Civil investigative demands were issued under the supervision of the United States Attorneys for Rhode Island and Connecticut to American Access Care LLC (AAC) and certain affiliated entities prior to the Company's acquisition of AAC in October 2011. In March 2012, a third subpoena was issued under the supervision of the United States Attorney for the Southern District of Florida (Miami). In May 2013, a fourth subpoena was served by the United States Attorney for the Eastern District of Virginia (Richmond). Also in May 2013, updated document productions were requested by the US Attorneys for Rhode Island and Connecticut. Although the subpoenas cover a wide range of documents and activities of AAC, the focus of the investigation is procedure coding and related billing practices and procedures. The Company has assumed responsibility for responding to the subpoenas and is cooperating fully with the United States Attorneys.

        The Company has received communications alleging certain conduct in certain countries outside the U.S. and Germany that may violate the U.S. Foreign Corrupt Practices Act ("FCPA") or other anti-bribery laws. In response to the allegations, the Audit and Corporate Governance Committee of the Company's Supervisory Board is conducting an internal review with the assistance of independent counsel retained for such purpose. The Company voluntarily advised the U.S. Securities and Exchange Commission and the U.S. Department of Justice that allegations have been made and of the Company's internal review. The Company's independent counsel, in conjunction with the Company's Compliance department, have reviewed the Company's anti-corruption compliance program, including internal controls related to compliance with international anti-bribery laws, and appropriate enhancements are being implemented. The Company is fully committed to FCPA compliance. It cannot predict the final outcome of its review.

35

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

        In December 2012 and January 2013, FMCH received subpoenas from the United States Attorneys for the District of Massachusetts and the Western District of Louisiana requesting production of a range of documents relating to products manufactured by FMCH, including the Granuflo® and Naturalyte® dialysate concentrate products. FMCH is cooperating fully in responding to these subpoenas.

        The Company filed claims for refunds contesting the Internal Revenue Service's ("IRS") disallowance of FMCH's civil settlement payment deductions taken by FMCH in prior year tax returns. As a result of a settlement agreement with the IRS, the Company received a partial refund in September 2008 of $37,000, inclusive of interest and preserved its right to pursue claims in the United States Courts for refunds of all other disallowed deductions, which totaled approximately $126,000. On December 22, 2008, the Company filed a complaint for complete refund in the United States District Court for the District of Massachusetts, styled as Fresenius Medical Care Holdings, Inc. v. United States. On August 15, 2012, a jury entered a verdict for FMCH granting additional deductions of $95,000. On May 31, 2013, the District Court entered final judgment for FMCH in the amount of $50,400. On July 18, 2013, the District Court denied the IRS's post trial motion seeking to set aside the verdict and judgment and closed the file. The IRS may appeal to the Court of Appeals for the First Circuit (Boston).

        From time to time, the Company is a party to or may be threatened with other litigation or arbitration, claims or assessments arising in the ordinary course of its business. Management regularly analyzes current information including, as applicable, the Company's defenses and insurance coverage and, as necessary, provides accruals for probable liabilities for the eventual disposition of these matters.

        The Company, like other healthcare providers, conducts its operations under intense government regulation and scrutiny. It must comply with regulations which relate to or govern the safety and efficacy of medical products and supplies, the marketing and distribution of such products, the operation of manufacturing facilities, laboratories and dialysis clinics, and environmental and occupational health and safety. With respect to its development, manufacture, marketing and distribution of medical products, if such compliance is not maintained, the Company could be subject to significant adverse regulatory actions by the FDA and comparable regulatory authorities outside the U.S. These regulatory actions could include warning letters or other enforcement notices from the FDA and/or comparable foreign regulatory authority, which may require the Company to expend significant time and resources in order to implement appropriate corrective actions. If warning letters or other enforcement notices are not addressed by the Company to the satisfaction of the FDA and/or comparable regulatory authorities outside the U.S., these regulatory authorities could take additional actions, including product recalls injunctions against the distribution of products or operation of manufacturing plants, civil penalties, seizures of the Company's products and/or criminal prosecution. The Company must also comply with the laws of the United States, including the federal Anti-Kickback Statute, the federal False Claims Act, the federal Stark Law and the federal Foreign Corrupt Practices Act as well as other federal and state fraud and abuse laws. Applicable laws or regulations may be amended, or enforcement agencies or courts may make interpretations that differ from the Company's interpretations or the manner in which it conducts its business. Enforcement has become a high priority for the federal government and some states. In addition, the provisions of the False Claims Act authorizing payment of a portion of any recovery to the party bringing the suit encourage private plaintiffs to commence "qui tam" or "whistle blower" actions. In May 2009, the scope of the False Claims Act was expanded and additional protections for whistle blowers and procedural provisions to aid whistle blowers' ability to proceed in a False Claims Act case were added. By virtue of this regulatory environment, the Company's business activities and practices are subject to extensive review by regulatory authorities and private parties, and continuing audits, investigative demands, subpoenas, other inquiries, claims and litigation relating to the Company's compliance with applicable laws and regulations. The Company may not always be aware that an inquiry or action has begun, particularly in the case of "whistle blower" actions, which are initially filed under court seal.

36

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

        The Company operates many facilities throughout the United States and other parts of the world. In such a decentralized system, it is often difficult to maintain the desired level of oversight and control over the thousands of individuals employed by many affiliated companies. The Company relies upon its management structure, regulatory and legal resources, and the effective operation of its compliance program to direct, manage and monitor the activities of these employees. On occasion, the Company may identify instances where employees or other agents deliberately, recklessly or inadvertently contravene the Company's policies or violate applicable law. The actions of such persons may subject the Company and its subsidiaries to liability under the Anti-Kickback Statute, the Stark Law, the False Claims Act and the Foreign Corrupt Practices Act, among other laws and comparable laws of other countries.

        Physicians, hospitals and other participants in the healthcare industry are also subject to a large number of lawsuits alleging professional negligence, malpractice, product liability, worker's compensation or related claims, many of which involve large claims and significant defense costs. The Company has been and is currently subject to these suits due to the nature of its business and expects that those types of lawsuits may continue. Although the Company maintains insurance at a level which it believes to be prudent, it cannot assure that the coverage limits will be adequate or that insurance will cover all asserted claims. A successful claim against the Company or any of its subsidiaries in excess of insurance coverage could have a material adverse effect upon it and the results of its operations. Any claims, regardless of their merit or eventual outcome, could have a material adverse effect on the Company's reputation and business.

        The Company has also had claims asserted against it and has had lawsuits filed against it relating to alleged patent infringements or businesses that it has acquired or divested. These claims and suits relate both to operation of the businesses and to the acquisition and divestiture transactions. The Company has, when appropriate, asserted its own claims, and claims for indemnification. A successful claim against the Company or any of its subsidiaries could have a material adverse effect upon its business, financial condition, and the results of its operations. Any claims, regardless of their merit or eventual outcome, could have a material adverse effect on the Company's reputation and business.

12.   Financial Instruments

        As a global supplier of dialysis services and products in more than 120 countries throughout the world, the Company is faced with a concentration of credit risks due to the nature of the reimbursement systems which are often provided by the governments of the countries in which the Company operates. Changes in reimbursement rates or the scope of coverage could have a material adverse effect on the Company's business, financial condition and results of operations and thus on its capacity to generate cash flow.

37

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

Non-derivative Financial Instruments

        The following table presents the carrying amounts and fair values of the Company's non-derivative financial instruments at June 30, 2013, and December 31, 2012.

		June 30, 2013				December 31, 2012
	Fair Value Hierarchy	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Assets
Cash and cash equivalents	1	$	585,857		585,857	$	688,040		688,040
Accounts Receivable	2		3,222,035		3,222,035		3,157,233		3,157,233
Liabilities
Accounts payable	2		693,232		693,232		745,644		745,644
Short-term borrowings	2		174,686		174,686		121,823		121,823
Long term debt, excluding 2012 Credit Agreement, Euro Notes and Senior Notes	2		563,986		563,986		721,928		721,928
2012 Credit Agreement	2		2,832,312		2,828,542		2,659,340		2,652,840
Senior Notes	2		4,730,687		5,075,954		4,743,442		5,296,325
Euro Notes	2		44,145		45,407		51,951		54,574
Noncontrolling interests subject to put provisions	3		541,347		541,347		523,260		523,260

        The carrying amounts in the table are included in the consolidated balance sheet under the indicated captions or in the case of long-term debt, in the captions shown in Note 6.

        The significant methods and assumptions used in estimating the fair values of non-derivative financial instruments are as follows:

        Cash and cash equivalents are stated at nominal value which equals the fair value.

        Short-term financial instruments such as accounts receivable, accounts payable and short-term borrowings are valued at their carrying amounts, which are reasonable estimates of the fair value due to the relatively short period to maturity of these instruments.

        The fair values of major long-term financial liabilities are calculated on the basis of market information. Instruments for which market quotes are available are measured using these quotes. The fair values of the other long-term financial liabilities are calculated at the present value of the respective future cash flows. To determine these present values, the prevailing interest rates and credit spreads for the Company as of the balance sheet date are used.

        The valuation of noncontrolling interests subject to put provisions is determined using significant unobservable inputs. See Note 9 for a discussion of the Company's methodology for estimating the fair value of these noncontrolling interests subject to put obligations.

        Currently, there is no indication that a decrease in the value of the Company's financing receivables is probable. Therefore, the allowances on credit losses of financing receivables are immaterial.

Derivative Financial Instruments

        The Company is exposed to market risk from changes in foreign exchange rates and interest rates. In order to manage the risk of currency exchange rate and interest rate fluctuations, the Company enters into various hedging transactions by means of derivative instruments with highly rated financial institutions as authorized by the Company's General Partner. On a quarterly basis the Company performs an assessment of its counterparty credit risk. The Company currently considers this risk to be low. The Company's policy,

38

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

which has been consistently followed, is that financial derivatives be used only for the purpose of hedging foreign currency and interest rate exposure.

        In certain instances, the Company enters into derivative contracts that do not qualify for hedge accounting but are utilized for economic purposes ("economic hedges"). The Company does not use financial instruments for trading purposes.

        The Company established guidelines for risk assessment procedures and controls for the use of financial instruments. They include a clear segregation of duties with regard to execution on one side and administration, accounting and controlling on the other.

        To reduce the credit risk arising from derivatives the Company concluded Master Netting Agreements with banks. Through such agreements, positive and negative fair values of the derivative contracts could be offset against one another if a partner becomes insolvent. This offsetting is valid for transactions where the aggregate amount of obligations owed to and receivable from are not equal. If insolvency occurs, the party which owes the larger amount is obliged to pay the other party the difference between the amounts owed in the form of one net payment.

        The Company elects not to offset the fair values of derivative financial instruments subject to master netting agreements in the statement of financial position.

        At June 30, 2013 and December 31, 2012, the Company had $16,854 and $32,044 of derivative financial assets subject to netting arrangements and $9,631 and $19,193 of derivative financial liabilities subject to netting arrangements. Offsetting these derivative financial instruments would have resulted in net assets of $11,937 and $20,773 as well as net liabilities of $4,714 and $7,922 at June 30, 2013 and December 31, 2012, respectively.

Foreign Exchange Risk Management

        The Company conducts business on a global basis in various currencies, though a majority of its operations are in Germany and the United States. For financial reporting purposes, the Company has chosen the U.S. dollar as its reporting currency. Therefore, changes in the rate of exchange between the U.S. dollar and the local currencies in which the financial statements of the Company's international operations are maintained affect its results of operations and financial position as reported in its consolidated financial statements.

        The Company's exposure to market risk for changes in foreign exchange rates relates to transactions such as sales and purchases. The Company has significant amounts of sales of products invoiced in euro from its European manufacturing facilities to its other international operations and, to a lesser extent, sales of products invoiced in other non-functional currencies. This exposes the subsidiaries to fluctuations in the rate of exchange between the euro and the currency in which their local operations are conducted. For the purpose of hedging existing and foreseeable foreign exchange transaction exposures the Company enters into foreign exchange forward contracts and, on a small scale, foreign exchange options. At June 30, 2013 the Company had no foreign exchange options.

        Changes in the fair value of the effective portion of foreign exchange forward contracts designated and qualifying as cash flow hedges of forecasted product purchases and sales are reported in accumulated other comprehensive income (loss) ("AOCI"). Additionally, in connection with intercompany loans in foreign currency, the Company uses foreign exchange swaps thus assuring that no foreign exchange risks arise from those loans, which, if they qualify for cash flow hedge accounting, are also reported in AOCI. These amounts recorded in AOCI are subsequently reclassified into earnings as a component of cost of revenues for those contracts that hedge product purchases or as an adjustment of interest income/expense for those contracts that hedge loans, in the same period in which the hedged transaction affects earnings. The notional amounts of foreign exchange contracts in place that are designated and qualify as cash flow hedges totaled $201,150 and $611,488 at June 30, 2013 and December 31, 2012, respectively.

39

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

        The Company also enters into derivative contracts for forecasted product purchases and sales and for intercompany loans in foreign currencies that do not qualify for hedge accounting but are utilized for economic hedges as defined above. In these cases, the change in value of the economic hedge is recorded in the income statement and usually offsets the change in value recorded in the income statement for the underlying asset or liability. The notional amounts of economic hedges that do not qualify for hedge accounting totaled $1,344,019 and $1,574,667 at June 30, 2013 and December 31, 2012, respectively.

Interest Rate Risk Management

        The Company enters into derivatives, particularly interest rate swaps and to a certain extent, interest rate options, to protect against the risk of rising interest rates. These interest rate derivatives are designated as cash flow hedges and have been entered into in order to effectively convert payments based on variable interest rates into payments at a fixed interest rate. The euro-denominated interest rate swaps expire in 2016 and have an interest rate of 1.73%. Interest payable and receivable under the swap agreements is accrued and recorded as an adjustment to interest expense.

        At June 30, 2013 and December 31, 2012, the notional amount of the euro-denominated interest rate swaps in place was €100,000 and €100,000 ($130,800 and $131,940 at June 30, 2013 and December 31, 2012, respectively).

Derivative Financial Instruments Valuation

        The following table shows the carrying amounts of the Company's derivatives at June 30, 2013 and December 31, 2012.

	June 30, 2013					December 31, 2012
	Assets(2)		Liabilities(2)			Assets(2)		Liabilities(2)
Derivatives in cash flow hedging relationships(1)
Current
Foreign exchange contracts		8,109		(1,566	)		7,839		(7,510	)
Non-current
Foreign exchange contracts		—		—			942		(187	)
Interest rate contracts		—		(4,246	)		—		(6,221	)
Total	$	8,109	$	(5,812	)	$	8,781	$	(13,918	)
Derivatives not designated as hedging instruments(1)
Current
Foreign exchange contracts		12,361		(6,217	)		23,396		(19,068	)
Non-current
Foreign exchange contracts		1,098		(1,227	)		132		(292	)
Total	$	13,459	$	(7,444	)	$	23,528	$	(19,360	)

(1)

At June 30, 2013 and December 31, 2012, the valuation of the Company's derivatives was determined using Significant Other Observable Inputs (Level 2) in accordance with the fair value hierarchy levels established in U.S. GAAP.

(2)

Derivative instruments are marked to market each reporting period resulting in carrying amounts being equal to fair values at the reporting date.

        The carrying amounts for the current portion of derivatives indicated as assets in the table above are included in Prepaid expenses and other current assets in the Consolidated Balance Sheets while the current portion of those indicated as liabilities are included in Accrued expenses and other current liabilities. The non-current portions indicated as assets or liabilities are included in the Consolidated Balance Sheets in Other assets or Other liabilities, respectively.

40

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

        The significant methods and assumptions used in estimating the fair values of derivative financial instruments are as follows:

        The fair value of interest rate swaps is calculated by discounting the future cash flows on the basis of the market interest rates applicable for the remaining term of the contract at the balance sheet date. To determine the fair value of foreign exchange forward contracts, the contracted forward rate is compared to the current forward rate for the remaining term of the contract at the balance sheet date. The result is then discounted on the basis of the market interest rates prevailing at the balance sheet date for the applicable currency.

        The Company includes its own credit risk for financial instruments deemed liabilities and counterparty-credit risks for financial instruments deemed assets when measuring the fair value of derivative financial instruments.

The Effect of Derivatives on the Consolidated Financial Statements

	Amount of Gain or (Loss) Recognized in OCI on Derivatives						Amount of (Gain) or Loss Reclassified from AOCI in Income (Effective Portion) for the six months ended June 30,
	(Effective Portion) for the six months ended June 30,
						Location of (Gain) or Loss Reclassified from AOCI in Income (Effective Portion)
Derivatives in Cash Flow Hedging Relationships	2013		2012				2013		2012
Interest rate contracts	$	3,585	$	(4,913	)	Interest income/expense	$	13,094	$	10,527
Foreign exchange contracts		1,962		8,883		Costs of Revenue		514		(7,261	)
Foreign exchange contracts						Interest income/expense		735		1,006
	$	5,547	$	3,970			$	14,343	$	4,272

		Amount of (Gain) or Loss Recognized in Income on Derivatives for the six months ended June 30,
	Location of (Gain) or Loss Recognized in Income on Derivative
Derivatives not Designated as Hedging Instruments		2013			2012
Foreign exchange contracts	Selling, general and administrative expense	$	(42,102	)	$	(1,458	)
Foreign exchange contracts	Interest income/expense		3,397			3,066
		$	(38,705	)	$	1,608

        For foreign exchange derivatives, the Company expects to recognize $974 of losses deferred in AOCI at June 30, 2013, in earnings during the next twelve months.

        The Company expects to incur additional interest expense of $19,787 over the next twelve months which is currently deferred in AOCI. At June 30, 2013, this amount reflects the projected amortization of the settlement amount of the terminated swaps and the current fair value of the additional interest payments resulting from the remaining interest rate swap maturing in 2016.

        At June 30, 2013, the Company had foreign exchange derivatives with maturities of up to 29 months and interest rate swaps with maturities of up to 40 months.

41

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

13.   Other Comprehensive Income (Loss)

        Changes in accumulated other comprehensive income (loss) by component for the six months ended June 30, 2013 and 2012 are as follows:

	Gain (Loss) related to cash flow hedges			Actuarial gain (loss) on defined benefit pension plans			Gain (loss) related to foreign- currency translation			Total, before non-controlling interests			Non-controlling interests			Total
Balance at December 31, 2011	$	(136,221	)	$	(111,215	)	$	(238,331	)	$	(485,767	)	$	3,048		$	(482,719	)
Other comprehensive income (loss) before reclassifications		(17,181	)		—			(47,702	)		(64,883	)		86			(64,797	)
Amounts reclassified from accumulated other comprehensive income (loss)(1)		4,892			5,316			—			10,208			—			10,208
Other comprehensive income (loss) after reclassifications		(12,289	)		5,316			(47,702	)		(54,675	)		86			(54,589	)
Balance at June 30, 2012	$	(148,510	)	$	(105,899	)	$	(286,033	)	$	(540,442	)	$	3,134		$	(537,308	)
Balance at December 31, 2012	$	(138,341	)	$	(179,423	)	$	(174,349	)	$	(492,113	)	$	2,869		$	(489,244	)
Other comprehensive income (loss) before reclassifications		4,902			—			(125,044	)		(120,142	)		(2,318	)		(122,460	)
Amounts reclassified from accumulated other comprehensive income (loss)(1)		9,974			7,877			—			17,851			—			17,851
Other comprehensive income (loss) after reclassifications		14,876			7,877			(125,044	)		(102,291	)		(2,318	)		(104,609	)
Balance at June 30, 2013	$	(123,465	)	$	(171,546	)	$	(299,393	)	$	(594,404	)	$	551		$	(593,853	)

(1)

See separate table below for details about these reclassifications.

42

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

        Reclassifications out of accumulated other comprehensive income (loss) for the six months ended June 30, 2013 and 2012 are as follows:

	Amount of (Gain) Loss reclassified from AOCI in Income
	For the six months ended June 30,
Details about Accumulated Other Comprehensive Income (Loss) ("AOCI") Components							Location of (Gain) Loss reclassified from AOCI in Income
	2013			2012
(Gain) Loss related to cash flow hedges
Interest rate contracts	$	13,094		$	10,527		Interest income/expense
Foreign exchange contracts		514			(7,261	)	Costs of Revenue
Foreign exchange contracts		735			1,006		Interest income/expense
		14,343			4,272		Total before tax
		(4,369	)		620		Tax expense or benefit
	$	9,974		$	4,892		Net of tax
Actuarial (Gain) Loss on defined benefit pension plans
Amortization of unrealized (gain) /loss		12,777			8,743		(1)
		12,777			8,743		Total before tax
		(4,900	)		(3,427	)	Tax expense or benefit
	$	7,877		$	5,316		Net of tax
Total reclassifications for the period	$	17,851		$	10,208		Net of tax

(1)

Included in the computation of net periodic pension cost (see Note 8 for additional details).

14.   Business Segment and Corporate Information

        The Company has identified three operating segments, North America Segment, EMEALA and Asia Pacific, which were determined based upon how the Company manages its businesses. All segments are primarily engaged in providing dialysis care services and the distribution of products and equipment for the treatment of ESRD. The Company has aggregated EMEALA and the Asia Pacific operating segments as the "International Segment." The segments are aggregated due to their similar economic characteristics. These characteristics include same services provided and same products sold, the same type patient population, similar methods of distribution of products and services and similar economic environments. The General Partner's management board member responsible for the profitability and cash flow of each segment's various businesses supervises the management of each operating segment. The accounting policies of the segments are the same as those the Company applies in preparing the consolidated financial statements under accounting principles generally accepted in the U.S. ("U.S. GAAP").

        Management evaluates each segment using a measure that reflects all of the segment's controllable revenues and expenses. With respect to the performance of business operations, management believes that the most appropriate measure in this regard is operating income which measures the Company's source of earnings. The Company does not include the investment gain resulting from the 2012 Liberty Acquisition nor income taxes as it believes these items to be outside the segments' control. Financing is a corporate function, which the Company's segments do not control. Therefore, the Company does not include interest expense relating to financing as a segment measurement. Similarly, the Company does not allocate "corporate costs," which relate primarily to certain headquarters overhead charges, including accounting and finance, global research and development, etc., because the Company believes that these costs are also not within the control of the individual segments. Production of products, production asset management, quality management and procurement are centrally managed in Corporate by Global Manufacturing

43

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

Operations. These corporate activities do not fulfill the definition of a segment. Products are transferred to the segments at cost; therefore no internal profit is generated. The associated internal revenues for the product transfers and their elimination are recorded as corporate activities. Capital expenditures for production are based on the expected demand of the segments and consolidated profitability considerations. In addition, certain revenues, investments and intangible assets, as well as any related expenses, are not allocated to a segment but are accounted for as "Corporate".

        Information pertaining to the Company's segments and its Corporate activities for the three- and six-month periods ended June 30, 2013 and 2012 is set forth below.

	North America Segment			International Segment			Segment Total			Corporate			Total
Three months ended June 30, 2013
Net revenue external customers	$	2,375,247		$	1,228,322		$	3,603,569		$	8,946		$	3,612,515
Inter—segment revenue		1,771			—			1,771			(1,771	)		—
Revenue		2,377,018			1,228,322			3,605,340			7,175			3,612,515
Depreciation and amortization		(81,208	)		(45,701	)		(126,909	)		(31,892	)		(158,801	)
Operating income		393,806			208,964			602,770			(58,531	)		544,239
Income (loss) from equity method investees		3,646			53			3,699			717			4,416
Capital expenditures, acquisitions and investments		107,948			66,175			174,123			41,757			215,880
Three months ended June 30, 2012
Net revenue external customers	$	2,248,692		$	1,170,902		$	3,419,594		$	8,379		$	3,427,973
Inter—segment revenue		3,088			—			3,088			(3,088	)		—
Revenue		2,251,780			1,170,902			3,422,682			5,291			3,427,973
Depreciation and amortization		(79,113	)		(42,914	)		(122,027	)		(28,850	)		(150,877	)
Operating income		431,084			207,223			638,307			(49,482	)		588,825
Income (loss) from equity method investees		8,338			62			8,400			(4,542	)		3,858
Capital expenditures, acquisitions and investments		101,463			60,934			162,397			35,985			198,382
Six months ended June 30, 2013
Net revenue external customers	$	4,662,497		$	2,396,974		$	7,059,471		$	16,965		$	7,076,436
Inter—segment revenue		2,846			—			2,846			(2,846	)		—
Revenue		4,665,343			2,396,974			7,062,317			14,119			7,076,436
Depreciation and amortization		(161,368	)		(90,954	)		(252,322	)		(62,832	)		(315,154	)
Operating Income		762,659			392,771			1,155,430			(117,878	)		1,037,552
Income (loss) from equity method investees		7,935			968			8,903			321			9,224
Segment assets		14,094,573			5,971,985			20,066,557			2,261,790			22,328,347
thereof investments in equity method investees		247,277			375,343			622,620			(5,190	)		617,430
Capital expenditures, acquisitions and investments(1)		220,280			148,877			369,157			66,294			435,451
Six months ended June 30, 2012
Net revenue external customers	$	4,353,276		$	2,306,991		$	6,660,267		$	16,461		$	6,676,728
Inter—segment revenue		6,540			—			6,540			(6,540	)		—
Revenue		4,359,816			2,306,991			6,666,807			9,921			6,676,728
Depreciation and amortization		(151,129	)		(85,841	)		(236,970	)		(57,281	)		(294,251	)
Operating Income		778,917			402,135			1,181,052			(89,261	)		1,091,791
Income (loss) from equity method investees		11,320			129			11,449			(2,094	)		9,355
Segment assets		13,788,169			5,695,843			19,484,012			2,260,398			21,744,410
thereof investments in equity method investees		246,161			360,169			606,330			(2,714	)		603,616
Capital expenditures, acquisitions and investments(2)		1,862,044			99,820			1,961,864			63,738			2,025,602

(1)

International acquisitions exclude $11,684 of non-cash acquisitions for 2013.

(2)

North America acquisitions exclude $496,386 of non-cash acquisitions and International acquisitions exclude $3,415 of non-cash acquisitions for 2012.

44

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

15.   Supplementary Cash Flow Information

        The following additional information is provided with respect to the consolidated statements of cash flows:

	Six months ended June 30,
	2013			2012
Supplementary cash flow information:
Cash paid for interest	$	191,259		$	155,263
Cash paid for income taxes(1)	$	225,740		$	229,128
Cash inflow for income taxes from stock option exercises	$	3,933		$	3,277
Supplemental disclosures of cash flow information:
Details for acquisitions:
Assets acquired	$	(130,864	)	$	(2,337,691	)
Liabilities assumed		17,173			226,377
Noncontrolling interest subject to put provisions		15,320			87,201
Noncontrolling interest		5,570			95,418
Obligations assumed in connection with acquisition		11,683			15,102
Cash paid		(81,118	)		(1,913,593	)
Less cash acquired		5,139			170,301
Net cash paid for acquisitions		(75,979	)		(1,743,292	)
Cash paid for investments		(22,894	)		(390	)
Cash paid for intangible assets		(2,936	)		(4,497	)
Total cash paid for acquisitions and investments, net of cash acquired, and purchases of intangible assets	$	(101,809	)	$	(1,748,179	)

(1)

Net of tax refund.

16.   Supplemental Condensed Combining Information

        FMC Finance III, a former wholly-owned subsidiary of the Company, issued 6⁷/8% Senior Notes due 2017 in July 2007. On June 20, 2011, Fresenius Medical Care US Finance, Inc. ("US Finance") acquired substantially all of the assets of FMC Finance III and assumed its obligations, including the 6⁷/8% Senior Notes and the related indenture. The 6⁷/8% senior notes are fully and unconditionally guaranteed, jointly and severally on a senior basis, by the Company and by D-GmbH and FMCH ("the Guarantor Subsidiaries"). The 6⁷/8% Senior Notes and related guarantees were issued in an exchange offer registered under the Securities Act of 1933. The financial statements in this report present the financial condition, results of operations and cash flows of the Company, on a consolidated basis at June 30, 2013 and December 31, 2012 and for the six-month periods ended June 30, 2013 and 2012. The following combining financial information for the Company is at June 30, 2013 and December 31, 2012 and for the six-month periods ended June 30, 2013 and 2012, segregated between FMC US Finance as issuer, the Company, the Guarantor Subsidiaries, and the Company's other businesses (the "Non-Guarantor Subsidiaries"). For purposes of the condensed combining information, the Company and the Guarantor Subsidiaries carry their investments under the equity method. Other (income) expense includes income (loss) related to investments in consolidated subsidiaries recorded under the equity method for purposes of the condensed

45

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

combining information. In addition, other (income) expense includes income and losses from profit and loss transfer agreements as well as dividends received.

	For the six months ended June 30, 2013
	Issuer			Guarantors
	FMC US Finance			FMC-AG & Co. KGaA			D-GmbH			FMCH			Non-Guarantor Subsidiaries		Combining Adjustment			Combined Total
Net revenue	$	—		$	—		$	1,006,662		$	—		$	7,664,410	$	(1,594,636	)	$	7,076,436
Cost of revenue		—			—			663,055			—			5,719,837		(1,574,347	)		4,808,545
Gross profit		—			—			343,607			—			1,944,573		(20,289	)		2,267,891
Operating expenses (income):
Selling, general and administrative(1)		—			40,547			106,983			(55,685	)		1,057,633		19,568			1,169,046
Research and development		—			—			36,549			—			24,912		(168	)		61,293
Operating (loss) income		—			(40,547	)		200,075			55,685			862,028		(39,689	)		1,037,552
Other (income) expense:
Interest, net		(3,417	)		95,049			3,804			87,078			24,349		417			207,280
Other, net		—			(615,001	)		164,333			(383,157	)		—		833,825			—
Income (loss) before income taxes		3,417			479,405			31,938			351,764			837,679		(873,931	)		830,272
Income tax expense (benefit)		1,240			(8,618	)		37,248			(12,385	)		285,430		(30,301	)		272,614
Net Income (loss)		2,177			488,023			(5,310	)		364,149			552,249		(843,630	)		557,658
Net Income attributable to noncontrolling interests		—			—			—			—			—		69,635			69,635
Net income (loss) attributable to shareholders of FMC-AG & Co. KGaA	$	2,177		$	488,023		$	(5,310	)	$	364,149		$	552,249	$	(913,265	)	$	488,023

(1)

Selling, general and administrative is presented net of Gain on Sale of dialysis clinics and net of income from equity method investees.

	For the six months ended June 30, 2012
	Issuer			Guarantors
	FMC US Finance			FMC-AG & Co. KGaA			D-GmbH		FMCH			Non-Guarantor Subsidiaries			Combining Adjustment			Combined Total
Net revenue	$	—		$	—		$	928,262	$	—		$	7,183,245		$	(1,434,779	)	$	6,676,728
Cost of revenue		—			—			587,675		—			5,317,223			(1,424,553	)		4,480,345
Gross profit		—			—			340,587		—			1,866,022			(10,226	)		2,196,383
Operating expenses (income):
Selling, general and administrative(1)		—			5,066			104,788		68,031			836,598			34,649			1,049,132
Research and development		—			—			34,134		—			21,326			—			55,460
Operating (loss) income		—			(5,066	)		201,665		(68,031	)		1,008,098			(44,875	)		1,091,791
Other (income) expense:
Investment gain		—			—			—		—			(139,600	)		—			(139,600	)
Interest, net		(3,412	)		103,541			1,741		72,356			28,849			—			203,075
Other, net		—			(817,512	)		130,561		(505,714	)		—			1,192,665			—
Income (loss) before income taxes		3,412			708,905			69,363		365,327			1,118,849			(1,237,540	)		1,028,316
Income tax expense (benefit)		1,250			49,070			58,233		(55,383	)		394,507			(138,359	)		309,318
Net Income (loss)		2,162			659,835			11,130		420,710			724,342			(1,099,181	)		718,998
Net Income attributable to noncontrolling interests		—			—			—		—			—			59,163			59,163
Net income (loss) attributable to shareholders of FMC-AG & Co. KGaA	$	2,162		$	659,835		$	11,130	$	420,710		$	724,342		$	(1,158,344	)	$	659,835

(1)

Selling, general and administrative is presented net of Gain on Sale of dialysis clinics and net of income from equity method investees.

46

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

	For the six months ended June 30, 2013
	Issuer		Guarantors
	FMC US Finance		FMC-AG & Co. KGaA			D-GmbH			FMCH			Non- Guarantor Subsidiaries			Combining Adjustment			Combined Total
Net Income	$	2,177	$	488,023		$	(5,310	)	$	364,149		$	552,249		$	(843,630	)	$	557,658
Gain (loss) related to cash flow hedges		—		14,431			—			—			5,459			—			19,890
Actuarial gain (loss) on defined benefit pension plans		—		65			1,267			11,335			110			—			12,777
Gain (loss) related to foreign currency translation		—		27,707			(6,535	)		—			(154,567	)		6,033			(127,362	)
Income tax (expense) benefit related to components of other comprehensive income		—		(4,162	)		(369	)		(4,472	)		(911	)		—			(9,914	)
Other comprehensive income (loss), net of tax		—		38,041			(5,637	)		6,863			(149,909	)		6,033			(104,609	)
Total comprehensive income	$	2,177	$	526,064		$	(10,947	)	$	371,012		$	402,340		$	(837,597	)	$	453,049
Comprehensive income attributable to noncontrolling interests		—		—			—			—			—			67,317			67,317
Comprehensive income attributable to shareholders of FMC-AG & Co. KGaA	$	2,177	$	526,064		$	(10,947	)	$	371,012		$	402,340		$	(904,914	)	$	385,732

	For the six months ended June 30, 2012
	Issuer		Guarantors
	FMC US Finance		FMC-AG & Co. KGaA			D-GmbH			FMCH			Non- Guarantor Subsidiaries			Combining Adjustment			Combined Total
Net Income	$	2,162	$	659,835		$	11,130		$	420,710		$	724,342		$	(1,099,181	)	$	718,998
Gain (loss) related to cash flow hedges		—		(5,916	)		(9	)		11,725			2,442			—			8,242
Actuarial gain (loss) on defined benefit pension plans		—		15			186			8,536			6			—			8,743
Gain (loss) related to foreign currency translation		—		26,112			18,886			—			(94,106	)		1,492			(47,616	)
Income tax (expense) benefit related to components of other comprehensive income		—		3,427			(51	)		(7,993	)		(19,341	)		—			(23,958	)
Other comprehensive income (loss), net of tax		—		23,638			19,012			12,268			(110,999	)		1,492			(54,589	)
Total comprehensive income	$	2,162	$	683,473		$	30,142		$	432,978		$	613,343		$	(1,097,689	)	$	664,409
Comprehensive income attributable to noncontrolling interests		—		—			—			—			—			59,249			59,249
Comprehensive income attributable to shareholders of FMC-AG & Co. KGaA	$	2,162	$	683,473		$	30,142		$	432,978		$	613,343		$	(1,156,938	)	$	605,160

47

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

	At June 30, 2013
	Issuer		Guarantors
	FMC US Finance		FMC-AG & Co. KGaA		D-GmbH		FMCH		Non- Guarantor Subsidiaries		Combining Adjustment			Combined Total
Current assets:
Cash and cash equivalents	$	1	$	4,932	$	595	$	—	$	550,768	$	29,561		$	585,857
Trade accounts receivable, less allowance for doubtful accounts		—		—		178,405		—		2,852,762		—			3,031,167
Accounts receivable from related parties		1,269,703		1,816,703		1,647,943		1,665,304		4,471,651		(10,680,436	)		190,868
Inventories		—		—		293,332		—		898,209		(136,442	)		1,055,099
Prepaid expenses and other current assets		—		104,662		46,298		67		842,973		777			994,777
Deferred taxes		—		—		—		—		291,134		899			292,033
Total current assets		1,269,704		1,926,297		2,166,573		1,665,371		9,907,497		(10,785,641	)		6,149,801
Property, plant and equipment, net		—		540		215,429		—		2,839,566		(120,395	)		2,935,140
Intangible assets		—		690		72,003		—		608,636		(65	)		681,264
Goodwill		—		—		54,374		—		11,414,225		—			11,468,599
Deferred taxes		—		69,036		7,645		—		123,080		(64,130	)		135,631
Other assets and notes receivables(1)		—		12,780,039		28,056		12,140,029		5,998,848		(29,989,060	)		957,912
Total assets	$	1,269,704	$	14,776,602	$	2,544,080	$	13,805,400	$	30,891,852	$	(40,959,291	)	$	22,328,347
Current liabilities:
Accounts payable	$	—	$	659	$	36,248	$	—	$	457,040	$	—		$	493,947
Accounts payable to related parties		—		2,064,018		730,076		1,597,911		6,525,218		(10,717,938	)		199,285
Accrued expenses and other current liabilities		29,771		45,648		133,908		3,262		1,618,116		459			1,831,164
Short-term borrowings		—		42		—		—		115,280		—			115,322
Short-term borrowings from related parties		—		—		—		—		59,364		—			59,364
Current portion of long-term debt and capital lease obligations		—		280,629		—		200,000		33,489		—			514,118
Income tax payable		—		103,521		—		—		41,548		9,869			154,938
Deferred taxes		—		4,820		9,638		—		63,487		(40,536	)		37,409
Total current liabilities		29,771		2,499,337		909,870		1,801,173		8,913,542		(10,748,146	)		3,405,547
Long term debt and capital lease obligations, less current portion		1,169,932		207,763		—		2,501,512		6,993,976		(3,216,171	)		7,657,012
Long term borrowings from related parties		—		3,185,549		651,161		2,006,006		7,433		(5,850,149	)		—
Other liabilities		—		5,775		13,340		11,830		261,047		32,346			324,338
Pension liabilities		—		9,464		208,554		—		214,042		—			432,060
Income tax payable		2,633		26,974		—		—		42,109		133,722			205,438
Deferred taxes		—		—		—		—		680,438		(27,826	)		652,612
Total liabilities		1,202,336		5,934,862		1,782,925		6,320,521		17,112,587		(19,676,224	)		12,677,007
Noncontrolling interests subject to put provisions		—		—		—		—		541,347		—			541,347
Total FMC-AG & Co. KGaA shareholders' equity		67,368		8,841,740		761,155		7,484,879		12,969,665		(21,283,067	)		8,841,740
Noncontrolling interests not subject to put provisions		—		—		—		—		268,253		—			268,253
Total equity		67,368		8,841,740		761,155		7,484,879		13,237,918		(21,283,067	)		9,109,993
Total liabilities and equity	$	1,269,704	$	14,776,602	$	2,544,080	$	13,805,400	$	30,891,852	$	(40,959,291	)	$	22,328,347

(1)

Other Assets and notes receivables are presented net of investment in equity method investees.

48

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

	At December 31, 2012
	Issuer		Guarantors
	FMC US Finance		FMC-AG & Co. KGaA		D-GmbH		FMCH		Non- Guarantor Subsidiaries			Combining Adjustment			Combined Total
Current assets:
Cash and cash equivalents	$	1	$	78	$	501	$	—	$	686,457		$	1,003		$	688,040
Trade accounts receivable, less allowance for doubtful accounts		—		—		170,627		—		2,848,797			—			3,019,424
Accounts receivable from related parties		1,269,471		2,257,445		1,449,317		3,562,953		4,398,630			(12,800,007	)		137,809
Inventories		—		—		271,039		—		885,613			(119,843	)		1,036,809
Prepaid expenses and other current assets		—		72,022		27,693		167		837,152			727			937,761
Deferred taxes		—		—		—		—		311,280			(3,667	)		307,613
Total current assets		1,269,472		2,329,545		1,919,177		3,563,120		9,967,929			(12,921,787	)		6,127,456
Property, plant and equipment, net		—		611		206,873		—		2,856,000			(122,881	)		2,940,603
Intangible assets		—		584		67,874		—		641,714			(56	)		710,116
Goodwill		—		—		54,848		—		11,367,041			—			11,421,889
Deferred taxes		—		51,111		10,123		—		131,452			(58,933	)		133,753
Other assets and notes receivables(1)		—		12,675,998		650,255		11,766,104		(4,751,531	)		(19,348,645	)		992,181
Total assets	$	1,269,472	$	15,057,849	$	2,909,150	$	15,329,224	$	20,212,605		$	(32,452,302	)	$	22,325,998
Current liabilities:
Accounts payable	$	—	$	1,935	$	41,114	$	—	$	579,245		$	—		$	622,294
Accounts payable to related parties		—		2,234,205		491,525		1,598,852		8,663,240			(12,864,472	)		123,350
Accrued expenses and other current liabilities		29,771		27,530		102,728		3,157		1,611,997			12,288			1,787,471
Short-term borrowings		—		38		—		—		117,812			—			117,850
Short-term borrowings from related parties		—		—		—		—		3,973			—			3,973
Current portion of long-term debt and capital lease obligations		—		207,160		—		100,000		27,587			—			334,747
Income tax payable		—		130,636		—		—		19,367			—			150,003
Deferred taxes		—		1,622		8,126		—		61,774			(41,219	)		30,303
Total current liabilities		29,771		2,603,126		643,493		1,702,009		11,084,995			(12,893,403	)		3,169,991
Long term debt and capital lease obligations, less current portion		1,172,397		285,049		—		2,559,340		7,020,190			(3,251,236	)		7,785,740
Long term borrowings from related parties		—		3,212,455		657,284		2,019,925		64,530			(5,898,020	)		56,174
Other liabilities		—		6,696		12,679		110,637		130,634			33,923			294,569
Pension liabilities		—		7,753		202,219		—		213,389			—			423,361
Income tax payable		2,113		264		—		—		52,684			146,581			201,642
Deferred taxes		—		—		—		—		685,158			(21,157	)		664,001
Total liabilities		1,204,281		6,115,343		1,515,675		6,391,911		19,251,580			(21,883,312	)		12,595,478
Noncontrolling interests subject to put provisions		—		—		—		—		523,260			—			523,260
Total FMC-AG & Co. KGaA shareholders' equity		65,191		8,942,506		1,393,475		8,937,313		173,011			(10,568,990	)		8,942,506
Noncontrolling interests not subject to put provisions		—		—		—		—		264,754			—			264,754
Total equity		65,191		8,942,506		1,393,475		8,937,313		437,765			(10,568,990	)		9,207,260
Total liabilities and equity	$	1,269,472	$	15,057,849	$	2,909,150	$	15,329,224	$	20,212,605		$	(32,452,302	)	$	22,325,998

(1)

Other Assets and notes receivables are presented net of investment in equity method investees.

49

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

	For the six months ended June 30, 2013
	Issuer			Guarantors
	FMC US Finance			FMC-AG & Co. KGaA			D-GmbH			FMCH			Non- Guarantor Subsidiaries			Combining Adjustment			Combined Total
Operating Activities:
Net income (loss)	$	2,177		$	488,023		$	(5,310	)	$	364,149		$	552,249		$	(843,630	)	$	557,658
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Equity affiliate income		—			(331,592	)		—			(383,157	)		—			714,749			—
Depreciation and amortization		—			330			24,691			—			305,236			(15,103	)		315,154
Change in deferred taxes, net		—			(19,248	)		3,651			—			18,363			(9,336	)		(6,570	)
(Gain) loss on sale of fixed assets and investments		—			(12	)		(153	)		—			(6,089	)		—			(6,254	)
Compensation expense related to stock options		—			12,777			—			—			—			—			12,777
Cash inflow (outflow) from hedging		—			(4,028	)		—			—			—			—			(4,028	)
Investments in equity method investees, net		—			22,691			—			—			(7,940	)		—			14,751
Changes in assets and liabilities, net of amounts from businesses acquired:
Trade accounts receivable, net		—			—			(11,574	)		—			(51,000	)		—			(62,574	)
Inventories		—			—			(24,736	)		—			(29,542	)		20,013			(34,265	)
Prepaid expenses and other current and non-current assets		—			10,768			(17,389	)		(53,403	)		60,215			28,585			28,776
Accounts receivable from / payable to related parties		(410	)		286,966			68,660			57,847			(462,322	)		70,579			21,320
Accounts payable, accrued expenses and other current and non-current liabilities		—			10,171			38,199			106			(53,631	)		(3,854	)		(9,009	)
Income tax payable		520			729			—			(12,385	)		(1,376	)		25,313			12,801
Net cash provided by (used in) operating activities		2,287			477,575			76,039			(26,843	)		324,163			(12,684	)		840,537
Investing Activities:
Purchases of property, plant and equipment		—			(45	)		(39,394	)		—			(311,089	)		16,886			(333,642	)
Proceeds from sale of property, plant and equipment		—			17			271			—			14,508			—			14,796
Disbursement of loans to related parties		—			45,738			—			28,419			—			(74,157	)		—
Acquisitions and investments, net of cash acquired, and purchases of intangible assets		—			(23,076	)		(1,943	)		—			(100,883	)		24,093			(101,809	)
Proceeds from divestitures		—			—			—			—			17,824			—			17,824
Net cash provided by (used in) investing activities		—			22,634			(41,066	)		28,419			(379,640	)		(33,178	)		(402,831	)
Financing Activities:
Short-term borrowings, net		—			4			(34,873	)		—			35,808			—			939
Long-term debt and capital lease obligations, net		(2,287	)		354			—			1,730,386			(1,769,326	)		74,157			33,284
Increase (decrease) of accounts receivable securitization program		—			—			—			—			23,000			—			23,000
Proceeds from exercise of stock options		—			32,210			—			—			3,932			—			36,142
Purchase of treasury stock		—			(230,654	)		—			—			—			—			(230,654	)
Dividends paid		—			(296,134	)		—			—			(1,665	)		1,665			(296,134	)
Capital increase (decrease)		—			—			—			(1,731,962	)		1,733,364			(1,402	)		—
Distributions to noncontrolling interest		—			—			—			—			(117,855	)		—			(117,855	)
Contributions from noncontrolling interest		—			—			—			—			27,157			—			27,157
Net cash provided by (used in) financing activities		(2,287	)		(494,220	)		(34,873	)		(1,576	)		(65,585	)		74,420			(524,121	)
Effect of exchange rate changes on cash and cash equivalents		—			(1,135	)		(6	)		—			(14,627	)		—			(15,768	)
Cash and Cash Equivalents:
Net increase (decrease) in cash and cash equivalents		—			4,854			94			—			(135,689	)		28,558			(102,183	)
Cash and cash equivalents at beginning of period		1			78			501			—			686,457			1,003			688,040
Cash and cash equivalents at end of period	$	1		$	4,932		$	595		$	—		$	550,768		$	29,561		$	585,857

50

FRESENIUS MEDICAL CARE AG & Co. KGaA

Notes to Consolidated Financial Statements (Continued)

(unaudited)

(in thousands, except share and per share data)

	For the six months ended June 30, 2012
	Issuer			Guarantors
	FMC US Finance			FMC-AG & Co. KGaA			D-GmbH			FMCH			Non- Guarantor Subsidiaries			Combining Adjustment			Combined Total
Operating Activities:
Net income (loss)	$	2,162		$	659,835		$	11,130		$	420,710		$	724,342		$	(1,099,181	)	$	718,998
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Equity affiliate income		—			(532,403	)		—			(505,714	)		—			1,038,117			—
Depreciation and amortization		—			221			23,540			—			284,698			(14,208	)		294,251
Change in deferred taxes, net		—			14,485			5,121			—			48,162			(2,834	)		64,934
(Gain) loss on sale of fixed assets and investments		—			(40	)		20			—			(32,954	)		—			(32,974	)
Investment (gain)		—			—			—			—			(139,600	)		—			(139,600	)
Compensation expense related to stock options		—			12,949			—			—			—			—			12,949
Cash outflow from hedging		—			1,334			—			—			(15,408	)		—			(14,074	)
Investments in equity method investees, net		—			36,785			—			—			(7,806	)		—			28,979
Changes in assets and liabilities, net of amounts from businesses acquired:
Trade accounts receivable, net		—			—			(13,554	)		—			1,056			—			(12,498	)
Inventories		—			—			(52,595	)		—			(19,998	)		7,772			(64,821	)
Prepaid expenses and other current and non-current assets		—			120,331			(21,321	)		73,363			(47,295	)		(820	)		124,258
Accounts receivable from / payable to related parties		(4,127	)		(241,016	)		66,759			70,910			36,203			52,513			(18,758	)
Accounts payable, accrued expenses and other current and non-current liabilities		—			(812	)		35,310			3,822			(19,087	)		(1,905	)		17,328
Income tax payable		252			(11,026	)		—			(55,383	)		54,560			(35,415	)		(47,012	)
Net cash provided by (used in) operating activities		(1,713	)		60,643			54,410			7,708			866,873			(55,961	)		931,960
Investing Activities:
Purchases of property, plant and equipment		—			(361	)		(31,912	)		—			(262,701	)		17,551			(277,423	)
Proceeds from sale of property, plant and equipment		—			40			147			—			3,477			—			3,664
Disbursement of loans to related parties		—			(45,917	)		82			513,595			—			(467,760	)		—
Acquisitions and investments, net of cash acquired, and purchases of intangible assets		—			(1,627,403	)		(488	)		—			(1,747,201	)		1,626,913			(1,748,179	)
Proceeds from divestitures		—			45			—			—			228,206			(45	)		228,206
Net cash provided by (used in) investing activities		—			(1,673,596	)		(32,171	)		513,595			(1,778,219	)		1,176,659			(1,793,732	)
Financing Activities:
Short-term borrowings, net		—			9,306			(21,944	)		—			27,972			—			15,334
Long-term debt and capital lease obligations, net		1,713			1,943,267			—			(521,303	)		(418,270	)		467,760			1,473,167
Increase (decrease) of accounts receivable securitization program		—			—			—			—			(82,500	)		—			(82,500	)
Proceeds from exercise of stock options		—			19,471			—			—			3,277			—			22,748
Dividends paid		—			(271,733	)		—			—			—			—			(271,733	)
Capital increase (decrease)		—			—			—			—			1,590,083			(1,590,083	)		—
Distributions to noncontrolling interest		—			—			—			—			(79,334	)		—			(79,334	)
Contributions from noncontrolling interest		—			—			—			—			11,763			—			11,763
Net cash provided by (used in) financing activities		1,713			1,700,311			(21,944	)		(521,303	)		1,052,991			(1,122,323	)		1,089,445
Effect of exchange rate changes on cash and cash equivalents		—			1,065			(12	)		—			(8,640	)		—			(7,587	)
Cash and Cash Equivalents:
Net increase (decrease) in cash and cash equivalents		—			88,423			283			—			133,005			(1,625	)		220,086
Cash and cash equivalents at beginning of period		1			2			144			—			457,145			—			457,292
Cash and cash equivalents at end of period	$	1		$	88,425		$	427		$	—		$	590,150		$	(1,625	)	$	677,378

51

Quantitative and Qualitative Disclosures About Market Risk

        During the period ended June 30, 2013, no material changes occurred to the information presented in Item 11 of the Company's Annual Report on Form 20-F for the year ended December 31, 2012, as amended.

52

Controls and Procedures

        The Company is a "foreign private issuer" within the meaning of Rule 3b-4(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). As such, the Company is not required to file quarterly reports with the Securities and Exchange Commission and is required to provide an evaluation of the effectiveness of its disclosure controls and procedures, to disclose significant changes in its internal control over financial reporting, and to provide certifications of its Chief Executive Officer and Chief Financial Officer under Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 only in its Annual Report on Form 20-F. The Company furnishes quarterly financial information to the Securities and Exchange Commission (the "Commission") and such certifications under cover of Form 6-K on a voluntary basis and pursuant to the provisions of the Company's pooling agreement entered into for the benefit of the public holders of our ordinary shares and the holders of our preference shares. In connection with such voluntary reporting, the Company's management, including the Chief Executive Officer and the Chief Financial Officer of the Company's general partner, has conducted an evaluation of the effectiveness of the Company's disclosure controls and procedures as of the end of the period covered by this report, of the type contemplated by Securities Exchange Act Rule 13a-15. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded in connection with the furnishing of this report, that the Company's disclosure controls and procedures are designed to ensure that the information the Company is required to disclose in the reports filed or furnished under the Act is recorded, processed, summarized and reported within the time periods specified in the Commission's rules and forms and are effective to ensure that the information the Company is required to disclose in its reports is accumulated and communicated to the General Partner's Management Board, including the General Partner's Chief Executive Officer and the Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. During the past fiscal quarter, there have been no significant changes in internal controls, or in factors that could significantly affect internal controls.

        During the first half of 2013, our Audit and Corporate Governance Committee continued its investigation, with the assistance of independent counsel, into allegations of conduct in our International segment that may violate the U.S. Foreign Corrupt Practices Act or other anti-bribery laws. For information with respect to that investigation, see Note 11, "Commitments and Contingencies—Legal and Regulatory Matters—Other Litigation and Potential Exposures," of the Notes to Consolidated Financial Statements (Unaudited) presented elsewhere in this report. The Company's independent counsel, in conjunction with the Company's Compliance department, have reviewed the Company's anti-corruption compliance program, including internal controls related to compliance with international anti-bribery laws, and appropriate enhancements are being implemented.

53

Other Information

Legal and Regulatory Matters

        The information in Note 11 of the Notes to Consolidated Financial Statements (Unaudited), "Commitments and Contingencies" presented elsewhere in this report is incorporated by this reference.

Submission of Matters to a Vote of Security Holders

        The Company held its Annual General Meeting ("AGM") in Frankfurt, Germany on May 16, 2013. Prior to the presentation of resolutions to the shareholders for vote, representation was as follows:

        Out of the ordinary capital stock of EUR 302,921,871 nominal value consisting of 302,921,871 ordinary shares, 226,072,802 shares were represented, which accounted for 74.63% of the ordinary share capital.

        Out of preference capital stock of EUR 3,973,333 nominal value consisting of 3,973,333 preference shares, 138,947 preference shares were represented, which is 3.50% of the preference capital.

        In total, capital stock of EUR 306,895,204 nominal value was represented with 226,211,749 shares, which is 73.71% of total capital.

        The nine resolutions proposed for actions by the ordinary shareholders at the AGM and the voting results thereon are set forth as follows:

		Votes (in percentage of shares actually voting)
	Resolution	In Favor			Opposed
TOPIC 1	Resolution on the approval of the annual financial statements of Fresenius Medical Care AG & Co. KGaA for the fiscal year 2012		99.99	%		0.01	%
TOPIC 2	Resolution on the allocation of distributable profit		99.86	%		0.14	%
TOPIC 3	Resolution on the approval of the actions of the General Partner		99.57	%		0.43	%
TOPIC 4	Resolution on the approval of the actions of the members of the Supervisory Board		99.56	%		0.44	%
TOPIC 5	Election of the auditors and consolidated group auditors for the fiscal year 2013		99.47	%		0.53	%
TOPIC 6	Resolution on the conversion of non-voting bearer preference shares into voting bearer ordinary shares by cancelling the preference in terms of dividend payments and amendments of the Articles of the Company		99.97	%		0.03	%
TOPIC 7	Resolution on the amendment to the 2001 International Stock Incentive Plan and on the amendment to the conditional capital pursuant to section 4 (5) of the Articles of the Company		99.96	%		0.04	%
TOPIC 8	Special resolution of the ordinary shareholders on the approval of the resolution on the conversion of non-voting bearer preference shares into voting bearer ordinary shares and amendments to the Articles of the Company and on the approval of the resolutions on the amendment to the 2001 International Employee Participation Program and to the conditional capital pursuant to section 4 (5) of the Articles of the Company		99.97	%		0.03	%
TOPIC 9	Amendment to section 15 of the Articles of the Company (Attendance at the General Meeting and exercise of the voting right)		99.85	%		0.15	%

54

        The Company held its Separate Meeting of Preference Shareholders in Frankfurt, Germany on May 16, 2013. Prior to the presentation of resolutions to the shareholders for vote, representation was as follows:

        Out of the preference capital stock of EUR 3,973,333, nominal value consisting of 3,973,333 preference shares, 3,210,711 preference shares were represented, which accounted for 80.81% of the preference share capital.

        The two resolutions proposed for actions by the preference shareholders at the separate meeting and the voting results thereon are set forth as follows:

		Votes (in percentage of shares actually voting)
	Resolution	In Favor			Opposed
TOPIC 1	Special resolution of the preference shareholders on the approval of the resolutions presumably passed by the ordinary General Meeting of May 16, 2013 under agenda item 6 regarding the conversion of non-voting bearer preference shares into voting bearer ordinary shares and amendments to the Articles of the Company		99.99	%		0.01	%
TOPIC 2	Special resolution of the preference shareholders on the approval to the presumed resolutions of the General Meeting of the Company of May 16, 2013 under agenda item 7 on the amendment to the 2001 International Employee Participation Program and on the amendment to the conditional capital pursuant to section 4 (5) of the Articles of the Company		99.98	%		0.02	%

55

Exhibits

Exhibit No.
	4.32	General Agreement 2013 (mainly related to information technology services) dated May 8, 2013 by and between FMC-AG and Fresenius Netcare GmbH.
	31.1	Certification of Chief Executive Officer and Chairman of the Management Board of the Company's General Partner Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	31.2	Certification of Chief Financial Officer and member of the Management Board of the Company's General Partner Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	32.1	Certification of Chief Executive Officer and Chairman of the Management Board of the Company's General Partner and Chief Financial Officer and member of the Management Board of the Company's General Partner Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (this exhibit accompanies this report as required by the Sarbanes-Oxley Act of 2002 and is not to be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended).
	101	The following financial statements as of and for the six-month period ended June 30, 2013 from FMC-AG & Co. KGaA's Report on Form 6-K for the month of July 2013, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Statements of Income, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Cash Flows, (v) Consolidated Statements of Shareholders' Equity and (vi) Notes to Consolidated Financial Statements.

56

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

        DATE: July 30, 2013

FRESENIUS MEDICAL CARE AG & Co. KGaA a partnership limited by shares, represented by:
FRESENIUS MEDICAL CARE MANAGEMENT AG, its general partner
By:	/s/ RICE POWELL
	Name:	Rice Powell
	Title:	Chief Executive Officer and Chairman of the Management Board of the General Partner
By:	/s/ MICHAEL BROSNAN
	Name:	Michael Brosnan
	Title:	Chief Financial Officer and member of the Management Board of the General Partner

57

EX-31.1

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

I, Rice Powell, certify that:

1.

I have reviewed this report on Form 6-K of Fresenius Medical Care AG & Co. KGaA (the "Report").

2.

Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;

3.

Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Report;

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and we have:

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and

d)

disclosed in this Report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: July 30, 2013

By: /s/ RICE POWELL
Rice Powell
Chief Executive Officer and Chairman of the
Management Board of the General Partner

QuickLinks

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

EX-31.2

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

I, Michael Brosnan, certify that:

1.

I have reviewed this report on Form 6-K of Fresenius Medical Care AG & Co. KGaA (the "Report");

2.

Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;

3.

Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Report;

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and we have:

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and

d)

disclosed in this Report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: July 30, 2013

By: /s/ MICHAEL BROSNAN
Michael Brosnan
Chief Financial Officer and member of the
Management Board of the General Partner

QuickLinks

Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

EX-32.1

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

        In connection with the report of Fresenius Medical Care AG & Co. KGaA (the "Company") on Form 6-K furnished for the month of July 2013 containing its unaudited financial statements as of June 30, 2013 and for the six-month periods ending June 30, 2013 & 2012, as submitted to the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Rice Powell, Chief Executive Officer and Michael Brosnan, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

By:	/s/ RICE POWELL Rice Powell Chief Executive Officer and Chairman of the Management Board of the General Partner
July 30, 2013
By:	/s/ MICHAEL BROSNAN Michael Brosnan Chief Financial Officer and member of the Management Board of the General Partner
July 30, 2013

QuickLinks

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

EX-4.32

Exhibit 4.32

General Agreement 2013

between

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„FME”)

and

Fresenius Netcare GmbH

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„NETCARE”)

Current status	:	18.02.2013
Last printed	:	18.2.2013
Version	:	1.0

Index

Preamble		3
1.	Contractual Structure and Scope of Application	5
2.	NETCARE’s Duties	8
3.	Use of Subcontractors	9
4.	FME’s duties	10
5.	Cooperation	11
6.	Prices, Invoice, Payments	11
7.	Governance Structure and Change Request Procedure	12
8.	Confidentiality	14
9.	Privacy Law/Safety/Compliance with GxP/Order-Data Processing	15
10.	Order-Data Processing (Auftragsdatenverarbeitung)	17
11.	Rights of Use and Intellectual Property RIGHTS	20
12.	Defects AND Warranty	22
13.	Liability	22
14.	Penalties	24
15.	Term and Termination	24
16.	Effect of Termination/Expiration	25
17.	Governing Law, Arbitration	27
18.	Miscellaneous	28

2

GENERAL AGREEMENT

This agreement is made and entered into on 01.01.2013 by and among Fresenius Medical Care AG & Co. KGaA, Else-Kröner-Straße 1, 61352 Bad Homburg v. d. H. (“FME”) and Fresenius Netcare GmbH, Else-Kröner-Straße 1, 61352 Bad Homburg v. d. H. (“NETCARE” and together with FME, the “Parties” and each a “Party”).

PREAMBLE

(A)FME is the parent company of a group that manufactures and distributes dialysisrelated products and provides dialysis services.

(B)NETCARE is a provider of IT services.

(C)The Parties entered into a General Agreement dated 8 December 2003 to provide for a legal framework under which NETCARE provided IT services to FME. The term of such General Agreement will expire on 31 December 2012.

(D)The Parties intend to continue the existing contractual relationship by entering into this General Agreement (hereinafter referred to as the “General Agreement”).

(E)FME, in its own name and on behalf of its current and future affiliates (as listed in Attachment 1 to this Agreement, as amended once a year in accordance with the procedure defined in the MSD), for each limited to users located in the Territory (“Territory” exclusively meaning: FME regions Europe, Africa, Middle East and Latin America, the “FME EMEALA”) and NETCARE intend to agree upon the parameters of their cooperation with respect to services in the field of information technology. This General Agreement and its Annexes and Service Agreements shall describe the services to be provided by NETCARE to FME and the terms and conditions under which the services will be provided and of the cooperation between the Parties with the intention to continue the long term business relationship in the same manner as under the expired General Agreement.

(F)NETCARE has the expertise, knowledge and capacity to provide the IT services under this General Agreement. Based on its previous role as service provider to FME, NETCARE is prepared to assume and render the services, functions and projects described in the Set of Contracts (as defined below) to FME.

(G)Such cooperation shall be governed by the following principles both Parties have accepted:

(i)Information Technology to support the FME business

(ii)Partnership

3

(iii)Transparency

(iv)Competitiveness

(v)Economic benefits and

(vi)Safety

(vii)Compliance

(H)Information Technology to Support FME business. The maxim of the FME EMEALA IT-strategy is to support the business units of FME through the use of information technologies efficiently. According to such maxim, technology is a method serving such purpose consequently and must not become an end in itself. Subject to the terms and conditions of this General Agreement, the Annexes and Service Agreements thereto, “Efficiently” in this context means the use of software close to the standard, the avoidance of custom-developments and, in given cases and subject to written -agreement thereon, the repatriation of uneconomic modifications deviating from the standard.

(I)Partnership. Reliable and high performing information technology may be achieved only in close collaboration between the Parties. Amicable collaboration in this context shall mean frequent communication through established channels of communication as defined in this General Agreement and a common pursuit for achieving goals. Cases of controversy shall be discussed openly and settled amicable. When using their discretion, both Parties shall in no instance disregard the other Party’s interests involved.

(J)Transparency. Either Party shall inform the respective other Party of projects which may affect the collaboration under this General Agreement in due time via the established communication channels as described within this General Agreement. Parties shall undertake to provide data for plausibility analysis if required by the General Agreement, Annexes or Service Agreements thereto.

(K)Competitiveness. Both prices and services or goods rendered shall be competitive to market prices. NETCARE shall be responsible for keeping its compensation scheme proportionate to the costs incurred. Savings earned through joint projects shall be allocated fairly. Pricing and price changes shall be discussed between the Parties and shall be jointly settled. FME may commission benchmark opinions by third Parties. NETCARE shall undertake to assists in such benchmark projects.

(L)Economic effects. It is understood that FME desires to save costs by means of information technology. It shall be a continuous task of both Parties to determine and to realize possible cost saving potentials made available by the use and operation of information

4

technology. However, cost saving measures shall not adversely affect the scope and quality of services rendered under the terms and conditions of any Annex or Service Agreement. (Both Parties are aware, that although the prices per user are envisioned to be decreasing the total cost may increase due to an increasing number of users and additional functionality). The goal of performing cost saving measures shall be a common one even though the intent of NETCARE to make profits contradicts FME’s desire to lower cost at first sight.

(M)Safety. FME shall have unhindered access to its proprietary data. However, unauthorized access by third Parties and employees shall be prevented. NETCARE may not misuse data security rationale for denying FME access to data, e. g. preventing FME to undertake additional data analysis with IT technology which is not covered by this General Agreement.

(N)Compliance. The Parties acknowledge that FME as a company with its business in the medical and pharmaceutical industry operates in a regulated market and is subject to certain legal and regulatory requirements, including, but not limited to GxP, SOX and data protection. NETCARE shall provide the services in a manner required by FME to ensure compliance of FME with such legal requirements and NETCARE shall reasonably assist FME upon request in complying with such legal requirements as far as the legal requirements impose requirements on the IT services and FME has notified NETCARE of the relevant requirements.

(O)Third Party comparison. Furthermore, this General Agreement and the Set of Contracts (as defined below) shall be drafted and construed without taking into account that the Parties are affiliated companies. Therefore, this General Agreement and modules attached hereto shall be in accordance with arm’s length principles and stand third Party comparison. In order to achieve this purpose, FME and NETCARE have commissioned Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft to issue a fairness opinion on the comparability of the terms and conditions of this present Set of Contracts with third Party agreements. The fairness opinion is attached hereto as Attachment 2.

1.CONTRACTUAL STRUCTURE AND SCOPE OF APPLICATION

1.1The complete agreement between the Parties and the contractual structure defined as “Set of Contracts” consists of:

a)this General Agreement; and

b)related documents (the Annexes) such as:

(i)Master Service Description;

5

(ii)Glossary

(iii)Fairness Opinion

c)Service Agreements

(i)Standard Service Agreements

(ii)Individual Service Agreements;

1.2The Set of Contracts is structured in a modular basis:

a)This General Agreement provides the legal framework that shall govern the cooperation between, and the overall relationship and general obligations of, the Parties. The provisions in this General Agreement shall apply as a general agreement to all Annexes and Service Agreements hereto between FME and NETCARE on services provided in the area of information technology.

b)The Service Agreements, as mutually agreed, will define specific Services and provide detailed provisions on individual Services.

1.3The following details shall be provided at a minimum:

6

a)Master Service Description (MSD)

(i)The MSD defines general processes, requirements and conditions for each Service or qualities for the Services.

(ii)MSD defines testing and acceptance procedures as well as general acceptance criteria for the Services.

(iii)MSD shall define the extent, type and purpose of the intended collection, processing or use of personal data, the type of data and categories of data subjects, if applicable to the type of services.

b)Service Agreements

(i)a specified description of the scope and the subject of the Services to be performed by NETCARE.

(ii)time and location of performance of Services.

(iii)tasks to be performed by FME and FME’s assistance.

(iv)reimbursements and service fees.

(v)definition of service levels and measure procedure.

1.4Existing contracts already created as Annexes under the former General Agreement as of 8th December 2003 and not terminated until 31.12.2012 shall become an integral part of the Set of Contracts and shall remain in effect subject to the terms of this General Agreement without amendment under this General Agreement until their regular termination.

1.5In cases of contradictions, clauses in Annexes shall supersede the clauses in this General Agreement, and clauses in Individual Service Agreements or Standard Service Agreements shall supersede the clauses in the General Agreement and the Annexes.

1.6The individual Services to be provided by NETCARE may qualify as service, work, rent or similar type of contract under civil law or a combination of various types of contracts defined under civil law. The Parties shall mutually agree and define the relevant obligations and the type of contract in a Service Agreement, as far as possible, in order to clarify the applicable legal regulations and obligations of the Parties;

1.7For the avoidance of doubt, the contractual provisions and principles set forth in the General Agreement, including but not limited to regulatory, data protection, shall only be subject to change in accordance with the change request procedure pursuant to

7

Section 7.

1.8This General Agreement shall govern all future Services ordered by FME or any of FME EMEALA’s affiliates and rendered by NETCARE to FME or any of FME EMEALA’s affiliates, even where no explicit reference is made hereto, unless the applicability of the General Agreement has been explicitly excluded.

2.NETCARE’S DUTIES

2.1NETCARE will provide Services in the area of information technology to FME. Individual Services and details are specified in the Annexes and Service Agreements.

2.2NETCARE shall

a)render the Services in accordance with the provisions defined in the Set of Contracts and, where applicable and where defined, at the place/location defined in a specific service description in a Service Agreement or, if not defined, at the location mutually agreed by both Parties;

b)render its Services in compliance with applicable statutory accident prevention regulations, applying to NETCARE and FME, if notified by FME of the relevant regulations, as well as applicable statutory health and safety regulations;

c)deliver services in compliance with the current state of the art, as applicable from time to time, according to best practice, and free of material Defects with respect to specifications for the Services.

d)comply, and procure that any of its sub-contractors complies, with FME’s security and control regulations and systems provided that NETCARE has been notified hereof at a reasonable time before the commencement of NETCARE’s performance.

e)procure licenses as agreed in Section 11.

f)provide and use appropriate verification tools to monitor and measure compliance with any service levels agreed in a Service Agreement, whereas such verification tool shall be appropriate if it measures the items to be measured according to the verification method agreed between the Parties in connection with such service level; whether non-compliance with agreed service levels results in legal consequences shall be agreed in the relevant Annex or Service Agreement.

g)be obliged to comply with the license terms of the third party licensor and not use the software in violation of such license. In particular, NETCARE shall notify

8

FME of any violations of such license agreement and terms defined therein.

h)allow FME or an agent of FME to audit whether NETCARE’s use of the software is consistent with the rights granted to NETCARE herein upon request by FME and provided there is a legitimate interest therein and to give full cooperation to FME or its agent carrying out such audit. In case of an audit by the licensor with respect to compliance of FME with the licensing conditions, NETCARE shall reasonably assist FME in providing the information reasonably requested by the licensor in connection with such audit.

2.3Unless explicitly agreed otherwise between the Parties, NETCARE shall not be obliged to consult with FME when modifying or changing any hardor software, or amending any system, used for rendering a Service, unless the modification or change adversely affects the performance of NETCARE or the compliance with any service levels agreed or the compliance with privacy law;

2.4NETCARE is not obliged to deliver the source code unless such obligation is agreed upon in the Service Agreements.

3.USE OF SUBCONTRACTORS

3.1NETCARE may use subcontractors for rendering the services in its own discretion. In no event will NETCARE be relieved of its obligations under this General Agreement as a result of its use of any subcontractors. NETCARE shall inform FME of any subcontractors used upon written request of FME.

3.2NETCARE’s obligations for imposing duties of secrecy and compliance with an obligation towards FME on subcontractors shall be governed by Section 8 and 9 and NETCARE shall ensure that all subcontractors are subject to and comply with the same obligations as are imposed on NETCARE under the terms agreed in the Set of Contracts.

3.3If FME determines that a subcontractor has to be replaced for good reasons, FME shall notify NETCARE explaining the reasons for such a replacement. Following receipt of this notification, NETCARE will promptly, or within such period of time reasonably agreed by the Parties, replace such a subcontractor by another third party or by NETCARE’s personnel. A good reason exists, in particular, if

a)a supervisory authority objects to or prohibits the engagement of a specific subcontractor or the subcontracting with respect to the services rendered by the subcontractor;

9

b)any rights or interests of FME or any of its affiliates with respect to confidentiality, data protection or data security are at risk;

c)a subcontractor engaged in data processing relocates its activities or the data processing or parts thereof to a country outside of the EU;

d)a competitor of FME holds or acquires more than 25% of the interests or voting rights in the subcontractor.

4.FME’S DUTIES

4.1FME shall

a)provide all required reasonable assistance and co-operate with NETCARE including

·the assignment of competent staff to a reasonable extent for problem solution.

·the assignment, supervision and control of FME staff and capacities.

·the assurance that FME employees will comply with FME´s guidelines implemented for the use of the services, data and applications.

b)provide to NETCARE all relevant information and documentation reasonably required by NETCARE for the provision of the Services under the Set of Contracts, including any (internal) guidelines or regulations NETCARE shall comply with when providing the Services.

c)if required, grant NETCARE and its agents and subcontractors access to FME’s premises and equipment free of charge for the time reasonably expectable for an appropriate performance under this Set of Contracts, at least during FME’s regular business hours.

d)assist and cooperate with NETCARE in implementing any changes or system requirements, i.e. by allowing NETCARE to train FME personnel.

e)be obliged to comply with the license terms of the third party licensor and not use the software in violation of such license. In particular, FME shall notify NETCARE of any violations of such license agreement and terms defined therein.

f)allow NETCARE or an agent of NETCARE to audit whether FME’s use of the software is consistent with the rights granted to FME herein upon request by

10

NETCARE and provided there is a legitimate interest therein and to give full co-operation to NETCARE or its agent carrying out such audit. In case of an audit by the licensor with respect to compliance of NETCARE with the licensing conditions, FME shall reasonably assist NETCARE in providing the information reasonably requested by the licensor in connection with such audit.

4.2The Parties shall agree on the specifications of any required assistance and cooperation in connection with a service and an Annex or Service Agreement.

5.COOPERATION

5.1The Parties shall

a)co-operate in good faith;

b)appoint relevant key personnel with respect to the overall management of the Set of Contracts and the cooperation between the Parties and shall ensure that such key personnel will only be replaced for good cause;

c)appoint responsible personnel and contact persons for the coordination and general management of the Services under this General Agreement, the MSD, other Annexes and Service Agreements;

d)inform the other Party of any circumstances that may have an impact on the provision of the services and result in a default with respect to the services as well as any actual default or remedy of defaults;

e)agree on and comply with a defined communication and escalation process which shall leave the obligations of the Parties under the Set of Contracts unaffected, in particular any retention rights or rights to non-performance shall be excluded;

f)co-operate and provide reasonable assistance for transition and migration of the relevant services after termination of any Annex, Service Agreement or this General Agreement.

g)agree on the performance of license management for FME.

6.PRICES, INVOICE, PAYMENTS

6.1All prices, conditions of payment, and schedules are subject to written agreements, and shall be as defined in the MSD and the Service Agreements, if Individual Services are concerned. As regards Standard Services, fees shall be equal to the up-to-

11

date prices listed in the price list for standard services of NETCARE, published, updated and agreed with FME each year.

6.2Services, where no fees have been agreed, shall be rendered according to the hourly or daily rate in accordance with latest price list as per 6.1.

6.3Prices shall be renegotiated and reasonably be modified if a Service Agreement is modified or amended.

6.4A price adjustment clause may be incorporated if applicable in any individual Service Agreement.

6.5Prices are net prices plus the applicable VAT (value added tax, in Germany currently 19%) and as determined in the specific Service Agreement.

6.6Payments hereunder shall be made in EURO.

6.7The payment terms should be agreed between NETCARE and the respective affiliate invoiced in a separate or the relevant Service Agreement. For Germany payment terms shall be according to the applicable Fresenius group procedures. A written invoice shall be provided to the respective affiliate even though the booking is done by EDI. Outside Germany, a payment range between 30 —60 days shall be applied.

6.8Overall NETCARE shall offer to FME competitive prices in the average for a Group of Services, based on the costs for the individual Services. FME shall be entitled to request a review of the prices for a Group of Services. Upon such request, the Parties shall make a benchmarking evaluation. If NETCARE’s prices are out of market range after such benchmarking evaluation, FME shall have the right to request an alternative offer from NETCARE within a period of one month after the benchmarking results. NETCARE shall have a period of three month to prepare such an offer. If FME accepts the alternative offer, acceptance may not be unreasonably withheld, adjusted pricing shall apply with retrospective effect from the date of receipt of FME’s request for an alternative offer. The same procedure shall apply as far as NETCARE’s prices are below market prices whereas NETCARE shall be entitled to submit the alternative offer to FME without request from FME and FME shall be obliged to reasonably accept the alternative offer. If a benchmark of the prices for a Group of Services has been conducted, FME shall not request another review for the next three years after completion of the benchmarking process. Upon request, the Parties shall make a benchmarking evaluation.

7.GOVERNANCE STRUCTURE AND CHANGE REQUEST PROCEDURE

7.1The Parties agree to implement and appoint certain committees and boards for the

12

coordination of the cooperation between the Parties. The governance structure shall have the following three levels:

a)Management Board: strategic level

b)Steering Committee: tactical level

c)Operation Units: operational level.

7.2Obligations and tasks of each level, the constitution and composition of each level as well as escalation procedures shall be governed by and defined in the MSD.

7.3Each Party shall have the right to request in writing a change to the contractual arrangements between the Parties, as agreed in the Set of Contracts, including the processes defined in the MSD, the Services or specifications.

a)Changes with an impact on the specifications or scope of the Services shall be subject to the change procedures defined in the MSD. The following provisions shall apply to any changes to the contractual provisions of this General Agreement or any processes defined in the MSD, the Attachments or any general provisions in the Annexes or Service Agreements that are meant to provide a deviation from the provisions in this General Agreement or the MSD and that do not have an impact on the content or scope of a Service, the service fees or alike (“Contractual Change”).Subject to the terms and conditions of this General Agreement, NETCARE shall undertake to comply with FME’s reasonable requests for a Contractual Change provided that the Parties have agreed in writing on the effects of any Contractual Change on this General Agreement or its Annexes.

b)If provisions in the Set of Contracts are erroneous, incomplete, ambiguous, or impossible to fulfill for anybody, the Parties shall upon request of one Party decide without undue delay on modifying and completing such provisions.

c)If changes in applicable laws, orders of authorities or courts have an impact on the Services or the Set of Contract or make changes to the Services or Set of Contract necessary, NETCARE shall implement such changes upon request of FME or in its own discretion provided that NETCARE will inform FME of such change. The Parties will mutually and reasonably agree on the relevant contractual changes necessary.

d)Neither Party shall unreasonably withhold or delay its consent to a Contractual Change. Any Contractual Change agreed between the Parties shall be made in writing and signed by the Parties.

13

e)Contractual Changes shall be discussed and agreed on the level of the Steering Committee.

8.CONFIDENTIALITY

8.1Each Party shall keep strictly confidential

a)all documents, information, and data, and

b)all trade secrets or confidential information proprietary to one of the Parties or a third Party disclosed to her or obtained by her incidental to the cooperation under the Set of Contracts (Confidential Information). Confidential Information shall include without limitation know-how, details of orders, contractual provisions and prices.

8.2The Parties shall disclose Confidential Information as defined in Section 8.1 to third Parties only upon prior written consent of the other Party. The Parties shall put all third Parties or companies who may receive Confidential Information or who are retained under this General Agreement under the same obligations as the respective Party has entered into.

8.3Subcontractors obtained by NETCARE shall not qualify as third parties under Section 8.2, provided that such subcontractors are under an obligation to keep information confidential at least as protective as the confidentiality provisions under this General Agreement and that the breach of such obligation shall be punishable by an adequate penalty. Confidential Information shall only be disclosed to subcontractors on a need to know basis.

8.4This obligation to keep confidential does not include

a)information which is now or hereafter becomes part of the public domain in other ways than by faults, acts or omissions of the Receiving Party;

b)information which hereafter lawfully comes into the Receiving Party’s possession from an independent third source without any obligation of secrecy;

c)information which the Receiving Party can show by sufficient evidence was in the Receiving Party’s possession prior to the time of receipt from the Disclosing Party, or information or knowledge which was independently developed by or for the Receiving Party without access to any of the Confidential Information disclosed hereunder.

d)information which the Receiving Party has an obligation or duty to disclose under applicable law or by order issued by the competent courts, provided

14

Disclosing Party is given a reasonable opportunity to review the planned disclosure and discuss the need for such with Receiving Party prior to the actual disclosure;

8.5FME shall ensure that any user names and passwords are kept confidential and that only authorized users use the Services and licenses rendered by NETCARE. User names and passwords shall not be disclosed to an third Party and shall be kept confidential in order to prevent access of not authorized third Parties.

9.PRIVACY LAW/SAFETY/COMPLIANCE WITH GXP/ORDER-DATA PROCESSING

9.1NETCARE shall comply with the data protection, data safety and security obligations imposed on FME by the applicable laws and regulations and the provisions of the Network Security Guideline of Fresenius Medical Care AG & Co. KGaA provided to NETCARE by FME.

9.2For that reason and according to requirements imposed on FME by law, regulations and safety aspects, FME has to insist on the obedience of the following terms and conditions. NETCARE acknowledges these terms and conditions as being mandatory for FME to comply with laws, regulations and safety aspects and for the fulfillment of FME’s business.

9.3NETCARE shall be liable to FME that

a)NETCARE follows FME’s instructions with regard to the creation and implementation of user profiles; and

b)system architecture shall maintain the security and consistency of the data, and access by FME officers, employees and agents shall be according to the user profiles; and

c)each of FME’s employees shall have unhindered access to FME’s proprietary data unless such access is restricted by the user profile and/or FME’s other instructions; and

d)no third Party (including employees or representatives of further companies of the Fresenius SE & Co. KGaA group of companies) shall, at any time, have access to FME’s data.

9.4FME shall be entitled to audit and/or qualify NETCARE with respect to the current quality management system and the quality management system envisioned to be implemented under section 9.5, the internal control system prescribed by FME’s corporate governance regulations, and/or, at FME’s choice, to let have an external auditor audit and/or qualify NETCARE once a year, or as deemed necessary, but reasonably

15

acceptable for NETCARE, in order to assure that NETCARE complies with its contractual obligations. Prior to such FME or third Party audit, FME shall give NETCARE timely prior written notice and FME or third Party access shall be limited to NETCARE’s normal business hours.

9.5NETCARE shall be obliged to maintain a quality management system meeting the requirements agreed in a separate quality assurance agreement. The quality assurance agreement shall define responsibilities, scope, regulatory requirements, validation and documentation requirements, among others.

9.6In general Netcare shall ensure that FME’s GxP-critical applications and data, as expressly defined by FME, are maintained and archived in a GxP-compliant way. Netcare shall ensure that all FME GxP-critical systems, applications and data will be operated GxP-compliant in accordance to the specifications as set forth in the applicable Service Agreement and instructions of FME. Further requirements concerning archiving and disaster recovery as well as how FME and Netcare work in GxPcritical projects shall be defined in the quality assurance agreement.

9.7Whenever FME shall be obligated by the applicable laws, regulations or requirements imposed on FME by the competent authorities or agencies to change, amend or modify its quality as well as corporate governance standards in order to fulfill the regulatory requirements for FME’s business, NETCARE shall be obligated to follow any of such FME’s requests in order to comply with any such changes, amendments or modifications. Any changes shall be made by applying the change procedures defined in this General Agreement or the MSD, as applicable.

9.8FME’s business is strongly regulated by governmental authorities. Due to regulation changes FME may be forced to changed business processes that may also affect NETCARE’s duties and may require NETCARE to exceed any cur r ent st andards, i. e.the requirements defined in the qualit y assur ance. As f ar as t he im plem ent at ion of such changes tr igg er s any m at er ial cost s NETCARE shall inform FME before implementation of such changes or requirements. Both Parties shall agree in accordance with the change procedures defined in this General Agreement or the MSD, as applicable, on the implementation of such changes and document in writing such changes and related costs. FME shall compensate NETCARE for any costs related to such changes based on the related effort and expenses.

Any measures and related costs in connection with the implementation, application and maintenance of any internal control system required by FME or FME’s corporate governance regulations shall be agreed in a separate Annex or Service Agreement.

16

10.ORDER-DATA PROCESSING (AUFTRAGSDATENVERARBEITUNG)

10.1The Parties acknowledge that NETCARE (as the processor) will provide services to FME (as the controller) on basis of order-data processing (Auftragsdatenverarbeitung). The following rules apply to all activities in which the staff of NETCARE or a third party acting on behalf of NETCARE may come into contact with Personal Data of FME. Personal Data means any individual element of information concerning the personal or material circumstances of an identified or identifiable natural person (individual).

10.2Duration (term) and subject of the order-data processing shall be defined in the Master Service Description, the Standard Service Agreement or the Individual Service Agreement — whichever is applicable.

10.3The extent, type and purpose of the intended collection, processing or use of personal data, the type of data and categories of data subjects are stipulated in Section 1 of this General Agreement.

10.4NETCARE shall take the appropriate technical and organizational measures to adequately protect FME’s Personal Data against misuse und loss in accordance with requirements of section 9 of the German Federal Data Protection Law (Bundesdatenschutzgesetz; hereinafter: BDSG). The measures are defined in the Master Service Description and may be expanded in Standard Service Agreements or Individual Service Agreements.

10.5The technical and organizational measures are subject to technical progress and development, and NETCARE may implement adequate alternative measures in accordance with Section 7.3 of this General Agreement. These must not however fall short of the level of security provided by the specified measures. Any material changes must be documented.

10.6FME and NETCARE are aware of the fact that, at present, NETCARE operates its services under the Set of Contracts through a “one-client-system”, i. e. FME and further companies of the Fresenius SE & Co. KGaA group of companies are within the same “client-system”.

10.7NETCARE is obliged to rectify, erase or block the Personal Data processed in accordance with the reasonable instructions of FME. NETCARE shall take the necessary precautions to ensure that Personal Data can be rectified, erased or blocked in its systems.

10.8If a data subject (individual person) should apply directly to NETCARE to request the correction or deletion of his Personal Data, NETCARE must forward this request to

17

FME without delay, unless the correction or deletion is part of the specific service.

10.9NETCARE shall collect, process and use Personal Data only within the Set of Contracts. NETCARE may not use Personal Data for any other purposes, including its own purposes.

10.10NETCARE shall ensure that any personnel entrusted with processing FME’s Personal Data have undertaken to comply with the principle of data secrecy in accordance with section 5 of the BDSG and have been duly instructed on the obligations of NETCARE to protect Personal Data. The obligation of confidentiality shall continue after their employment ends.

10.11NETCARE shall monitor compliance with the provision of this section by means of regular tests.

10.12Where stipulated by law, NETCARE shall appoint a data protection officer, able to discharge his duties as set out in sections 4f and 4g of the BDSG. The officer’s contact details must be supplied to FME to enable direct contact to be made.

10.13Upon FME’s request, NETCARE shall provide all information necessary for compiling the overview defined by section 4g (2) sentence 1 of the BDSG.

10.14NETCARE may use sub-contractors according to Section 3 of this General Agreement.

10.15FME must be granted the right to monitor and inspect the sub-contractor in all cases of order-data processing.

10.16In addition to Section 10.7 of this General Agreement, FME may carry out the job control stipulated in No. 6 of the annex to the BDSG, or appoint auditors to do so.

10.17NETCARE shall provide FME with the information required to meet its job control obligation, and shall make the necessary documentation available.

10.18With regard to the monitoring obligations of FME under section 11 (2) sentence 4 BDSG before the start of data processing and throughout the term of the commission, NETCARE must ensure that FME can confirm adherence to the technical and organizational measures taken. For this purpose, NETCARE must provide FME upon request with evidence of the implementation of the technical and organizational measures pursuant to section 9 of the BDSG and the annex thereto. Evidence of the implementation of any measures that do not only affect the specific commission may also be presented in the form of up-to-date attestations, reports or extracts thereof from independent bodies (e.g. external auditors, internal audit, the data protection officer, the IT security department or quality auditors) or suitable certification by way of

18

an IT security or data protection audit.

10.19In addition to Section 5 of this General Agreement, NETCARE shall notify FME in all cases of violations of data protection provisions.

10.20Where FME’s Personal Data becomes subject to search and seizure, an attachment order, confiscation during bankruptcy or insolvency proceedings, or similar events or measures by third parties while being processed, NETCARE shall inform FME without undue delay. NETCARE also shall, without undue delay, notify to all pertinent parties in such action, that any Personal Data affected thereby is in FME’s sole property and area of responsibility, that Personal Data is at FME’s sole disposition, and that FME is the responsible body in the sense of the BDSG.

10.21The Parties are aware that section 42a of the BDSG may impose a duty to inform in the event of the loss or unlawful disclosure of Personal Data or access to it. Such incidents should therefore be notified by NETCARE to FME immediately, regardless of their origin. This also applies to serious operational faults or where there is any suspicion of an infringement of provisions relating to the protection of Personal Data or other irregularities in the handling of Personal Data belonging to FME. In consultation with FME, NETCARE must take appropriate measures to secure the data and limit any possible detrimental effect on the data subjects. Where obligations are placed in FME under section 42a of the BDSG, NETCARE must assist in meeting them.

10.22FME is responsible for compliance with the BDSG and other relevant regulations on data protection, and retains control over the extent of the data to be processed.

10.23FME shall have the right to give NETCARE reasonable instructions as to the nature, scope and method of data processing. The proceeding of FME’s authority to issue instructions is stipulated in Section 7 of this General Agreement.

10.24Any changes to the subject-matter of the processing must be agreed in writing by the Parties and documented together.

10.25NETCARE shall inform FME immediately if NETCARE believes that an instruction violates privacy laws. NETCARE may then postpone the execution of the relevant instruction until it is confirmed or changed by FME.

10.26After the termination of a commission under this General Agreement NETCARE must return to FME all of FME’s Personal Data in NETCARE’s possession and all Personal Data collected and produced in connection with the commission, or delete them with the prior written consent of FME. The deletion log must be presented upon request.

10.27Documentation intended as proof of proper data processing must be kept by NETCARE beyond the end of the Set of Contracts in accordance with relevant retention

19

periods. NETCARE may hand such documentation over to FME after expiry of this General Agreement or its Annexes.

11.RIGHTS OF USE AND INTELLECTUAL PROPERTY RIGHTS

11.1NETCARE shall procure, operate and maintain any software, licenses and rights needed by NETCARE for the provision of the Services.

11.2As a matter of principle, NETCARE shall procure and acquire licenses and rights in connection with the Services in its own name and sublicense such licenses or grant to FME the rights of use for software or other deliverables to the extent required by FME in connection with, or as a result of, the relevant Service Agreement for the use of the Services under the Set of Contracts in accordance with the provisions defined in this Section 11, unless otherwise agreed in a Service Agreement.

11.3Any rights granted by NETCARE to FME under this Agreement shall not entitle FME, without NETCARE’s prior consent, to modify, decompile, translate, decrypt, decompose, or copy the deliverable, unless otherwise expressly agreed herein or in a Service Agreement.

11.4With respect to third party standard software or NETCARE’s own software, not specifically and exclusively developed for FME, which is used by NETCARE to provide the Services (“Standard Software”), NETCARE shall grant FME the non-exclusive, nontransferable right to use without limitation in time, scope or place subject to the terms of this General Agreement and the relevant Service Agreement, in particular limited to the purpose described in the relevant Service Agreement. The scope of the right of use of FME shall be in accordance with the license and right of use granted by the third party licensor to NETCARE. NETCARE shall ensure that it will obtain all required rights and licenses to sub-license or transfer the license to FME for the required purposes.

11.5To the extent that any rights derive from software or other deliverables expressly developed for and on behalf of FME by NETCARE, including new developments of interfaces, platforms, changes, etc., provided that NETCARE has not used any proprietary software of NETCARE or any third party, any intellectual property rights shall vest in FME and FME shall be the owner of any intellectual property rights in connection with such deliverable. FME grants to NETCARE the non-exclusive, transferable right to use, to copy, to revise and to decompile the deliverables without limitation in time, scope or place subject to the terms of the Set of Contracts. The right to use is limited to the purposes described in the Service Agreement applicable to the relevant deliverable. The right to copy, revise and decompile the deliverable shall be limited, however, to the maintenance or reinstatement of the agreed functionality of the deliverable.

20

11.6As far as NETCARE develops any deliverable only partly for and on behalf of FME or FME only partly reimburses the costs associated with a deliverable, NETCARE and FME shall be co-owners of such deliverable in the proportion of the relevant contribution to the development of the deliverable. FME shall have the non-exclusive, transferable right to use the deliverable for the purpose of this General Agreement. NETCARE shall have the non-exclusive, transferable right to use, to copy, to revise and to decompile the deliverables without limitation in time, scope or place subject to the terms of the Set of Contracts. The right to use is limited to the purposes described in the Service Agreement applicable to the relevant deliverable. The right to copy, revise and decompile the deliverable shall be limited, however, to the maintenance or reinstatement of the agreed functionality of the deliverable. NETCARE shall have the right to sublicense such rights to affiliated companies and to provide maintenance, update and upgrade services with respect to the deliverables to such affiliated companies as agreed between the Parties in a Service Agreement.

11.7In case of developments, updates, upgrades and changes to Standard Software or NETCARE’s proprietary software, provided that such updates and upgrades are not available on the market, including customizing and adjustments to general structures, systems, configurations, scripts and other customizing, NETCARE shall grant FME the non-exclusive, transferable right for the term of this General Agreement to use the developments in connection with the basis software without additional charges.

11.8Own developments of NETCARE shall be solely in the property of NETCARE. Any rights of use of FME shall be granted in accordance with Section 11.4.

11.9As far as FME has acquired licenses or rights in connection with a Service from a third party, that are required for the use of the Services, or FME is obliged in connection with a Service to provide standard software or other individual software developed for FME, FME shall grant to NETCARE the non-exclusive, non-transferable right to use the software or deliverables for the purposes and as far as necessary for the provision of the Services to FME under the Set of Contracts. As far as necessary for the provision of the Services FME shall also grant NETCARE the right to copy, revise and decompile the software, whereas such right shall be limited to the maintenance or reinstatement of the agreed functionality of the software. The Parties shall agree on the specific rights in the relevant Service Agreement. The scope of the right of use of NETCARE shall be in accordance with the license and right of use granted by the third party licensor to FME. FME shall be obliged to ensure that any relevant license permits NETCARE’s use of any licensed rights granted hereunder to NETCARE for the required purpose and FME shall inform NETCARE of any license terms applicalble. NETCARE shall be obliged to comply with the license terms of the third party licensor and not use or revise the software in violation of such license. In particular, NETCARE shall notify FME of any violations of such license agreement and terms

21

defined therein.

12.DEFECTS AND WARRANTY

12.1NETCARE shall render its Services in accordance with the service levels defined, if any, or any specifications defined in the relevant Service Agreement and the Services shall be free of defects of priority 1, 2 and 3. Services rendered by NETCARE or its subcontractors not complying with the aforementioned standards shall be deemed “Defects”.

12.2In the event of Defects of an agreed product or works that shall be supplied, FME’s claims shall expire twenty four months after delivery of the respective product or works. FME shall notify NETCARE of any Defects immediately upon delivery, or in case of hidden Non-Conformities upon discovery, at the latest within 10 business days.

12.3NETCARE shall have opportunity to cure all Defects free of charge and within reasonable time. NETCARE may choose to remedy by repair or redelivery within its discretion. NETCARE shall have two attempts to remedy a Defects. If NETCARE fails to cure before an appropriate dead-line set by FME expires FME may appropriately reduce the price. If said Defect that has not been remedied by NETCARE does not affect economically reasonable uses of the remaining parts of services or goods which NETCARE has delivered or shall deliver and FME makes such use thereof, FME’s rights shall be limited to the defect service or part of NETCARE’s performance. Save for the provisions in Section 15 FME shall have no right to terminate the relevant Service Agreement or this General Agreement due to a Defect.

12.4Unless otherwise agreed between the Parties in this Section 12 any Defects shall be regulated by the relevant warranty provisions defined by statutory law, as applicable to the Service.

13.LIABILITY

13.1Either Party shall be liable without limitation for all damages caused by intent or gross negligence of the Party or its vicarious agents as well as Defects fraudulently concealed and all mandatory statutory liability.

13.2Parties shall be liable for all personal injuries up to an amount of Euro 500,000 (five hundred thousand Euros) for each incident, in a total for all such damages up to an amount of Euro 5,000,000 (five million Euros), provided that such liability is not covered by section 13.1. For all other civil liability arising out of slight negligence by the Parties and their relevant vicarious agents not covered by section 13.1 or 13.2 the following applies:

22

a)for all damages to material objects (Eigentumsverletzungen) in the property of or leased by FME which are caused as a direct consequence of the services performed under the Set of Contracts, such as but not limited to excess of voltage, damages to hard and software due to services rendered under the Set of Contracts the injured Party may recover the amount necessary for repair or for compensation of such damages up to an amount of Euro 2,000,000 (two million Euro) for each incident.

b)For all damages caused by negligent breach of contract, such as but not limited to system break-downs and which FME has to incur in accordance with claims of third contractors which cannot be solved amicably, FME is to be held harmless by NETCARE by a calendar-year compensation cap up to 15% (Fifteen percent) of the contractual value of the respective Service Agreement reduced by the penalty, if any, as defined in the respective Service Agreement. NETCARE shall be informed about the facts underlying such case in a maximum transparent manner. FME shall use best efforts to defend such cases.

c)No Party shall be liable for lost profits, potential savings, consequential or indirect damages.

13.3Should NETCARE be held liable for a breach of contract or other liability, FME’s contributory fault shall be reasonably considered. NETCARE shall not be liable for damages caused by instructions, information, documents, materials, or contributions or support provided by FME to NETCARE.

13.4NETCARE shall in no instance be liable for deficiencies of software, assistance or other appliances that FME has ordered from third parties or that FME has provided. NETCARE shall support FME by problem solving with best effort against compensation, if not agreed otherwise within the specific Service Agreement. NETCARE shall in no event be liable under this Section 13 if FME (without NETCARE’s written approval) or a third party has modified Services delivered by NETCARE, FME has used the Service in breach of the Set of Contracts (handling error), FME has not provided its cooperation obligations in a proper or timely manner, the Defect arises from instructions of FME provided that NETCARE has notified FME of the associated risks that lead to the Defect.

13.5In the event that NETCARE retained a subcontractor upon FME’s sole and specific request to use such subcontractor, NETCARE hereby assigns all its claims and rights vis-á-vis such subcontractor under the relevant contract with the subcontractor to FME. To the extent of such assignment, FME’s claim against NETCARE shall be fulfilled and NETCARE shall not be liable for any damages, losses or claims of FME or any third party resulting from the services of such subcontractor. FME authorizes NETCARE to make any claims and enforce any claims against such subcontractor.

23

NETCARE shall reasonably enforce any claims out of or in courts and FME will assist NETCARE in any actions. NETCARE shall in any event consult and coordinate any actions with FME and follow instructions of FME in connection with the enforcement of a claim. The aforementioned shall also apply in case NETCARE has integrated or used a certain product or software or procured such product or software from a designated subcontractor upon FME’s request.

13.6NETCARE shall be responsible for the services and contractual deliverables rendered by its own subcontractors to the same extent NETCARE itself is liable for the Services. Contractual partner of subcontractors shall solely be NETCARE and the scope of services to be rendered by NETCARE to FME shall not be affected by the use of subcontractors.

13.7The aforementioned provisions shall apply to the personal liability of all statutory representatives, senior management, agents, subcontractors and employees as far as these qualify as vicarious agents of the relevant Party.

13.8NETCARE shall be excused from performance of its obligations and the Services under this General Agreement, any Annex and Service Agrement affected and shall not be held liable for any losses, damages or delays, including consequential damages, resulting from any event or cause beyond its reasonable control, including earthquake, fire, flood, explosion, war, embargo, transportation shortage or delay, breakage of machinery or electric power outage.

14.PENALTIES

14.1The sum of any penalties accrued under the Set of Contracts for the period of one year shall not exceed 5 % of the total remuneration under the Set of Contract, excluding remuneration for Projects, for the previous year. For the purposes of this section the yearly remuneration and sum of penalties shall not be calculated on the basis of the calendar year but on a rolling basis, i.e. the 12 months prior to the event triggering the penalty.

15.TERM AND TERMINATION

15.1The term of this General Agreement shall commence on January 1, 2013 and shall extend to December 31, 2017. Thereafter, the General Agreement shall automatically renew by another period of five years unless one Party terminates the agreement by giving six months prior written notice to the end of the term. From then on the General Agreement will be extended automatically for successive one year periods unless one of the parties terminates this General Agreement by giving 6 months prior written notice to the expiration of the then current term.

24

15.2The Parties shall be entitled to terminate individual Service Agreements by giving 6 months written notice prior to the end of the agreed term unless otherwise agreed under applicable termination clauses in the Service Agreements.

15.3Each Party shall be entitled to terminate this General Agreement and the Set of Contracts in whole or in part with immediate effect by giving written notice if (a) the other Party becomes insolvent, (b) the other Party is the subject of any winding up, dissolution, insolvency or liquidation proceedings, or makes any assignment of materially all assets for the benefit of creditors, (c) the other Party terminates its business in whole or in substantial part, or (d) in case of a merger or acquisition, whereby the common shareholder Fresenius SE & Co. KGaA transfers its controlling interest, be it by transfer of assets or by transfers of shares or dilution of the interest of Fresenius SE & Co. KGaA, in the non-terminating Party to a third Party which is not under the control of Fresenius SE & Co. KGaA.

15.4Furthermore, FME shall be entitled to terminate the Set of Contracts upon giving reasonable notice, if NETCARE (i) unreasonably restricts FME from accessing data for processing in other systems; (ii) breaches the terms and conditions of Sections 9.1, 9.3, 9.5, 9.6 or 9.7 above and/or (iii) after discussion in the Steering Committee, will not be able to comply with the terms and conditions as outlined under Sections 9.1, 9.3, 9.5, 9.6 or 9.7 above.

16.EFFECT OF TERMINATION/EXPIRATION

16.1The termination of this General Agreement shall not affect the term of its Service Agreements or any Annex and no such Service Agreement or Annex shall be terminated unless expressly and separately terminated by the terminating Party. In case of a termination of this General Agreement the terminating Party shall have a special termination right with respect to each Annex and Service Agreement being part of the Set of Contracts.

16.2The termination of a Service Agreement or Annex shall not affect this General Agreement or any other Annex or document of this Set of Contracts unless expressly agreed for certain cases in Section 16.

16.3After termination or expiration of the contractual relationship the Parties shall undertake to modify the remainder of the Set of Contracts as economically indicated and according to the factual situation. Furthermore, they shall return all documents and other information which they have received from the other Party because of or incidental to the cooperation upon first request. The correspondence between the Parties and all documents and papers that have to be kept available as required by laws or

25

regulations or papers and documents that are destined to remain with the respective Party.

16.4After termination of the General Agreement or Service Agreement hereto, NETCARE shall be obliged to deliver the services agreed upon hereunder to FME upon FME’s request for such period which is required by FME to retain an alternative service provider. FME’s obligations defined under Section 4 shall remain in effect for such transition period. However, FME shall not be required to buy these services from NETCARE. In case that FME decides to discontinue individual services or parts thereof NETCARE shall not be responsible for the remainder of the services to be delivered to FME, provided, that the discontinued services were required for rendering the remainder of the services. Furthermore, NETCARE shall reasonably cooperate with FME on the transfer of any services or system operated or maintained under this Set of Contracts to an alternative service provider. Remuneration for services rendered and other terms and conditions for this transition period shall be analogous to the terms of this General Agreement or any Service Agreement referred to of the year of termination. Additional services required for the transition or migration of services to an alternative service provider shall be agreed separately and shall be compensated by FME in accordance with the agreed prices in the relevant up-to-date price list of NETCARE or as separately agreed.

16.5Details regarding the services and transfer of data shall be agreed upon in the Steering Committee. As far as an agreement about the reintegration and continuation of the services has not been achieved within 3 months after written notice, an external Party shall be commissioned for defining the scope of services to be rendered by NETCARE and FME’s or any third Parties responsibilities and assistance. The external Party shall be nominated by FME and NETCARE in mutual agreement, however, if such consensus cannot be reached by FME and NETCARE, the arbitrator under Section 17.3 shall nominate the external Party.

16.6NETCARE shall grant to FME upon termination/expiration of the contractual relationship a license for the use of all intellectual property rights owned by NETCARE at the time of termination/expiration of the contractual relationship, with respect to NETCARE’s own developments, including modifications, add-ons, developments, required to operate and run the system governed by and arising out of the Set of Contracts. Such license shall be non-exclusive, unlimited, unrestricted and shall include the right to grant sublicenses to re-outsourcers for the purposes of providing services to FME, however, the right to grant further sublicenses shall not be included. Such license shall be granted free of charge and shall enable FME for further development for internal purposes.

16.7Upon termination of this Set of Contracts, neither tangible nor intangible assets shall be transferred from NETCARE to FME and neither claim for such transfer shall vest in

26

FME except for those where FME is the owner of such tangible or intangible assets. Additionally, FME shall in no event actively pursue employment of employees of NETCARE during the term of the General Agreement and for the period of two years thereafter.

16.8Upon termination of this General Agreement and/or its applicable Annexes and Service Agreements under the Set of Contracts FME shall neither be entitled without the prior written consent of NETCARE nor shall FME be contractually obligated to take over any employee of NETCARE. In the event FME is obligated to take over such employees or employment contracts according to the respective law, NETCARE shall be obligated to compensate FME any costs and expenses which FME might incur thereby for employees FME is not willing to take over provided that FME is not actively deploying such employees.

16.9The following provisions shall survive a termination of this General Agreement and shall remain in effect upon a termination for a period of at least five years or applicable storage and documentation obligations, whichever is longer: Sections 5, 8, 9, 13, 16, 17, 18.

17.GOVERNING LAW, ARBITRATION

17.1The Set of Contracts shall be governed by the laws of Germany (excluding UN-CISG and the rules and principles on the conflict of laws).

17.2Any dispute, controversy or claim, arising out of or in connection with the Set of Contracts, or the breach, termination or invalidity thereof (the “Controversies”), shall be governed by the following dispute resolution mechanism:

17.3Controversies shall be settled amicably between the Parties on operational level and according to the escalation procedure as defined in the MSD. If the Parties are unable to reach a mutual consensus, the Parties shall be entitled to file for arbitration complaints in the arbitration panel of the Deutsche Gesellschaft für Recht and Informatik e.V. (“DGRI”), according to its Rules of Arbitration. The place of arbitration shall be in Frankfurt am Main, Germany. The numbers of arbitrators shall be [3]. English shall be used in the arbitrational proceedings.

17.4In order to allow the arbitration to proceed the Parties waive the defense of expiration of statute of limitation for all claims arising in the disputed matter, starting with the request for arbitration filed with the DGRI and until one month after the end of the arbitration process. The expiration of statute of examination shall be suspended for the time of the arbitration proceeding.

17.5The decision of the arbitration panel shall be binding.

27

18.MISCELLANEOUS

18.1All Annexes, the Attachments, and the Preamble are incorporated into this General Agreement. The Preamble shall reflect the intentions of the Parties as of the effective date of the General Agreement and shall have legal effect, however, only insofar as it may be used for interpretative purposes in case of controversy over the interpretation of certain clauses in the General Agreement, Annexes or the Attachments or if Section 17 is applicable.

18.2Neither Party’s general terms and conditions (Allgemeine Geschäftsbedingungen) shall be incorporated in this Set of Contracts.

18.3The rights inuring to the benefits of the Parties under the Set of Contracts shall be non-transferable unless the other Party has agreed to the transfer in writing. Such consent shall not be unreasonably withheld if the rights are transferred to Parties under common control of Fresenius SE & Co. KGaA or Fresenius Medical Care AG & Co. KGaA.

18.4No action or inaction of one of the Parties shall be construed as a waiver of rights or shall affect such rights, unless this General Agreement does provide to the contrary.

18.5Alterations of and amendments to the Set of Contracts must be made in writing. This applies also to this requirement of writing.

18.6If any provision of the General Agreement is held to be invalid or unenforceable, the validity of the remaining provisions shall not be affected. The Parties shall replace the invalid or unenforceable provision by a valid and enforceable provision closest to the intention of the Parties when signing the General Agreement.

18.7Same shall apply to all contractual provisions that the Parties may have omitted to include in this General Agreement.

18.8As far as the language of Set of Contracts uses the name under which a software is marketed all later releases shall be included.

18.9FME may execute rights to hold back or to set off only upon claims uncontested by NETCARE, or sums finally awarded by DGRI under Section 17 of this General Agreement.

28

Bad Homburg, Bad Homburg, 08.05.2013

Fresenius Medical Care AG & Co. KGaA		Fresenius Netcare GmbH
represented by its General Partner		represented by
Fresenius Medical Care Management AG,
represented by
By:	/s/ Rice Powell	By:	/s/ Klaus Kieren
	Rice Powell		Klaus Kieren
	Global Chief Executive Officer and		Chairman
	Chairman of Management Board
By:	/s/ Dr. Emanuele Gatti	By:	/s/ Jurgen Kunze
	Dr. Emanuele Gatti		Jürgen Kunze
	CEO Europe, Latin America,		Vice Chairman
	Middle East and Africa
	Global Chief Strategist

Attachment 1:	List of Affiliates
Attachment 2:	Fairness Opinion
Attachment 3:	Glossary
Attachment 4:	Master Service Description

29

Attachment 1 to the General Agreement

List of Affiliates based on FNC’s customer master data

Attachment 1 to the General Agreement

List of Affiliates

Branch	Debitor	Affiliate	Unit	Location	Country  code
N210	60000252	FMC D GmbH	-Zahler-	Bad Homburg	DE
N210	60000295	FMC D GmbH	GB ZE Overhead/Key Turn Proj.	Bad Homburg	DE
N210	60000296	FMC D GmbH	Projektierung	Bad Homburg	DE
N210	60000300	FMC D GmbH	Marketing Technik	Bad Homburg	DE
N210	60000305	FMC D GmbH	IT-Projektierung	Bad Homburg	DE
N210	60000306	FMC D GmbH	GB ZE Production	Bad Homburg	DE
N210	60000388	GFI - Deltronix	Ges. für Informationssysteme mbH	Fürth / Bayern	DE
N210	60000728	FMC D GmbH	GB ZE OVH Technics /Training & Educ	Bad Homburg	DE
N210	60000729	FMC D GmbH	GB ZE Technical Service Internation	Bad Homburg	DE
N211	60000128	Fresenius Medical Care Deutschland	Bereich EMEA - Overhead EMEA +Comme	Bad Homburg	DE
N211	60000130	Fresenius Medical Care Deutschland	Bereich EMEA - Controlling	Bad Homburg	DE
N211	60000134	Fresenius Medical Care Deutschland	Bereich EMEA - SCE Distribution	Bad Homburg	DE
N211	60000267	Fresenius Medical Care Deutschland	Bereich EMEA - NESEE Overhead	Bad Homburg	DE
N211	60000268	Fresenius Medical Care Deutschland	Bereich EMEA - Supply Network Plann	Bad Homburg	DE
N211	60000269	Fresenius Medical Care Deutschland	Bereich EMEA - SC OVH&SCPI	Bad Homburg	DE
N211	60000270	Fresenius Medical Care Deutschland	Bereich EMEA - EEMEA BG/PL/RO	Bad Homburg	DE
N211	60000271	Fresenius Medical Care Deutschland	Bereich EMEA - Clinical Governance	Bad Homburg	DE
N211	60000394	Fresenius Medical Care Deutschland	Bereich EMEA - CS Latin America	Bad Homburg	DE
N211	60000395	Fresenius Medical Care Deutschland	Bereich EMEA - SCE CDC	Bad Homburg	DE
N211	60000592	FMC D GmbH	International Marketing & Medicine	Bad Homburg	DE
N211	60000618	Fresenius Medical Care Deutschland	Bereich EMEALA - POI	Bad Homburg	DE
N211	60000619	Fresenius Medical Care Deutschland	Bereich EMEA - Overhead EEMEA + Pro	Bad Homburg	DE
N211	60000620	Fresenius Medical Care Deutschland	Bereich EMEA - Russian Speaking	Bad Homburg	DE
N211	60000621	Fresenius Medical Care Deutschland	Bereich EMEA - Middle East Overhead	Bad Homburg	DE
N211	60000622	Fresenius Medical Care Deutschland	Bereich EMEA - W Africa Overhead	Bad Homburg	DE
N211	60000623	Fresenius Medical Care Deutschland	Bereich EMEA - SE Africa Overhead	Bad Homburg	DE
N211	60000753	Fresenius Medical Care Deutschland	Bereich EMEA - Supply Chain F&D	Bad Homburg	DE
N211	60000759	Fresenius Medical Care Deutschland	Bereich EMEA - Supply Chain Executi	Bad Homburg	DE
N211	60000760	Fresenius Medical Care Deutschland	Bereich EMEA - System & Demand Plan	Bad Homburg	DE
N211	60000761	Fresenius Medical Care Deutschland	Bereich EMEA - Business Operation	Bad Homburg	DE

1

N211	60000762	Fresenius Medical Care Deutschland	Bereich EMEA - Medical Reporting &	Bad Homburg	DE
N211	60000763	Fresenius Medical Care Deutschland	Bereich EMEA - Clinical Research	Bad Homburg	DE
N211	60000764	Fresenius Medical Care Deutschland	Bereich EMEA - Nephrocare Coordinat	Bad Homburg	DE
N211	60000871	Fresenius Medical Care Deutsch. - G	Bereich EMEA -	Bad Homburg	DE
N211	60000878	Fresenius Medical Care Deutschland	WE OVH	Bad Homburg	DE
N211	60000879	Fresenius Medical Care Deutschland	TME	Bad Homburg	DE
N213	60000132	FMC GmbH	Sales Region	Bad Homburg	DE
N213	60000297	FMC GmbH	Marketing Deutschland	Bad Homburg	DE
N213	60000298	FMC GmbH	Technical Service National	Bad Homburg	DE
N213	60000299	FMC GmbH	Stammdaten & Projektmanagement	Bad Homburg	DE
N213	60000301	FMC GmbH	Commercial Department OVH	Bad Homburg	DE
N213	60000302	FMC GmbH	Material Planning	Bad Homburg	DE
N213	60000303	FMC GmbH	Logistics	Bad Homburg	DE
N213	60000304	FMC GmbH	Congresses	Bad Homburg	DE
N213	60000727	FMC GmbH	Overhead	Bad Homburg	DE
N213	60000730	FMC GmbH	Application Service	Bad Homburg	DE
N213	60000742	FMC GmbH	-Zahler-	Bad Homburg	DE
N213	60000777	FMC GmbH	Provider Deutschland	Bad Homburg	DE
N219	60000137	FMC D GmbH	Executive Medical Consulting	Bad Homburg	DE
N219	60000138	FMC D GmbH	Renal Pharma	Bad Homburg	DE
N219	60000141	FMC D GmbH	IBD Corp. Finance	Bad Homburg	DE
N219	60000143	FMC D GmbH	Human Resources	Bad Homburg	DE
N219	60000144	FMC D GmbH	Quality/Regulatory/Environment	Bad Homburg	DE
N219	60000147	FMC D GmbH	R&D (HG)	Bad Homburg	DE
N219	60000148	FMC D GmbH	Vorstand	Bad Homburg	DE
N219	60000487	FMC D GmbH	R&D (SW)	Schweinfurt	DE
N219	60000635	FMC D GmbH	Business Development	Bad Homburg	DE
N219	60000858	FMC D GmbH	International Strategic Development	Bad Homburg	DE
N219	60000882	FMC D GmbH	R&D (WND)	Bad Homburg	DE
N220	60000005	FMC Nederland B.V.	Administratie	VLIJMEN	NL
N220	60000006	Fresenius Medical Care (Schweiz) AG		Oberdorf	CH
N220	60000011	FMC AUSTRIA GmbH		WIEN	AT

2

N220	60000021	FMC Belgium NV		ANTWERPEN - WILRIJK	BE
N220	60000389	Fresenius Medical Care	Slovenija d.o.o.	Zrece	SI
N220	60000773	Fresenius Medical Care	Servizi Logistici SA	Manno	CH
N221	60000003	FMC Ltda., Portugal		Moreira - Maia	PT
N221	60000004	FMC ITALIA S.P.A		PALAZZO PIGNANO(CREMONA)	IT
N221	60000007	FMC Magyarország Egészségügyi Kft		BUDAPEST	HU
N221	60000015	FMC FRANCE SAS		FRESNES Cedex	FR
N221	60000017	Fresenius Medical Care Espana S.A.		MADRID	ES
N221	60000023	FRESENIUS MEDIKAL HIZMETLER A.S.	Free Trade Zone Branch	Antalya	TR
N221	60000026	FMC UK. Ltd.		Huthwaite Nottinghamshire	GB
N221	60000032	NMC of Spain S.A.		Madrid	ES
N221	60000035	Fresenius Medical Care Suomi Oy		HELSINKI	FI
N221	60000036	Fresenius Medical Care Denmark A/S		Taastrup	DK
N221	60000052	FMC ITALIA S.P.A	Naples Office	PALAZZO PIGNANO(CREMONA)	IT
N221	60000058	FMC France S.A. - Provider		FRESNES CEDEX	FR
N221	60000196	Dialifluids S.r.l.		Canosa Sannita CH	IT
N221	60000217	NephroCare Portugal SA		-233 Lisboa (Portugal)	PT
N221	60000224	Fresenius Medical Care - DS, s.r.o.	Provider	Praha 6	CZ
N221	60000391	Fresenius Medical Care Slovensko Gm	Product company	Piestany	SK
N221	60000407	FMC Swerige AB		Sollentuna	SE
N221	60000452	Fresenius Medical Care Maroc		Casablanca	MA
N221	60000457	Fresenius Medical Care Romania S.R.	Baneasa Business Center	Bucharest	RO
N221	60000458	Fresenius Medical Care Polska SA		Poznan (PL 78314807	PL
N221	60000459	FRESENIUS MEDIKAL HIZMETLER A.S.Mai		Maslak/Istanbul	TR
N221	60000488	Fresenius Medical Care Hrvatska d.o	Mr. Davorka Jaman	Zagreb	HR
N221	60000507	Fresenius Medical Care Bulgaria Gmb		Gabrovo	BG
N221	60000518	ZAO Fresenius SP	INN 7736045187 / KPP 772301001	Moscow	RU
N221	60000527	Fresenius HemoCare Adsorber	Technology Middle East S.A.R.L.	Hamra - Beirut	LB
N221	60000547	Saudi Advanced Renal Services	Corporation Ltd.	Riyadh	SA
N221	60000581	Fresenius Diyaliz Hizmetleri A.S		Maslak/Istanbul	TR
N221	60000747	Fresenius Medical Care BH d.o.o.	Sarajevo	Sarajevo, Bosnia and Hercegovina	BA
N221	60000867	Fresenius Medical Care LLC		Kiew	UA

3

N221	60000869	Fresenius Medical Care LLC	Mr. Dmytro Iarmak	Kiew	UA
N221	60000870	Health Care Facility - Hospital	“International Dialysis Center”	Banja Luka	BA
N223	60000002	SMAD S. A.	Z.I. DE LA PONCHONNIERE	L’ARBRESLE	FR
N223	60000016	SIS-TER S.P.A.		PALAZZO PIGNANO (CREMONA)	IT
N223	60000057	Novamed GmbH	Free Trade Zone, Production Plant	Antalya	TR
N223	60000071	FMC Thalheim GmbH	Herr Gerd Bucher	Stollberg	DE
N223	60000145	FMC D GmbH	Production Unit Machines (PUM SW)	Schweinfurt	DE
N223	60000553	Fresenius Medical Care Adsorber Tec		Krems	AT
N223	60000567	Fresenius Medical Care Srbija d.o.o	Predstavnistvo Beograd	Novi Beograd / SERBIA MONTENEGRO	RS
N223	60000625	Fresenius Medical Care Ceská republ	spol.s.r.o. - Product -	Praha 6	CZ
N224	60000206	FMC D GmbH	Global Infrastructure	Bad Homburg	DE
N224	60000342	FMC D GmbH	Inventory EMEALA	Bad Homburg	DE
N224	60000343	FMC D GmbH	International Corporate Finance	Bad Homburg	DE
N224	60000344	FMC D GmbH	Reporting & Master Data	Bad Homburg	DE
N224	60000346	FMC D GmbH	- Financial Statements -	Bad Homburg	DE
N224	60000347	FMC D GmbH	International Consolidation	Bad Homburg	DE
N224	60000398	FMC D GmbH	P & C	Bad Homburg	DE
N224	60000537	FMC-D GmbH	ITSA	Bad Homburg	DE
N224	60000538	FMC D GmbH	CSE	Bad Homburg	DE
N224	60000626	FMC D GmbH	Strategic Controlling	Bad Homburg	DE
N224	60000627	FMC D GmbH	Financial Compliance & Risk Managem	Bad Homburg	DE
N224	60000643	FMC D GmbH	INSITE	Bad Homburg	DE
N224	60000842	FMC-D GmbH	IT Processes	Bad Homburg	DE
N224	60000843	FMC-D GmbH	Integrated Learning	Bad Homburg	DE
N224	60000854	FMC-D GmbH	NCIS	Bad Homburg	DE
N224	60000855	FMC-D GmbH	HBAM	Bad Homburg	DE
N224	60000859	FMC-D GmbH	Business Intelligence	Bad Homburg	DE
N225	60000135	FMC D GmbH	Manufacturing Operations Dialysis	Bad Homburg	DE
N225	60000136	FMC D GmbH	Global Manufacturing Operations (GM	Bad Homburg	DE
N225	60000140	FMC D GmbH	QS EMEA GMO	Bad Homburg	DE
N225	60000146	FMC D GmbH	Purchasing Consulting Center (PCC)	Bad Homburg	DE
N225	60000477	Fresenius Medical Care Deutschland	Folienentwicklung St. Wendel	St. Wendel	DE

4

N225	60000478	Fresenius Medical Care Deutschland	PU Disposables St. Wendel	St. Wendel	DE
N225	60000479	Fresenius Medical Care Deutschland	PU Disposables St. Wendel	St. Wendel	DE
N225	60000480	Fresenius Medical Care Deutschland	PU Disposables St. Wendel	St. Wendel	DE
N225	60000481	Fresenius Medical Care Deutschland	PU Disposables St. Wendel	St. Wendel	DE
N225	60000482	Fresenius Medical Care Deutschland	PU Disposables St. Wendel	St. Wendel	DE
N225	60000483	Fresenius Medical Care Deutschland	PU Disposables St. Wendel	St. Wendel	DE
N225	60000484	Fresenius Medical Care Deutschland	PU Disposables St. Wendel	St. Wendel	DE
N225	60000486	Fresenius Medical Care Deutschland	PU Disposables St. Wendel	St. Wendel	DE
N225	60000779	Fresenius Medical Care Deutschland	Membranentwicklung	St. Wendel	DE
N229	60000387	Fresenius Medical Care SA (Pty) Ltd		Midrand	ZA
N230	60000012	FMC Argentina S.A.		BUENOS AIRES	AR
N230	60000013	Fresenius Medical Care Colombia S.		Bogota, Colombia	CO
N230	60000131	FMC D GmbH	Latin America	Bad Homburg	DE
N230	60000183	FMC Brazil Ltda.		Rio de Janeiro/RJ, Brazil	BR
N230	60000218	FMC D GmbH	DLV Argentinien	Bad Homburg	DE
N230	60000259	FMC de Venezuela C.A.	Zona Industrial Municipal Norte	Valencia, Estado Carabobo	VE
N230	60000332	FMC Brazil Sao Paulo Ltda.	Headquarter	Chácara Snato antonio	BR
N230	60000361	Nephrocare Chile S.A.		San Miguel, Santiago	CL
N230	60000463	FMC D GmbH	DLV Kolumbien	Bad Homburg	DE
N230	60000464	FMC D GmbH	DLV Brasilien	Bad Homburg	DE
N230	60000466	FMC D GmbH	DLV Venezuela	Bad Homburg	DE
N230	60000467	FMC D GmbH	DLV Chile	Bad Homburg	DE
N230	60000468	FMC D GmbH	DLV BRASILIEN / SAO PAOLO	Bad Homburg	DE
N230	60000557	Fresenius Medical Care de Peru S.A.		Lima 3	PE
N230	60000558	FMC D GmbH	DLV Peru	Bad Homburg	DE
N230	60000883	FMC D GmbH	DLV Eucador	Bad Homburg	DE
N230	60000884	Fresenius Medical Care Ecuador Hold	Mr. Bolivar Cordero	Quito	EC

5

Attachment 2 to the General Agreement

Fairness Opinion regarding

the General Agreement 2013

for IT services to be realized between

Fresenius Medical Care AG & Co. KGaA

and

Fresenius Netcare GmbH

Fresenius Medical Care Deutschland GmbH

17 December 2012

Fairness Opinion regarding the General
Agreement 2013 for IT services to be realized between

Fresenius Medical Care AG &. Co. KGaA

and

Fresenius Netcare GmbH

Table of content

I.	INTRODUCTION AND SCOPE OF WORK	1
A.	BACKGROUND	1
B.	SCOPE OF OUR WORK	1
II.	BASIS FOR OUR WORK	3
III.SUMMARY OF THE CONSIDERATIONS MADE BY FME AND FNC REGARDING TERMS AND CONDITIONS FOR THE CONCLUSION OF A GENERAL AGREEMENT 2013		5
A.	BACKGROUND	5
B.	CURRENT CONSIDERATIONS OF FME AND FNC FOR THE CONCLUSION OF A GENERAL AGREEMENT 2013	5
C	CURRENT CONSIDERATIONS OF FME AND FNC REGARDING THE PRICING MECHANISM UNDER THE GA 2013	7
IV.ASSESSMENT ON THE PLAUSIBILITY OF THE CONSIDERATIONS MADE BY FME AND FNC IN THE INTENDED CONTRACTUAL REGULATIONS COMPARED TO WHAT WOULD BE EXPECTED BETWEEN THIRD PARTIES		8
A.	ASSESSMENT ON THE GENERAL APPROACH OF FME AND FNC	8
B.	ASSESSMENT ON THE TERM OF THE GENERAL AGREEMENT 2013	9
C.	ASSESSMENT ON THE PRICING MECHANISM FORESEEN IN THE GENERAL AGREEMENT 2013	10
D.	ASSESSMENT ON THE MAN DAY RATE FOR INTERNAL RESOURCES OF FNC CONSIDERED IN THE PRICE LIST 2013	12
E.	ASSESSMENT ON THE EXPECTED IT COST AS PERCENTAGE OF REVENUE UNDER THE TERMS AND CONDITIONS OF THE GA 2013	12
V.CONCLUSION WITH REGARD TO THE PLAUSIBILITY OF THE CONSIDERATIONS MADE BY FME AND FNC REGARDING TERMS AND CONDITIONS UNDER THE GENERAL AGREEMENT 2013 COMPARED TO WHAT WOULD BE EXPECTED AMONG THIRD PARTIES		16
VI.	NOTES TO OUR PROFESSIONAL STATEMENT	17
ATTACHMENT 1: GENERAL AGREEMENT 2013 BETWEEN FME UND FNC (“GA 2013”), DATED 17 DECEMBER 2012		I
ATTACHMENT 2: OVERVIEW ON THE VOLUME OF EXPECTED IT COST FOR OPERATIONS AND PROJECTS UNDER THE GENERAL AGREEMENT 2013 FOR THE YEARS 2013 TO 2022 (“FNC COST ESTIMATE”) INCLUDING ADDITIONAL CALCULATIONS		II
ATTACHMENT 3: GENERAL TERMS AND CONDITIONS AS OF MAY 2012		III

I

I.Introduction and Scope of Work

Based on the engagement agreement dated 6 November 2012 Fresenius Medical Care Deutschland GmbH (hereinafter “FMCD”) commissioned us with a project to prepare an independent fairness opinion with respect to the intended contractual IT service cooperation between Fresenius Medical Care AG & Co. KGaA (hereinafter “FME”) and Fresenius Netcare GmbH (hereinafter “FNC”) as described in the General Agreement 2013 (hereinafter “GA 2013”). This was done by conducting a plausibility check of the intended contractual regulations between FME and FNC regarding comparability with what would be expected between third parties at this stage of negotiations.

A.Background

FME and FNC are currently negotiating the conditions of a contract governing the provision of IT services through FNC for FME and its affiliates. As the legal representatives and oversight bodies of FME want to ensure that such contract is comparable to what would be reasonably expected between third parties they have raised the request for an independent fairness opinion to be based on the actual status of the negotiations which is considered close to final.

B.Scope of our Work

In this context Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft (“E&Y”) was engaged by FMCD to make an assessment if the current considerations of the parties involved (FME and FNC) regarding terms and conditions of the contract to be concluded between FME and FNC are comparable to what would be expected among third parties at this stage of the negotiations of a contract.

For this purpose, E&Y reviewed the respective considerations as provided by FMCD, FME and FNC and assessed the plausibility of these considerations compared to what would be expected among third parties at this stage of the negotiation of a contract.

E&Y did not review or assess the General Agreement 2013 in relation to the following points:

·legal or tax aspects,

·content of the services,

·technical realization,

·amount of total cost to be expected for the services

·adequacy of the IT measures,

·adequacy of the IT support level,

·adequacy of single pricing elements,

1

The aforementioned listing is a non-exhaustive enumeration and for illustration purpose only.

The following areas were specifically agreed to be excluded from the scope of the project:

·A market evaluation by setting up a “Request for Proposal” to the external market for the IT services covered by the GA 2013 to have comparable figures for the services to be provided by FNC.

·Specific benchmarking studies for the various services to be provided by FNC under the GA 2013.

·A legal judgment of the existing contracts and Service Level Agreements.

·A review of the current service relationship.

·Any detailed analysis outside the scope of discussing the information provided by FMCD, FME and FNC with employees or service providers of these companies.

·Verification or reconciliation of the contractual information.

·Verification or reconciliation of the volume of expected IT cost for Operations and Projects under the General Agreement 2013 for the years 2013 to 2022

·Validation of the requirements and assumptions taken as basis for negotiating the GA 2013.

·Evaluation of any fairness aspects on a per-country or per-region basis.

The statements included in our fairness opinion reflect our opinion, based on our professional experience. The fairness opinion is only for use of FMCD. However, FMCD is allowed to provide the fairness opinion to its related parties and to the legal bodies of such related parties (e.g. their supervisory board).

Our fairness opinion is the result of our observation of the situation at a given point in time under the constraints and environmental factors valid at this given point in time and based on the information provided to us by FMCD, FME and FNC in the documents and correspondence listed below. We made use of no other FMCD, FME or FNC related information sources for the purpose of our review.

Risks relating to dependencies on documents we did not review were not considered for the purpose of our fairness opinion. We did also not specifically check the existence of all documents referenced to in the reviewed documents and correspondence. If any such documents do not exist or have not yet been agreed and signed they could affect the overall fairness of the GA 2013 defined between FME and FNC. Both parties could have a disagreement on the content and validity of the definition.

Furthermore we were requested to take special consideration of the fact that the negotiations regarding the GA 2013 relate to a contract to be concluded between two entities of the same parent company who are currently already in a successful customer and service provider relationship based on contracts for which the arm’s length nature has been confirmed by a Fairness Opinion from PwC Deutsche Revision

2

Aktiengesellschaft Wirtschaftsprüfungsgesellschaft (hereinafter “PwC”) dated 14 August 2003.

II.Basis for our Work

Our work was performed using the following key data files and documents provided by FMCD, FME and FNC:

·Documents provided by Mr. Griesenbeck from FMCD on 2 November 2012:

·Draft General Agreement 2013 between FME und FNC, dated 29 October 2012 [20121029 GA V1.0 Final (frozen).docx]

·FNC Price List 2013 V1.1, Summary of Standard Services, Prices and Charging Conditions (“Price List 2013”) [PRICE_LIST_2013.pdf]

·SAP Price List V 1.0.10-0 (“SAP Price List”) [SAP Price List V 1.0.10-0.xlsx]

·Documents provided by Mr. Griesenbeck from FMCD on 27 November 2012:

·Overview on the volume of expected IT cost for Operations and Projects under the General Agreement 2013 for the years 2013 to 2022 (“FNC Cost Estimate”) [FMC 10 Years_final-ovw.xlsx]

·Expected IT service cost for 2013 under the General Agreement 2013 by category (“IT cost detail 2013”) [Warengruppe_Material_2013.xlsx]

·Document provided by Mr. Griesenbeck from FMCD on 17 December 2012

·General Agreement 2013 between FME und FNC (“GA 2013”), dated 17 December 2012 [20121217 GA V1.0 Final (frozen).docx]

The following supporting documents and information were taken into account for the purpose of our fairness opinion:

·Documents provided by Mr. Griesenbeck from FMCD on 2 November 2012 or earlier:

·General Agreement between Fresenius Medical Care AG (FME) and Fresenius Netcare GmbH (FNC) on services provided in the area of information technology within the Territory and related to named subsidiaries of FME dated 8 December 2003 (“General Agreement 2003” or “GA 2003”)

·Attachment 1 to the GA 2003: FME Affiliates under this Agreement

·Annex 08 to the GA 2003 between FME and FNC governing individual EDP projects mutually agreed between FME and FNC commencing as of 1 January 2003 (“Annex 8”)

·Glossary as Annex to the General Agreement 2013 (“Glossary”)

·Master Service Description as Annex to the General Agreement 2013 (“MSD”)

·FNC Service Catalog 2013 (“Service Catalog 2013”)

·Service Agreement SAP to the General Agreement 2013 (“Service Agreement SAP”)

·SAP Service Level Agreements to the General Agreement 2013/ Service Agreement SAP for the SAP System Families BO, X11,X12,X13,X20,X22,X24,X25,X27,X29,X39,X45,X46,X50 and X57 each (“SAP SLA GA 2013”)

3

·Annexes 9,10,14,15,17,18,22,23,24,25,27,28,30,31,33,34,35,36 and 40 to the GA 2003 (“Enduring Annexes GA 2003”)

·Information provided by Mr. Griesenbeck on 5 December 2012 regarding expected FME EMEALA revenue growth until 2022

·Information provided by Mr. Griesenbeck on 17 December 2012 regarding expected FME EMEALA revenues for 2012

In addition, various verbal and e-mail communication has been held with the following persons to discuss the considerations during the negotiations between FME and FNC and discuss the plausibility of the current approach in the draft contract compared to what would be expected among third parties:

·Mr. Grimm of FME (Head of IT Coordination EMEALA)

·Mr. Griesenbeck of FMCD (IT Service Management)

4

III.Summary of the considerations made by FME and FNC regarding terms and conditions for the conclusion of a General Agreement 2013

A.Background

Based on the General Agreement 2003 and several Annexes to the General Agreement 2003, FNC is acting as IT Service provider for FME, FMCD and other FME affiliates since several years with a wide functional range. FNC has therefore deep insight into and knowledge of the Fresenius Medical Care group wide IT landscape.

The initial term for major parts of the General Agreement 2003 and its Annexes ends as of 31 December 2012.

FME and FNC are therefore in continuous negotiations to finalize a contract governing the provision of IT services through FNC for FME and its affiliates. Such contract is referred to as “General Agreement 2013” or “GA 2013”.

B.Current Considerations of FME and FNC for the conclusion of a General Agreement 2013

FME and FNC have generally taken the terms and conditions agreed under the General Agreement 2003 as starting point for their negotiations regarding the General Agreement 2013.

Such GA 2013 shall be concluded by FME in its own name and on behalf of its current and future affiliates as listed and continuously updated in Attachment 1 to the GA 2013.

The GA 2013 shall govern the parameters of cooperation between FME and FNC with regard to services in the field of information technology for users in the FME regions Europe, Africa, Middle East and Latin America, the “FME EMEALA”.

The intention is to continue the long term business relationship in the same manner as under the expiring GA 2003.

Partnership, transparency and competitiveness of both prices and services rendered are among the basic principles for the cooperation as defined in the Preamble of the GA 2013.

Moreover, based on the Preamble, the GA 2013 and its modules shall be construed without taking into account that the Parties are affiliated companies.

The complete agreement between the Parties and the modular contractual structure as governed by the GA 2013 and referred to as “Set of Contracts” is set-up as follows:

5

1.General Agreement 2013 and

2.related documents (the Annexes) such as:

Master Service Description

Glossary

Fairness Opinion

List of Affiliates

3.Service Agreements

Standard Service Agreements

Individual Service Agreements

The following graphic illustrates the intended structure of the contractual relationship under the GA 2013:

6

Under this structure, the GA 2013 provides the legal framework that shall govern the cooperation between, and the overall relationship and general obligations of, the Parties. The provisions in this GA 2013 shall apply as a general agreement to all Annexes and Service Agreements hereto between FME and FNC on services provided in the area of information technology.

The Master Service Description (“MSD”) defines general processes, requirements, conditions and quality levels usually relevant for each Service in order to ensure a high quality Service provision from FNC to FME. It is structured according to the cooperation interfaces between FNC and FME.

The MSD furthermore defines testing and acceptance procedures as well as general acceptance criteria for the Services.

Moreover the MSD shall define the extent, type and purpose of the intended collection, processing or use of personal data, the type of data and categories of data subjects, if applicable to the type of services.

The Service Agreements, as mutually agreed, will define specific Services and provide detailed provisions on individual Services including timing and reimbursement.

For recurring Standard Services a Service Catalogue (“Service Catalog 2013)” as well as a respective Price List (“Price List 2013”) have been compiled.

In addition, existing contracts already created as Annexes under the former General Agreement 2003 and not terminated until 31.12.2012 shall become an integral part of the Set of Contracts under the GA 2013 (“Enduring Annexes GA 2003”) and shall remain in effect subject to the terms of this GA 2013 without amendment under this GA 2013 until their regular termination.

The GA 2013 shall govern all future Services ordered by FME or any of FME EMEALA’s affiliates and rendered by FNC to FME or any of FME EMEALA’s affiliates, even where no explicit reference is made hereto, unless the applicability of the GA 2013 has been explicitly excluded. The initial term for the GA 2013 is five years with an automatic renewal for another five years unless one of the parties terminates the GA with a six month notice period to the end of the first five years term.

C.Current considerations of FME and FNC regarding the pricing mechanism under the GA 2013

The GA 2013 states in § 6.1 that all prices, conditions of payment, and schedules are subject to written agreements, and shall be as defined in the MSD and the Service Agreements, if Individual Services are concerned. Regarding Standard Services, fees shall be equal to the up-to-date prices listed in the price list for standard services of FNC, published, updated and agreed with FME each year.

As we were told, the Price List 2013 was developed and agreed between FNC and FME by taking the prices applied under the GA 2003 until its expiration as basis.

7

Services for which no fees have been specifically agreed, shall be rendered according to the hourly or daily rate in accordance with the latest price list.

According to the Price List 2013 the hourly rate for internal FNC personnel is 122,50 EUR, the corresponding daily rate defined is 980,00 EUR.

In § 6.8 of the GA 2013 it is further stated that FNC shall offer to FME competitive prices in the average for a Group of Services, based on the costs for the individual Services.

FME shall be entitled to request a review of the prices for a Group of Services. Upon such request, the Parties shall make a benchmarking evaluation. If FNC’s prices are out of market range after such benchmarking evaluation, FME shall have the right to request an alternative offer from FNC within a period of one month after the benchmarking results. FNC shall have a period of three month to prepare such an offer. If FME accepts the alternative offer, acceptance may not be unreasonably withheld, adjusted pricing shall apply with retrospective effect from the date of receipt of FME’s request for an alternative offer.

The same procedure shall apply as far as FNC’s prices are below market prices. FNC shall then be entitled to submit the alternative offer to FME without request from FME and FME shall be obliged to reasonably accept the alternative offer.

If a benchmark of the prices for a Group of Services has been conducted, FME shall not request another review for the next three years after completion of the benchmarking process. Upon request, the Parties shall make a benchmarking evaluation.

IV.Assessment on the plausibility of the considerations made by FME and FNC in the intended contractual regulations compared to what would be expected between third parties

A.Assessment on the general approach of FME and FNC

The general approach to take the regulations of the expiring GA 2003 as basis for the negotiations of the GA 2013 is reasonable for us.

In our view the contractual framework of the GA 2013 including its different modules referred to as “Set of Contracts” provides a very detailed and structured framework for the provision of IT services. This goes beyond the set-up of the GA 2003 which mainly consisted of the GA 2003 and different, partly heterogeneous appendices to this GA 2003.

As this increases clarity and reliability for the contractual Parties, the set-up of the GA 2013 is generally as we would expect it between independent third parties.

8

The GA 2013 provides detailed regulations regarding both parties’ duties as well as regarding practically relevant issues like the use of subcontractors, compliance with GxP, rights of use and intellectual property rights.

Governance structure, change request procedures, confidentiality and privacy law matters are also defined in the GA 2013.

Moreover the GA 2013 is clear on defect and warranty as well as on liability and penalties.

As far as we can assess the respective regulations are well balanced between service provider and service recipient interests as would be expected between independent parties. They do also include measures usually installed between independent parties to enforce that contractual obligations are kept.

Examples for this are FME’s right to audit or qualify FNC’s quality management system (§ 9.4), the definition of a mechanism for penalties (§ 14) or the granting of an extraordinary termination right for FME in case FNC should violate core duties (§ 15.4).

More general principles or obligations stipulated in the GA 2013 are than further broken down in additional documents like the MSD.

This does for example include in § 7 of the MSD a detailed description of the order process including request for quotation and approval which is necessary before FNC is allowed to work on individual service requests of FME.

Another example are the binding project management methods defined in § 8 of the MSD in dependence on the project volume.

These are examples for what would typically be expected between independent parties to ensure sufficient cost control.

As a summary, the general approach taken by FME and FNC as to the conceptual set up of the contractual relationship stands a third party comparison in our view.

B.Assessment on the term of the General Agreement 2013

§ 15.1 of the GA 2013 defines that the term of the GA 2013 as framework agreement shall last from 1 January 2013 until 31 December 2017. Thereafter the GA 2013 shall automatically renew by another period of five years unless one party terminates the agreement by giving six months prior written notice to the end of the term. After the second five years term the GA 2013 will be extended automatically for successive one year periods unless one of the parties terminates the GA 2013 by giving six months prior written notice to the expiration of the then current term.

In addition immediate or reasonable notice termination rights for the GA 2013 are foreseen in §§ 15.3 and 15.4 for extraordinary events like for example insolvency, transfer of controlling interest or violation of core contractual duties.

9

According to § 15.2 of the GA 2013 the individual Service Agreements concluded under the GA 2013 can be terminated by giving 6 months written notice prior to the end of the agreed term of the respective Service Agreement unless otherwise agreed under applicable termination clauses in the Service Agreements.

Based on §§ 16.1 and 16.2 the termination of single Service Agreements shall not affect the term of the GA 2013 and vice versa. In case the GA 2013 is terminated, § 16.1 grants to the terminating party a special termination right with respect to each Annex and Service Agreement being part of the Set of Contracts under the GA 2013.

In our view the initial five years term of the GA 2013 with an automatic renewal for another five years is comparable to what would be expected among third parties for a framework agreement given the previous and planed future breadth and depth of the cooperation between FME and FNC in IT matters.

The fact that the termination rights for individual service agreements under the GA 2013 are more flexible is reasonable for us as this would also be an important aspect among third parties to enable service and cost level control within the cooperation under the framework agreement.

In addition, the GA 2013 foresees a variety of detailed regulations for an orderly transition in case the GA 2013 should be terminated.

This is also what third parties would typically establish.

As a result we consider the term of the GA 2013 as comparable to what third parties would agree under comparable circumstances.

C.Assessment on the pricing mechanism foreseen in the General Agreement 2013

The basic idea of taking the service remunerations applied under the expiring GA 2003, which was considered as fair, as basis for negotiating the terms of the new GA 2013 is plausible for us and can be expected to be applied in comparable manner among third parties.

The idea to establish a price list for recurring standard services including unit price per service and the related material number for a service follows the mutual economic interest of reducing fulfilment time and costs for high volume recurring customer requests. It can thus be expected to be applied among independent parties in comparable manner.

The fact that § 10.5 of the MSD foresees that an agreement on prices for new services and price changes for existing services has to be achieved annually during the budget process between FME and FNC is for us another indicator that the terms are comparable to what would be expected between independent parties.

Another strong indicator for the third party comparability of the GA 2013 is in our view the benchmarking process foreseen in § 6.8 of the GA 2013. This mechanism

10

exercises a strong pressure on both parties to keep the service prices within a competitive market range.

A further indicator for the parties’ efforts to establish their contractual relationship under the GA 2013 at arm’s length is the regulation stated in § 8.6 of the MSD for individual projects with a “time and material for effort” remuneration agreement.

Based on this regulation, FNC shall immediately inform FME and shall state reasons should the estimated and agreed upon time and material for such project be exceeded by 10% or more. Only after written approval by FME such additional costs shall be deemed accepted and refundable by FME. If FME does not respond within one business day after the receipt of FNC’s notification the progress of the individual project is agreed. FNC bears the onus of proof that such notification has been received by the respective FME project manager.

In addition, all project related expenditures (e.g. travel expenses, travel time, out-of-pocket expenses) which will be charged to FME by FNC have to be documented and to be acknowledged by FME in advance, unless otherwise agreed within the respective Individual Service Agreement.

With respect to projects it is also foreseen in § 8.7 of the MSD that FME may, at any time and at its sole discretion, terminate individual projects by giving FNC written notice thereof. On the other hand FME is than obliged to compensate FNC with 15% of the remaining budget, as agreed in the respective Individual Service Agreement for free capacities which cannot be utilized due to the termination of the Individual Service Agreement.

The regulations related to projects are in our view comparable to what would be expected between independent parties.

Another element of the pricing mechanism that ensures transparency and thus third party comparability is the fact that § 10.1 of the MSD foresees that the price model is principally based on unit prices and the actual quantity ordered and received by FME.

Such price model shall define charging criteria for each service depending on utilization (such as number of end devices for a defined category, number of mailboxes, file space used, etc.).

§ 5.1 of the Service Agreement SAP foresees a comparable principle according to which the most common pricing principles that should be applied to the SAP system families are as follows:

·Consumption based pricing calculated based upon the amount of usage

·User based remuneration based on number of named users

·      Lump sum based pricing

The type of pricing that shall be applied to a specific service shall be defined in the respective SAP Price List.

In our view this is basically what can be expected between independent parties.

11

D.Assessment on the man day rate for internal resources of FNC considered in the Price List 2013

The man day rate stated in the Price List 2013 for internal resources of FNC amounts to 980 EUR per day.

As the man day rate applicable for the year 2011 under the expiring General Agreement 2003 on IT services between FME and FNC was 960 EUR, the man day rate for 2013 appears to be reasonably developed from the terms and conditions valid under the GA 2003.

Third parties would also be expected to take the current man day rate applicable under a valid contract as basis for their considerations during negotiations for contracts on further periods.

In addition, we were told that the man day rate of EUR 980 is slightly below the range of average man day rates which was derived from proposals of external IT service companies during the RFP for the project inSITE. As we were told, the average man day rates for external IT service companies were in the range from EUR 995 to 1,160. From our point of view this is an additional indicator that the man day rate of EUR 980 used for FNC’s services can be considered to be arm’s length and in line with third party behaviour.

Also in view of the external IT consultants’ Accenture and SAP Germany rate cards, which are quoted in the Service Level Agreement Annexes for the project inSITE for Germany with a man day rate range from EUR 1,000 to 2,650 respectively EUR 602 to 3,008 depending on role level, the man day rate of EUR 980 for FNC appears reasonable to us.

E.Assessment on the expected IT cost as percentage of revenue under the terms and conditions of the GA 2013

Expected IT cost charged by FNC under the GA 2013

During the negotiations regarding the GA 2013, FME was provided by FNC with an estimate of the total IT cost resulting from FNC services governed by the GA 2013 for the years 2012 to 2022 (“FNC Cost Estimate”). The FNC Cost Estimate distinguishes between operational IT cost in four categories (SAP, Communication, Infrastructure and Other) and project related cost.

Basis for such cost estimate was the detailed budget discussed between FME and FNC for the year 2013. In such budget different FNC service types are stated with a specific article group number, planned quantity and planned cost.

Based on the information exchanged between FME and FNC concerning FME’s expectations regarding business and IT service level development during the years up to 2022, FNC has compiled the cost estimate for the two initial five years terms of the GA 2013 until the end of the year 2022.

12

According to the FNC Cost Estimate the total contract value for the 10 years period based on the current knowledge regarding the expected service levels and projects is MEUR 319 until the end of the year 2022. MEUR 246 of such expected cost are related to operational categories whereas MEUR 73 are related to projects currently foreseen.

An annual projection of service levels for the upcoming year is also agreed as standard between FME and FNC in § 10.3 of the MSD. According to this paragraph FNC shall provide it’s FME customers in the course of the yearly budget process with data regarding current service volumes adjusted to the known volume variations as expectation values for the following year.

Benchmarking of total expected IT cost for the year 2013

The IT cost information compiled in the FNC Cost Estimate was used to benchmark the IT cost under the GA 2013 on a plausibility level with IT cost information available from independent sources.

For this purpose the annual IT Spending and Staffing Benchmarks study 2011/2012 published by Computer Economics Inc. (“CE Study”) was taken as primary source of reference.

The key metric used for testing the adequacy of the terms established under the GA 2013 was the Total IT Spending as Percentage of Revenue.

Due to the availability of detailed planning data the analysis was focused on the year 2013.

In order to approach the relevant total IT cost for the FME region EMEALA, the IT service cost anticipated to be charged by FNC for 2013 with EUR 42,012,081 under the GA 2013 for operations and projects were taken as basis.

The expected IT cost under the GA 2013 taken from the FNC Cost Estimate as well as the following calculation steps are also outlined in Attachment 2 to this Fairness Opinion.

As we were informed by FME that the amounts charged by FNC to FME make up approximately 60% of FME’s total IT cost, the assumed amount of total IT cost was calculated by dividing the amount expected to be charged by FNC for the year 2013 by 0.6.

This resulted in estimated total FME EMEALA IT cost for 2013 including projects of EUR 70,020,136.

In order to assess the corresponding revenues for FME EMEALA, the expected FME EMEALA revenues for the year 2012 have been taken as basis. According to the information we received such revenues amount to EUR 2,910,708,661 (3,696,600,000 USD at an average rate of 1.27 USD/EUR).

13

As we were told that the Compound Annual Growth Rate (CAGR) of such sales is expected to be 8% over the next years, the relevant FME EMEALA sales for 2013 have been assumed with EUR 2,910,708,661 * 1.08 = EUR 3,143,565,354.

The calculated expected total IT Spending as percentage of revenue for FME EMEALA 2013 is thus 2.23 %. This percentage was than compared to the available benchmarks from the CE Study.

According to this CE Study, total IT spending as percentage of revenue for organizations across all sectors is 2.00% of revenue at the median, ranging from 1.00% at the 25th percentile to 3.5% at the 75th percentile. The 25th percentile and the 75th percentile show the range of values for the sample within the benchmark study, within which half of the organizations fall (“inter quartile range”).

As a conclusion, FME’s expected IT spending for 2013 including projects, which is mainly driven by FNC charges under the planned GA 2013, lies close to the median of companies benchmarked across all sectors in the PE study in terms of total IT spending as percentage of revenue.

Taking also into consideration the industry specific benchmark ranges published in the PE study for total IT spending as percentage of revenue, FME EMEALA’s calculated value of 2.23% for 2013 lies within the inter quartile range for Discrete Manufacturing ranging from 1.10% at the 25th percentile to 2.3% at the 75th percentile with a median of 1.6% and is slightly below the inter quartile range for Healthcare Providers lasting from 2.30% at the 25th percentile to 4.9% at the 75th percentile with a median of 3.6%.

An additional corroboration with the total IT Spending as Percentage of Revenue for 2010 published in Gartner Inc.’s annual report 2011 of IT spending and staffing metrics for Pharmaceuticals, Life Sciences and Medical Products with 3.3%, for Healthcare Providers with 3.2% and for Industrial manufacturing with 1.9% confirmed that the total IT spending as percentage of revenue that is expected by FME and FNC for FME EMEALA after conclusion of the GA 2013 is within a range that can also be expected for independent companies.

Benchmarking of operational IT cost for the year 2013

The same logic used for total IT spending was applied to the operational IT cost expected to be charged by FNC to FME under the GA 2013 for 2013 as additional corroboration.

The operational IT cost expected to be charged by FNC according to the FNC Cost Estimate were assumed to represent 60% of FME EMEALA’s operational IT spending. The total operational IT spending was thus derived by dividing the expected operational FNC charges by 0.6. The resulting amount was then divided by the expected FME EMEALA revenue for 2013 as already outlined above.

As a result FME EMEALA’s calculated total operational IT cost for the year 2013 amount to 1.16% of the revenue expected for 2013.

14

The inter quartile range for IT operational budgets as percentage of revenue across all sectors which can be taken from the PE Study lasts from 0.90% to 3.20% with 1.60% as median.

Consequently also FME’s expected operational IT spending for 2013 excluding projects, which is mainly driven by FNC charges under the planned GA 2013, lies within the inter quartile range of companies benchmarked in the PE study in terms of operational IT budget as percentage of revenue.

Taking into consideration also the industry specific benchmark ranges published in the PE study for operational IT spending as percentage of revenue, FME EMEALA’s calculated value of 1.16% for 2013 lies within the inter quartile range for Discrete Manufacturing ranging from 1.0% at the 25th percentile to 2.0% at the 75th percentile with a median of 1.4% and is below the inter quartile range for Healthcare Providers lasting from 1.6% at the 25th percentile to 3.6% at the 75th percentile with a median of 2.5%.

This confirms that the operational IT spending as percentage of revenue expected by FME and FNC for FME EMEALA after conclusion of the GA 2013 is within a range that can also be expected for independent companies.

Development of assumed IT cost

Based on the expected FNC IT cost charges for the years 2014-2022 under the GA 2013 as outlined in the FNC Cost Estimate, the development of IT Spending as Percentage of Revenue has been compared to the benchmarks that can be taken from the CE study.

For this purpose the total expected IT Spending for the years 2014-2022 was derived from the FNC charges outlined in the FNC Cost Estimate by dividing them by 0.6.

In addition it was assumed that FME EMEALA revenues increase with a CAGR of 8% until 2022 as informed by FMCD.

Under these assumptions taken by FME and FNC, the IT operational budget as percentage of revenue decreases from 1.10 % in 2014 to 0.73% in 2022.

The total IT spending as percentage of revenue decreases from 1.82% in 2014 to 0.83% in 2022.

Although the accuracy of the underlying data does certainly diminish due to the long term under consideration, the calculation nevertheless indicates in our view that the expected IT cost mainly driven by FNC charges under the GA 2013 come close to the benchmark inter quartile ranges known from the 2011/2012 PE study.

Summary

As a summary the FME EMEALA IT cost level mainly driven by the FNC charges under the GA 2013 as forecasted by FNC and FME is in our view comparable to what can be benchmarked from independent sources in terms of percentage of revenue.

15

This is a clear indicator for us that the terms and conditions of the GA 2013 are comparable to what independent parties would be expected to agree.

V.Conclusion with regard to the plausibility of the considerations made by FME and FNC regarding terms and conditions under the General Agreement 2013 compared to what would be expected among third parties

On the basis of the information provided to us we have not identified areas where the considerations made by FME and FNC regarding terms and conditions for the conclusion of a General Agreement 2013 deviate significantly from the considerations that may be expected between two independent parties at this stage of the negotiation of a contract.

We therefore conclude that these considerations are plausible compared to what would be expected between two independent parties at this stage.

This report is backed by two attachments that were provided by FME and FNC as basis for our work as well as by the General Terms and Conditions as of May 2012.

The report was prepared to the best of our knowledge and ability. It is based on the examination and discussion of the information and documentation made available to us by FME and FNC.

16

VI.Notes to our professional statement

This professional statement is based on documents and oral information provided to us. If the facts or assumptions underlying this professional statement prove to be incorrect or change, this may affect the validity of this professional statement.

This professional statement is based on the law as of the date of this professional statement and reflects our interpretation of the applicable laws and regulations and the corresponding court rulings.

In the course of time, laws, their interpretation and court rulings may change. Such changes may necessitate a revision of this professional statement.

Please note that we are not obliged to review and revise this professional statement in the event of changes in the underlying facts, assumptions, laws or court rulings, unless we are engaged to do so.

This professional statement was prepared solely for our client on the basis of the engagement agreement concluded between the client and ourselves. It is not intended to serve third parties as basis for their decisions. Third parties’ notice of its contents is entirely at their own risk. We have no obligation, responsibility or duty of care towards third parties (reliance restricted), unless otherwise confirmed to a third party in advance in writing.

****

Ernst & Young GmbH
Wirtschaftsprüfungsgesellschaft

/s/ Oliver Wehnert	/s/ ppa. Thomas Wilwers
Oliver Wehnert	ppa. Thomas Wilwers
Partner	Senior Manager

17

Attachment 1:General Agreement 2013 between FME und FNC (“GA 2013”), dated 17 December 2012

I

General Agreement 2013

between

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„FME”)

and

Fresenius Netcare GmbH

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„NETCARE”)

Current status	:	17.12.2012
Last printed	:	17.12.2012
Version	:	1.0

Index

Preamble		3
1.	Contractual Structure and Scope of Application	5
2.	NETCARE’s Duties	8
3.	Use of Subcontractors	9
4.	FME’s duties	10
5.	Cooperation	11
6.	Prices, Invoice, Payments	11
7.	Governance Structure and Change Request Procedure	12
8.	Confidentiality	14
9.	Privacy Law/Safety/Compliance with GxP/Order-Data Processing	15
10.	Order-Data Processing (auftragsdatenverarbeitung)	16
11.	Rights of Use and Intellectual Property RIGHTS	20
12.	Defects AND Warranty	21
13.	Liability	22
14.	Penalties	24
15.	Term and Termination	24
16.	Effect of Termination/Expiration	25
17.	Governing Law, Arbitration	27
18.	Miscellaneous	27

2

GENERAL AGREEMENT

This agreement is made and entered into on 01.01.2013 by and among Fresenius Medical Care AG & Co. KGaA, Else-Kröner-Straße 1, 61352 Bad Homburg v. d. H. (“FME”) and Fresenius Netcare GmbH, Else-Kröner-Straße 1, 61352 Bad Homburg v. d. H. (“NETCARE” and together with FME, the “Parties” and each a “Party”).

PREAMBLE

(A)FME is the parent company of a group that manufactures and distributes dialysis-related products and provides dialysis services.

(B)NETCARE is a provider of IT services.

(C)The Parties entered into a General Agreement dated 8 December 2003 to provide for a legal framework under which NETCARE provided IT services to FME. The term of such General Agreement will expire on 31 December 2012.

(D)The Parties intend to continue the existing contractual relationship by entering into this General Agreement (hereinafter referred to as the “General Agreement”).

(E)FME, in its own name and on behalf of its current and future affiliates (as listed in Attachment 1 to this Agreement, as amended once a year in accordance with the procedure defined in the MSD), for each limited to users located in the Territory (“Territory” exclusively meaning: FME regions Europe, Africa, Middle East and Latin America, the “FME EMEALA”) and NETCARE intend to agree upon the parameters of their cooperation with respect to services in the field of information technology. This General Agreement and its Annexes and Service Agreements shall describe the services to be provided by NETCARE to FME and the terms and conditions under which the services will be provided and of the cooperation between the Parties with the intention to continue the long term business relationship in the same manner as under the expired General Agreement.

(F)NETCARE has the expertise, knowledge and capacity to provide the IT services under this General Agreement. Based on its previous role as service provider to FME, NETCARE is prepared to assume and render the services, functions and projects described in the Set of Contracts (as defined below) to FME.

(G)Such cooperation shall be governed by the following principles both Parties have accepted:

(i)       Information Technology to support the FME business

(ii)      Partnership

3

(iii)Transparency

(iv)Competitiveness

(v)Economic benefits and

(vi)Safety

(vii)Compliance

(H)Information Technology to Support FME business. The maxim of the FME EMEALA IT-strategy is to support the business units of FME through the use of information technologies efficiently. According to such maxim, technology is a method serving such purpose consequently and must not become an end in itself. Subject to the terms and conditions of this General Agreement, the Annexes and Service Agreements thereto, “Efficiently” in this context means the use of software close to the standard, the avoidance of custom-developments and, in given cases and subject to written -agreement thereon, the repatriation of uneconomic modifications deviating from the standard.

(I)Partnership. Reliable and high performing information technology may be achieved only in close collaboration between the Parties. Amicable collaboration in this context shall mean frequent communication through established channels of communication as defined in this General Agreement and a common pursuit for achieving goals. Cases of controversy shall be discussed openly and settled amicable. When using their discretion, both Parties shall in no instance disregard the other Party’s interests involved.

(J)Transparency. Either Party shall inform the respective other Party of projects which may affect the collaboration under this General Agreement in due time via the established communication channels as described within this General Agreement. Parties shall undertake to provide data for plausibility analysis if required by the General Agreement, Annexes or Service Agreements thereto.

(K)Competitiveness. Both prices and services or goods rendered shall be competitive to market prices. NETCARE shall be responsible for keeping its compensation scheme proportionate to the costs incurred. Savings earned through joint projects shall be allocated fairly. Pricing and price changes shall be discussed between the Parties and shall be jointly settled. FME may commission benchmark opinions by third Parties. NETCARE shall undertake to assists in such benchmark projects.

(L)Economic effects. It is understood that FME desires to save costs by means of information technology. It shall be a continuous task of both Parties to determine and to realize possible cost saving potentials made available by the use and operation of information

4

technology. However, cost saving measures shall not adversely affect the scope and quality of services rendered under the terms and conditions of any Annex or Service Agreement. (Both Parties are aware, that although the prices per user are envisioned to be decreasing the total cost may increase due to an increasing number of users and additional functionality). The goal of performing cost saving measures shall be a common one even though the intent of NETCARE to make profits contradicts FME’s desire to lower cost at first sight.

(M)Safety. FME shall have unhindered access to its proprietary data. However, unauthorized access by third Parties and employees shall be prevented. NETCARE may not misuse data security rationale for denying FME access to data, e.g. preventing FME to undertake additional data analysis with IT technology which is not covered by this General Agreement.

(N)Compliance. The Parties acknowledge that FME as a company with its business in the medical and pharmaceutical industry operates in a regulated market and is subject to certain legal and regulatory requirements, including, but not limited to GxP, SOX and data protection. NETCARE shall provide the services in a manner required by FME to ensure compliance of FME with such legal requirements and NETCARE shall reasonably assist FME upon request in complying with such legal requirements as far as the legal requirements impose requirements on the IT services and FME has notified NETCARE of the relevant requirements.

(O)Third Party comparison. Furthermore, this General Agreement and the Set of Contracts (as defined below) shall be drafted and construed without taking into account that the Parties are affiliated companies. Therefore, this General Agreement and modules attached hereto shall be in accordance with arm’s length principles and stand third Party comparison. In order to achieve this purpose, FME and NETCARE have commissioned Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft to issue a fairness opinion on the comparability of the terms and conditions of this present Set of Contracts with third Party agreements. The fairness opinion is attached hereto as Attachment 2.

1.CONTRACTUAL STRUCTURE AND SCOPE OF APPLICATION

1.1The complete agreement between the Parties and the contractual structure defined as “Set of Contracts” consists of:

a)this General Agreement; and

b)related documents (the Annexes) such as:

(i)   Master Service Description;

5

(ii)Glossary

(iii)Fairness Opinion

c)Service Agreements

(i)Standard Service Agreements

(ii)Individual Service Agreements;

1.2The Set of Contracts is structured in a modular basis:

a)This General Agreement provides the legal framework that shall govern the cooperation between, and the overall relationship and general obligations of, the Parties. The provisions in this General Agreement shall apply as a general agreement to all Annexes and Service Agreements hereto between FME and NETCARE on services provided in the area of information technology.

b)The Service Agreements, as mutually agreed, will define specific Services and provide detailed provisions on individual Services.

1.3The following details shall be provided at a minimum:

6

a)Master Service Description (MSD)

(i)The MSD defines general processes, requirements and conditions for each Service or qualities for the Services.

(ii)MSD defines testing and acceptance procedures as well as general acceptance criteria for the Services.

(iii)MSD shall define the extent, type and purpose of the intended collection, processing or use of personal data, the type of data and categories of data subjects, if applicable to the type of services.

b)Service Agreements

(i)a specified description of the scope and the subject of the Services to be performed by NETCARE.

(ii)time and location of performance of Services.

(iii)tasks to be performed by FME and FME’s assistance.

(iv)reimbursements and service fees.

(v)definition of service levels and measure procedure.

1.4Existing contracts already created as Annexes under the former General Agreement as of 8th December 2003 and not terminated until 31.12.2012 shall become an integral part of the Set of Contracts and shall remain in effect subject to the terms of this General Agreement without amendment under this General Agreement until their regular termination.

1.5In cases of contradictions, clauses in Annexes shall supersede the clauses in this General Agreement, and clauses in Individual Service Agreements or Standard Service Agreements shall supersede the clauses in the General Agreement and the Annexes.

1.6The individual Services to be provided by NETCARE may qualify as service, work, rent or similar type of contract under civil law or a combination of various types of contracts defined under civil law. The Parties shall mutually agree and define the relevant obligations and the type of contract in a Service Agreement, as far as possible, in order to clarify the applicable legal regulations and obligations of the Parties;

1.7For the avoidance of doubt, the contractual provisions and principles set forth in the General Agreement, including but not limited to regulatory, data protection, shall only be subject to change in accordance with the change request procedure pursuant to

7

Section 7.

1.8This General Agreement shall govern all future Services ordered by FME or any of FME EMEALA’s affiliates and rendered by NETCARE to FME or any of FME EMEALA’s affiliates, even where no explicit reference is made hereto, unless the applicability of the General Agreement has been explicitly excluded.

2.NETCARE’S DUTIES

2.1NETCARE will provide Services in the area of information technology to FME. Individual Services and details are specified in the Annexes and Service Agreements.

2.2NETCARE shall

a)render the Services in accordance with the provisions defined in the Set of Contracts and, where applicable and where defined, at the place/location defined in a specific service description in a Service Agreement or, if not defined, at the location mutually agreed by both Parties;

b)render its Services in compliance with applicable statutory accident prevention regulations, applying to NETCARE and FME, if notified by FME of the relevant regulations, as well as applicable statutory health and safety regulations;

c)deliver services in compliance with the current state of the art, as applicable from time to time, according to best practice, and free of material Defects with respect to specifications for the Services.

d)comply, and procure that any of its sub-contractors complies, with FME’s security and control regulations and systems provided that NETCARE has been notified hereof at a reasonable time before the commencement of NETCARE’s performance.

e)procure licenses as agreed in Section 11.

f)provide and use appropriate verification tools to monitor and measure compliance with any service levels agreed in a Service Agreement, whereas such verification tool shall be appropriate if it measures the items to be measured according to the verification method agreed between the Parties in connection with such service level; whether non-compliance with agreed service levels results in legal consequences shall be agreed in the relevant Annex or Service Agreement.

g)be obliged to comply with the license terms of the third party licensor and not use the software in violation of such license. In particular, NETCARE shall notify

8

FME of any violations of such license agreement and terms defined therein.

h)allow FME or an agent of FME to audit whether NETCARE’s use of the software is consistent with the rights granted to NETCARE herein upon request by FME and provided there is a legitimate interest therein and to give full cooperation to FME or its agent carrying out such audit. In case of an audit by the licensor with respect to compliance of FME with the licensing conditions, NETCARE shall reasonably assist FME in providing the information reasonably requested by the licensor in connection with such audit.

2.3Unless explicitly agreed otherwise between the Parties, NETCARE shall not be obliged to consult with FME when modifying or changing any hard- or software, or amending any system, used for rendering a Service, unless the modification or change adversely affects the performance of NETCARE or the compliance with any service levels agreed or the compliance with privacy law;

2.4NETCARE is not obliged to deliver the source code unless such obligation is agreed upon in the Service Agreements.

3.USE OF SUBCONTRACTORS

3.1NETCARE may use subcontractors for rendering the services in its own discretion. In no event will NETCARE be relieved of its obligations under this General Agreement as a result of its use of any subcontractors. NETCARE shall inform FME of any subcontractors used upon written request of FME.

3.2NETCARE’s obligations for imposing duties of secrecy and compliance with an obligation towards FME on subcontractors shall be governed by Section 8 and 9 and NETCARE shall ensure that all subcontractors are subject to and comply with the same obligations as are imposed on NETCARE under the terms agreed in the Set of Contracts.

3.3If FME determines that a subcontractor has to be replaced for good reasons, FME shall notify NETCARE explaining the reasons for such a replacement. Following receipt of this notification, NETCARE will promptly, or within such period of time reasonably agreed by the Parties, replace such a subcontractor by another third party or by NETCARE’s personnel. A good reason exists, in particular, if

a)a supervisory authority objects to or prohibits the engagement of a specific subcontractor or the subcontracting with respect to the services rendered by the subcontractor;

9

b)any rights or interests of FME or any of its affiliates with respect to confidentiality, data protection or data security are at risk;

c)a subcontractor engaged in data processing relocates its activities or the data processing or parts thereof to a country outside of the EU;

d)a competitor of FME holds or acquires more than 25% of the interests or voting rights in the subcontractor.

4.FME’S DUTIES

4.1FME shall

a)provide all required reasonable assistance and co-operate with NETCARE including

·the assignment of competent staff to a reasonable extent for problem solution.

·the assignment, supervision and control of FME staff and capacities.

·the assurance that FME employees will comply with FME’s guidelines implemented for the use of the services, data and applications.

b)provide to NETCARE all relevant information and documentation reasonably required by NECTARE for the provision of the Services under the Set of Contracts, including any (internal) guidelines or regulations NETCARE shall comply with when providing the Services.

c)if required, grant NETCARE and its agents and subcontractors access to FME’s premises and equipment free of charge for the time reasonably expectable for an appropriate performance under this Set of Contracts, at least during FME’s regular business hours.

d)assist and cooperate with NETCARE in implementing any changes or system requirements, i.e. by allowing NETCARE to train FME personnel.

e)be obliged to comply with the license terms of the third party licensor and not use the software in violation of such license. In particular, FME shall notify NETCARE of any violations of such license agreement and terms defined therein.

f)allow NETCARE or an agent of NETCARE to audit whether FME’s use of the software is consistent with the rights granted to FME herein upon request by

10

NETCARE and provided there is a legitimate interest therin and to give full co-operation to NETCARE or its agent carrying out such audit. In case of an audit by the licensor with respect to compliance of NETCARE with licensing conditions, FME shall reasonably assist NETCARE in providing the information reasonably requested by the licensor in connection with such audit.

4.2The Parties shall agree on the specifications of any required assistance and co-operation in connection with a service and an Annex or Service Agreement.

5.COOPERATION

5.1The Parties shall

a)co-operate in good faith;

b)appoint relevant key personnel with respect to the overall management of the Set of Contracts and the cooperation between the Parties and shall ensure that such key personnel will only be replaced for good cause;

c)appoint responsible personnel and contact persons for the coordination and general management of the Services under this General Agreement, the MSD, other Annexes and Service Agreements;

d)inform the other Party of any circumstances that may have an impact on the provision of the services and result in a default with respect to the services as well as any actual default or remedy of defaults;

e)agree on and comply with a defined communication and escalation process which shall leave the obligations of the Parties under the Set of Contracts unaffected, in particular any retention rights or rights to non-performance shall be excluded;

f)co-operate and provide reasonable assistance for transition and migration of the relevant services after termination of any Annex, Service Agreement or this General Agreement.

g)agree on the performance of license management for FME.

6.PRICES, INVOICE, PAYMENTS

6.1All prices, conditions of payment, and schedules are subject to written agreements, and shall be as defined in the MSD and the Service Agreements, if Individual Services are concerned. As regards Standard Services, fees shall be equal to the up-to-

11

date prices listed in the price list for standard services of NETCARE, published, updated and agreed with FME each year.

6.2Services, where no fees have been agreed, shall be rendered according to the hourly or daily rate in accordance with latest price list as per 6.1.

6.3Prices shall be renegotiated and reasonably be modified if a Service Agreement is modified or amended.

6.4A price adjustment clause may be incorporated if applicable in any individual Service Agreement.

6.5Prices are net prices plus the applicable VAT (value added tax, in Germany currently 19%) and as determined in the specific Service Agreement.

6.6Payments hereunder shall be made in EURO.

6.7The payment terms should be agreed between NETCARE and the respective affiliate invoiced in a separate or the relevant Service Agreement. For Germany payment terms shall be according to the applicable Fresenius group procedures. A written invoice shall be provided to the respective affiliate even though the booking is done by EDI. Outside Germany, a payment range between 30 —60 days shall be applied.

6.8Overall NETCARE shall offer to FME competitive prices in the average for a Group of Services, based on the costs for the individual Services. FME shall be entitled to request a review of the prices for a Group of Services. Upon such request, the Parties shall make a benchmarking evaluation. If NETCARE’s prices are out of market range after such benchmarking evaluation, FME shall have the right to request an alternative offer from NETCARE within a period of one month after the benchmarking results. NETCARE shall have a period of three month to prepare such an offer. If FME accepts the alternative offer, acceptance may not be unreasonably withheld, adjusted pricing shall apply with retrospective effect from the date of receipt of FME’s request for an alternative offer. The same procedure shall apply as far as NETCARE’s prices are below market prices whereas NETCARE shall be entitled to submit the alternative offer to FME without request from FME and FME shall be obliged to reasonably accept the alternative offer. If a benchmark of the prices for a Group of Services has been conducted, FME shall not request another review for the next three years after completion of the benchmarking process. Upon request, the Parties shall make a benchmarking evaluation.

7.GOVERNANCE STRUCTURE AND CHANGE REQUEST PROCEDURE

7.1The Parties agree to implement and appoint certain committees and boards for the

12

coordination of the cooperation between the Parties. The governance structure shall have the following three levels:

a)Management Board: strategic level

b)Steering Committee: tactical level

c)Operation Units: operational level.

7.2Obligations and tasks of each level, the constitution and composition of each level as well as escalation procedures shall be governed by and defined in the MSD.

7.3Each Party shall have the right to request in writing a change to the contractual arrangements between the Parties, as agreed in the Set of Contracts, including the processes defined in the MSD, the Services or specifications.

a)Changes with an impact on the specifications or scope of the Services shall be subject to the change procedures defined in the MSD. The following provisions shall apply to any changes to the contractual provisions of this General Agreement or any processes defined in the MSD, the Attachments or any general provisions in the Annexes or Service Agreements that are meant to provide a deviation from the provisions in this General Agreement or the MSD and that do not have an impact on the content or scope of a Service, the service fees or alike (“Contractual Change”).Subject to the terms and conditions of this General Agreement, NETCARE shall undertake to comply with FME’s reasonable requests for a Contractual Change provided that the Parties have agreed in writing on the effects of any Contractual Change on this General Agreement or its Annexes.

b)If provisions in the Set of Contracts are erroneous, incomplete, ambiguous, or impossible to fulfill for anybody, the Parties shall upon request of one Party decide without undue delay on modifying and completing such provisions.

c)If changes in applicable laws, orders of authorities or courts have an impact on the Services or the Set of Contract or make changes to the Services or Set of Contract necessary, NETCARE shall implement such changes upon request of FME or in its own discretion provided that NETCARE will inform FME of such change. The Parties will mutually and reasonably agree on the relevant contractual changes necessary.

d)Neither Party shall unreasonably withhold or delay its consent to a Contractual Change. Any Contractual Change agreed between the Parties shall be made in writing and signed by the Parties.

13

e)Contractual Changes shall be discussed and agreed on the level of the Steering Committee.

8.CONFIDENTIALITY

8.1Each Party shall keep strictly confidential

a)all documents, information, and data, and

b)all trade secrets or confidential information proprietary to one of the Parties or a third Party disclosed to her or obtained by her incidental to the cooperation under the Set of Contracts (Confidential Information). Confidential Information shall include without limitation know-how, details of orders, contractual provisions and prices.

8.2The Parties shall disclose Confidential Information as defined in Section 8.1 to third Parties only upon prior written consent of the other Party. The Parties shall put all third Parties or companies who may receive Confidential Information or who are retained under this General Agreement under the same obligations as the respective Party has entered into.

8.3Subcontractors obtained by NETCARE shall not qualify as third parties under Section 8.2, provided that such subcontractors are under an obligation to keep information confidential at least as protective as the confidentiality provisions under this General Agreement and that the breach of such obligation shall be punishable by an adequate penalty. Confidential Information shall only be disclosed to subcontractors on a need to know basis.

8.4This obligation to keep confidential does not include

a)information which is now or hereafter becomes part of the public domain in other ways than by faults, acts or omissions of the Receiving Party;

b)information which hereafter lawfully comes into the Receiving Party’s possession from an independent third source without any obligation of secrecy;

c)information which the Receiving Party can show by sufficient evidence was in the Receiving Party’s possession prior to the time of receipt from the Disclosing Party, or information or knowledge which was independently developed by or for the Receiving Party without access to any of the Confidential Information disclosed hereunder.

d)information which the Receiving Party has an obligation or duty to disclose under applicable law or by order issued by the competent courts, provided

14

Disclosing Party is given a reasonable opportunity to review the planned disclosure and discuss the need for such with Receiving Party prior to the actual disclosure;

8.5FME shall ensure that any user names and passwords are kept confidential and that only authorized users use the Services and licenses rendered by NETCARE. User names and passwords shall not be disclosed to an third Party and shall be kept confidential in order to prevent access of not authorized third Parties.

9.PRIVACY LAW/SAFETY/COMPLIANCE WITH GXP/ORDER-DATA PROCESSING

9.1NETCARE shall comply with the data protection, data safety and security obligations imposed on FME by the applicable laws and regulations and the provisions of the Network Security Guideline of Fresenius Medical Care AG & Co. KGaA provided to NETCARE by FME.

9.2For that reason and according to requirements imposed on FME by law, regulations and safety aspects, FME has to insist on the obedience of the following terms and conditions. NETCARE acknowledges these terms and conditions as being mandatory for FME to comply with laws, regulations and safety aspects and for the fulfillment of FME’s business.

9.3NETCARE shall be liable to FME that

a)NETCARE follows FME’s instructions with regard to the creation and implementation of user profiles; and

b)system architecture shall maintain the security and consistency of the data, and access by FME officers, employees and agents shall be according to the user profiles; and

c)each of FME’s employees shall have unhindered access to FME’s proprietary data unless such access is restricted by the user profile and/or FME’s other instructions; and

d)no third Party (including employees or representatives of further companies of the Fresenius SE & Co. KGaA group of companies) shall, at any time, have access to FME’s data.

9.4FME shall be entitled to audit and/or qualify NETCARE with respect to the current quality management system and the quality management system envisioned to be implemented under section 9.5, the internal control system prescribed by FME’s corporate governance regulations, and/or, at FME’s choice, to let have an external auditor audit and/or qualify NETCARE once a year, or as deemed necessary, but reasonably

15

acceptable for NETCARE, in order to assure that NETCARE complies with its contractual obligations. Prior to such FME or third Party audit, FME shall give NETCARE timely prior written notice and FME or third Party access shall be limited to NETCARE’s normal business hours.

9.5NETCARE shall be obliged to maintain a quality management system meeting the requirements agreed in a separate quality assurance agreement. The quality assurance agreement shall define responsibilities, scope, regulatory requirements, validation and documentation requirements, among others.

9.6In general Netcare shall ensure that FME’s GxP-critical applications and data, as expressly defined by FME, are maintained and archived in a GxP-compliant way. Netcare shall ensure that all FME GxP-critical systems, applications and data will be operated GxP-compliant in accordance to the specifications as set forth in the applicable Service Agreement and instructions of FME. Further requirements concerning archiving and disaster recovery as well as how FME and Netcare work in GxP-critical projects shall be defined in the quality assurance agreement.

9.7Whenever FME shall be obligated by the applicable laws, regulations or requirements imposed on FME by the competent authorities or agencies to change, amend or modify its quality as well as corporate governance standards in order to fulfill the regulatory requirements for FME’s business, NETCARE shall be obligated to follow any of such FME’s requests in order to comply with any such changes, amendments or modifications. Any changes shall be made by applying the change procedures defined in this General Agreement or the MSD, as applicable.

9.8FME’s business is strongly regulated by governmental authorities. Due to regulation changes FME may be forced to changed business processes that may also affect NETCARE’s duties and may require NETCARE to exceed any current standards, i.e.the requirements defined in the quality assurance. As far as the implementation of such changes triggers any material costs NETCARE shall inform FME before implementation of such changes or requirements. Both Parties shall agree in accordance with the change procedures defined in this General Agreement or the MSD, as applicable, on the implementation of such changes and document in writing such changes and related costs. FME shall compensate NETCARE for any costs related to such changes based on the related effort and expenses.

Any measures and related costs in connection with the implementation, application and maintenance of any internal control system required by FME or FME’s corporate governance regulations shall be agreed in a separate Annex or Service Agreement.

16

10.ORDER-DATA PROCESSING (AUFTRAGSDATENVERARBEITUNG)

10.1The Parties acknowledge that NETCARE (as the processor) will provide services to FME (as the controller) on basis of order-data processing (Auftragsdatenverarbeitung). The following rules apply to all activities in which the staff of NETCARE or a third party acting on behalf of NETCARE may come into contact with Personal Data of FME. Personal Data means any individual element of information concerning the personal or material circumstances of an identified or identifiable natural person (individual).

10.2Duration (term) and subject of the order-data processing shall be defined in the Master Service Description, the Standard Service Agreement or the Individual Service Agreement – whichever is applicable.

10.3The extent, type and purpose of the intended collection, processing or use of personal data, the type of data and categories of data subjects are stipulated in Section 1 of this General Agreement.

10.4NETCARE shall take the appropriate technical and organizational measures to adequately protect FME’s Personal Data against misuse und loss in accordance with requirements of section 9 of the German Federal Data Protection Law (Bundesdaten-schutzgesetz; hereinafter: BDSG). The measures are defined in the Master Service Description and may be expanded in Standard Service Agreements or Individual Service Agreements.

10.5The technical and organizational measures are subject to technical progress and development, and NETCARE may implement adequate alternative measures in accordance with Section 7.3 of this General Agreement. These must not however fall short of the level of security provided by the specified measures. Any material changes must be documented.

10.6FME and NETCARE are aware of the fact that, at present, NETCARE operates its services under the Set of Contracts through a “one-client-system”, i. e. FME and further companies of the Fresenius SE & Co. KGaA group of companies are within the same “client-system”.

10.7NETCARE is obliged to rectify, erase or block the Personal Data processed in accordance with the reasonable instructions of FME. NETCARE shall take the necessary precautions to ensure that Personal Data can be rectified, erased or blocked in its systems.

10.8If a data subject (individual person) should apply directly to NETCARE to request the correction or deletion of his Personal Data, NETCARE must forward this request to FME without delay, unless the correction or deletion is part of the specific service.

10.9NETCARE shall collect, process and use Personal Data only within the Set of Contracts.

17

NETCARE may not use Personal Data for any other purposes, including its own purposes.

10.10NETCARE shall ensure that any personnel entrusted with processing FME’s Personal Data have undertaken to comply with the principle of data secrecy in accordance with section 5 of the BDSG and have been duly instructed on the obligations of NETCARE to protect Personal Data. The obligation of confidentiality shall continue after their employment ends.

10.11NETCARE shall monitor compliance with the provision of this section by means of regular tests.

10.12Where stipulated by law, NETCARE shall appoint a data protection officer, able to discharge his duties as set out in sections 4f and 4g of the BDSG. The officer’s contact details must be supplied to FME to enable direct contact to be made.

10.13Upon FME’s request, NETCARE shall provide all information necessary for compiling the overview defined by section 4g (2) sentence 1 of the BDSG.

10.14NETCARE may use sub-contractors according to Section 3 of this General Agreement.

10.15FME must be granted the right to monitor and inspect the sub-contractor in all cases of order-data processing.

10.16In addition to Section 10.7 of this General Agreement, FME may carry out the job control stipulated in No. 6 of the annex to the BDSG, or appoint auditors to do so.

10.17NETCARE shall provide FME with the information required to meet its job control obligation, and shall make the necessary documentation available.

10.18With regard to the monitoring obligations of FME under section 11 (2) sentence 4 BDSG before the start of data processing and throughout the term of the commission, NETCARE must ensure that FME can confirm adherence to the technical and organizational measures taken. For this purpose, NETCARE must provide FME upon request with evidence of the implementation of the technical and organizational measures pursuant to section 9 of the BDSG and the annex thereto. Evidence of the implementation of any measures that do not only affect the specific commission may also be presented in the form of up-to-date attestations, reports or extracts thereof from independent bodies (e.g. external auditors, internal audit, the data protection officer, the IT security department or quality auditors) or suitable certification by way of an IT security or data protection audit.

10.19In addition to Section 5 of this General Agreement, NETCARE shall notify FME in all

18

cases of violations of data protection provisions.

10.20Where FME’s Personal Data becomes subject to search and seizure, an attachment order, confiscation during bankruptcy or insolvency proceedings, or similar events or measures by third parties while being processed, NETCARE shall inform FME without undue delay. NETCARE also shall, without undue delay, notify to all pertinent parties in such action, that any Personal Data affected thereby is in FME’s sole property and area of responsibility, that Personal Data is at FME’s sole disposition, and that FME is the responsible body in the sense of the BDSG.

10.21The Parties are aware that section 42a of the BDSG may impose a duty to inform in the event of the loss or unlawful disclosure of Personal Data or access to it. Such incidents should therefore be notified by NETCARE to FME immediately, regardless of their origin. This also applies to serious operational faults or where there is any suspicion of an infringement of provisions relating to the protection of Personal Data or other irregularities in the handling of Personal Data belonging to FME. In consultation with FME, NETCARE must take appropriate measures to secure the data and limit any possible detrimental effect on the data subjects. Where obligations are placed in FME under section 42a of the BDSG, NETCARE must assist in meeting them.

10.22FME is responsible for compliance with the BDSG and other relevant regulations on data protection, and retains control over the extent of the data to be processed.

10.23FME shall have the right to give NETCARE reasonable instructions as to the nature, scope and method of data processing. The proceeding of FME’s authority to issue instructions is stipulated in Section 7 of this General Agreement.

10.24Any changes to the subject-matter of the processing must be agreed in writing by the Parties and documented together.

10.25NETCARE shall inform FME immediately if NETCARE believes that an instruction violates privacy laws. NETCARE may then postpone the execution of the relevant instruction until it is confirmed or changed by FME.

10.26After the termination of a commission under this General Agreement NETCARE must return to FME all of FME’s Personal Data in NETCARE’s possession and all Personal Data collected and produced in connection with the commission, or delete them with the prior written consent of FME. The deletion log must be presented upon request.

10.27Documentation intended as proof of proper data processing must be kept by NETCARE beyond the end of the Set of Contracts in accordance with relevant retention periods. NETCARE may hand such documentation over to FME after expiry of this General Agreement or its Annexes.

19

11.RIGHTS OF USE AND INTELLECTUAL PROPERTY RIGHTS

11.1NETCARE shall procure, operate and maintain any software, licenses and rights needed by NETCARE for the provision of the Services.

11.2As a matter of principle, NETCARE shall procure and acquire licenses and rights in connection with the Services in its own name and sublicense such licenses or grant to FME the rights of use for software or other deliverables to the extent required by FME in connection with, or as a result of, the relevant Service Agreement for the use of the Services under the Set of Contracts in accordance with the provisions defined in this Section 11, unless otherwise agreed in a Service Agreement.

11.3Any rights granted by NETCARE to FME under this Agreement shall not entitle FME, without NETCARE’s prior consent, to modify, decompile, translate, decrypt, decompose, or copy the deliverable, unless otherwise expressly agreed herein or in a Service Agreement.

11.4With respect to third party standard software or NETCARE’s own software, not specifically and exclusively developed for FME, which is used by NETCARE to provide the Services (“Standard Software”), NETCARE shall grant FME the non-exclusive, non-transferable right to use without limitation in time, scope or place subject to the terms of this General Agreement and the relevant Service Agreement, in particular limited to the purpose described in the relevant Service Agreement. The scope of the right of use of FME shall be in accordance with the license and right of use granted by the third party licensor to NETCARE. NETCARE shall ensure that it will obtain all required rights and licenses to sub-license or transfer the license to FME for the required purposes.

11.5To the extent that any rights derive from software or other deliverables expressly developed for and on behalf of FME by NETCARE, including new developments of interfaces, platforms, changes, etc., provided that NETCARE has not used any proprietary software of NETCARE or any third party, any intellectual property rights shall vest in FME and FME shall be the owner of any intellectual property rights in connection with such deliverable. FME grants to NETCARE the non-exclusive, transferable right to use, to copy, to revise and to decompile the deliverables without limitation in time, scope or place subject to the terms of the Set of Contracts. The right to use is limited to the purposes described in the Service Agreement applicable to the relevant deliverable. The right to copy, revise and decompile the deliverable shall be limited, however, to the maintenance or reinstatement of the agreed functionality of the deliverable.

11.6As far as NETCARE develops any deliverable only partly for and on behalf of FME or FME only partly reimburses the costs associated with a deliverable, NETCARE and

20

FME shall be co-owners of such deliverable in the proportion of the relevant contribution to the development of the deliverable. FME shall have the non-exclusive, transferable right to use the deliverable for the purpose of this General Agreement. NETCARE shall have the non-exclusive, transferable right to use, to copy, to revise and to decompile the deliverables without limitation in time, scope or place subject to the terms of the Set of Contracts. The right to use is limited to the purposes described in the Service Agreement applicable to the relevant deliverable. The right to copy, revise and decompile the deliverable shall be limited, however, to the maintenance or reinstatement of the agreed functionality of the deliverable. NETCARE shall have the right to sublicense such rights to affiliated companies and to provide maintenance, update and upgrade services with respect to the deliverables to such affiliated companies as agreed between the Parties in a Service Agreement.

11.7In case of developments, updates, upgrades and changes to Standard Software or NETCARE’s proprietary software, provided that such updates and upgrades are not available on the market, including customizing and adjustments to general structures, systems, configurations, scripts and other customizing, NETCARE shall grant FME the non-exclusive, transferable right for the term of this General Agreement to use the developments in connection with the basis software without additional charges.

11.8Own developments of NETCARE shall be solely in the property of NETCARE. Any rights of use of FME shall be granted in accordance with Section 11.4.

11.9As far as FME has acquired licenses or rights in connection with a Service from a third party, that are required for the use of the Services, or FME is obliged in connection with a Service to provide standard software or other individual software developed for FME, FME shall grant to NETCARE the non-exclusive, non-transferable right to use the software or deliverables for the purposes and as far as necessary for the provision of the Services to FME under the Set of Contracts. As far as necessary for the provision of the Services FME shall also grant NETCARE the right to copy, revise and decompile the software, whereas such right shall be limited to the maintenance or reinstatement of the agreed functionality of the software. The Parties shall agree on the specific rights in the relevant Service Agreement. The scope of the right of use of NETCARE shall be in accordance with the license and right of use granted by the third party licensor to FME. FME shall be obliged to ensure that any relevant license permits NETCARE’s use of any licensed rights granted hereunder to NETCARE for the required purpose and FME shall inform NETCARE of any license terms applicable. NETCARE shall be obliged to comply with the license terms of the third party licensor and not use or revise the software in violation of such license. In particular, NETCARE shall notify FME of any violations of such license agreement and terms defined therein.

21

12.DEFECTS AND WARRANTY

12.1NETCARE shall render its Services in accordance with the service levels defined, if any, or any specifications defined in the relevant Service Agreement and the Services shall be free of defects of priority 1, 2 and 3. Services rendered by NETCARE or its subcontractors not complying with the aforementioned standards shall be deemed “Defects”.

12.2In the event of Defects of an agreed product or works that shall be supplied, FME’s claims shall expire twenty four months after delivery of the respective product or works. FME shall notify NETCARE of any Defects immediately upon delivery, or in case of hidden Non-Conformities upon discovery, at the latest within 10 business days.

12.3NETCARE shall have opportunity to cure all Defects free of charge and within reasonable time. NETCARE may choose to remedy by repair or redelivery within its discretion. NETCARE shall have two attempts to remedy a Defects. If NETCARE fails to cure before an appropriate dead-line set by FME expires FME may appropriately reduce the price. If said Defect that has not been remedied by NETCARE does not affect economically reasonable uses of the remaining parts of services or goods which NETCARE has delivered or shall deliver and FME makes such use thereof, FME’s rights shall be limited to the defect service or part of NETCARE’s performance. Save for the provisions in Section 15 FME shall have no right to terminate the relevant Service Agreement or this General Agreement due to a Defect.

12.4Unless otherwise agreed between the Parties in this Section 12 any Defects shall be regulated by the relevant warranty provisions defined by statutory law, as applicable to the Service.

13.LIABILITY

13.1Either Party shall be liable without limitation for all damages caused by intent or gross negligence of the Party or its vicarious agents as well as Defects fraudulently concealed and all mandatory statutory liability.

13.2Parties shall be liable for all personal injuries up to an amount of Euro 500,000 (five hundred thousand Euros) for each incident, in a total for all such damages up to an amount of Euro 5,000,000 (five million Euros), provided that such liability is not covered by section 13.1. For all other civil liability arising out of slight negligence by the Parties and their relevant vicarious agents not covered by section 13.1 or 13.2 the following applies:

a)for all damages to material objects (Eigentumsverletzungen) in the property of or leased by FME which are caused as a direct consequence of the services performed under the Set of Contracts, such as but not limited to excess of voltage,

22

damages to hard- and software due to services rendered under the Set of Contracts the injured Party may recover the amount necessary for repair or for compensation of such damages up to an amount of Euro 2,000,000 (two million Euro) for each incident.

b)For all damages caused by negligent breach of contract, such as but not limited to system break-downs and which FME has to incur in accordance with claims of third contractors which cannot be solved amicably, FME is to be held harmless by NETCARE by a calendar-year compensation cap up to 15% (Fifteen percent) of the contractual value of the respective Service Agreement reduced by the penalty, if any, as defined in the respective Service Agreement. NETCARE shall be informed about the facts underlying such case in a maximum transparent manner. FME shall use best efforts to defend such cases.

c)No Party shall be liable for lost profits, potential savings, consequential or indirect damages.

13.3Should NETCARE be held liable for a breach of contract or other liability, FME’s contributory fault shall be reasonably considered. NETCARE shall not be liable for damages caused by instructions, information, documents, materials, or contributions or support provided by FME to NETCARE.

13.4NETCARE shall in no instance be liable for deficiencies of software, assistance or other appliances that FME has ordered from third parties or that FME has provided. NETCARE shall support FME by problem solving with best effort against compensation, if not agreed otherwise within the specific Service Agreement. NETCARE shall in no event be liable under this Section 13 if FME (without NETCARE’s written approval) or a third party has modified Services delivered by NETCARE, FME has used the Service in breach of the Set of Contracts (handling error), FME has not provided its cooperation obligations in a proper or timely manner, the Defect arises from instructions of FME provided that NETCARE has notified FME of the associated risks that lead to the Defect.

13.5In the event that NETCARE retained a subcontractor upon FME’s sole and specific request to use such subcontractor, NETCARE hereby assigns all its claims and rights vis-á-vis such subcontractor under the relevant contract with the subcontractor to FME. To the extent of such assignment, FME’s claim against NETCARE shall be fulfilled and NETCARE shall not be liable for any damages, losses or claims of FME or any third party resulting from the services of such subcontractor. FME authorizes NETCARE to make any claims and enforce any claims against such subcontractor. NETCARE shall reasonably enforce any claims out of or in courts and FME will assist NETCARE in any actions. NETCARE shall in any event consult and coordinate any actions with FME and follow instructions of FME in connection with the enforcement

23

of a claim. The aforementioned shall also apply in case NETCARE has integrated or used a certain product or software or procured such product or software from a designated subcontractor upon FME’s request.

13.6NETCARE shall be responsible for the services and contractual deliverables rendered by its own subcontractors to the same extent NETCARE itself is liable for the Services. Contractual partner of subcontractors shall solely be NETCARE and the scope of services to be rendered by NETCARE to FME shall not be affected by the use of subcontractors.

13.7The aforementioned provisions shall apply to the personal liability of all statutory representatives, senior management, agents, subcontractors and employees as far as these qualify as vicarious agents of the relevant Party.

13.8NETCARE shall be excused from performance of its obligations and the Services under this General Agreement, any Annex and Service Agrement affected and shall not be held liable for any losses, damages or delays, including consequential damages, resulting from any event or cause beyond its reasonable control, including earthquake, fire, flood, explosion, war, embargo, transportation shortage or delay, breakage of machinery or electric power outage.

14.PENALTIES

14.1The sum of any penalties accrued under the Set of Contracts for the period of one year shall not exceed 5 % of the total remuneration under the Set of Contract, excluding remuneration for Projects, for the previous year. For the purposes of this section the yearly remuneration and sum of penalties shall not be calculated on the basis of the calendar year but on a rolling basis, i.e. the 12 months prior to the event triggering the penalty.

15.TERM AND TERMINATION

15.1The term of this General Agreement shall commence on January 1, 2013 and shall extend to December 31, 2017. Thereafter, the General Agreement shall automatically renew by another period of five years unless one Party terminates the agreement by giving six months prior written notice to the end of the term. From then on the General Agreement will be extended automatically for successive one year periods unless one of the parties terminates this General Agreement by giving 6 months prior written notice to the expiration of the then current term.

15.2The Parties shall be entitled to terminate individual Service Agreements by giving 6

24

months written notice prior to the end of the agreed term unless otherwise agreed under applicable termination clauses in the Service Agreements.

15.3Each Party shall be entitled to terminate this General Agreement and the Set of Contracts in whole or in part with immediate effect by giving written notice if (a) the other Party becomes insolvent, (b) the other Party is the subject of any winding up, dissolution, insolvency or liquidation proceedings, or makes any assignment of materially all assets for the benefit of creditors, (c) the other Party terminates its business in whole or in substantial part, or (d) in case of a merger or acquisition, whereby the common shareholder Fresenius SE & Co. KGaA transfers its controlling interest, be it by transfer of assets or by transfers of shares or dilution of the interest of Fresenius SE & Co. KGaA, in the non-terminating Party to a third Party which is not under the control of Fresenius SE & Co. KGaA.

15.4Furthermore, FME shall be entitled to terminate the Set of Contracts upon giving reasonable notice, if NETCARE (i) unreasonably restricts FME from accessing data for processing in other systems; (ii) breaches the terms and conditions of Sections 9.1, 9.3, 9.5, 9.6 or 9.7 above and/or (iii) after discussion in the Steering Committee, will not be able to comply with the terms and conditions as outlined under Sections 9.1, 9.3, 9.5, 9.6 or 9.7 above.

16.EFFECT OF TERMINATION/EXPIRATION

16.1The termination of this General Agreement shall not affect the term of its Service Agreements or any Annex and no such Service Agreement or Annex shall be terminated unless expressly and separately terminated by the terminating Party. In case of a termination of this General Agreement the terminating Party shall have a special termination right with respect to each Annex and Service Agreement being part of the Set of Contracts.

16.2The termination of a Service Agreement or Annex shall not affect this General Agreement or any other Annex or document of this Set of Contracts unless expressly agreed for certain cases in Section 16.

16.3After termination or expiration of the contractual relationship the Parties shall undertake to modify the remainder of the Set of Contracts as economically indicated and according to the factual situation. Furthermore, they shall return all documents and other information which they have received from the other Party because of or incidental to the cooperation upon first request. The correspondence between the Parties and all documents and papers that have to be kept available as required by laws or regulations or papers and documents that are destined to remain with the respective Party.

25

16.4After termination of the General Agreement or Service Agreement hereto, NETCARE shall be obliged to deliver the services agreed upon hereunder to FME upon FME’s request for such period which is required by FME to retain an alternative service provider. FME’s obligations defined under Section 4 shall remain in effect for such transition period. However, FME shall not be required to buy these services from NETCARE. In case that FME decides to discontinue individual services or parts thereof NETCARE shall not be responsible for the remainder of the services to be delivered to FME, provided, that the discontinued services were required for rendering the remainder of the services. Furthermore, NETCARE shall reasonably cooperate with FME on the transfer of any services or system operated or maintained under this Set of Contracts to an alternative service provider. Remuneration for services rendered and other terms and conditions for this transition period shall be analogous to the terms of this General Agreement or any Service Agreement referred to of the year of termination. Additional services required for the transition or migration of services to an alternative service provider shall be agreed separately and shall be compensated by FME in accordance with the agreed prices in the relevant up-to-date price list of NETCARE or as separately agreed.

16.5Details regarding the services and transfer of data shall be agreed upon in the Steering Committee. As far as an agreement about the reintegration and continuation of the services has not been achieved within 3 months after written notice, an external Party shall be commissioned for defining the scope of services to be rendered by NETCARE and FME’s or any third Parties responsibilities and assistance. The external Party shall be nominated by FME and NETCARE in mutual agreement, however, if such consensus cannot be reached by FME and NETCARE, the arbitrator under Section 17.3 shall nominate the external Party.

16.6NETCARE shall grant to FME upon termination/expiration of the contractual relationship a license for the use of all intellectual property rights owned by NETCARE at the time of termination/expiration of the contractual relationship, with respect to NETCARE’s own developments, including modifications, add-ons, developments, required to operate and run the system governed by and arising out of the Set of Contracts. Such license shall be non-exclusive, unlimited, unrestricted and shall include the right to grant sublicenses to re-outsourcers for the purposes of providing services to FME, however, the right to grant further sublicenses shall not be included. Such license shall be granted free of charge and shall enable FME for further development for internal purposes.

16.7Upon termination of this Set of Contracts, neither tangible nor intangible assets shall be transferred from NETCARE to FME and neither claim for such transfer shall vest in FME except for those where FME is the owner of such tangible or intangible assets. Additionally, FME shall in no event actively pursue employment of employees of

26

NETCARE during the term of the General Agreement and for the period of two years thereafter.

16.8Upon termination of this General Agreement and/or its applicable Annexes and Service Agreements under the Set of Contracts FME shall neither be entitled without the prior written consent of NETCARE nor shall FME be contractually obligated to take over any employee of NETCARE. In the event FME is obligated to take over such employees or employment contracts according to the respective law, NETCARE shall be obligated to compensate FME any costs and expenses which FME might incur thereby for employees FME is not willing to take over provided that FME is not actively deploying such employees.

16.9The following provisions shall survive a termination of this General Agreement and shall remain in effect upon a termination for a period of at least five years or applicable storage and documentation obligations, whichever is longer: Sections 5, 8, 9, 13, 16, 17,18.

17.GOVERNING LAW, ARBITRATION

17.1The Set of Contracts shall be governed by the laws of Germany (excluding UN-CISG and the rules and principles on the conflict of laws).

17.2Any dispute, controversy or claim, arising out of or in connection with the Set of Contracts, or the breach, termination or invalidity thereof (the “Controversies”), shall be governed by the following dispute resolution mechanism:

17.3Controversies shall be settled amicably between the Parties on operational level and according to the escalation procedure as defined in the MSD. If the Parties are unable to reach a mutual consensus, the Parties shall be entitled to file for arbitration complaints in the arbitration panel of the Deutsche Gesellschaft for Recht and Informatik e.V. (“DGRI”), according to its Rules of Arbitration. The place of arbitration shall be in Frankfurt am Main, Germany. The numbers of arbitrators shall be [3]. English shall be used in the arbitrational proceedings.

17.4In order to allow the arbitration to proceed the Parties waive the defense of expiration of statute of limitation for all claims arising in the disputed matter, starting with the request for arbitration filed with the DGRI and until one month after the end of the arbitration process. The expiration of statute of examination shall be suspended for the time of the arbitration proceeding.

17.5The decision of the arbitration panel shall be binding.

27

18.MISCELLANEOUS

18.1All Annexes, the Attachments, and the Preamble are incorporated into this General Agreement. The Preamble shall reflect the intentions of the Parties as of the effective date of the General Agreement and shall have legal effect, however, only insofar as it may be used for interpretative purposes in case of controversy over the interpretation of certain clauses in the General Agreement, Annexes or the Attachments or if Section 17 is applicable.

18.2Neither Party’s general terms and conditions (Allgemeine Geschäftsbedingungen) shall be incorporated in this Set of Contracts.

18.3The rights inuring to the benefits of the Parties under the Set of Contracts shall be non-transferable unless the other Party has agreed to the transfer in writing. Such consent shall not be unreasonably withheld if the rights are transferred to Parties under common control of Fresenius SE & Co. KGaA or Fresenius Medical Care AG & Co. KGaA.

18.4No action or inaction of one of the Parties shall be construed as a waiver of rights or shall affect such rights, unless this General Agreement does provide to the contrary.

18.5Alterations of and amendments to the Set of Contracts must be made in writing. This applies also to this requirement of writing.

18.6If any provision of the General Agreement is held to be invalid or unenforceable, the validity of the remaining provisions shall not be affected. The Parties shall replace the invalid or unenforceable provision by a valid and enforceable provision closest to the intention of the Parties when signing the General Agreement.

18.7Same shall apply to all contractual provisions that the Parties may have omitted to include in this General Agreement.

18.8As far as the language of Set of Contracts uses the name under which a software is marketed all later releases shall be included.

18.9FME may execute rights to hold back or to set off only upon claims uncontested by NETCARE, or sums finally awarded by DGRI under Section 17 of this General Agreement.

28

Bad Homburg,	Bad Homburg,
Fresenius Medical Care AG & Co. KGaA	Fresenius Netcare GmbH
represented by its General Partner	represented by
Fresenius Medical Care Management AG, represented by
[Name]	[Name]
Member of Management Board	[Title]
[Name]	[Name]
Member of Management Board	[Title]

29

Attachment 2: Overview on the volume of expected IT cost for Operations and Projects under the General Agreement 2013 for the years 2013 to 2022 (“FNC Cost Estimate”) including additional calculations

II

Attachment 2: FNC Cost Estimate including additional calculations

IT cost expected to be charged by FNC under the GA 2013 in EUR:

Category	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	Total
SAP	9.629.885	10.052.242	10.515.499	11.009.333	11.530.004	11.986.358	12.464.868	13.077.427	13.727.442	14.420.068	118.413.127
Communication	4.624.457	4.686.558	4.752.186	4.821.517	4.894.735	4.972.035	5.053.617	5.139.697	5.230.496	5.326.252	49.501.549
Infrastructure	4.500.606	4.489.355	4.478.131	4.466.936	4.455.769	4.444.629	4.433.518	4.422.434	4.411.378	4.400.349	44.503.105
Other	3.175.669	3.202.792	3.231.327	3.261.346	3.292.921	3.326.131	3.361.058	3.397.786	3.436.407	3.477.014	33.162.452
Total Operational IT cost charged by FNC	21.930.618	22.430.946	22.977.143	23.559.131	24.173.430	24.729.153	25.313.061	26.037.344	26.805.723	27.623.683	245.580.234
Total Operational IT cost (FNC/0.6)	36.551.030	37.384.911	38.295.239	39.265.219	40.289.050	41.215.255	42.188.435	43.395.574	44.676.206	46.039.471	409.300.389
Projects FNC	20.081.463	14.562.187	14.506.182	3.699.621	3.000.000	3.150.000	3.307.500	3.472.875	3.646.519	3.828.845	73.255.192
Total IT cost charged by FNC	42.012.081	36.993.133	37.483.325	27.258.752	27.173.430	27.879.153	28.620.561	29.510.219	30.452.242	31.452.527	318.835.425
Total IT Cost (FNC/0.6)	70.020.136	61.655.222	62.472.209	45.431.254	45.289.050	46.465.255	47.700.935	49.183.699	50.753.737	52.420.879	531.392.375

Additional Calculations:

Revenue FME EMEALA under consideration of 8% CAGR 2013-2022 on 2012 basis:	3.143.565.353,88		3.395.050.582,19		3.666.654.628,77		3.959.986.999,07		4.276.785.958,99		4.618.928.835,71		4.988.443.142,57		5.387.518.593,97		5.818.520.081,49		6.284.001.688,01
Total Operational IT cost als % of revenue:	1,16	%	1,10	%	1,04	%	0,99	%	0,94	%	0,89	%	0,85	%	0,81	%	0,77	%	0,73	%
Total IT Cost as % of revenue:	2,23	%	1,82	%	1,70	%	1,15	%	1,06	%	1,01	%	0,96	%	0,91	%	0,87	%	0,83	%

Attachment 3:   General Terms and Conditions as of May 2012

III

GENERAL TERMS AND CONDITIONS

Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft

as of May 2012

This is an English translation of the German text (please refer to http://www.ey.com/DE/DE/Home and click on “AAB” at the bottom of the website, please refer to the section “Non-Assurance Dienstleistungen”), the German text being the sole authoritative version

Our Relationship with You

1.We will perform the Services1 in accordance with the standards of proper professional conduct (“Grundsätze ordnungsmäßiger Berufsausübung”) for the sole benefit of you, our Client.

2.We are a member of the global network of Ernst & Young firms (“EY Firms”), each of which is a separate legal entity.

3.We will provide the Services to you as an independent contractor and not as your employee, agent, partner or joint venturer. Neither you nor we have any right, power or authority to bind the other.

4.We may subcontract portions of the Services to other EY Firms, as well as to other service providers, who may deal with you directly. Nevertheless, we alone will be responsible to you for the Reports (as defined in Section 11), the performance of the Services, and our other obligations under this Agreement1.

5.We will not assume any management responsibilities in connection with the Services. We will not be responsible for the use or implementation of the output of the Services.

Your Responsibilities

6.You shall assign a qualified person to oversee the Services. You are responsible for all management decisions relating to the Services, the use or implementation of the output of the Services and for determining whether the Services are appropriate for your purposes.

7.You shall provide (or cause others to provide) to us, promptly, the information, resources and assistance (including access to records, systems, premises and people) that we reasonably require to perform the Services. This also applies to those supporting documents and records, events and circumstances which first become known during our work.

8.All information provided by you or on your behalf (“Client Information”) shall be accurate and complete. The provision of Client Information to us will not infringe any copyright or other third-party rights.

9.We may rely on Client Information made available to us and, unless we expressly agree otherwise, will have no responsibility to evaluate or verify it.

10.You shall be responsible for your personnel’s compliance with your obligations under this Agreement.

Our Reports

11.Any information, advice, recommendations or other content of any reports, presentations or other communications we provide under this Agreement (“Reports”), other than Client Information, are for your internal use only (consistent with the purpose of the Services).

12.You may not disclose a Report (or any portion or summary of a Report) externally (including to your affiliates), or refer to us or to any other EY Firm in connection with the Services, except:

(a)to your lawyers subject to these disclosure restrictions who may review it only in connection with advice relating to the Services,

(b)to the extent, and for the purposes, required by applicable law and you will promptly notify us of such legal requirement to the extent you are permitted to do so,

(c)to other persons (including your affiliates) with our prior written consent, who have executed an access letter and who may use it only as we have specified in our consent, or

(d)to the extent it contains Tax Advice, as set forth in Section 13.

If you are permitted to disclose a Report (or a portion thereof), you shall not alter, edit or modify it from the form we provided.

13.You may disclose to anyone a Report (or any portion thereof) solely to the extent that it relates to tax matters, including tax advice, tax opinions, tax returns, or the tax treatment or tax structure of any transaction to which the Services relate (“Tax Advice”). With the exception of tax authorities, you shall inform those to whom you disclose Tax Advice that they may not rely on it for any purpose without our prior written consent.

14.You may incorporate into documents that you intend to use our summaries, calculations or tables based on Client Information contained in a Report, but not our recommendations, conclusions or findings. You must assume sole responsibility for the contents of those documents and you must not externally - directly or indirectly - refer to us or any other EY Firm in connection with them.

15.If we are required to present the results of our work in writing, only that written presentation is authoritative.

You may not rely on any draft Reports (which are non-binding), but only on final written Reports. Draft Reports only serve our internal purposes and/or the coordination with you and, therefore, only constitute preliminary stages of Reports and are neither final nor binding and are subject to further review. We shall not be required to update any final Report for circumstances of which we become aware, or events occurring, after the cut-off date indicated in the Report or, in absence of such date, the delivery date of the Report, unless otherwise agreed or we are obliged to do so with regard to the Services provided by us.

Limitations of Our Liability

16.(a) Pursuant to Section 54a para. 1 No. 2 WPO2 our liability for claims of compensatory damages of any kind - except for damages resulting from injury to life, body or health - for an individual case of damages resulting from negligence is limited to EUR 4 million; this also applies if liability to a person other than you should be established.

1 Terms which are not defined in these General Terms and Conditions are defined in the Cover Letter.

2“Wirtschaftspruferordnung” (Public Accountant Act)

(b) An individual case of damages also exists in relation to a uniform damage arising from a number of breaches of duty. The individual case of damages encompasses all consequences from a breach of duty without taking into account whether the damages occurred in one year or in a number of successive years. In this case multiple acts or omissions of acts based on a similar source of error or on a source of error of an equivalent nature are deemed to be a uniform breach of duty if the matters in question are legally or economically connected to one another. In this event the claim against us is limited to EUR 5 million.

17.If you consider the liability limit stipulated in Section 16 and the amount our liability is limited to where Section 16 applies (“Maximum Liability Amount”) as inappropriate, please inform us of the extension of our liability you would like to be agreed on instead. In this case we will endeavor to obtain additional insurance for such increased amount (“Increased Amount”). Provided that you are furthermore prepared to bear the additional costs arising from the additional insurance covering the Increased Amount, we are prepared to agree with you on a corresponding extension of our liability. We emphasize that an increase of Maximum Liability Amount only applies if agreed on in writing.

18.If legitimate claims falling within our limitation of liability are brought against us by you and/or one or more third parties who are entitled to invoke this Agreement, the Maximum Liability Amount will be - in accordance with Section 428 BGB3 - available only once to all - including all future - claimants collectively. Hence, any payment by us to you has discharging effect towards all claimants. In case the sum of all claims (including future claims) to which our limitation-of-liability-provisions apply exceed the Maximum Liability Amount, the allocation of this Maximum Liability Amount amongst all claimants (incl. you) is entirely a matter for discussion amongst all claimants.

19.A compensatory damages claim may only be lodged within a preclusive deadline of one year of the rightful claimant having become aware of the damage and of the event giving rise to the claim - at the very latest, however, within 5 years subsequent to the event giving rise to the claim. The claim expires if legal action is not taken within a six month deadline subsequent to the written refusal of acceptance of the indemnity and you were informed of this consequence. The right to assert the bar of the preclusive deadline remains unaffected.

20.Should, as an exception in an individual case, any persons other than you, our Client, have a right to invoke this Agreement, the provisions of Section 16 through 21 also apply to such third parties. Section 334 BGB shall apply.

21.You may not make a contractual claim or bring proceedings arising from the provision of the Services or otherwise based on this Agreement against any other EY Firm or our or its subcontractors, members, shareholders, directors, officers, partners, principals or employees (“EY Persons”). You shall make any contractual claim or bring such proceedings only against us.

Indemnity

22.You shall indemnify us, the other EY Firms and the EY Persons against all claims by third parties (including your affiliates  and lawyers)   and   resulting  liabilities,   losses, damages, costs and expenses (including reasonable external legal costs) arising out of the third party’s use of or reliance on any Report (induding Tax Advice) disclosed to it by or through you or at your request. You shall have no obligation hereunder to the extent that we have specifically authorized, in writing, the third party’s reliance on the Report.

Intellectual Property Rights

23.We may use data, software, designs, utilities, tools, models, systems and other methodologies and know-how (“Materials”) that we own in performing the Services. Notwithstanding the delivery of any Reports, we retain all intellectual property rights in the Materials (including any improvements or knowledge developed while performing the Services), and in any working papers compiled in connection with the Services (but not Client Information reflected in them).

Confidentiality

24.We are bound by the strict professional confidentiality obligations as stipulated in Section 43 WPO and Section 57 StBerG4 and, except as otherwise permitted by this Agreement, neither of us may disclose to third parties the contents of this Agreement or any information (other than Tax Advice) provided by or on behalf of the other that ought reasonably to be treated as confidential and/or proprietary.

25.Notwithstanding any superseding legal professional secrecy obligation, either of us may, however, disclose such information to the extent that it

(a)is or becomes public other than through a breach of this Agreement,

(b)is subsequently received by the recipient from a third party who, to the recipient’s knowledge, owes no obligation of confidentiality to the disclosing party with respect to that information,

(c)was known to the recipient at the time of disclosure or is thereafter created independently,

(d)is disclosed as necessary to enforce the recipient’s rights under this Agreement, or

(e)must be disclosed under applicable law or professional regulations.

26.Either of us may use electronic media to correspond or transmit information and such use will not in itself constitute a breach of any confidentiality obligations under this Agreement and acknowledge that sending information and documents in electronic form (in particular by e-mail) entails risks.

27.We may disclose Client Information to other EY Firms, EY Persons, which may use, transfer, store or otherwise process it to facilitate performance of the Services, to comply with regulatory requirements, to check conflicts, or for quality, risk management or financial accounting purposes. The Client Consent for such purposes is attached to this Agreement for signature.

28.With respect to any Services if U.S. Securities and Exchange Commission auditor independence regulations apply to the relationship between you or any of your associated entities and any EY Firm, you represent, to the

3 “Burgerliches Gesetzbuch” (German Civil Code)

4 “Steuerberatungsgesetz” (Tax Advisory Act)

2

best of your knowledge, as of the date of this Agreement, that neither you nor any of your affiliates has agreed, either orally or in writing, with any other advisor to restrict your ability to disclose to anyone the tax treatment or tax structure of any transaction to which the Services relate. An agreement of this kind could impair an EY Firm’s independence as to your audit or that of any of your affiliates, or require specific tax disclosures as to those restrictions. Accordingly, you agree that the impact of any such agreement is your responsibility.

Data Protection

29.We may collect, use, transfer, store or otherwise process (collectively, “Process”) Client Information that can be linked to specific individuals (“Personal Data”). We may Process Personal Data in various jurisdictions in which we and the other EY Firms operate (which are listed at www.ey.com) to facilitate performance of the Services, comply with regulatory requirements, check conflicts, or for quality, risk management or financial accounting purposes. We will Process the Personal Data in accordance with applicable law and professional regulations, including (without limitation) the BDSG5. We will require any service provider that Processes Personal Data on our behalf to adhere to such requirements.

30.You warrant that you have the authority to provide the Personal Data to us in connection with the performance of the Services and that the Personal Data provided to us has been processed in accordance with applicable law.

Fees and Expenses Generally

31.You shall pay our professional fees and specific expenses in connection with the Services as detailed in the applicable Statement of Work or any of its appendices. You shall also reimburse us for other reasonable expenses incurred in performing the Services. Our fees are exclusive of taxes or similar charges, as well as customs, duties or tariffs imposed in respect of the Services, all of which you shall pay (other than taxes imposed on our income generally). We may claim appropriate advances for remuneration and reimbursement of outlays and make the rendering of our Services dependent upon complete satisfaction of our claims. Unless otherwise set forth in the applicable Statement of Work, payment is due within 30 days following receipt of each of our invoices.

32.We may charge additional professional fees if events beyond our control (including your acts or omissions) affect our ability to perform the Services as originally planned or if you ask us to perform additional tasks.

33.If we are required by applicable law, legal process or government action to produce information or personnel as witnesses with respect to the Services or this Agreement, you shall reimburse us for any professional time and expenses (including reasonable external legal costs) incurred to respond to the request, unless we are a party to the proceeding or the subject of the investigation or unless we do get fully reimbursed by public authorities.

34.If you default in accepting the Services offered by us or if you do not provide the assistance incumbent on you pursuant to Section 7, 8 or otherwise, we are entitled to cancel the Agreement immediately. Our right to compensation for additional  expenses as well  as for damages caused by the default or the lack of assistance is not affected, even if we do not exercise our right to cancel.

Force Majeure

35.Neither you nor we shall be liable for breach of this Agreement (other than payment obligations) caused by circumstances beyond your or our reasonable control.

Term and Termination

36.This Agreement applies to the Services whenever performed (including before the date of this Agreement).

37.This Agreement shall terminate on the completion of the Services. Either of us may terminate it, or any particular Services, earlier upon 90 days’ prior written notice to the other. In addition, we may terminate this Agreement, or any particular Services, immediately upon written notice to you if we reasonably determine that we can no longer provide the Services in accordance with applicable law or professional obligations. Sections 626 and 627 BGB shall remain unaffected.

38.You shall pay us for all work-in-progress, Services already performed, and expenses incurred by us up to and including the effective date of the termination of this Agreement.

39.Our respective confidentiality obligations under this Agreement, as well as other provisions of this Agreement that give either of us rights or obligations beyond its termination, shall continue indefinitely following the termination of this Agreement.

Governing Law and Jurisdiction

40.This Agreement, and any non-contractual matters or obligations arising out of this Agreement or the Services, shall be governed by, and construed in accordance with, the laws of Germany.

41.Any dispute relating to this Agreement or the Services shall be subject to the exclusive jurisdiction of the courts of Stuttgart, Germany, to which each of us agrees to submit for these purposes, or, at our discretion, (i) the court located where our office that conducted the main part of the work is registered or (ii) the courts located where you are registered.

Miscellaneous

42.Upon our request, you must confirm in a written statement drafted by us that the supporting documents and records and the information and explanations provided are complete.

43.You guarantee to refrain from everything which may endanger the independence of our staff. This particularly applies to offers of employment and offers to undertake engagements on one’s own account.

44.Where there are deficiencies, you are entitled to subsequent fulfillment of the Agreement. You may demand a reduction in fees or the cancellation of the contract only for the failure to subsequently fulfill the Agreement; if the Agreement was awarded by a person carrying on a commercial business as part of that commercial business, a government-owned legal person under public law or a special government-owned fund under public law, you may demand the cancellation of the Agreement only if the Services rendered are of no interest to you due to the failure to subsequently fulfill the Agreement. Section 16

5  “Bundesdatenschutzgesetz” (German Data Protection Act)

3

through 21 applies to the extent that claims of damages exist beyond this.

You must assert your claim for the correction of deficiencies in writing without delay. Claims pursuant to the first paragraph not arising from an intentional tort cease to be enforceable one year after the commencement of the statutory time limit for enforcement.

Obvious deficiencies, such as typing and arithmetical errors and deficiencies associated with technicalities contained in a Report may be corrected - and also the applicable versus third parties - by us at any time. Errors which may call into question the conclusions contained in our Reports entitle us to withdraw - also versus third parties - such Reports. In the cases noted we should first hear you, if possible.

45.We retain, for ten years, the supporting documents and records in connection with the completion of the Agreement - that had been provided to us and that we have prepared ourselves - as well as the correspondence with respect to the Agreement.

After the settlement of our claims arising from the Agreement we, upon your request, must return all supporting documents and records obtained from you or for you by reason of our work on the Agreement This does not, however, apply to correspondence exchanged between you and us and to any documents of which you have the original or a copy. We may prepare and retain copies or photocopies of supporting documents and records which we return to you.

46.This Agreement constitutes the entire agreement between us as to the Services and the other matters it covers, and supersedes all prior agreements, understandings and representations with respect thereto, including any confidentiality agreements previously delivered.

47.This Agreement and/or any Statement of Work hereunder (and modifications to them) must be executed in written form in the sense of Section 126 para. 1 BGB. Each of us may sign a different copy of the same document

48.Each of us represents that the person signing this Agreement and/or any Statement of Work hereunder on its behalf is also authorized to execute it and to bind each of us to its terms.

You represent that your affiliates and any others for whom Services are performed shall be bound by the terms of this Agreement and the applicable Statement of Work.

49.You agree that we and the other EY Firms may, subject to professional obligations, act for other clients, including your competitors.

50.Neither of us may assign any of our rights, obligations or claims under this Agreement.

51.If any provision of this Agreement (in whole or part) is held to be illegal, invalid or otherwise unenforceable, the other provisions shall remain in full force and effect.

52.If there is any inconsistency between provisions in different parts of this Agreement, those parts shall have precedence as follows (unless expressly agreed otherwise): (a) the Cover Letter, (b) the applicable Statement of Work (incl. - as the case may be - the Agreement on Fees), (c) the Client Consent, (d) these General Terms and Conditions, and (e) other annexes to this Agreement

53.Neither of us may use or reference the other’s name, logos or trademarks without its prior written consent. Once we have obtained your prior consent by the attached Client Consent, we are allowed to use your name publically to identify you as a client in connection with specific Services or otherwise.

54.The limitations in Sections 16 to 21 and the provisions of Sections 22, 27, 29 and 49 are intended to benefit the other EY Firms and all EY Persons, who shall be entitled to enforce them.

4

ALLGEMEINE AUFTRAGSBEDINGUNGEN

der Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft

Stand: Mai 2012

Die Grundlagen der Auftragsbeziehung

1.Die Leistungen(1) werden von uns in Übereinstimmung mit den Grundsätzen ordnungsmäßiger Berufsausübung ausschließlich für Sie als unseren Mandanten erbracht.

2.Wir sind Mitglied des weltweiten Verbunds der Ernst & Young-Gesellschaften („EY-Mitglieder”); jedes EY-Mitglied ist ein eigenständiger Rechtsträger.

3.Die Leistungen erbringen wir für Sie als unabhängiger Vertragspartner und nicht als Ihr Mitarbeiter, Vertreter, Gesellschafter oder Mitunternehmer. Weder Sie noch wir sind berechtigt, ermächtigt oder befugt, die jeweils andere Vertragspartei zu verpflichten.

4.Wir sind berechtigt, Teile der Leistungen an andere EY-Mitglieder oder sonstige Dienstleister als Unterauftragnehmer zu vergeben, die direkt mit Ihnen in Kontakt treten können. Die Verantwortlichkeit für die Arbeitsergebnisse (vgl. Definition in Ziff. 11), die Erbringung der Leistungen und für unsere sonstigen aus der Mandatsvereinbarung resultierenden Verpflichtungen liegt ausschließlich bei uns.

5.Im Zusammenhang mit unseren Leistungen übernehmen wir keine Aufgaben der Geschäftsführung. Für die Nutzung oder Umsetzung der Ergebnisse unserer Leistungen sind wir nicht verantwortlich.

Ihre Verantwortlichkeiten

6.Sie benennen uns einen qualifizierten Ansprechpartner für die Begleitung unserer Leistungen. Sie sind verantwortlich für sämtliche Geschäftsführungsentscheidungen im Zusammenhang mit unseren Leistungen, die Nutzung oder Umsetzung der Ergebnisse unserer Leistungen und die Entscheidung darüber, inwieweit unsere Leistungen für Ihre Zwecke geeignet sind.

7.Sie werden (oder veranlassen andere), uns sämtliche für die Erbringung der Leistungen erforderlichen Informationen, Ressourcen und Unterstützung (einschließlich des Zugangs zu Unterlagen, Systemen, Räumlichkeiten und Personen) unverzüglich zur Verfügung stellen. Dies gilt auch für solche Unterlagen, Nachweise, Vorgänge und Umstände, die erst während unserer Tätigkeit bekannt werden.

8.Sämtliche Informationen, die uns von Ihnen oder in Ihrem Auftrag zur Verfügung gestellt werden („Mandanteninformationen“), müssen richtig und vollständig sein. Sie stellen sicher, dass uns zur Verfügung gestellte Mandanteninformationen weder Urheberrechte noch sonstige Rechte Dritter verletzen.

9.Wir sind berechtigt, uns auf uns zur Verfügung gestellte Mandanteninformationen zu verlassen und sind, sofern nicht ausdrücklich etwas Abweichendes vereinbart wurde, nicht dafür verantwortlich, diese zu bewerten oder deren Richtigkeit zu überprüfen.

10.Sie übernehmen die Verantwortung dafür, dass Ihre Mitarbeiter die Ihnen gemäß der Mandatsvereinbarung obliegenden Pflichten einhalten.

Unsere Arbeitsergebnisse

11.Mit Ausnahme der Mandanteninformationen sind sämtliche Informationen, Beratungsleistungen, Empfehlungen oder sonstige Inhalte von Berichten, Präsentationen oder sonstigen Mitteilungen, die wir Ihnen in Erfüllung der Mandatsvereinbarung zur Verfügung stellen (die „Arbeitsergebnisse”), ausschließlich (im Einklang mit dem Zweck der Leistungen) zu Ihrer internen Verwendung bestimmt.

12.Sie sind nicht dazu berechtigt, Arbeitsergebnisse (ebenso wie einen Teil oder eine Zusammenfassung eines solchen) gegenüber Dritten (einschließlich Ihrer verbundenen Unternehmen) offenzulegen oder sich auf uns oder ein anderes EY-Mitglied im Zusammenhang mit den Leistungen zu beziehen; dies gilt nicht

(a) gegenüber Ihren Rechtsanwälten, wenn diese, vorbehaltlich dieses Offenlegungsverbots, die Arbeitsergebnisse ausschließlich dazu prüfen, Sie im Zusammenhang mit den Leistungen zu beraten,

(b) soweit Sie aufgrund eines Gesetzes (zur Offenlegung (über die Sie uns soweit zulässig unverzüglich in Kenntnis setzen) verpflichtet sind,

(c) gegenüber anderen Personen oder Unternehmen (einschließlich Ihrer verbundenen Unternehmen), wenn wir zuvor schriftlich unsere Zustimmung erteilt haben, diese unsere Informationsvereinbarung unterzeichnet haben und diese die Arbeitsergebnisse lediglich im Rahmen der erteilten Zustimmung verwenden, oder

(d) soweit die Arbeitsergebnisse eine Steuerberatung im Sinne der Ziff. 13 zum Gegenstand haben.

Soweit Sie dazu berechtigt sind, Arbeitsergebnisse (oder Teile davon) offenzulegen, ist es Ihnen dennoch nicht gestattet, Änderungen, Bearbeitungen oder Modifizierungen der Arbeitsergebnisse vorzunehmen.

13.Soweit ein Arbeitsergebnis steuerliche Angelegenheiten zum Gegenstand hat, einschließlich Steuerberatung, Steuergutachten, Steuererklärungen sowie die steuerliche Behandlung oder Gestaltung einer Transaktion, die Gegenstand der Leistungen ist (insgesamt „Steuerberatung”), sind Sie dazu berechtigt, das Arbeitsergebnis (ebenso wie einen Teil dessen) gegen-über Dritten offenzulegen. Sie bleiben jedoch dazu verpflichtet, den Dritten, dem Sie die Steuerberatung offenlegen, darüber zu informieren, dass er ohne unsere vorherige schriftliche Zustimmung für keinerlei Zwecke auf die Steuerberatung vertrauen darf. Diese Verpflichtung zur Information gilt nicht gegenüber den Steuerbehörden.

14.Sie sind dazu berechtigt, Zusammenfassungen, Berechnungen oder Tabellen, die in einem Arbeitsergebnis enthalten sind und auf Mandanteninformationen basieren, in Dokumente, die Sie zu verwenden beabsichtigen, aufzunehmen, nicht jedoch unsere Empfehlungen, Schlussfolgerungen oder Feststellungen. Sie übernehmen die alleinige Verantwortung für den Inhalt solcher Dokumente, und Sie sind nicht dazu berechtigt gegenüber Dritten, - direkt oder indirekt- auf uns oder ein anderes EY-Mitglied im Zusammenhang mit diesen zu verweisen.

15.Wenn wir dazu verpflichtet sind, die Ergebnisse unserer Tätigkeit schriftlich darzustellen, ist nur die schriftliche Darstellung maßgebend.

Sie sind nicht dazu berechtigt, sich auf die Entwurfsfassung eines Arbeitsergebnisses (die unverbindlich ist) zu verlassen, sondern lediglich auf dessen finale schriftliche Fassung. Entwurfsfassungen eines Arbeitsergebnisses dienen lediglich unseren internen Zwecken und/oder der Abstimmung mit Ihnen und stellen demzufolge nur eine Vorstufe des Arbeitsergebnisses dar und sind weder final noch verbindlich und erfordern eine weitere Durchsicht. Wir sind nicht dazu verpflichtet, ein finales Arbeitsergebnis im Hinblick auf Umstände, die uns seit dem im Arbeitsergebnis benannten Zeitpunkt des Abschlusses unserer Tätigkeit,

1 Begriffe, die nicht in diesen Allgemeinen Auftragsbedingungen definiert werden, sind im Anschreiben definiert.

oder - in Ermangelung eines solchen Zeitpunkts - der Auslieferung des Arbeitsergebnisses zur Kenntnis gelangt sind oder eintreten, zu aktualisieren. Dies gilt dann nicht, wenn wir von Ihnen entsprechend beauftragt wurden oder wir aufgrund der Natur der Leistungen dazu verpflichtet sind.

Haftungsbeschränkung

16.(a) Unsere Haftung für Schadensersatzansprüche jeder Art, mit Ausnahme von Schäden aus der Verletzung von Leben, Körper und Gesundheit, ist gemäß § 54 a Abs. 1 Nr. 2 WPO bei einem fahrlässig verursachten ein zelnen Schadensfall auf EUR 4 Mio. begrenzt; dies gilt auch dann, wenn eine Haftung gegenüber einer anderen Person als Ihnen begründet sein sollte.

(b) Ein einzelner Schadensfall ist auch bezüglich eines aus mehreren Pflichtverletzungen stammenden einheitlichen Schadens gegeben. Der einzelne Schadensfall umfasst sämtliche Folgen einer Pflichtverletzung ohne Rücksicht darauf, ob Schäden in einem Jahr oder in mehreren aufeinanderfolgenden Jahren entstanden sind. Dabei gilt mehrfaches auf gleicher oder gleichartiger Fehlerquelle beruhendes Tun oder Unterlassen als einheitliche Pflichtverletzung, wenn die betreffenden Angelegenheiten miteinander in rechtlichem oder wirtschaftlichem Zusammenhang stehen. In diesem Fall können wir nur bis zur Höhe von EUR 5 Mio. in Anspruch genommen werden.

17.Sollte die in Ziff. 16 vorgesehene Haftungsbeschränkung und die dort genannte Haftungssumme („Haftungshöchstbetrag”) nicht angemessen sein, so teilen Sie uns bitte den von Ihnen gewünschten Haftungshöchstbetrag mit. In diesem Fall werden wir uns bemühen, einen entsprechenden zusätzlichen Versicherungsschutz zu erhalten („Höherversicherung”). Sofern Sie zudem den zusätzlichen Aufwand aus der Höherversicherung tragen, sind wir bereit, mit Ihnen einen entsprechenden erweiterten Haftungsrahmen zu vereinbaren. Wir weisen darauf hin, dass eine Erhöhung des Haftungshöchstbetrags nur dann zur Anwendung kommt, wenn sie schriftlich zwischen uns vereinbart wurde.

18.Werden berechtigte Ansprüche, die unserer Haftungsbeschränkung unterfallen, von Ihnen und/oder einem oder mehreren Dritten, die sich auf die Mandatsvereinbarung berufen dürfen, gegen uns geltend gemacht, steht der Haftungshöchstbetrag in Obereinstimmung mit § 428 BGB sämtlichen - auch künftigen - Anspruchsberechtigten gemeinsam nur einmal zu. Demnach können wir mit schuldbefreiender Wirkung gegenüber allen Gläubigern an Sie leisten. Sollte die Summe aller Ansprüche (einschließlich künftiger Ansprüche), auf die die Bestimmungen dieses Abschnitts „Haftungsbeschränkung” Anwendung finden, den Haftungshöchstbetrag überschreiten, so obliegt die Aufteilung dieses Haftungshöchstbetrags Ihnen und allen weiteren Anspruchsberechtigten.

19.Ein Schadensersatzanspruch kann nur innerhalb einer Ausschlussfrist von einem Jahr geltend gemacht werden, nachdem der Anspruchsberechtigte von dem Schaden und von dem anspruchsbegründenden Ereignis Kenntnis erlangt hat, spätestens aber innerhalb von fünf Jahren nach dem anspruchsbegründenden Ereignis. Der Anspruch erlischt, wenn nicht innerhalb einer Frist von sechs Monaten seit der schriftlichen Ablehnung der Ersatzleistung Klage erhoben wird, sofern Sie auf diese Folge hingewiesen wurden. Das Recht, die Einrede der Verjährung geltend zu machen, bleibt unberührt.

20.Sollten ausnahmsweise im Einzelfall auch andere Personen als Sie dazu berechtigt sein, Ansprüche aus der Mandatsvereinbarung gegen uns geltend zu machen, so gelten auch gegenüber solchen Dritten die Bestimmungen der Ziff. 16 bis 21. §334 BGB findet Anwendung.

21.Sie sind nicht dazu berechtigt, vertragliche Ansprüche oder Verfahren im Zusammenhang mit den Leistungen oder generell auf der Grundlage der Mandatsvereinbarung gegen ein anderes EY-Mitglied oder dessen oder unsere Unterauftragnehmer, Mitglieder, Anteilseigner, Geschäftsführungsmitglieder, Partner oder Mitarbeiter („EY-Personen’) geltend zu machen bzw. anzustrengen. Sie verpflichten sich, vertragliche Ansprüche ausschließlich uns gegenüber geltend zu machen bzw. Verfahren nur uns gegenüber anzustrengen.

Haftungsfreistellung

22.Sie sind dazu verpflichtet, uns, andere EY-Mitglieder und EY-Personen von allen Ansprüchen Dritter (einschließlich Ihrer verbundenen Unternehmen und Anwälte) sowie daraus folgenden Verpflichtungen, Schäden, Kosten und Aufwendungen (insbesondere angemessene externe Anwaltskosten) freizustellen, die aus der Verwendung des Arbeitsergebnisses durch Dritte oder weil ein Dritter auf das Arbeitsergebnis (einschließlich Steuerberatung) vertraut, resultieren und die Weitergabe direkt oder indirekt durch Sie oder auf Ihre Veranlassung erfolgt ist. Diese Verpflichtung besteht nicht, sofern wir uns ausdrücklich schriftlich damit einverstanden erklärt haben, dass der Dritte auf das Arbeitsergebnis vertrauen darf.

Nutzungsrechte

23.Im Rahmen der Erbringung unserer Leistungen sind wir berechtigt, Daten, Software, Muster, Hilfsmittel, Tools, Modelle, Systeme sowie andere Methoden und Fachwissen („Know-How“) zu nutzen, die in unserem Eigentum stehen. Ungeachtet der Auslieferung des Arbeitsergebnisses verbleibt das geistige Eigentum am Know-How (einschließlich der im Rahmen der Erbringung der Leistungen entwickelten Verbesserungen oder der erworbenen Kenntnisse) und an sämtlichen im Rahmen der Leistungen zusammengestellten Arbeitspapieren (mit Ausnahme der in diesen wiedergegebenen Mandanteninformationen) weiterhin bei uns.

Vertraulichkeit

24.Wir sind an die strengen berufsrechtlichen Verschwiegenheitspflichten gemäß § 43 WPO und § 57 StBerG gebunden. Soweit in der Mandatsvereinbarung nichts Anderweitiges geregelt ist, ist keine der Vertragsparteien dazu berechtigt, die Inhalte der Mandatsvereinbarung oder sonstige Informationen (mit Ausnahme der Steuerberatung), die von der jeweils anderen Vertragspartei oder in deren Namen zur Verfügung gestellt wurden und nach vernünftigen Erwägungen vertraulich sind und/oder als schützenswert zu behandeln sind, gegenüber Dritten offenzulegen.

25.Vorbehaltlich vorrangiger gesetzlicher Verschwiegenheitspflichten ist den Vertragsparteien eine Offenlegung solcher Informationen jedoch gestattet, soweit sie

(a) ohne Verstoß gegen die Mandatsvereinbarung öffentlich bekannt geworden sind oder öffentlich bekannt werden,

(b) der Empfänger nach Abschluss der Mandatsvereinbarung von einem Dritten erhalten hat, der nach Kenntnis des Empfängers gegenüber der offenlegenden Partei im Hinblick auf die Informationen nicht zur Vertraulichkeit verpflichtet ist,

2

(c) dem Empfänger bereits zum Zeitpunkt der Offenlegung bekannt waren oder danach unabhängig entwickelt wurden,

(d) offengelegt werden, soweit dies erforderlich ist, um die Rechte des Empfängers aus der Mandatsvereinbarung durchzusetzen,

(e) aufgrund gesetzlicher Vorschriften oder berufsrechtlicher Vorgaben offengelegt werden müssen.

26.Den Vertragsparteien ist die Verwendung elektronischer Medien zum Austausch und zur Übermittlung von Informationen gestattet. Eine solche Verwendung stellt per se keinen Verstoß gegen die Verschwiegenheitspflichten gemäß der Mandatsvereinbarung dar. Den Vertragsparteien ist bewusst, dass die elektronische Übermittlung von Informationen (insbesondere per E-Mail) Risiken birgt.

27.Wir sind berechtigt, zum Zwecke der Erbringung unserer Leistungen, zur Einhaltung berufsrechtlicher Vorschriften, zur Vermeidung von Interessenskonflikten und zum Zwecke des Qualitäts- und Risikomanagements sowie der Rechnungslegung Mandanteninformationen an andere EY-Mitglieder und EY-Personen, die solche Daten verwenden, übertragen, speichern oder anderweitig verarbeiten können, weiterzugeben. Eine entsprechende Einwilligungserklärung ist der Mandatsvereinbarung zur Unterschrift beigefügt.

28.Soweit die Unabhängigkeitsvorschriften der U.S. Security and Exchange Commission für die Mandatsbeziehung zwischen Ihnen bzw. einem Ihrer verbundenen Unternehmen und einem EY-Mitglied gelten, bestätigen Sie nach bestem Wissen und Gewissen in Bezug auf sämtliche Leistungen, dass bei Abschluss der Mandatsvereinbarung weder Sie noch eines Ihrer verbundenen Unternehmen mit einem anderen Berater schriftlich oder mündlich Beschränkungen für die Offenlegung der steuerlichen Behandlung oder der steuerlichen Gestaltung einer Transaktion, die Gegenstand der Leistungen sind, vereinbart haben. Eine derartige Vereinbarung könnte die Unabhängigkeit eines EY-Mitglieds hinsichtlich Ihrer Prüfung oder der Prüfung eines Ihrer verbundenen Unternehmen beeinträchtigen bzw. bestimmte steuerliche Angaben zu diesen Beschränkungen erforderlich machen. Demzufolge stimmen Sie zu, dass Konsequenzen einer solchen Vereinbarung allein in Ihrer Verantwortung liegen.

Datenschutz

29.Wir sind dazu berechtigt, Mandanteninformationen, die bestimmten Personen zugeordnet werden können (,personenbezogene Daten”), zu erheben, zu verwenden, zu übertragen, zu speichern oder anderweitig zu verarbeiten (zusammen „verarbeiten”). Zum Zwecke der Erbringung unserer Leistungen, zur Einhaltung berufsrechtlicher Vorschriften, zur Vermeidung von Interessenskonflikten und zum Zwecke des Qualitäts- und Risikomanagements sowie der Rechnungslegung sind wir berechtigt, personenbezogene Daten in den verschiedenen Jurisdiktionen, in denen wir und die anderen EY-Mitglieder tätig sind (eine Aufstellung ist unter www.ey.com abrufbar), zu verarbeiten. Wir verarbeiten personenbezogene Daten ausschließlich in Übereinstimmung mit berufsrechtlichen Vorschriften und geltendem Recht, insbesondere unter Beachtung des BDSG. Wir verpflichten sämtliche Auftragnehmer, die in unserem Auftrag personenbezogene Daten verarbeiten, sich ebenfalls an diese Bestimmungen zu halten.

30.Sie garantieren uns, dass Sie befugt sind, uns personenbezogene Daten im Zusammenhang mit der Erbringung unserer Leistungen zur Verfügung zu stellen und dass die uns zur Verfügung gestellten personenbezogenen Daten in Übereinstimmung mit geltendem Recht verarbeitet wurden.

Vergütung

31.Ihre Vergütungsverpflichtung umfasst die Zahlung unserer Vergütung und bestimmter Auslagen für unsere Leistungen in Übereinstimmung mit der entsprechenden Leistungsbeschreibung bzw. deren Anlagen. Sie sind zudem verpflichtet, uns weitere angemessene Auslagen zu erstatten, die uns im Rahmen der Erbringung unserer Leistungen entstanden sind. Unsere Vergütung versteht sich exklusive Steuern oder ähnlichen Aufwendungen oder Zöllen, Gebühren oder Abgaben, die im Zusammenhang mit den Leistungen anfallen; diese sind von Ihnen zu tragen (mit Ausnahme der allgemeinen Besteuerung des Einkommens). Wir können angemessene Vorschüsse auf unsere Vergütung und Auslagenersatz verlangen und die Auslieferung unserer Arbeitsergebnisse von der vollen Befriedigung unserer Ansprüche abhängig machen. Soweit in der Leistungsbeschreibung nicht anderweitig geregelt, ist die Vergütung 30 Tage nach Zugang unserer Rechnung fällig.

32.Wir haben Anspruch auf eine zusätzliche Vergütung, soweit Ereignisse außerhalb unseres Einflussbereichs (einschließlich Ihrer Handlungen oder Unterlassungen) uns daran hindern, die Leistungen wie ursprünglich geplant zu erbringen oder wenn Sie uns mit der Wahrnehmung zusätzlicher Aufgaben betrauen.

33.Soweit wir von Gesetzes wegen oder aufgrund richterlicher oder sonstiger hoheitlicher Anordnung verpflichtet sind, Informationen als Beweismittel oder Personal als Zeugen im Zusammenhang mit unseren Leistungen oder der Mandatsvereinbarung zur Verfügung zu stellen, sind Sie dazu verpflichtet, uns den dadurch entstandenen Zeit- und Kostenaufwand (inklusive externer Rechtsberatungskosten) zu erstalten, sofern wir nicht selbst Partei des Verfahrens bzw. Subjekt der Ermittlungen sind oder soweit wir nicht durch staatliche Stellen entschädigt werden.

34.Kommen Sie mit der Annahme der von uns angebotenen Leistungen in Verzug oder unterlassen Sie eine Ihnen nach Ziff. 7, 8 oder anderweitig obliegende Mitwirkungshandlung, so sind wir zur fristlosen Kündigung der Mandatsvereinbarung berechtigt. Unberührt bleibt unser Anspruch auf Ersatz zusätzlich entstandener Kosten sowie der uns durch den Verzug oder die von Ihnen unterlassene Mitwirkung entstandenen Schäden, und zwar auch dann, wenn wir von dem Kündigungsrecht keinen Gebrauch machen.

Höhere Gewalt

35.Keine der Vertragsparteien ist für einen Bruch der Mandatsvereinbarung verantwortlich (mit Ausnahme von Zahlungsverpflichtungen), wenn diese durch Umstände verursacht wurde, die außerhalb des Einflussbereiches der Vertragsparteien liegen („höhere Gewalt“).

Laufzeit und Beendigung

36.Die Bedingungen der Mandatsvereinbarung finden unabhängig vom Zeitpunkt ihrer Ausführung für die Leistungen dieser Mandatsvereinbarung Anwendung (einschließlich solcher Leistungen, die vor Unterzeichnung der Mandatsvereinbarung erbracht wurden).

37.Die Mandatsvereinbarung endet mit dem Abschluss der Leistungen. Jede Vertragspartei ist berechtigt, die Mandatsvereinbarung bzw. eine bestimmte Leistung vorzeitig unter Einhaltung einer Frist von 90 Tagen schriftlich zu kündigen. Darüber hinaus sind wir zur fristlosen Kündigung der Mandatsvereinbarung bzw. einer bestimmten Leistung berechtigt, wenn wir aus vernünftigen Erwägungen zu dem Schluss kommen, die Leistungen nicht mehr in Übereinstimmung

3

mit geltendem Recht oder unseren Berufspflichten erbringen zu können. §§ 626 und 627 BGB bleiben unberührt.

38.Sie sind verpflichtet, uns bereits begonnene oder abgeschlossene Leistungen zu vergüten sowie entstandene Aufwendungen und Auslagen zu ersetzen, die uns bis zum Tag der Beendigung der Mandatsvereinbanjng entstanden sind.

39.Unsere Verschwiegenheitspflichten gemäß der Mandatsvereinbanjng sowie andere Bestimmungen der Mandatsvereinbarung, die Rechte und Pflichten der Vertragsparteien über die Beendigung der Mandalsvereinbarung hinaus begründen, bestehen auch nach Beendigung der Mandatsvereinbarung zeitlich unbegrenzt fort.

Anwendbares Recht und Gerichtsstand

40.Auf die Mandatsvereinbarung und sämtliche außervertraglichen Angelegenheiten oder Verpflichtungen, die sich aus der Mandatsvereinbarung oder den Leistungen ergeben, findet deutsches Recht Anwendung.

41.Ausschließlicher Gerichtsstand für alle in Verbindung mit der Mandatsvereinbarung oder den Leistungen entstehenden Rechtsstreitigkeiten ist Stuttgart, Deutschland, oder nach unserer Wahl, (i) das Gericht, bei dem unsere mit der Erbringung der Leistungen schwerpunktmäßig befassle Niederlassung ihren Sitz hat oder (ii) die Gerichte an dem Ort, an dem Sie Ihren Sitz haben.

Sonstiges

42.Auf unsere Aufforderung hin werden Sie uns in einer schriftlichen von uns vorformulierten Erklärung bestätigen, dass die unserer Beratung zugrunde gelegten Dokumente und Ihre Informationen und Erklärungen vollständig sind.

43.Sie sichern zu, alles zu unterlassen, was die Unabhängigkeit unserer Mitarbeiter gefährden könnte. Dies gilt insbesondere für Angebote auf Anstellung und für Angebote, Aufträge auf eigene Rechnung zu übernehmen.

44.Bei etwaigen Mängeln haben Sie Anspruch auf Nacherfüllung durch uns. Nur bei Fehlschlagen der Nacherfüllung können Sie Herabsetzung der Vergütung oder Rückgängigmachung der Mandatsvereinbarung verlangen; wenn der Auftrag von einem Kaufmann im Rahmen seines Handelsgewerbes, einer juristischen Person des öffentlichen Rechts oder von einem öffentlichrechtlichen Sondervermögen erteilt wurde, so können Sie die Rückgängigmachung der Mandatsvereinbarung nur verlangen, wenn die erbrachten Leistungen wegen Fehlschlagens der Nacherfüllung für Sie ohne Interesse sind. Soweit darüber hinaus Schadensersatzansprüche bestehen, gelten Ziff. 16 bis 21.

Der Anspruch auf Beseitigung von Mängeln muss von Ihnen unverzüglich schriftlich geltend gemacht werden. Ansprüche nach dem vorstehenden Absatz, die nicht auf einer vorsätzlichen Handlung beruhen, verjähren nach Ablauf eines Jahres ab dem gesetzlichen Verjährungs-beginn.

Offensichtliche Unrichtigkeiten, wie z. B. Schreibfehler, Rechenfehler und formelle Mängel, die in einem Arbeitsergebnis enthalten sind, können jederzeit von uns - auch Dritten gegenüber - berichtigt werden. Unrichtigkeiten, die geeignet sind, in unserem Arbeitsergebnis enthaltene Ergebnisse in Frage zu stellen, berechtigen uns, das Arbeitsergebnis auch Dritten gegenüber zurückzunehmen. Sofern dies möglich und zumutbar ist, werden wir Ihnen in den vorgenannten Fällen vorab Gelegenheit zur Stellungnahme geben.

45.Wir bewahren die im Zusammenhang mit der Erfüllung der Mandatsvereinbarung uns übergebenen und von uns selbst angefertigten Unterlagen sowie den in Zusammen hang mit der Mandatsvereinbarung geführten Schrift wechsel zehn Jahre auf.

Nach Befriedigung unserer Ansprüche aus der Mandatsvereinbarung haben wir auf Ihr Verlangen alle Unterlagen herauszugeben, die wir in Erfüllung der Mandatsvereinbarung von Ihnen oder für Sie erhalten haben. Dies gilt jedoch nicht für den Schriftwechsel avischen Ihnen und uns und für Schriftstücke, die Ihnen bereits in Urschrift oder Abschrift vorliegen. Wir sind berechtigt, von Unterlagen, die wir an Sie zurückgeben, Abschriften oder Fotokopien zum Verbleib anzufertigen.

46.Die Mandatsvereinbarung stellt die gesamte Vereinbarung im Hinblick auf die Leistungen und die sonstigen in der Mandatsvereinbarung geregelten Angelegenheiten zwischen den Vertragsparteien dar und ersetzt alle vorangegangenen diesbezüglichen Vereinbarungen, Übereinkünfte und Erklärungen einschließlich früher geschlossener Vertraulichkeitsvereinbarungen.

47.Die Mandatsvereinbarung und/oder die Leistungsbeschreibung (sowie Änderungen derselben) bedürfen der Schriftform gem. §126 Abs. 1 BGB. Für die Wirksamkeit der Mandatsvereinbarung ist es ausreichend, wenn jede der Vertragsparteien eine separate Ausfertigung desselben Dokuments unterzeichnet

48.Jede Partei sichert der anderen zu, dass die Personen, die die Mandatsvereinbarung und/oder die Leistungsbeschreibung in ihrem Namen unterzeichnen, berechtigt sind, die jeweilige Partei vertraglich zu binden.

Sie sichern zu, dass Ihre verbundenen Unternehmen oder andere Parteien, für die die Leistungen erbracht werden, und die Bedingungen der Mandatsvereinbarung und der Leistungsbeschreibung gebunden sind.

49.Sie stimmen hiermit zu, dass wir und die anderen EY-Mitglieder unter Einhaltung der berufsrechtlichen Vorschriften für andere Mandanten - einschließlich Ihrer Wettbewerber - tätig werden dürfen.

50.Eine Abtretung der Rechte, Pflichten oder Ansprüche aus der Mandatsvereinbarung ist nicht zulässig.

51.Sollten eine oder mehrere Bestimmungen der Mandatsvereinbarung teilweise oder vollständig unwirksam, nichtig oder in sonstiger Weise undurchführbar sein, so berührt dies nicht die Wirksamkeit der übrigen Bestimmungen.

52.Bei Widersprüchen oder Unklarheiten zwischen den Bestimmungen der Mandatsvereinbarung gilt folgende Rangfolge (sofern nicht ausdrücklich etwas anderes vereinbart ist): (a) das Anschreiben, (b) die entsprechende Leistungsbeschreibung (ggf. inkl. Vergütungsvereinbarung). (c) Einwilligungserklärung, (d) diese Allgemeinen Auftragsbedingungen und (e) die übrigen Anlagen zur Mandatsvereinbarung.

53.Keine Partei ist berechtigt, den Namen, das Logo oder die Marke der jeweils anderen Partei ohne deren vorherige Zustimmung zu verwenden oder darauf Bezug zu nehmen. Sofern wir Ihre vorherige Zustimmung durch die beiliegende Einwilligungserklärung erhalten, dürfen wir Ihre Firmierung öffentlich im Zusammenhang mit den erbrachten Leistungen oder auf andere Art Sie als unseren Mandanten nennen.

54.EY-Mitglieder und EY-Personen sind berechtigt, sich auf die Beschränkungen aus Ziff. 16 bis 21 und die Bestimmungen der Ziff. 22, 27, 29 und 49 zu berufen.

4

Glossary

to the General Agreement 2013

between

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„FME”)

and

Fresenius Netcare GmbH

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„NETCARE”)

Current status	:	22.01.2013
Last printed	:	18-Jul-13 10:08:00
Version	:	1.0

1

Version History

This section ensures tracking of changes and thereby enhances the quality of the document. Each change has to be documented up to the final version. The next subversion will start from beginning.

New releases as a result of major reviews of the service model will cause a higher number before the dot. Therefore all service descriptions have the same release number at a certain time, starting with 1.x after initial release.

Updated versions as a result of general maintenance work will cause a higher number behind the dot, starting with .01, continuing with .02, .03 and so on.

This document is an attachment to the General Agreement and may be updated regularly by the Service Management Units of the Parties. Changes to this Glossary require the approval of the Steering Committee.

Vers.	Change	Section	Created by / When	Reviewed by / When	Approved by / When
1.0	Creation of the document	all	FNC-ITSM / 04.10.2012	FME-ITC / 11.10.2012	Steering Committee / 26.10.2012

2

Definitions

Acceptance	means the acknowledgement by FME to NETCARE that the Project or Service has been received as defined in the respective Service Agreement.
Annex	means an annex to the General Agreement, including but not limited to the MSD, this Glossary, Fairness Opinion.
Change Management	means the handling of changes and change requests in accordance with the processes defined either in the GA or the MSD.
Confidential Information	means any information as defined in Section 8 of the General Agreement.
Continuous Improvement Process	means an ongoing effort to improve Services or processes.
Contractual Change	means any changes to the contractual provisions as defined in Section 7 of the GA.
Customer	means, for the purposes of invoicing and billing, an individual unit or entity of FME as defined in the NETCARE invoicing system.
Defects	means non-compliance with any Service Levels or the specifications agreed with respect to a Service or a defect in the priorities level 1, 2 or 3 as defined in the MSD and the GA.
Emergency Support Service	means NETCARE’s Service providing support outside the regular service times as described in the Standard Service Agreement.
Escalation Level	means the various management levels 1, 2 and 3 for the clearance and settlement of any disputes between the Parties as defined in the MSD.
Escalation Management Process	is the process for involving higher level management in the course of the handling of a critical issue or dispute as defined in Section 4 of the MSD.
FME	means Fresenius Medical Care AG & Co. KGaA.
FME EMEALA	means FME regions Europe, Africa, Middle East and Latin

3

	America.
GA	means General Agreement. This is the framework agreement governing the contractual relationship between FME and NETCARE with respect to IT Services to be provided with effect from 1 January 2013 and replacing the General Agreement dated 8 December 2003.
GxP	Means Good Practice guidelines as applicable and agreed, e.g. GMP (Good Manufacturing Practice).
Group of Services	means a group of Services that form a comprehensible package to be defined by the Parties in connection with a benchmarking request.
Incident	is any event, which is not part of the standard operation of a Service and which causes an interruption to, or a reduction in the quality of the Service including Defects.
Individual Service	means a service which is not (yet) covered via the Standard Service Agreement, i.e. not yet covered via the Service Catalogue.
Individual Service Agreement	means an agreement between the Parties with respect to an Individual Service.
Intellectual Property Rights	means any rights relating to trademarks, registered designs, patents, applications for any of the foregoing, copyrights, design rights, know-how, trade and business names, publication rights, goodwill and any other similar rights which are protected by law in a country in the Territory.
Known Error	is a problem that has a documented root cause and a Workaround.
Known Error Database	is created by Problem Management and used by Incident and Problem Management to manage all Known Errors.
Management Board	means the highest level in the approval process, Escalation Management Process and management of the service relationship between the Parties as defined in detail in the MSD.
MSD	means the Master Service Description.

4

NETCARE	means Fresenius Netcare GmbH.
Operation Units	mean the local units of FME and NETCARE involved in the daily management of service operation under the Set of Contracts at an operational level.
Party	means either FME or NETCARE.
Parties	means collectively FME and NETCARE.
FNC Price List	means NETCARE’s standard price list “Summary of Standard Services, Prices and Charging Conditions” available on NETCARE´s Intranet.
Person Days	means the time period of 8 business hours.
Price List	means a price list for FME as agreed by the Steering Committee each year based on the FNC Price List.
Problem	means a cause of one or more Incidents. The cause is not usually known at the time a Problem is created.
Project	means a temporary endeavor with defined time, budget and scope in order to develop or implement a Service.
Project Leading Committee	means a specific steering committee in connection with a Project.
Operation Units	focus on the daily management of the Service provisioning.
Request for Change	means a request for a Technical Change submitted by FME or NETCARE.
Service Agreement	means any agreement between the Parties with respect to any standard or individual services provided by NETCARE to FME under the General Agreement and includes the Individual Service Agreements and Standard Service Agreements.
Service Catalogue	means a catalogue of standard services published on NETCARE´s Intranet.
Service Desk	means a single point of contact for FME employees requiring IT support.
Service Level	means those service standards in relation to a Service which are to be achieved by NETCARE and which are specified in a Service

5

	Agreement relating to a specific Service.
Service Level Agreement	means a Service Agreement with defined Service Levels.
Service Management Units	are generally focused on the operational management of the Service provision from NETCARE to FME as agreed under the Set of Contracts.
Service Meeting	means a regular meeting of the Service Management Units.
Services	means any services or works performed by NETCARE in accordance with the terms of the Set of Contracts and defined in a Standard Service Agreement or an Individual Service Agreement.
Service Change	means a change with respect to the type, scope, price or quality of a Service or any other change with an impact on a Service.
Service Component Description	means description of in-scope and out-of-scope activities, availability of the Service, the order process, and optionally selectable service features.
Set of Contracts	means collectively the terms of the General Agreement, any Annexes and Service Agreements and any other documents which may be referenced therein (and as may be amended from time to time), between the Parties.
Service Request	means any kind of request by FME for the provision of a Service.
Standard Service	means a service which covers recurring customer requests as defined in a Service Catalogue and agreed in a Standard Service Agreement.
Standard Service Agreement	means an agreement between the Parties regarding Standard Services based on NETCARE´s Service Catalogue.
Standard Software	means any third party standard software or NETCARE’s own software not specifically and exclusively developed for FME.
Steering Committee	forms the central steering body of the service relationship between the contractual bodies as defined in detail in the MSD.
Support Level	means First-Level-Support (Service Desk) and further support levels like Second-Level-Support and Third-Level-Support as described in the MSD.

6

Systems	means the hardware and/or operating software needed for the provision of the Services.
Technical Changes	The addition, modification or removal of Hardware and Software that could have an effect on IT services.
Territory	means FME regions Europe, Africa, Middle East and Latin America.
Third Party	means a person or company other than NETCARE or FME or any of their respective affiliates.

7

Master Service Description

to the General Agreement 2013

between

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„FME”)

and

Fresenius Netcare GmbH

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„NETCARE”)

Current status	:	23.01.2013
Last printed	:	23.1.2013
Version	:	1.0

1

Index

1.	Introduction			4
	1.1	Version History		4
	1.2	Contractual Structure		5
2.	Governance			7
	2.1	Contractual Bodies		8
		2.1.1	Management Board	9
		2.1.2	Steering Committee	9
		2.1.3	Service Management Units	10
		2.1.4	Operation Units	10
	2.2	Risk Management		10
3.	Service Change Management			11
	3.1	Principles of Service Change Management:		11
	3.2	Principles of Change Approval		12
	3.3	Principles of Signatures		13
4.	Escalation Management			14
5.	IT Service Management			15
	5.1	Service Level Management		16
	5.2	Incident Management		17
		5.2.1	Ticket Lifecycle	18
		5.2.2	Support Channels	19
		5.2.2.1	Central Service Desk Bad Homburg	19
		5.2.2.2	Central SAP Service Desk Bad Homburg	19
		5.2.2.3	Decentralized Service Desks	19
	5.3	Technical Change Management		20
	5.4	IT Service Continuity Management		20
	5.5	IT Security Management		21
	5.6	Service Catalogue Management		21
6.	Standard Service Requests			22
7.	Individual Service Requests			22
8.	Projects			23
	8.1	Project Management Method		23
		8.1.1	Project Definition	24
		8.1.2	Project Planning	24
		8.1.3	Project Execution	24
		8.1.4	Project Closure	24

2

	8.2	Project Changes		24
	8.3	Committees		25
	8.4	Responsibilities within an Individual Project		25
		8.4.1	NETCARE’s Responsibilities and Services	25
		8.4.2	FME Responsibilities and Services	26
	8.5	Project and Service Approval		26
	8.6	General Terms for Project Pricing		28
	8.7	Advanced Termination of Projects		29
9.	Continual Service Improvement			30
	9.1	Service Meeting		30
	9.2	Continuous Improvement Process (CIP)		30
	9.3	Complaint Management		31
10.	Service Accounting & Charging			31
	10.1	Price Model		31
	10.2	Price Setting for Standard Services		32
	10.3	Service Volume		33
	10.4	Volume and Master Data Variations		33
	10.5	Yearly Reconciliation with FME		33
	10.6	Invoice Reporting		34
11.	Technical and organizational measures (9 BDSG)			34
	11.1	Access Control to Premises and Facilities (Entry Control)		34
	11.2	Access Control to Systems (Admission Control)		34
	11.3	Data Access Control		35
	11.4	Disclosure Control		35
	11.5	Input Control		35
	11.6	Job Control		35
	11.7	Availability Control		36
	11.8	Segregation Control		36

3

1.Introduction

1.1Version  History

This Section ensures tracking of changes and thereby enhances the quality of the document. Each change has to be documented up to the final version. The next subversion will start from beginning.

New releases as a result of major reviews of the Service model will cause a higher number before the dot. Therefore all Service descriptions have the same release number at a certain time, starting with 1.x after initial release.

Updated versions as a result of general maintenance work will cause a higher number behind the dot, starting with .01, continuing with .02, .03 and so on.

This document is an attachment to the General Agreement and may be updated regularly by the Service Management Units of the Parties. Changes to this MSD require the approval of the Steering Committee.

Vers.	Change	Section	Created by / When	Reviewed by / When	Approved by/ When
1.0	Creation of the document	all	FNC-ITSM / 04.10.2012	FME-ITC / 11.10.2012	Steering Committee / 26.10.2012

4

1.2Contractual Structure

The complete agreement between the Parties and the contractual structure defined as “Set of Contracts” consists of:

a)this General Agreement; and

b)related documents (the Annexes) such as:

i.Master Service Description;

ii.Glossary

iii.Fairness Opinion

iv.List of Affiliates

v.others

c)Service Agreements

i.Standard Service Agreements

ii.Individual Service Agreements.

The order of precedence of the documents under the Set of Contracts is defined in the General Agreement in Section 1. The General Agreement provides the legal framework that shall govern the cooperation between, and the overall relationship and general obligations of, the Parties.

The List of Affiliates shall be amended according to the procedure defined in Section 10.5.

5

The MSD is structured according to the interfaces between NETCARE and FME extended by additional topics which describe the general processes necessary for a high quality Service provision from NETCARE to FME.

6

2.Governance

In addition to the general governance structure set forth in the GA, the Parties agreed upon the committees and their roles, focus, tasks and responsibilities as described in this Section. The defined contractual bodies shall be staffed with equal representation of FME and NETCARE and decisions shall be mutually agreed.

The Parties commit themselves to collaborate at least with the below mentioned and described bodies:

7

2.1          Contractual Bodies

Management Board (meeting cycle: on request)

Party	Participating Roles	Person Acting
FME	Board Member for Global Manufacturing Operations	Kent Wanzek
	CEO of Region EMEALA	Dr. Emanuele Gatti
	Board Member for Global Law, Compliance, Intellectual Property, Corporate Business Development	Dr. Rainer Runte
NETCARE	Chairman	Klaus Kieren
	Vice Chairman	Jürgen Kunze
	Member of the Management Board	Stephan Sturm

Steering Committee (meeting cycle: regular, minimum four times per year (quarterly)

Party	Participating Roles	Person Acting
FME	Chief Financial Officer EMEALA	Thomas Dimt
	Head of IT Coordination EMEALA	Klaus Grimm
NETCARE	Vice Chairman	Jürgen Kunze
	Head of Global IT Service Office & European Regions	Ralf Ehrenborg

8

Service Management Units (meeting cycle: regular, minimum on monthly basis

Party	Participating Roles	Person Acting
FME	Head of IT Service Management	Winfried Döll
	IT Service Coordinator	Florian Griesenbeck
	Controlling EMEALA	Holger Neumann
NETCARE	Head of IT Service Management	Hermann Luckhardt
	Head of Commercial Business	Andreas Standfest
	Consultant IT Service Management	Sebastian Biebl

Operation Units (meeting cycle: on request)

Party	Participating Roles	Person Acting
FMER	Participants on request from local Operation Units	On request
NETCARE	Participants on request from local Operation Units	On request

2.1.1       Management Board

The Management Board as defined hereunder shall be consistent of at least 2 representatives of both Parties’ Management Boards.

The Management Board agrees on the Set of Contracts in general and acts as highest escalation level in case of any dispute, controversy or claim arising out of or in connection with the Set of Contracts.

The Management Board will make every effort to settle amicably any escalation and avoid a lawsuit. Furthermore the Management Board has an important role for contractual management as described in Section 3.

2.1.2       Steering Committee

The Steering Committee forms the central steering body of the Service relationship between the contractual bodies. In addition to relationship and Escalation Management, its main focus is the examination of operative and strategic plans and the related achievement of

9

objectives. This body decides about production and process issues and controls and evaluates the Services rendered by NETCARE with regards to quality, continuity and risk.

The Steering Committee allocates necessary budgets and resources and initiates Projects or working groups. In this respect the Steering Committee centrally steers and supervises measures and Projects related to the Service relationship of the Parties.

In addition, the Steering Committee is the last Escalation Level before the Management Board. FME and NETCARE aim at resolving or settling preferably all escalations and conflicts on the level of the Steering Committee. The Steering Committee meets at regular intervals or if necessary.

2.1.3       Service Management Units

The Service Management Units comprehend FME Information Technology Coordination EMEALA Department (ITC), NETCARE IT Service Management (ITSM) and NETCARE Commercial Business. This contractual body is generally focused on the operational management of the Service provision from NETCARE to FME as agreed under the Set of Contracts. Also monitoring of Service Levels and scope of Services as well as Service Changes during the period of Service provisioning shall be the responsibility of such units.

2.1.4       Operation Units

The Operation Units comprehend FME local units and NETCARE departments on an operational level. The Operation Units provide the governance for the daily management of the Service provisioning.

2.2          Risk Management

NETCARE performs risk management with the aim to identify the GMP-critical processes for a prospective validation of the business processes based on the process description and other related documentation. The risk analysis will be executed and documented. Furthermore the risk management is one of the core elements within NETCARE’s quality management system. The figure below describes NETCARE’s approach to ensure GxP-compliant IT Services.

10

3.      Service Change Management

In accordance with §7 of the General Agreement, changes with an impact on the specifications or scope of the Services (Service Changes) will be handled as described hereunder. Contractual Changes will be handled according to the change procedure as defined in the General Agreement.

3.1          Principles of Service Change Management:

Service Changes have to be discussed and prepared on certain levels:

1.     Changes with impact to the General Agreement, Master Service Description, global Standard Services and global Individual Services are in the responsibility of the defined Service Management Units.

2.     Changes with impact to local Individual Services and local Standard Services are in the responsibility of the respective Operation Units.

11

3.2          Principles of Change Approval

Service Changes have to be approved on certain levels:

1.     Changes with impact to the General Agreement, Master Service Description, global Standard Services and global Individual Services are in the responsibility of the defined Steering Committee.

2.     Changes with impact to local Standard Services and local Individual Services are in the responsibility of the Service Management Units.

12

3.3          Principles of Signatures

Service Changes have to be signed on certain levels:

1.     Changes with impact to the General Agreement are in the responsibility of the Management Board.

2.     Changes with impact to the Master Service Description, global Standard Services and global Individual Services are in the responsibility of the Steering Committee.

3.     Changes with impact to local Standard Services and local Individual Services are in the responsibility of the respective Operation Units.

The principles defined above shall not affect the signature authorities defined in the relevant signature policies (Unterschriftenrichtlinie) of the Parties.

13

4.     Escalation Management

Both Parties agree to cooperate in good faith as it is outlined in §5 of the General Agreement. Nevertheless there is a need for an Escalation Management in order to manage the collaboration efficiently and effectively, to solve issues on the appropriate organizational level and to proactively prevent any potential law suits.

The Parties agree to institute the Escalation Management Process described hereunder before taking any other legal steps including initiation of arbitration proceedings as specified in the General Agreement. Furthermore the Parties agree to mutually tend to find a consensus involving the respective Operation Units of FME and NETCARE, as far as reasonable, before instituting the Escalation Management Process.

Any disagreements shall first be discussed on operational level. As far as a consensus cannot be reached each Party may initiate the following Escalation Management Process in case of dissension regarding Service provisioning, Service quality, operational topics or dissension about any other agreement in the context of the Set of Contracts.

1. Escalation Level: The Party initiating the Escalation Management Process is obliged to provide a statement in writing or text outlining the reasons for the dissension and the

14

escalation to the first Escalation Level being the Service Management Unit of both Parties. The statement shall include at least the reason for the dissension, the reference to the relevant provisions and documents in the Set of Contracts and possible alternatives to settle the dissension. The other Party is obliged to react with a statement in writing or text on the dissension. The Service Management Units shall discuss the dissension and agree on a settlement as soon as reasonable.

2. Escalation Level: If no settlement can be reached by the Service Management Units (this requires in general unanimity) the request for further escalation including the statements shall be processed to the next Escalation Level being the Steering Committee. The Steering Committee shall discuss the dissension and agree on a settlement as soon as reasonable.

3. Escalation Level: If no settlement can be reached in the Steering Committee the request for further escalation including the statements shall be processed to the last Escalation Level being the Management Board. If the Management Board is not able to reach a unanimous settlement agreement each Party may independently from the other declare the Escalation Management Process as failed and initiate arbitration proceedings as defined in the General Agreement.

5.     IT Service Management

NETCARE shall establish and maintain a state of the art Service management which orientates on the good practices collected in the IT Infrastructure Library (currently version V3). The objective of NETCARE’s IT Service management is to ensure that their IT Services provide best possible support for FME’s business. The established Service management processes include but are not limited to:

·              NETCARE’s Service management processes with interface to FME

·Service Level Management

·Incident Management

·Technical Change Management

·IT Service Continuity Management

·IT Security Management

·Service Catalogue Management

·              NETCARE’s internal Service management processes

15

·Availability Management

·Event Management

·Financial Management

·Knowledge Management

·Problem Management

·Release & Deployment Management

·Request Fulfillment.

This MSD focuses on the above mentioned Service management processes with interface to FME and does not describe NETCARE’s internal processes implemented to ensure that the Service provision meets the agreed Service Levels.

5.1          Service Level Management

Service Level Management includes the processes of planning, coordinating, drafting, agreeing, monitoring and reporting of Service Agreements, and the ongoing review of Service achievements to ensure that the required and cost-justifiable Service quality is maintained and gradually improved.

The Service Agreements agreed between the Parties shall comprise at least the following provisions:

·      introduction

·version, change history, author

·validity

·      territory

·      timeframe

·Service description

·      overview

·      short summary

·assumptions

·      scope of Services

·detailed Service description

16

·      in-scope Services

·      out-of-scope Services

·      optional Services

·dependencies

·obligation of FME

·      Service Level

·definition of Service Level and/or classes of Service Levels

·definition of measurements (KPIs) and measurement methods

·reporting

·      conditions and exceptions of Service provision

·      deviances from the GA; MSD or other agreements under the Set of Contracts

·      service price (if not covered within the Price List)

·      signatures

·      glossary

·      attachments

NETCARE performs Service Level Management in order to conclude Service Agreements with FME. In terms of Service Agreements the Parties distinguish between Individual Service Agreements and Standard Service Agreements.

The differentiation between Individual and Standard Service Agreement depends on the kind of demand of FME. If FME has a new demand not covered via an existing Service Agreement or a demand for a change to an existing Service Agreement this shall be covered via an Individual Service Agreement. If the demand of FME shows that there is a need for certain recurring requests this shall be covered within the umbrella of the Standard Service Agreement between NETCARE and FME, i.e. via the Services from the Service Catalogue. If no deviance from NETCAREs Service Catalogue is agreed by the Parties the Service Catalogue acts as Standard Service Agreement.

Furthermore NETCARE’s Service Level Management monitors the adherence to the agreed Service Levels and ensures a regular discussion within the Service Meetings as described in Section 9.1.

17

5.2Incident Management

NETCARE provides FME with a state of the art Incident Management. The aim of this Incident Management is to resolve any Incidents causing an interruption of Service provided by NETCARE to FME in the quickest and most effective way possible. This includes also monitoring the effectiveness and efficiency of the IT support. FME can trigger the Incident Management process via user calls or mails to the Service Desk as described in Section 5.2.2. Furthermore NETCARE performs a state of the art Event Management in order to proactively avoid any Incidents. Therefore Incidents can be triggered by system monitoring or information from NETCARE staff as well.

The Incident Management performed by NETCARE comprises:

·registration of Incidents,

·prioritization of Incidents,

·direct resolution of Incidents (First Level Support),

·resolution of complex Incidents (Second & Third Level Support),

·closure of Incidents and analysis of Incidents,

·performance of Incident Management reporting,

·monitoring and escalation of Incidents,

·proactive information of the users,

·maintenance of the Support Knowledge Base.

Beside the Incident Management NETCARE performs Problem Management with the purpose to manage all Problems throughout their lifecycle, proactively identify similar support cases with unknown cause and provide and maintain a Known Error Database. The goal is to identify the root cause of a Problem and develop a solution that eliminates this root cause in order to prevent potential or further occurrences of similar Incidents. If it is not possible to avoid support cases, the goal is to minimize the impact on FME.

5.2.1   Ticket Lifecycle

NETCARE shall ensure that every Incident is inserted in the Service Desk’s ticketing system and the information received is registered, such as name of the FME user, date and time of registration, short text and description, category of request, priority, etc. If the Incident can be resolved immediately by the Service Desk (First Level Support), the ticket will be closed. If not, the ticket will be prioritized and then passed to the appropriate department (Second Level Support, Third Level Support, third party suppliers). A reminder function is active for the Service Desk, so the state of the ticket will be requested, if not solved/closed after the appropriate period. The Service Desk is responsible for the coordination of all Incidents up to

18

a final closure of the tickets. NETCARE shall notify the requesting FME employee after an Incident has been closed.

5.2.2   Support Channels

NETCARE provides FME with a decentralized support concept that considers the local conditions and/or specific requirements as described in the Service Catalogue. This Section is a summary of the available support channels. The NETCARE Intranet contains information regarding the Service Desks which enables the user to choose the correct support channel. In general the Service Desk(s) can be contacted by FME via e-mail or phone.

NETCARE’s decentralized support concept differentiates the Central Service Desk Bad Homburg, the Central SAP Service Desk Bad Homburg and the decentralized Service Desks.

Outside the regular Service times NETCARE provides an Emergency Support Service in order to support business critical IT Systems and their supportive infrastructure. Furthermore NETCARE provides FME with Onsite Support such as providing IMAC Services (IMAC = install, move, add, change) which comprise the setup, disassembly and move of NETCARE’s Services as well as the elimination of interferences and changes to the FME user’s IT equipment.

5.2.2.1   Central Service Desk Bad Homburg

The Central Service Desk is the single point of contact for all non-SAP-Services provided by NETCARE in the Rhine-Main region (e.g. standard applications, Services, hardware, user administration, contact details, non-standard applications where possible).

5.2.2.2   Central SAP Service Desk Bad Homburg

The Central SAP Service Desk is the single point of contact for all SAP-Services provided by NETCARE in the Rhine-Main region.

5.2.2.3   Decentralized Service Desks

The decentralized Service Desks cover each a location and/or several locations in a country or region. They are specialized on the service portfolio that is used at the particular location. Whenever there is a local Service Desk available for a location, this is the first point of contact for NETCARE’s Services provided in the specific region / location. As far as a local SAP Service Desk is available this is the first point of contact for SAP Services provided in the specific region / location.

19

5.3Technical Change Management

NETCARE performs a state of the art Technical Change management with the aim to ensure the adherence to internal and external guidelines regarding the operation of Systems and applications. Thereby the Technical Change Management enables NETCARE to maintain a validated status of the Systems and applications and ensures the consistence of FME requirements and available functionalities. NETCARE’s Technical Change Management has additionally the objectives to reduce the number of Incidents and to increase the stability of the IT environment.

In general the Technical Change management process is triggered by Incidents, Problems, requests, ideas or during Projects. The initiation of the Technical Change management process is always a Request for Change (RfC) which runs through a two-tier procedure based on permission and approval, involving customers’ test contribution and explicit customer approvals.

The permission of RFCs requires a description of the change, its organizational and technical classification and the agreement of actions and documentation requirements necessary for an RfC-approval and following go-live.

The RfC-approval, which is the second step in the two-tier procedure, ensures the adherence to the agreed actions and documentation requirements before a go-live can take place.

Thereby NETCARE’s Technical Change management process ensures that legal requirements are fulfilled and that changes affecting configuration items within the productive environment are traceable, documented, coordinated and planned.

5.4IT Service Continuity Management

As agreed in the respective Service Agreements NETCARE performs IT Service Continuity Management for IT Services belonging to critical business Services in order to enable FME’s business continuity with a defined minimum Service provision in case of a disaster. Main steps to reach this objective are:

·the creation of a Service criticality description or risk assessment document based on a risk or availability assessment,

·the creation of a recovery plan for data or IT Services covering the requirements of the respective Service Agreement including the definition of the recovery time objective and recovery point objective,

·the deployment and testing of the recovery plan.

20

5.5IT Security Management

NETCARE performs IT Security Management on behalf of FME in order to enable and maintain a secure IT environment. In general both Parties maintain an IT security framework. NETCARE implements the defined technical security measures on behalf of FME and assures Service delivery in line with FME’s IT security guidelines. State of the art IT security processes are performed by NETCARE in all relevant areas.

This includes but is not limited to antivirus, data encryption, penetration tests and intrusion detection systems. NETCARE IT Security Management covers all Systems and Services provided by NETCARE if not otherwise agreed between the Parties in Service Agreements.

The collaboration of NETCARE and FME related to IT Security Management happens on two levels:

1.Governance level: Security governance, checklists and policies are discussed and coordinated by the IT Security Managers of FME and NETCARE. They collaborate within the Risk, Security & Compliance Working Group (RSCWG) to be established by the Parties.

2.Operational level: NETCARE provides security support for FME through the proactive analysis and management of security advisories. A security advisory is a notification about a potential or existing security gap which is currently provided to NETCARE by third-party. These security advisories are monitored and categorized on a regular basis and if necessary appropriate actions are performed in order to maintain a secure IT environment for FME. Furthermore NETCARE’s Service Desk acts as single point of contact for FME users in case of security issues. NETCARE’s Service Desk involves the respective technical support teams as necessary in case of Incidents. Additionally the Service Desk informs user groups about important security information via e-mail if necessary.

5.6Service Catalogue Management

NETCARE performs Service Catalogue Management in order to ensure that a Service Catalogue is produced and maintained, containing accurate information on all operational Services. Service Catalogue Management provides vital information for all other Service management processes including Service details and the Services’ interdependencies. FME can order Services from the Service Catalogue via Standard Service Requests as described in Section 6.

21

6.  Standard Service Requests

Standard Service Requests shall cover recurring customer requests in order to reach the Parties’ mutual target to save fulfillment time and costs. FME users may request Standard Services via the NETCARE Intranet based on NETCARE’s general Service Catalogue.

Under the Set of Contracts FME and NETCARE agree on a certain level of Service provisioning based on this Service Catalogue, called Standard Service Agreement. The MSD applies for all Services listed in the Service Catalogue.

The NETCARE Service Catalogue consists of two parts:

·Standard Services, which are described in a clear and comprehensive language, free from IT-specific terminology whenever possible.

·Service Component Descriptions, which provide information concerning in-scope and out-of-scope activities, availability of the Service, the order process, and optionally selectable service features.

7.  Individual Service Requests

Individual Service Requests shall be placed if FME has a demand which is not (yet) covered via Standard Services in the Service Catalogue. This can include the establishment of new Services, Service Changes, feasibility studies, concepts or other Projects. Any FME employee is enabled and allowed to place an IT request with respect to the local guidelines defined by FME. Whenever FME plans to involve IT resources or spend IT budget and order NETCARE, a request in FME’s demand management tool has to be placed which ensures that the FME approval process is adhered to.

The order process contains the following steps:

1.Request for Quotation (RFQ): FME describes the request from business perspective and transfers it to NETCARE. NETCARE provides FME an offer covering the demand described in the RFQ.

2.Approval Process: All FME Project and change requests run through the FME approval process.

3.Order Process: With successful completion of the approval process the order is officially placed to NETCARE and the related fulfillment processes to the request are triggered.

No work shall be performed by NETCARE without an officially placed order by FME. NETCARE is not allowed to accept any request by FME which is not submitted via the procedure mentioned above.

22

The responsibility for the customizing and the development of applications shall solely be assigned to NETCARE and such Services shall be handled in a separate Project to be agreed between the Parties according to the regulations outlined in the GA and this MSD. Both the above mentioned written offer by NETCARE detailing the specification of the Individual Service Request and the price of Services to be rendered by NETCARE thereunder and an order confirmation by FME lead to an Individual Service Agreement mutually agreed between the Parties.

8.  Projects

This Section shall govern all Projects which have been mutually agreed between FME and NETCARE and are not superseded by stipulations set forth in Individual Service Agreements for specific Projects.

8.1Project Management Method

The procedure for executing Projects is described in the NETCARE Project Management Manual (PM@FNC) that applies to all employees of NETCARE and/or subcontractors commissioned by NETCARE who are either involved in the execution of Projects, are processing activities with a project character or are responsible for providing project management services and/or having such services provided. PM@FNC is aligned with the V-Model for Software Development & Implementation. In general NETCARE’s project methodology PM@FNC will be used for Projects with a budget volume higher than 35.000 € if not otherwise agreed between the Parties.

The project management activities performed by the defined project team during a Project shall cover:

·roles & responsibilities

·project plan

·risk management

·quality management

·escalation & issue management

·communication & stakeholder management

23

·standard reporting.

Each Project shall be divided in the following phases:

8.1.1   Project Definition

The goal of this first phase of the project management lifecycle is to provide all necessary information for the approval of the Project.

8.1.2   Project Planning

The goal of this phase is to establish solid foundation for the Project enabling the management to understand the work that needs to be done to deliver the Service before the implementation of the Project is approved.

8.1.3   Project Execution

In this phase the defined requirements are realized.

8.1.4   Project Closure

During this phase the official closure of the Project is performed and finally documented (e. g. end project report including follow-on action recommendations and lessons learned, validation accept, FME approval).

8.2Project Changes

FME reserves the right to demand from NETCARE, at any time during the performance of an individual Project, to carry out changes in such individual Project including alterations, modifications in the type or extent of the individual Project being an amendment, omission or addition, increase or decrease in its quantity, acceleration etc. whichever FME in its sole discretion considers necessary or desirable. NETCARE shall be obligated to carry out such changes, if mutually agreed upon between the Parties. NETCARE shall only be entitled to withhold its consent to any such change requests if NETCARE can show that such change request were to materially violate NETCARE’s rights.

During the performance of the individual Project NETCARE may propose in writing to FME any changes that NETCARE considers necessary and/or desirable in order to effect cost savings and/or improve the quality, efficiency of the individual Project and/or

24

otherwise to the benefit of FME. FME shall be entitled, at its sole discretion, to approve or reject any changes proposed by NETCARE.

NETCARE shall submit to FME for its proper evaluation a written summary of such changes requested and/or proposed such as but not limited to indicating the time required for carrying out the change and any effect on the schedule, as well as the costs associated therewith.

If FME desires to accept such change the Parties shall add such corresponding changes to the scope of Services, the schedule, and the agreed costs as reduced into writing by the project managers.

8.3Committees

Individual project values of more than 100.000 € shall require a mandatory implementation of a Project Leading Committee according to the PM@FNC project methodology. The participants of the Project Leading Committee shall at least consist of one member of FME and NETCARE senior management.

8.4Responsibilities within an Individual Project

The following general responsibilities apply to all Projects in addition to the responsibilities set forth in the GA.

8.4.1   NETCARE’s Responsibilities and Services

·A removal of NETCARE employees from the project team within an ongoing Project needs to be discussed with FME in advance.

·If NETCARE removes project members from the project team, NETCARE is obliged to replace the resource with internal or external resources with the same skill level. Any additional costs caused by the replacement will not be charged to FME, unless it has been agreed otherwise between the two Parties.

·As far as no fixed payment terms have been agreed upon between the Parties, services rendered by NETCARE shall be payable only upon sufficient proof such as a detailed report of performed activities which shall be made available to FME with each monthly invoice. Detailed regulations shall be agreed upon between the Parties and shall then be part of the Individual Service Agreement.

·The individual Project has to be fulfilled by NETCARE according to the NETCARE project guidelines mentioned in Section 8.1 and regulations of NETCARE and FME. In case of conflicts between such guidelines and regulations, the project managers of both, FME and NETCARE, shall undertake to find a compromise. If such conflict

25

persists the issue shall be submitted to the Project Leading Committee and, if the conflict cannot be settled, further escalated to the Steering Committee in accordance with the Escalation Management Process.

·Responsibilities of NETCARE and third parties, if any, shall be agreed upon by the Parties in greater detail in each Individual Service Agreement and shall be binding with respect to the individual Project.

8.4.2   FME Responsibilities and Services

·A removal of FME employees from the project team within an ongoing project needs to be discussed with NETCARE in advance.

·If FME removes project members from the project team, FME is obliged to replace the resource with internal or external resources with the same skill level. Any additional costs caused by the replacement will be covered by FME, unless it has been agreed between the two Parties.

·For each individual Project one responsible FME project manager has to be assigned by FME.

·Responsibilities of FME shall be agreed upon by the Parties in greater detail in each Individual Service Agreement and shall be binding with respect to the individual Project.

8.5Project and Service Approval

NETCARE shall inform FME of the readiness for testing and Acceptance upon completion of the Project. Where the Parties have agreed on certain delivery dates for the deliverable under the Project, NETCARE shall inform FME of the readiness for testing and Acceptance 15 days prior to the delivery date.

Within a period of 10 days after receipt of the notification NETCARE and FME shall carry out an acceptance test and review in accordance with the acceptance and test plan agreed for the relevant deliverable or as appropriate for the Acceptance of the deliverable.

Defects ascertained during the acceptance testing and review shall be documented by FME and reported to NETCARE without undue delay. NETCARE shall subsequently remedy these Defects in accordance with the priorities and categories defined below.

26

Defects determined in the performance or part performance under review shall be divided into the following error categories:

Category 1: As a result of the error, the System as a whole or the part of the System under review cannot be used. If the effect of simultaneous existence of Defects in category 2 and category 3 is equivalent to that of a category 1 Defect, such simultaneous Defects shall constitute a category 1 Defect.

Category 2: The error causes substantial restrictions in the use of important functions, which cannot be circumvented by suitable measures for a reasonable time from FME’s point of view. If the effect of simultaneous existence of Defects in category 3 is equivalent to that of a category 2 Defect, such simultaneous Defects shall constitute a category 2 Defect.

Category 3: All other errors.

The Parties shall agree on the classification of a Defect to a category. If this cannot be achieved within undue delay after identification of such Defect, the matter shall be resolved through the Escalation Management Process.

FME shall only be entitled to refuse its Acceptance as a result of Defects in the categories 1 and 2. Category 3 Defects shall not prevent the Acceptance of the performance, but shall be remedied as part of the rights in case of Defects. Such Defects shall be recorded as Defects in the written acceptance declaration. Following remedy of the Defects relevant for Acceptance, the Parties shall without undue delay repeat the acceptance testing. If Defects are still discovered during the testing, NETCARE shall undertake further remedial work to correct such Defects. Where, after the third acceptance testing Defects are still discovered relevant for Acceptance, the Parties may agree and declare the remedy as failed and FME shall be entitled to either require NETCARE to provide at no extra charge such replacement or additional services as will enable such deliverable to pass the acceptance testing within a reasonable time or accept such deliverable with a reasonable abatement of charges for such deliverable.

After the acceptance review has been successfully completed, FME must declare its Acceptance without undue delay, to be made in writing if requested by NETCARE. If FME does not declare its Acceptance within a period of 30 business days upon completion of the acceptance review, NETCARE shall be entitled to request Acceptance from FME within an additional period of 20 business days. The deliverable shall be deemed accepted upon

27

expiry of such period unless FME notifies NETCARE of any material Defects of categories 1 or 2 in the deliverable and rejects Acceptance within such period.

Acceptance of a final deliverable will be deemed Acceptance of parts included and incorporated into the final deliverable.

If there can be no Acceptance because of the nature of the services rendered under the Project, then the provision and delivery of the services shall replace such Acceptance.

Where a Service qualifies as a works result or NETCARE is obliged to provide a deliverable, Acceptance shall be required in accordance with the acceptance testing and review procedure set forth in this Section 8.5.

8.6General Terms for Project Pricing

The Parties agree to the following terms, unless different conditions have been defined in the respective Individual Service Agreement:

·In general Projects are offered by NETCARE on time & material basis.

·The prices per person day are applied as specified in the Price List in and outside of regular business hours.

·Any additional costs for external resources need to be negotiated between NETCARE and FME in the Individual Service Agreement.

·If the Services rendered by NETCARE or, as far as applicable by subcontractors on behalf of NETCARE, do not require full Person Days, such Services shall be reimbursed by FME pro rata temporis.

·All expenditures (e.g. travel expenses, travel time, out-of-pocket expenses) which will be charged to FME by NETCARE have to be documented and to be acknowledged by FME in advance, unless otherwise agreed within the respective Individual Service Agreement.

·Alternatively and upon FME’s request, NETCARE shall offer one of the following pricing models:

·fixed price for the overall individual Project:

·realization of defined requirements at an agreed price and date

28

·upper price limit for the overall individual Project:

·agreement of an upper price limit which may not be exceeded

·charging according to services rendered on the basis of Person Days

·If FME acknowledges in writing a request by NETCARE to increase prices, the respective Individual Service Agreement shall be modified accordingly. Otherwise the individual Project shall be fulfilled as already stipulated in the respective Individual Service Agreement.

·If the Parties agree upon one of the pricing models as outlined above, such terms and details shall be implemented in the respective Individual Service Agreement.

·If NETCARE foresees that in case of fixed price or upper price limit agreements, the costs might exceed the agreed upon price, for example due to additional requirements, NETCARE shall:

·immediately inform FME thereof and state reasons

·not be entitled to invoice higher cost if such cost is not caused by additional requirements requested by FME (following the above mentioned change procedure).

·If the price is an “upper limit price” NETCARE shall not charge FME for the capacity which NETCARE has kept available but which was not required for the finalization of the individual Project.

·Should the estimated and agreed upon time and material for effort Projects be exceeded by 10% or more (Additional Costs), NETCARE shall immediately inform FME thereof and shall state reasons. Only after written approval by FME such Additional Costs shall be deemed accepted and refundable by FME. If FME does not respond within one business day after the receipt of NETCARE’s notification the progress of the individual Project is agreed. NETCARE bears the onus of proof that such notification has been received by the respective FME project manager.

8.7Advanced Termination of Projects

FME may, at any time and at its sole discretion, terminate individual Projects by giving NETCARE written notice thereof. Immediately after receipt of written notice for termination, NETCARE shall terminate its Services according to such terminated individual Project. FME shall be obligated to reimburse NETCARE for the services

29

rendered until the termination date. Furthermore, FME shall be obligated to reimburse NETCARE with 15% of the remaining budget, as agreed in the respective Individual Service Agreement as compensation for free capacities which cannot be utilized according to the termination of the Individual Service Agreement. NETCARE shall be obliged to utilize the free capacity in other Projects, if possible, and the above mentioned reimbursement of 15% shall then be reduced accordingly. NETCARE is obliged to negotiate identical terms with subcontractors involved in individual Projects to reduce risk for FME in the case of prior termination. As far as the subcontractor is not willing to accept such terms FME’s written confirmation has to be obtained. In case of FME’s acknowledgement in writing to such deviating terms, FME is obliged to pay all costs which may be caused by prior termination with subcontractors. No additional payment obligations or compensation of whatsoever nature shall vest in FME with respect to the terminated Individual Service Agreement.

9. Continual Service Improvement

9.1Service Meeting

NETCARE and FME agree to perform regular Service Meetings with the objective to reach customer satisfaction through the delivery of the right Service at the right time within the defined Service Level. These meetings are performed on operational level on a monthly basis involving the Service Management Units of NETCARE and FME and the agenda shall cover at least:

·A discussion about the reports provided by NETCARE in the last reporting period.

·A discussion about the service portfolio of NETCARE focusing not only on the currently productive Services but also on new demands of FME or Services which are close to the end of their lifecycle and can be withdrawn from NETCARE’s current service portfolio.

·A handling of issues or requests for Service Changes. In case of dissension the Service Management Units shall initiate the Escalation Management Process.

9.2Continuous Improvement Process (CIP)

NETCARE’s quality management comprises a Continuous Improvement Process (CIP). CIP is an instrument used for process optimization to continuously check NETCARE’s quality management system for its effectiveness and to update it at regular intervals to reflect the

30

state of the art. The following two basic approaches are used for the continuous improvement of the quality management system, the processes as well as Services:

·Deming Cycle approach - Plan - Do - Check - Act (PDCA)

·QM documentation.

9.3Complaint Management

Complaint management provides the FME users with the possibility to raise a complaint if a NETCARE Service is perceived less than satisfactory. A complaint has to be differentiated from a Defect of a Service. Defects shall be handled in the Incident Management as described in Section 5.2.

NETCARE’s Service Desks serve as preferred point of contact for all FME users having a complaint regarding Services provided by NETCARE. After a complaint has been reported by FME, NETCARE analyzes the complaint and triggers Problem Management or the Continuous Improvement Process if necessary. Until the complaint is finally closed NETCARE keeps in touch with the user who raised the complaint and regularly informs him about the actions taken in order to recover customer satisfaction.

10. Service Accounting & Charging

10.1        Price Model

Unless otherwise agreed in Section 8.6 the Parties agree upon monthly payment for the Services rendered by NETCARE under the Set of Contracts. The price model is based on unit prices and the actual quantity ordered and received by FME.

This price model defines charging criteria for each Service depending on utilization (such as number of end devices for a defined category, number of mailboxes, file space used, etc.).

The price model is based on:

·Prices for Standard Services according to Price List

·Prices for Individual Services as agreed between the Parties in the Individual Service Agreements

Optional Services can be charged based on daily rates according to skill level or special conditions (monthly fixed prices). The Price List for FME is generated based on the standard FNC Price List available on NETCARE´s Intranet and is agreed by the Steering Committee each year as described in Section 10.5.

31

10.2Price Setting for Standard Services

Each Service has a specific material number. The unit price per Service and the related material number for a Service are named in the Price List.

For charging the IT Standard Services, each entity and unit of FME will be defined as Customer in NETCARE’s invoicing system. A Customer may involve several internal FME cost centers but NETCARE will only charge to a single clearing cost center to be provided by the Customer. FME shall be solely responsible for the allocation of the users / Services to the individual internal FME cost centers.

The particular Services will be captured and administered in sub systems containing data relevant for the invoicing process. These sub systems will be summarized monthly in one NETCARE invoice.

Planned Time Schedule Invoicing

From 12th to 17th day of the month	·  Accumulation of invoicing data
From 17th — 19th day of the month	·  Inspection of invoicing data
From 20th to 23rd day of the month	·  Generation of invoices followed by dispatch
From 23rd day of the month	·  Data import into Business Warehouse (P20/Portal)

If the above mentioned dates do not occur on a weekend or public holiday, the above mentioned time schedule should be observed.

In December the dates will vary well-planned from the above mentioned time schedule as charging has to be carried out one week in advance due to year-end closing activities of the businesses in Germany and abroad. Hence in December, three weeks of Services will be charged and five weeks the following January correspondingly. This mainly concerns Services depending on volume such as SAP usage, telephone charge units and Internet volume.

Due to the time schedule, changes (cancellations and transfer registrations) of names, cost centers or Services can only be considered until the 14th day of a current month within an invoicing cycle. Changes received later will be processed during the following billing process.

32

10.3Service Volume

In the course of the yearly budget processes (Group regulation) the Customers are provided with the current data in due time (end of June / beginning of July) adjusted to the known volume variations as expectation values for the following year.

The actual volumes per Customer are determined on a monthly basis and transferred to the charging system per Service.

10.4Volume and Master Data Variations

Master data (names, cost centers and customer assignments) are maintained by the respective Operation Units of NETCARE.

Changes to master data can be considered until the 14th day of a current month.

·Master data for equipment (including PC back-up and Credant) can be entered by the respective user at the beginning of the month via self-service in the “inventory inquiry”.

·It is possible to make use of a registration / deregistration tool for user or Service Changes

·In case of substantial changes, it is advisable to prepare an Excel Sheet. These changes will be carried out by Commercial Business or forwarded to the respective Operation Units.

10.5Yearly Reconciliation with FME

Within the yearly budget process the following activities have to be coordinated with FME IT Coordination:

·Agree on scheduling at the beginning of each budget process

·Alignment of Customer master data (new customers, changes in organization, cost centers, etc.). This results in an update of the List of Affiliates which contains FME’s affiliated companies receiving Services from NETCARE. If necessary the list shall be updated during the year.

·Verification of Service volume

·Agreement on prices for new Services and price changes for existing Services - if any.

33

·Provision of Service Agreement per Customer incl. Standard and Individual Services

The result of the reconciliation process has to be presented to and approved by the Steering Committee.

10.6Invoice Reporting

A contact person from Commercial Business will grant the authorizations necessary to access invoice details per Customer. Sending an email request is sufficient. Data can be accessed via the SAP BI system (P20) or portal. This service is free of charge for FME.

11. Technical and organizational measures (9 BDSG)

NETCARE is obliged to pursue the following general technical and organizational measures in order to adhere to Section §9 BDSG and annex.

11.1Access Control to Premises and Facilities (Entry Control)

Unauthorized access (in the physical sense) must be prevented. Technical and organizational measures to control access to premises and facilities, particularly to check authorization may include but are not limited to:

·establishing and maintaining staggered access authorizations for employees and third parties

·close loop lifecycle process for employees and visitors identity cards

·guarding by security Service outside working hours

·appropriate physical security measures

·any other appropriate measures for data security.

11.2Access Control to Systems (Admission Control)

Unauthorized access to IT Systems by NETCARE personnel must be prevented.

Technical (ID/password security) and organizational (user master data) measures for user identification and authentication for NETCARE personnel may include but are not limited to:

·definition of authorized persons

·personalized user account and password

·password procedures

·segmentation of networks

·use of antivirus software and personal firewalls

·rules of behavior for the use of mobile devices and laptops

34

·appropriate WLAN security

11.3Data Access Control

Access to processed data not covered by the allocated access rights must be prevented.

Definition of the authorization scheme and access rights driven by data security requirements may include but are not limited to:

·differentiated access rights

·monitoring and logging of violations

·restrictions of access rights of non-administrators

·management of access rights only by administrators

·usage of data processing equipment only after identifying and authenticating the user.

11.4Disclosure Control

Aspects of the disclosure of personal data must be controlled and monitored.

Measures for storing, transporting or transmitting data may include but are not limited to:

·appropriate measures must be in place while transmitting or transporting data

·appropriate security for data on mobile devices

·disclosure of data to third parties contracted by NETCARE only with legal permit

·restrictions of persons authorized to transfer data.

11.5Input Control

Documentation of data management and maintenance must be maintained.

Measures for subsequent checking whether data have been entered, changed or removed (deleted), and by whom:

·instructions for the collection of data

·logging and reporting systems

·write access by role

11.6Job Control

Commissioned data processing must be carried out according to instructions.

Measures (technical/organizational) to segregate the responsibilities between FME and the NETCARE:

35

·unambiguous wording of the contract

·formal commissioning (request form) in accordance to BDSG

·criteria for selecting the NETCARE as processor

·regular monitoring and control of contract performance by NETCARE

·subcontract only with equivalent level of safety.

11.7Availability Control

The data must be protected against accidental destruction or loss.

Measures to assure data security (physical/logical) may include but are not limited to:

·backup procedures

·mirroring of hard disks

·uninterruptible power supply (UPS)

·malicious software

·disaster recovery plan based on the requirements provided by FME.

11.8Segregation Control

Data collected for different purposes must be processed separately.

Measures to provide separate processing (storage, amendment, deletion, transmission) of data for different purposes may include but are not limited to:

·segregation of functions (production/testing)

·logical or physical data separation

·Multi-Client-System, except the systems which are as of the effective date One- Client-Systems. Within such clients, for “cost-sharing” purposes, applications of other Fresenius companies are operated.

36

Standard Service Agreement

to the General Agreement

between

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„FME”)

and

Fresenius Netcare GmbH

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„NETCARE”)

Table of Content

Servicecatalog 2013 - EN, 11.12.2012 V. 02.02

Price List 2013 - EN, 29.10.2012 V. 01.4

Signatures

Current status	:	22.01.2013
Last printed	:	12/21/2012 11:48:00 AM
Version	:	1.0

SERVICE CATALOG 2013

Fresenius Netcare GmbH

Else-Kröner Straße 1

61352 Bad Hornburg v.d.H.

T: +49 (0) 6172 608 0

E: service@fresenius-netcare.com

I: www.fresenius-netcare.com

Stand: December 2012

Inhalt

·	Servicecatalog
	IT Workstation	6
	Email Communication Services	9
	Telephony at Workstation	12
	Mobile Phones and Data Connections	14
	Home office	16
	FAX Connection Service	19
	Secure Data Connections to Fresenius	20
	Conferencing Services	22
	Service Desk & Support	24
	Terminal Server (Citrix)	29
·	End User Services
	Basic IT Operation Package	31
	Client Backup	33
	Hard Drive Protection	34
	First Installation Service	35
	IT Equipment Moving Service	36
	On-site Support	37
	Computer Pick-up Service	38
	Central Service Desk Bad Homburg	39
	Decentralized Service Desks	41
	FNC Emergency Support	43
	Email Plus with User Support	45
	Email Facility Connection Standard	47
	Email Facility Connection Plus	49
	Email Web Solution Basic	51
	Email Web Solution Extended	53
	Mobile Email for BlackBerrys	55
	Software Packaging and Deployment	57
	Terminal Server	59
	E-Fax	61
·	Network- and Telecommunications
	Network Printer Access	62
	Internet Access Basic	63
	VPN Connect Full Access	65
	VPN Connect Basic Application	67
	VPN WEB Connect	69
	Home Office Basic	71
	Home Office Comfort	73
	Voice Telephone	75
	Voice Mailbox	77
	Fax Connection	78
	Mobile Phones and Data Connections	79
	Audio Conferencing	81
	Room Video Conferencing	82
	Desktop Video Conferencing	83

·	Hosting
	Output Management Internal	85
	Output Management External	86
·	Application-Management
	One-time License Fee SAP ERP 6.0 and SAP Maintenance	87
	SAP Usage	89
	SAP Support	90
	SAP Project capacity for application development	91
	Electronic Data Interchange	93
	IT Training	94
	SAP Travel Management	95
	Online Learning Center	97

Health is everything we lay its foundation

IT Workstation

Desktop computers and laptops for the mobile workstation
or the office workstation

Contact Person:

Lothar Gützkow

Which service suits me best?

In the service “IT Workstation” you find all FNC services to equip your workstation with a computer or laptop. This portfolio includes a data protection package that protects your important data from any third party and from loss in a reliable manner. Should you require support with an error that occurs at your IT workstation, the central service desk will gladly assist you at the following telephone number: +49-6172-608-1111 and our on-site technicians are available as well.

You can combine whichever service components you want. To provide you with some assistance, we have assembled two different recommendations for an optimal workstation. Please select the appropriate services:

Service components	Standard workstation	Mobile workstation	Description
Hardware and related equipment	X	X	Select a desktop computer or laptop from our standard portfolio.
Basic package - workstation connection	X	X	Infrastructure (e.g. network, standard office programs, antivirus protection)
Applications (subject to licensing)	X	X	Use professional software to optimize your results. In addition to the standard applications included, you can also purchase software that is subject to licensing.
Laptop / Computer data backup (Client Backup)	X	X	Protect your local data automatically from data loss.
Internet access	X	X	Access to internet.
Hard disk encryption		X	With the service “Hard Disk Encryption”, sensitive data is inaccessible for third parties if your laptop is lost or stolen.
VPN Connect - full access		X	Access your internal resources, such as data and applications, while on the go.
Mobile data connection		X	By using an UMTS card, connect to the internet or the Fresenius resources via the mobile phone network.

6

How can I obtain this service?

Hardware and Related Equipment*

Choose Standard Computer / Laptop in the FNC-Intranet. Relay purchase requisition (BANF) to FNC purchasing department.

* Service fees are calculated per order item (I00084) 23,62 € or bundle (I000285) 50,00 €

Basic Package - Workstation Connection (I000045)
(Basic IT-Operation Package) per device € 85.00 / month

After ordering the hardware with FNC Procurement, you will receive a configuration form by email. Please complete this form and have it signed by your line manager. Afterwards please fax the form to Hardware Delivery (fax number +49-(0)-6172-608-7513).

Applications (subject to licensing) The price depends on the applicable license fees plus a flat rate for the software procurement

Please complete the order specifications for the application to be procured and send these to FNC Procurement (fax number: +49 6172 608 395655). Then the application is purchased for you and activated in the software depot, if possible. Alternatively, the software is delivered to your workstation. Our User Support will gladly assist you (where possible) with the installation.

Laptop / Computer Data Backup (I000222)	per device € 11.80 / month
(Client Backup)

You obtain the Client Backup via the software depot (Start - Software Depot). You will be prompted to enter your cost unit. Please provide the necessary information. The service will be invoiced automatically every month.

Internet-Access (I000048) Internet-Access Volume (I000081) € 4.00 incl. 20 MB data volume / month each additional MB € 0.14

For data volumes exceeding 3 GB, we charge an additional fee of € 31.50 per GB and month.

Hard Disk Encryption (I000269) per device € 4.85 / month

You obtain the Hard Disk Encryption via the software depot (Start - Software - Depot - Security - Credant Mobile Guardian). You will be prompted to enter your cost unit. Please provide the necessary information. The service will be invoiced automatically every month.

VPN Connect — Full Access (I000171) € 23.75 plus data volume / month

See FNC Services “Secure Data Connection to Fresenius”

7

On-Site Assignments

See FNC Services “FNC User Support”

On-site services	Description	Price per hour (target prices)*
One-site Support (I000205)	Interference elimination and changing of IT equipment (e.g. adding memory)	84 €
First Installation Service (1000203)	Configuring, delivering and installing new IT equipment	84 €
IT Equipment Moving Service (1000204)	Moving IT equipment (order through Central Services)	84 €
Computer Pick-up Service (1000211)	Disposing of used devices and returning to lessor, as well as backing up your data	84 €
Software Packaging and Deployment	Mass rollout of software components Installation, update, de-installation (software life cycle management)	by request

Terminal Server (Citrix): (I000252) per device 19.90 € / month

Please fill out a requisition form, in which you specify the number of your order item or send an email to: lothar.guetzkow@fresenius-netcare.com

With the aid of the terminal server (Citrix) technology, office applications (currently Office 2003 / 2010, Kipdips, Applix, SPAGUI (current version)) are operated in the FNC Data Center. In this way, you have — independent of your end device - a secure and fast working environment. Software installations and updates of existing programs are executed centrally by FNC so that they are available to all users within a very short time. By request, we will also provide you with other applications via Citrix. The work required for this is invoiced according to time and effort.

Note: License fees are not included!

Where can I get help?

If you have questions or problems, please contact our service desk from Monday through Friday (except public holidays) from 06:00 to 18:00 CET at the following telephone number: +49 6172 608 1111.

8

Email Communication Services

Worldwide email communication and scheduling

Contact Person:

Gianpietro Alpiani

Which service suits me best?

The Fresenius communication platform — based on Lotus Notes — provides you with a wide range of functions for your daily communication with customers, suppliers and colleagues. In addition to sending emails, you can also use the platform for scheduling and task management. The setup of new Notes user accounts and the user support will be provided either by FNC or by a local administrator, depending on the Fresenius location.

Please select the appropriate service:

	Email Plus with User Support (I000051)	Email Location Integration Standard (I000036)	Email Web Solution Basic (I000173)	Email Web Solution Extended (I000305)
Availability	Rhine-Main Area	worldwide	worldwide	worldwide
Mailbox size in MB	300	depending on local memory	100	100
User support	Service Desk	provided by the location	provided by the location	provided by the location
Email server operation	by FNC	provided by the location	by FNC	by FNC
One-time license fees per user (I000054)	€ 47.25	€ 47.25	none	none
Price per user per month	€ 9.50	€ 7.53	€ 2.50	€ 3.50
Available extensions	· mailbox extension · E-fax · mobile email · BlackBerrys · email · long-term-archiving	· email location integration plus · mobile email BlackBerrys	none	· mobile email

9

Which extensions are available?

Email Mailbox Extension (I000087) per additional 50 MB € 3.88 per month

With the service component “Email Plus with User Support”, the mailbox size is limited to 300 MB. This is the total size of emails including all folders, such as “inbox”, “sent”, etc. Shortly before this limit is reached - at 280 MB -, you will automatically receive a warning by email. You can request an expansion* of your mailbox by sending an email to the central service desk (hotline-pc@fresenius-netcare.com), in which you specify your cost unit.

*for FMC max. extension up to 500 MB possible

Email Facility Connection Plus (I000051) per user / month € 9.50

For locations that do not want to operate their own email infrastructure, FNC provides and operates the infrastructure with the aid of local partners.

The following services are provided by FNC:

· Deployment and maintenance of required email hardware

(email server - without local IT infrastructure)

· Installation of new releases (operating system software versions) for server application

E-Fax (I000033) per user / month € 4.00

With the extension package “E-Fax”, you can receive and send faxes via your email mailbox. Additionally, you will receive your personal fax number next to your existing telephone number. In addition to faxing emails, you can also fax email attachments, e.g. Excel, Word or PowerPoint files. The document is automatically opened and reaches the recipient as a fax.

Mobile Email BlackBerrys (I000172) per connection / month € 13.75

Connect your mailbox to your BlackBerry. With this service you can send and receive emails; furthermore, you have access to your calendar. As a result, information concerning your latest scheduling is readily available, and in this way you are in a position to send or respond to invitations while on the go.

Please find additional information under the service “Mobile Phones and Data Connections”.

Email Long-Term Archiving onto Server (I000277) per 10 MB /month € 0.14

With the option “Email Long-Term Archiving onto Server” you can back up your actual email correspondence at a reasonable price and you can access it again when needed. With long-term archiving you can keep your mailbox ‘slim’.

10

How can I obtain this service?

Email Plus with User Support:

Request a new Lotus Notes user account via the IT requests in the FNC intranet:

You will find these in the FNC intranet portal under “IT Requests”

Bad Homburg	Friedberg
Network and Notes users	Service Desk Pfingstweide 53
Central Service Desk	T: +49 6172 686 - 8823
T: +49 6172 608 - 1111	Service Desk Freseniusstr. 1
E: hotline-pc@fresenius-netcare.com	T: +49 6172 686 - 6135
St. Wendel	Oberursel (Borkenberg)
Service Desk St. Wendel	Network and Notes users
T: +49 6851 807 - 555	Service Desk Borkenberg
E: de-wn.it-support@fresenius-netcare.com	T: +49 6172 608 - 4444
	E: B14-FNC@fresenius-netcare.com

Please find additional user information, such as “First Steps in Lotus Notes”, in IT Proficiency (“IT-Führerschein”) in the FNC intranet.

Email Location Integration Standard and Email Web Solution:

To request a new Lotus Notes user account, please contact the Lotus Notes administrator responsible for your location. If the local administrator is not known, please contact the central service desk.

11

Telephony at Workstation

Digital landline telephone connections, -end devices
and telephony features for the office workstation

Contact Person:

Gerhard Rettenbacher

Which service suits me best?

FNC provides you with a digital landline telephone with a wide range of business func-tions at your office workstation. By request, you can individually extend the standard scope of service. Please select the appropriate option from our service portfolio below:

Digital Office Telephone:

FNC provides you with a digital landline telephone with business functions - such as call forwarding, call re-routing or conference calls - at your office workstation, at your workplace in the production department, or in your meeting room.

Related Equipment for Office Telephones:

You have the option to enhance your office telephone with different headset solutions. This is especially useful, if you spend most of your daily working time answering and conducting telephone calls. You will find an overview of the related equipment in the FNC intranet.

Voice Mailbox Standard:

The free voice mailbox is a virtual answering machine which enables you to never miss another call. You can listen to your voice mailbox from your telephone at any time.

Voice to Mail:

With the option “Voice-to-Mail”, your voice mailbox is extended. With this extension, all recorded calls are sent to you as an audio file from your voice mailbox via email.

You will find the instruction manuals in the intranet under:

Infos & News / Technical Directions and Info / Phone Devices Quick Guides

How can I obtain this service?

Digital Office Telephone (I000075):	€ 21.50 month per device
Invoicing per unit (I000080):	€ 0,013 per unit

You wil find the IT request in the FNC-Intranet under:

IT requests / Phone Service Request

12

Voice Mailbox Standard (Voice Mailbox) (included in the digital telephone connection)

You can order the voice mailbox through the service desk via email (informal text). Contact: hotline-pc@fresenius-netcare.com

Voice to Mail (I000033):	€ 4 per device / month
	€ 52.50 one time fee per device

1.An existing Lotus Notes account and an existing telephone number are required

2.Ordering a new Lotus Notes fax account in the intranet
(IT-requests - Network & Notes HG - request type: New Lotus Notes Fax Account)

3.After ordering you will receive an email with all necessary information and brief instructions.
For further information and/or questions, please contact the central service desk.

You can order the voice mailbox through the service desk via email (informal text).

Note: In your order, please provide the telephone number for which you require the installation.

Contact: hotline-pc@fresenius-netcare.com

Where can I get help?

If you have questions or problems, please contact our service desk from Monday through Friday (except public holidays) from 06:00 to 18:00 CET at the following telephone number: +49 6172 608 – 1111.

13

Mobile Phones and Data Connections

Models and information concerning mobile phones,
smartphones and mobile telephoning with Fresenius

Contact Person:

Jürgen Schulz

Which service suits me best?

Together, FNC and D2 Vodafone offer mobile phones (handys), smartphones (BlackBerrys) and data connections for mobile internet. When signing a new contract or after a contract duration of two years, you can acquire a subsidized end device.

For the models from the Fresenius standard portfolio, FNC ensures full integration into the Fresenius infrastructure (e. g. email programs) and extensive support. When purchasing an end device that is not part of the Fresenius portfolio, increased support expenditures become necessary, which will be invoiced separately.

The information mentioned here are refer to the Rhein-Main region. Other locations may have diverging regulations.

To choose the service best suited for you, please download the current prices from the FNC intranet: (Services & Produkte - Mobilfunk - Standard mobile phones)

Further information to specific tariffs and options can be found in the telephone guidelines:
(Services & Produkte - Mobilfunk - Standard mobile phones)

If you require a mobile phone handsfree set for your car, please contact the following contact person with regards to availability:

Mister Joerg Buckisch (Joerg.buckisch@fmc-ag.de or under the direct dial +49 6172 8383).

How can I obtain this service?

Mobile Phones and Data Connections:

Please fill out a purchase requisition and send it to:

Telecommunicationfnc@fresenius-netcare.com

Mobile E-Mail (BlackBerrys):

For ordering a BlackBerry, you merely need the form that can be found by following this link: http://fnc.intra.fresenius.de/cps/rde/xfw/fnc-intranet/Order_Form_BB(1).XLS

Simply fill out the form, have it signed by your superior and fax it to:

+49 6172 608 - 7513.

Employees of Fresenius SE and Fresenius Medical Care, please use the following approval workflow:

(Approval form) notes://FRE-DE-RM-A07/apps/fmc/bbwf.nsf

By following this link, you can take a look at the current BlackBerry models:

http://fnc.intra.fresenius.de/cps/rde/xfw/fnc-intranet/Fresenius-Standard.pdf

14

Where can I get help?

Technical disturbances and defektive end devices:

Central service desk in Bad Homburg

Monday through Friday (except public holidays) from 06:00 – 18:00 CET

T: +49 6172 608 – 1111

E: hotline-pc@fresenius-netcare.com

Advanced questions:

Vodafone-Business-Team-Hotline

Monday through Friday from 06:00 – 24:00 CET

toll-free when calling from German Vodafone network as well as from German landline.

T: +49 172 1234 oder +49 800 1721234

If you have questions concerning:

·Tariffs

·Bills and frame conditions

·Renewal of contracts

·Eligibility for subsidies

·Loss of card

·Rental devices

please contact:

Juergen Schulz

Telecommunications

T: +49 6172 608 - 7543

F: +49 6172 608 39 -7543

E: telecommunicationfnc@fresenius-netcare.com

15

Home office

Staff members in their home office have
access to internal Fresenius IT resources

Contact Person:

Gerhard Rettenbacher

Which service suits me best?

FNC equips your home work station with a secure and reliable connection to your Fresenius resources. In addition, we set up a telephone connection for you. Please select the appropriate service from our range of services below:

Home Office: Telephone ISDN Connection

For a home workstation, an ISDN connection is requested. The features of the connection correspond to the most reasonable base line available at the time of installation. If the installation of a digital connection is not possible due to time constraints, structural or similar reasons, an analog connection, if applicable, will be installed for the time being.

Landline hardware for a home office

Siemens Gigaset SX795 ISDN

Price: approx € 103

· Integrated answering machine with 30-minutes of recording time

· Completely compatible with ISDN

· Integrated Bluetooth® wireless technology

· Caller display with picture (Picture CLIP)

Home Office: Internet Connection

FNC offers you two different services to establish a connection from your home office to internal Fresenius IT resources. Please select the appropriate option:

16

The variations and their performance characteristics.

	Basic	Comfort
	(I000202)	(I000213)
Incident resolution on router or DSL line via remote connection	optional	yes
Replacing defective end devices (router)	optional	yes
Wi-Fi	optional	yes
Feasible statistics about utilization / performance	no	yes
Performing necessary hardware/software maintenance for router (proactive)	no	yes
Alternative connection (second ISDN line) to Fresenius re-sources possible (separate compensation)	no	yes
Charge per month	€ 67	€ 90
One-time setup fee per user	€ 700	€ 400
VPN Connect Full Access	yes	yes

Basic	The service includes the hardware required to access internal Fresenius IT resources. Any maintenance and support services are invoiced according to time and effort. Hardware that enables wireless (Wi-Fi) internet access is available, subject to an additional charge.
Comfort	With “Home Office Comfort” you obtain the carefree package for your workstation at home. FNC provides all necessary maintenance for your internet and Fresenius access. Should the connection be down, FNC makes certain that the components are repaired or replaced as quickly as possible.

17

For information concerning DSL availability at your home workstation, and for questions about new or existing contracts, please contact:

Telecommunications

Jürgen Schulz

T: +49 6172 608 - 7543

F: +49 6172 608 39 - 7543

E: telecommunicationfnc@fresenius-netcare.com

Service Desk in Bad Homburg

T: +49 6172 608 - 1111

E: fgn@fresenius-netcare.com

If you are ecountering technical difficulties with your existing home office connection, please contact our service desk.

How can I obtain this service?

Please request the home office connections via BANF to Mr. Schulz.

Where can I get help?

If you have questions or problems, please contact our service desk from Monday through Friday (except public holidays) from 06:00 to18:00 CET at the following telephone number: +49 6172 608 – 1111.

18

FAX Connection Service

Sending and receiving faxes by fax machine, multi-function device or via the Lotus Notes email mailbox

Contact Person:

Gerhard Rettenbacher

Which service suits me best?

With this service you can send and receive faxes with your own fax machine at your workstation or via a multi-function device with a fax function. Alternatively, you can receive and send faxes directly via your Lotus Notes mailbox. Please select the appropriate option:

·Fax machines: You receive a lot of faxes and need your own fax machine at your workstation or in your department.

·Multi-function devices: You need or already have a multi-function device in your department for faxing, copying and printing.

·E-Fax: You compose faxes on your own computer and you want to send and receive them directly via Lotus Notes.

How can I obtain this service?

Fax Machines / Faxing via Multi-function Devices (I000075) € 21.50 per device / month

1.Selecting the fax machine or multi-function device in the FNC intranet. FNC Procurement will gladly assist you with your selection (telephone: +49 6172 608 7512). You will find an overview of the currently available hardware in the FNC intranet under the following link:(Service & Products - Workstation - User Equipment - Fax) (Service & Products - Workstation - User Equipment - Multi-function Devices)

2.Ordering a fax connection in the FNC intranet. If you need assistance with completing the form, please contact the central service desk at: +49 6172 608 – 1111.
(IT Requests - Requesting Telephone Service)

3.After delivery of the fax machines, please request their setup and configuration with the service desk at: +49 6172 608 – 1111.

The setup and installation of multi-function devices is provided by the supplier.

E-Fax (I000033) € 4 per device / month

1.An existing Lotus Notes account and an existing telephone number are required

2.Ordering a new Lotus Notes fax account in the intranet (IT Requests - Network Access HG - Request Type: New Lotus Notes Fax Account)

3.After ordering you will receive an email with all necessary information and brief instructions. For further information and/or questions, please contact the central service desk at: +49 6172 608 - 1111.

19

Secure Data Connections to Fresenius

Secure worldwide access to Fresenius information,
applications and data networks

Contact Person:

Gerhard Rettenbacher

Which service suits me best?

With the FNC services “Secure Data Connections to Fresenius” you can access the Fresenius network via the internet. Please select the appropriate service, depending on your specific requirements:

VPN-Connect Basic Applications	For Fresenius staff members who only want to use the Fresenius core applications (email, SAP and intranet) while on the go. The access method is tied to a selected computer.
VPN Connect Full Access	For Fresenius staff members who want to use all Fresenius applications with their Fresenius standard computer, as usual, while on the go. The access method is tied to a selected computer.
VPN WEB Access	For Fresenius staff members or external staff and/or business partners who want to use Fresenius email, SAP or intranet contents while on the go. The connection to the Fresenius network can be established from any internet-capable computer. The token - an external password generator — ensures maximum security when logging in.

20

	VPN Connect	VPN Connect	VPN-WEB
Service name	Basic Applications	Full Access	Access
Order number	(I000228)	(I000171)	(I000227)
Support by FNC service desk	included	included	included
Suitable for the following computers	Run on a Fresenius computer	Tied to a Fresenius computer	Computer independent
Suitable for external staff / external suppliers	no	no	yes
Access to the following Fresenius applications	Core applications	All applications	Core applications
One-time configuration on computer necessary	no	yes	no
Requirements
Internet connection required	yes	yes	yes
Service features
Guaranteed service times: Monday through Friday (except public holidays) 06:00-18:00 CET	yes	yes	yes
Prices
VPN service incl. 5 GB data transmission	€ 14 per month	€ 23.75 per month	€ 21 per month
One-time setup fee	€ 105	€ 105	€ 105
Additional GB transmission	€ 31.50 per GB	€ 31.50 per GB	€ 31.50 per GB
On-site support by FNC technician	€ 84 per hour	€ 84 per hour	€ 84 per hour

How can I obtain this service?

VPN-Connect Basic Applications (I000228)

1.Please request the service via the FNC intranet (IT requests - combined VPN-request)

2.You will receive an email with further instructions on installing your Fresenius connection

VPN-Connect Full Access (I000171)

1.Please request the service via the FNC intranet

2.You will receive an email with further instructions on installing your Fresenius connection

VPN-WEB Access (I000227)

1.Please request the service via the FNC intranet (IT requests - combined VPN-request)

2.You will receive an email with further instructions on installing your Fresenius connection

3.Your personal password generator will be sent to you by postal mail

21

Conferencing Services

Video and telephone conferencing services for conference rooms / workplace

Contact Person:

Andreas Schaubert

Which service suits me best?

The “FNC Conference Services” connect you and your business partners worldwide via video or telephone conference. FNC offers you telephone conferences with up to 60 participants. Additionally, FNC cooperates with external service providers in order to organize mass-conferences. You have the option of having your conference channel monitored by a professional administrator. Please choose the most suitable conference service from the following chart:

Service Component	Description
Telephone Conferencing	You receive a central telephone number and necessary access codes for your telephone conference with up to 60 participants
Videoconferencing at the workplace*	This service grants you the option of initiating or participating in video conferences from your workplace.
Videoconferencing from conference room	Equip your conference rooms with videoconferencing systems and perform worldwide video conferences with your locations and business partners.

Functions	Telephone Conference (I000262)	Videoconferencing at the workplace (I000261)	Videoconferencing from conference room (I000262)
Dial-Up Options	Mobile Phone / Conference Phone	Workplace Computer / Laptop with connection to the Fresenius Network*	Conference rooms with videoconferencing systems
Max. Participants	60
Connection Informationn	Email	Email and address list	Email and conference room list
Monitoring of the connection by an operator		Optional € 1.00 per minute	Optional € 1.00 per minute
Price	€ 0.06 per minute per user	€ 19.70 per month plus € 100.00 one time installation fee	€ 19.70 per month zzgl. 100,00 € one time installation fee

* Requirement for the use of the desktop video conferencing component is - if not integrated in the device - a headset and a video camera.

22

How can I obtain this service?

Telephone and video conferencing:

Please write an informal email to the contact person of the specialized department with reference to the required component. Afterwards, you will receive the installation as well as all additionally necessary information.

If you need audio and/ or video conferencing regularly, you will receive access to a Lotus Notes databank, with which you can book the required service directly.

Contact person for telephone and videoconferencing:

Erkan.Taskor@fresenius-netcare.com

Joerg.Hagemeyer@fresenius-netcare.com

Where can I get help?

If you have questions or problems, please contact our service desk from Monday through Friday (except public holidays) from 06:00 to 18:00 CET at the following telephone number: +49 6172 608 – 1111.

23

Service Desk & Support

Worldwide support for dependable IT services

Contact Person:

Branimir Madzarevic

How is the FNC support organized?

FNC offers a decentralized support concept that considers local conditions and specific requirements. At most greater Fresenius locations, FNC offers its own support crew in order to provide the best possible help to local users.

We provide you information on planned maintenance and present disturbances of the IT systems. These can be found at “Maintenance & Disturbances” on the FNC intranet.

If you would like to actively be informed on disturbances, then please register with the Customer Alert Tool. This service includes the sending of disturbance and status notices via email and/or IM.

Which service desk should I contact?

Central Service Desk Bad Homburg (Central Service HG)

The central service desk provides aid and consultation for all your question and problems concerning FNC services such as standard applications, standard services, standard hardware, user administration, contact data and — as far as possible — nonstandard applications. If you are looking for a local FNC contact person of a contact person for specific applications, the central service desk is also your single point of contact. If you have questions about SAP, please consult with the SAP service desk (see paragraph SAP Support Service).

Service Desk	Contact Information	Service Times
Central Service Desk Bad Homburg	+49 6172 608 - 1111 hotline-pc@fresenius-netcare.com	Mo.-Fr. 06:00 - 18:00 GMT +1

24

Decentralized Service Desks

The decentralized service desks serve either a single or multiple locations of a state or region. They are specialized on the service offers that are mostly used at the location. If your location offers a local service desk then that is your first contact point for your questions and problems concerning FNC services. If you have questions about SAP, please consult with the SAP service desk (see paragraph SAP Support Service).

Service Desk	Contact Information	Service Times
IT Service Oberursel / B14	+49 (6172) 608 – 4444 B14-FNC@fresenius-netcare.com	Mo.-Fr. 09.00 - 17:00 GMT +1
IT Service Desk St. Wendel	+49 (6851) 807 – 555 de-wn.it-support@fresenius-netcare.com	Mo.-Fr. 08:00 - 17:00 GMT +1
Service Desk UK & Ireland	+44 (1928) 533 – 700 IT.Helpdesk-UK@fresenius-netcare.com	Mo.-Fr. 08.30 - 17.30 GMT
IT Service Desk Emmer-Compascuum	+31 (591) 355 – 874 (Intern: 666) IT-Helpdesk.FHCN@fresenius-netcare.com	Mo.- Fr. 08:00 - 17:00 GMT +1
APP Service and Support Center	+1 (888) 254 – 3954 SSC@fresenius-kabi.com	Mo.-Fr. 5.30 - 20.00 GMT -6
IT Support Center China	+86 510 85960190	Mo.-Fr. 08.00 - 17:00 GMT +8

SAP Support Service

Fresenius’ business operations are primarily supported by SAP. In order to give you the best possible support with questions revolving around SAP, FNC runs an extensive SAP support organization.

Please select your local SAP service desk:

Service Desk	Contact Information	Service Times
SAP Service Desk Bad Homburg	+49 6172 608 - 7577 hotline-sap@fresenius-netcare.com	Mo.-Fr. 08.00 - 18:00 GMT +1
SAP Support St. Wendel	+49 6851 807 - 666 de-wn.sap@fresenius-netcare.com	Mo.-Fr. 08.00 - 17:00 GMT +1
SAP Support Austria	+43 316 249 - 1111 | +43 732 7651 - 1111 austria.sap-hotline@fresenius-kabi.com	Mo.-Th. 08:00 - 17:00 und Fr. 08:00 - 14.00 GMT +1
Sam.ware Support	+49 6851 807 - 123 de-wn.samware@fresenius-netcare.com	Mo.-Fr. 08:00 - 17:00 GMT +1
SAP Service Desk Netcare France	+ 33 1 41 14 26 00 (Paris) | + 33 474 01 60 00 (Lyon) fnc-hotline.france@fresenius-netcare.com	Mo.-Fr. 9:00 - 18.00 GMT +1
SAP Support Munich	+49 8165 901 560 helmut.spindler@fresenius-netcare.com	Mo.- Fr. 09:00 - 16:00 GMT +1

25

Service Desk	Kontaktdaten	Bürozeiten
SAP Support Uppsala / Sweden	+46 18644550	Mo.- Fr. 08:30 - 17:00 GMT +1
SAP Support Emmer-Compascuum	+31 591 355 768 SAP-Hotline.FHCN@fresenius-netcare.com	Mo.- Fr. 08:00 - 17:00 GMT +1
SAP Support Belgium & Netherlands	+49 6851 807 666 de-wn.sap@fresenius-netcare.com	Mo.- Fr. 08:00 - 17:00 GMT +1
SAP Support Switzerland	+49 6851 807 666 de-wn.sap@fresenius-netcare.com	Mo.- Fr. 08:00 - 17:00 GMT +1
SAP Support Russia	+7 495 789 - 64 # 54	Mo.- Fr. 09:30 - 17:30 GMT +2
SAP Service Italy	+39 0373 275 420 fnc-hotline.italy@fresenius-netcare.com	Mo.-Fr. 9:00 - 13:00 und 14:00 - 18:00 GMT +1
SAP Service Turkey	+39 0373 275 420 fnc-hotline.italy@fresenius-netcare.com	Mo.-Fr. 9:00 - 13:00 und 14:00 - 18:00 GMT +1
SAP Service Greece	+39 0373 275 420 fnc-hotline.italy@fresenius-netcare.com	Mo.-Fr. 9:00 - 13:00 und 14:00 - 18:00 GMT +1
SAP Service Switzerland	+39 0373 275 420 fnc-hotline.italy@fresenius-netcare.com	Mo.-Fr. 9:00 - 13:00 und 14:00 - 18:00 GMT +1
SAP Service Spain	+34 932 256 583 fnc-hotline.italy@fresenius-netcare.com	Mo.-Fr. 9:00 - 13:00 und 14:00 - 18:00 GMT +1
SAP Service Portugal	+35 1232 831 253	Mo.-Fr. 9:00 - 13:00 und 14:00 - 18:00 GMT
SAP Service Chile & Argentina	+54 11 4130 1143	Mo.-Fr. 09:00 - 18:00 GMT-4
SAP Service Mexico & Colombia	+52 333 540 4312	Mo.-Fr. 09:00 - 18:00 GMT-6
SAP Service Brazil	+55 19 3847 9742	Mo.-Fr. 09:00 - 18:00 GMT-4
SAP Service Desk China	+86 105 909 6937	Mo.-Fr. 09:00 - 18:00 GMT +8
SAP Service Desk Hong Kong	+85 221 521 318	Mo.-Fr. 09:00 - 18:00 GMT +8
SAP Service Desk Taiwan	+886 227 398 800 # 151	Mo.-Fr. 09:00 - 18:00 GMT +8
SAP Service Desk Japan & Korea	+82 10 2688 3457	Mo.-Fr. 09:00 - 18:00 GMT +9
SAP Service Desk Australia	+61 2 9391 5553	Mo.-Fr. 09:00 - 18:00 GMT +10
SAP Service Desk Thailand	+66 2651 8245 | +66 81753 5192	Mo.-Fr. 09:00 - 18:00 GMT +7
SAP Service Desk India	+91 1244 885 286	Mo.-Fr. 09:00 - 18:00 GMT +5.5
Healthcare Service Desk	+49 6172 608 - 5199	Mo.-Fr. 09:00 - 16:00 GMT +1
HCM Service Desk	+49 6172 608 - 7699	Mo.-Do. 09:00 - 17:00 und Fr. 09:00 - 16:00 GMT +1
SEM Service	+49 6172 608 - 4000	According to service agreement

26

Emergency Support from € 480.00

The emergency support is available for the main Fresenius systems. With the emergency support, the support times outside the regular service times are provided. Attention please! The service shall only be used for major IT problems that fundamentally affect smooth business processes.

When using the emergency support, the following charges apply:

·Each case / incident is invoiced at € 480 (up to two hours).

·If the efforts on the case exceed two hours, each additional hour commenced is invoiced at € 240.

·All other services that are not described in the service component “FNC Emergency Support” are invoiced according to time and effort.

Service Desk	Kontaktdaten	Bürozeiten
Emergency Support	+49 6172 608 - 7877	Mo.-Fr. 18:00 - 08:00 GMT +1 Sa, Su, bank holidays 0:00 - 24:00
Emergency Support St. Wendel	+49 6851 807 - 100	Mo.-Su. 04:00 - 08:00 GMT +1 Sa, Su, bank holidays 08:00 - 12:00 GMT +1

Which on-site support services does FNC provide for my IT equipment?

IMAC - Services and On Site Support € 84.00

With the IMAC services (IMAC = Install, Move, Add, Change), the FNC technicians provide setup, disassembly, moving services and interference elimination as well as any changes to your IT equipment. The service is available for locations in the Rhine-Main area. On-site services are invoiced according to time and effort or at a flat rate.

Services	Description	Price per hour (target prices)*
On-site Support (I000205)	Interference elimination and changing of IT equipment (e.g. adding memory)	€	84
First Installation Service (1000203)	Configuring, delivering and installing new IT equipment	€	84
IT Equipment Moving Service (1000204)	Moving IT equipment (order through Central Services)	€	84
Computer Pick-up-Service (1000211)	Disposing of used devices and returning to lessor, as well as backing up your data	€	84

* The services are always invoiced according to time and effort. The target prices are based on empirical values of average time and effort.

27

How is the FNC incident priority assigned?

After receipt of an Incident, the processing front line staff shall prioritize the ticket. All received tickets shall be processed according to the priority of the ticket. The following priorities shall apply (for the avoidance of doubt, the requirements in each priority hereunder shall be cumulative only if explicitly indicated by the use of the word “and”):

Priority 1: Critical

A service in its entirety or an important part of a service is not available and processes important or critical to FME’s businesses cannot be used or are materially affected by a problem. Service levels are violated or such violation is very probable. The Incident may seriously affect FME’s business relationships. A material number of FME’s staff cannot perform their assigned duties or are materially affected in performing their permanent du- ties. FME has no immediate alternative in order to perform the affected business process.

Priority 2: High

A material function of an Application is not available and no workaround is available for an immediate solution. Frequently used business processes are affected by the Incident and a violation of service levels is probable. It is likely that the Incident may affect FME’s business relationships. Numerous FME staff may be frequently affected in performing their temporarily assigned duties or a single staff cannot perform his/her permanently assigned duties. This priority is applicable, e.g., if order registration and commissioning is affected. For the avoidance of doubt, events more critical than the ones defined under Priority 2 shall be exclusively governed by Priority 1.

Priority 3: Medium

An Application is not complying with specifications and/or a workaround for a Priority 1 or Priority 2 Incident is available. The effect on business process is of non-material nature. Violations of Service Levels are of non-material nature or not likely. Effects on FME’s business relationships are non-material. FME staff is affected in performing their duties only occasionally or they may perform other duties during Incident solution. Priority 3 shall apply if procurement orders, booking of cost accounts except for the purpose of month end closing and invoicing review is affected.

Priority 4: Low

An Incident not or minimally affecting business processes. There is no direct effect on FME’s clients. The Inci- dent may cause an inconvenience to single employees. E.g., Incidents may affect reporting, headlines are not formatted, sums and selections are not correct.

28

Terminal Server (Citrix)

Virtual hardware independent from working environment

Contact Person:
Lothar Gützkow

Which service suits me best?

Your application program is available to you on a central server. This allows a safe and fast working environment, since data management and processing power of the active program are run on the central server as well. Software installations and updates of current programs are run centrally, making them available to all users within a very short timeframe.

How can I obtain this service?

Provision of basic applications (currently Office 2003 / 2010, Kipdips, Applix, SPAGUI (recent version)):

Note: License fees are not included!

Rhine-Main-Area: (I000252) € 19.50 per device / month

Please fill out the BANF, in which you specify the number of your order item and send to:

lothar.guetzkow@fresenius-netcare.com

Other locations: (I000252) € 19.50 per device / month

Please write an informal email, in which you specify the service “Terminal Server” to:

lothar.guetzkow@fresenius-netcare.com

By request, we will also provide you with other applications via Citrix. The work required for this is invoiced according to time and effort.

Where can I get help?

If you have questions or problems, please contact our service desk from Monday through Friday (except public holidays) from 06:00 to 18:00 CET at the following telephone number: +49 6172 608 1111.

29

Component catalog

	End User Services
	Network and Telecommunication Services
	Hosting

Basic IT Operation Package

Operating hardware and software in the
Fresenius systems landscape

Contact Person: Lothar Gützkow | Availability: Rhine-Main-Area Material No.: I000045

SERVICE COMPONENT DESCRIPTION

The software and/or hardware used in the Fresenius IT landscape has to be integrated into the Fresenius systems landscape after the purchase. Therefore, it is necessary to install software for the distribution and to configure the hardware and the software products in such a way that they can be used in the Fresenius network. All of those individual and in part very complex tasks, as well as the operation, are combined in this service component.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Montag bis Freitag (außer an Feiertagen) 06:00-18:00Uhr
Maintenance window in hours per week:	10 (Saturdays 16:00 – 20:00 CET Sundays 08:00 – 14:00 CET or by arrangement)
Availability in % per month:	98*

* Based on a three month average

FUNCTIONALITIES

·File, backup, restore for backend systems (DC-relevant systems)

·Data server standard is 100 MB

·Network access to Fresenius Global Network

·Network printing (print server)

·Client security (firewall, antivirus, malware, intrusion detection)

·Software distribution via push and pull

·Central firewall

DEPLOYMENT

·Installation, configuration and integration of:

·Backend hardware and software

·  Frontend software for standard applications

·Installation of releases, patches, updates, for standard applications

PROVISIONS BY FNC

·Infrastructure provided by FNC Data Center in Bad Homburg/Germany

·LAN connection (connected to the Fresenius Global Network)

·Storage space on file server

·Domain controller

·Print service

·Client protection (e.g. antivirus firewall,…)

·Software depot service

·System-related software (e.g. network client, PDF viewer, backend infrastructure licenses, browser, MS CAL, archive tool (zip)…)

·User and directory services

·Network services (DHCP, WINS, DNS, ...)

31

Basic IT Operation Package

Operating hardware and software in the Fresenius systems landscape

OPERATIONS

·Concept design of standard system configurations

·Maintenance of software standards

·Maintenance and further development of technology

·Implementation of current security standards

·Infrastructure operation and maintenance

·Domains management

·Policies for client configuration per Group Policies (GPOs)

·Availability monitoring for file and print services

·Availability reporting for file and print services

·Maintenance of standard applications (deployment, patches, updates); distribution is carried out via software depot

·Hardware maintenance for backend systems

·Software Deployment for standard applications

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Connecting and configuring local printers

·Connecting peripheral devices

·Client / user configuration

·Additional storage space for file server

USER / CUSTOMER PARTICIPATION

·Maintaining master data

·Reporting changes within your organisation (e.g. the company changes) to service desk

OUT OF SCOPE

·Laptop client / desktop client (hardware & software)

·Printers, peripherals and other hardware

·Operating system software for clients

·Internet access

·Messaging and email services

·Terminal server services

·Remote access services (RAS, VPN)

·User training sessions and consultations

·Installation, configuration and integration of frontend hardware

·Upgrading/rebuilding of:

·Desktop hardware, peripherals, components

·Backend hardware, peripherals, components

·Installation and de-installation of software

·IT workstation moves

·Removal and disposal of hardware, if applicable

·Extraction of software from the system environment

32

Client Backup

Data backup of workstation computers used by the Fresenius staff

Contact Person: Lothar Gützkow | Availability: worldwide Material No.: I000222

SERVICE COMPONENT DESCRIPTION

The volume of important data increases continuously on the hard disks of mobile computers. That is why regular backups are so essential. If, for example, a local hard disk becomes defective or is stolen, the data is usually irretrievably lost. The service component “Client Backup” by FNC addresses this risk and provides you with the complete solution for protecting the data on mobile clients.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Maintenance window in hours per week:	24 At the weekend with advance notice
Availability in % per month:	98*
Max. recovery period for selected backup sets in days:	30
Versions of data backup:	10

* Based on a three month average

FUNCTIONALITIES

·Automatic data backups on central backup server
(Rechenzentrum Bad Homburg)

PROVISIONS BY FNC

·Backup software

OPERATIONS

·Define client backup concept (recommendation for client backup)

·Carry out necessary systems maintenance

·Performing backup and restore for:

·user data

·systems data (the user can configure this with the software)

·Test restore concept at regular intervals

·Availability monitoring

·Create / adjust user documentation

DEPLOYMENT

·Client software via software depot

·Release installation software via software depot (if available)

·Installation of patches, updates for software, deployment via client backup server

·Capacity, utilisation and performance monitoring

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

USER / CUSTOMER PARTICIPATION

·Installing software via software depot

·Observing user documentation (backup concept)

·Restore has to be triggered by the customer

33

Hard Drive Protection

Reliable hard drive data protection for Fresenius computers

Contact Person: Lothar Gützkow | Availability: worldwide Material No.: I000269

SERVICE COMPONENT DESCRIPTION

Continuously increasing user mobility in the form of laptops, CDs, DVDs, USB sticks or external hard disks entails high risks. Especially the loss of such devices or media — for instance through theft — poses a high risk. In this way company secrets or patient data can quickly fall into the wrong hands and lead to serious problems. By using this service component “Harddisk Protection”, the risk is minimized to a great extent due to data encryption.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Maintenance window in hours per week:	4 Saturdays 16:00 – 20:00 CET, after announcement

FUNCTIONALITIES

·Identifying the user via domain user

·Client file encryption

·Encryption of USB removable storage media

·Encryption of CD and DVD

PROVISIONS BY FNC

·Encryption software

·Patches, client updates, releases

·Deployment of key recovery technology

DEPLOYMENT

·Installation via software distribution (if available) or via email dispatch

OPERATIONS

·Defining standard encryption policy

·Capacity and performance planning for the infrastructure

·Central key management

·Policy management

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Recovery installations, e.g. in case of hardware damage or hardware exchange

USER / CUSTOMER PARTICIPATION

·Installation of software via software depot (if possible) with declaration concerning the assumption of costs

·Request for new user via email to 2nd Level, if Empirum is not available

34

First Installation Service

Setup and Configuration of a new computer for your workstation

Contact Person: Christian Scheerer | Availability: Rhine-Main Area Material No.: I000203

SERVICE COMPONENT DESCRIPTION

With the service component “First Installation Service “ FNC configures your new computer for the Fresenius IT environment. In addition to the configuration, a service technician sets up your new computer — by request at your workstation - and carries out a first functional check.

QUALITY PARAMETERS

Request handling:	Monday through Friday (except public holidays) 08:00 - 16:30 CET
Installation of a new workstation:	One week after the hardware and the completed configuration sheet are available

OPERATIONS

·IMAC preparation, scheduling and coordination

·Image installation on Clients (Fresenius standard)

·Setting up the hardware at the workstation, by request in compliance with the German Ordinance on Working with Screens, incl. functional check and acceptance

·Installation, configuration and integration of hardware and software

·Systems inventory and personalization

·Initial instructions for users

·Network connection setup

·User instructions

·Functional check and acceptance

·Documentation of the procedure

·Data migration < 1 GB

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Data migration > 1 GB

·Software/hardware installation beyond the standard

·Short instructions for additional persons

USER / CUSTOMER PARTICIPATION

·Scheduling a date and place for installation

·Opening a ticket at service desk

·If necessary, completing IT request / orders

·Necessary requirements (requests / orders etc.) have to be fulfilled

OUT OF SCOPE

·Travelling to on-site assignments (expenses)

·Consumables

35

IT Equipment Moving Service

Moving IT workstations and IT systems

Contact Person: Christian Scheerer | Availability: Rhine-Main Area Material No.: I000204

SERVICE COMPONENT DESCRIPTION

With the service component “IT Equipment Moving Service” you obtain professional preparation and execution of IT moves. The Fresenius IT equipment that needs to be moved is subject to a functional check after the move. Installation / de-installation and the removal of the equipment will be carried out by specially trained staff.

QUALITY PARAMETERS

Operating times:	Monday through Friday (except public holidays) 08:00 - 16:30 CET
Moving and dismantling of system:	Within a week*

*For single moving

OPERATIONS

·Preparation, scheduling and coordinating of IT moves

·On-site setup / removal of devices

·Installation of system incl. functional check and acceptance

·Patching LAN connection

·Logical move (assigning printer, IP area etc.)

·Setup of telephone connection to the Fresenius telephone server

·Selection and coordination of local IT suppliers for infrastructure, if required

INCIDENT MANAGEMENT & SUPPORT

·2nd Level Support

USER / CUSTOMER PARTICIPATION

·Scheduling a date and time for the IT move

·Opening a ticket at service desk

·If necessary, completing IT request / orders

OUT OF SCOPE

·Travelling to on-site assignments (expenses)

·Consumables

·Transport between the sites

·Mass move ( > 3)

·Packing, preparing for the transport (carried out by an external service provider)

36

On-site Support

On-site IT support for hardware and software by FNC technicians

Contact Person: Christian Scheerer | Availability: Rhine-Main Area Material No.:  I000205

SERVICE COMPONENT DESCRIPTION

With the service component “On-site Support” you obtain the FNC on-site IT support. The FNC staff member comes directly to your workstation for support and for the resolution of IT incidents, for upgrading your hardware (e.g. increasing the main memory or software installation, software update), for replacing a defective device/component or exchanging it for a higher-performance model/ component. Administrative incident resolution (e.g. password reset) is provided via remote support. The service component is invoiced according to time and effort.

QUALITY PARAMETERS

Guaranteed service times: Monday through Friday (except public holidays) 08:00 - 16:30 CET

OPERATIONS

·IMACs preparation, scheduling and coordination

·1st and 2nd Level Support

·Software and hardware installation, incl. functional check and acceptance

·Systems inventory and personalization

·User instructions in case of new hardware

·Coordinating the replacement of defective end devices by supplier (only within the supplier´s warranty)

·Hardware refurbishment (refurbishing and checking the hardware), return to customer, if applicable

·On-site incident isolation / resolution and repair

·Remote interference elimination

·Feedback to 1st Level Support

·Escalation to 3rd Level Support

·Scheduling the Installation, Move, Add and Change measures (IMAC)

·Virus removal, removal of spy- and malware

·Data backup and restore

·Setting up the hardware, by request in compliance with the German Ordinance on Screens

·Hardware upgrading / rebuilding and adjusting

·Remote “Incident Resolution” Technical

·support during conferences Forwarding

·repair requests to manufacturer (within the manufacturer´s warranty)

USER / CUSTOMER PARTICIPATION

·Scheduling a date and time for on-site support

·Opening a ticket at service desk

·If necessary, completing IT request and/or orders

·Necessary requirements (requests / orders etc.) have to be fulfilled

OUT OF SCOPE

·User training sessions and consultations

·Group training sessions

·Travelling to the place of the assignment (expenses)

·Consumables

37

Computer Pick-up Service

De-installation of your Fresenius hardware or software

Contact Person: Christian Scheerer | Availability: Rhine-Main Area Material No.: I000211

SERVICE COMPONENT DESCRIPTION

The service component “Computer Pick-up Service” contains the disassembling of a device / component and/or de-installation of the software. Prior to the proper return to the lessor, existing data shall be backed up — depending on the component — and deleted on the device that needs to be returned.

QUALITY PARAMETERS

Request handling Monday through Friday (except public holidays) 08:00-16:30 CET

OPERATIONS

·Preparation, scheduling and coordination

·Pickup of device

·Software and hardware de-installation service, incl. functional check and acceptance

·Systems inventory and personalization

·Disassebly and disposal or return to hardware lessor, if applicable

·Deletion of hard disk in case of a hardware return

·Remote support for de-install

INCIDENT MANAGEMENT & SUPPORT

·2nd Level Support

USER / CUSTOMER PARTICIPATION

·Scheduling a date and place for de-installation

·Opening a ticket at service desk

·If necessary, completing IT request / orders

·Necessary requirements (requests / orders etc.) have to be fulfilled

OUT OF SCOPE

·Travelling to on-site assignments

38

Central Service Desk Bad Homburg

The central service desk is the main point of contact for
all service requests within our organizational structure

Contact Person: Marc Kreischer | Availability: Bad Homburg

SERVICE COMPONENT DESCRIPTION

The Central Service Desk is your first point of contact whenever you have problems revolving around your computer workstation. In addition to the central service desk in Bad Homburg/Germany, there are local service desks that cover the respective specific local requirements. You will find the latest service desks` contact details in the FNC intranet under “Service Desk / Hotline”.

What we offer our customers:

·Personal contact, no voice computer

·No re-directing or long, cost-intensive waiting loops — on average, 80% of the calls are answered within 30 seconds (see also “Service Reporting”)

·Friendly, quick and reliable assistance

·Trained service desk staff for the particular IT environments

·A high direct incident resolution rate at the service desk (“Skilled Service Desk”)

·Defining workarounds

·Monitoring the service levels within the scope of ITIL-based incident management

Processing time

Service times (active call answering):	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Accepting calls:	75% of all incoming calls*
Response time:	75% of accepting calls in less than 30 seconds*
Initial incident first time:	80%*

* Based on a three month average

PROVISIONS BY FNC

·Single point of contact

·Ticketing system

·Processing of:

· Information and service requests

· Hardware / software incidents

· Password resets (automatic process)

· Non-standard application incidents (where possible)

·Request / contact acceptance via: telephone, email, fax

REPORTING

·Monthly service reports shall be provided by FNC and published in the FNC intranet

39

Central Service Desk Bad Homburg

The central service desk is the main point of contact for

all service requests within our organizational structure

OPERATIONS

·Scheduling the Installation Move, Add, Change (IMAC) process

·Incident analysis, prioritisation, classification and documentation in the ticketing system

·User administration on the application level (users, groups, rights,… .) for selected software

·Ad-hoc assistance / incident resolution (by back office)

·Remote support in accordance with Fresenius policy (IMAC, subject to a charge)

·Escalation management

·Current information to customer in the event of an escalation

·Forwarding / escalating and tracking of tickets to 2nd Level Support

·Instructions, individual user training sessions up to 30 minutes for selected software

·Consultation on hardware, applications and training options

QUALITÄTSPARAMETER

Resolution time for priority 1:	90% in 6 hours (business hours)*
Resolution time for priority 2:	90% on the next business day*
Resolution time for priority 3	90% within 3 business days*
Resolution time for priority 4:	Status report after one week

* Based on a three month average

Processing time for creating, changing or deleting user accounts: 80% within 3 business days

USER / CUSTOMER PARTICIPATION

·Keeping information about the incident ready

·Contacting service desk in charge

·Using tips, FAQ and/or user manuals for possible own incident resolution

·Contacting service desk via defined paths

·Required request forms have to be completely filled in and released

OUT OF SCOPE

·Accepting requests / contacts via web self service

·On-site incident resolution
(applies also to IMAC actions which are carried out via remote connection)

40

Decentralized Service Desks

FNC provides the appropriate support structure for
on-site services or special applications

Contact Person: Branimir Madzarevic | Availability: worldwide

SERVICE COMPONENT DESCRIPTION

FNC provides you with a decentralized support concept which takes the local conditions and/or specific requirements of our customers into account. At most of the larger Fresenius locations, FNC has its own staff in order to offer the best possible support to the local users. In addition to the central service desk in Bad Homburg/Germany, there are local service desks that cover the respective specific requirements. You will find the latest service desks´ contact details in the FNC intranet under “Service Desk / Hotline”.

Processing time

Service times (active call answering):	See local service times
Accepting calls:	75% of all incoming calls*
Response time:	75% of accepting calls in less than 30 seconds*
Initial incident first time:	80%*

*Based on a three month average

PROVISIONS BY FNC

·Single point of contact for local site

·Ticketing system

·Proc1essing of:

·Information and service requests

·Hardware / software incidents

·Password resets (automatic process)

·Non-standard application incidents (where possible)

·Incidents in the Fresenius SAP systems

·Request / contact acceptance via: telephone, e-mail, fax

REPORTING

·Monthly service reports shall be provided by FNC and published in the FNC intranet (depending on the local infrastructure)

OPERATIONS

·Scheduling the Installation Move, Add, Change (IMAC) process

·Incident analysis, prioritisation, classification and documentation in the ticketing system

·User administration on the application level (users, groups, rights,…) for selected software

·Ad-hoc assistance / incident resolution (by back office)

·Remote support in accordance with Fresenius policy (IMAC, subject to a charge)

·Escalation management

·Forwarding / escalating and tracking of tickets to 2nd Level Support

·Current information to customer in the event of an escalation

·Instructions, individual user training sessions up to 30 minutes for selected software

·Consultation on hardware, applications and training options

41

Decentralized Service Desks

FNC provides the appropriate support structure for
on-site services or special applications

QUALITY PARAMETERS

Resolution time for priority 1	90% on the next business day*
Resolution time for priority 2	90% in 6 hours (business hours)*
Resolution time for priority 3	90% within 3 business days*
Resolution time for priority 4	Status report after one week

* Based on a three month average. Measurability depending on location and infrastructure.

USER / CUSTOMER PARTICIPATION

·Keeping information about the incident ready

·Contacting service desk in charge

·Using FAQ and/or user manuals for possible own incident resolution

·Contacting service desk via defined channels

·Required request forms have to be completely filled in and released

OUT OF SCOPE

·Accepting requests / contacts via web self service

·On-site incident resolution (applies also to IMAC actions which are carried out via remote connection)

GENERAL NOTE

·The performance portfolio provided herein is dependent on the particular location of the service desk. The service desk responsible for you informs you about its local range of services. In addition, the FNC intranet provides further information.

42

FNC Emergency Support

Support for IT systems that are critical for business

outside the standard support times

Contact Person: Lothar Löser | Availability: worldwide                                              Material No.: I000283

SERVICE COMPONENT DESCRIPTION

The scope of the emergency support covers the support of IT systems that are critical for business as well as their supporting infrastructure. The emergency service enables the users to report emergencies, classified as “Priority 1”, to FNC outside its regular working hours. A list of the systems that are critical for business is stored in the FNC intranet.

A “Priority 1” incident meets the following criteria:

·An application in its entirety is not available and processes that are critical for business are not executable or fundamentally affected by this incident.

·Fresenius customer Service Level Reporting cannot be adhered to or is seriously jeopardized.

·There is the risk that business relations to Fresenius´ customers will be disrupted.

·Many staff members cannot perform their assigned tasks.

·The customer does not have an immediate alternative in order to carry out the affected business process.

The emergency service is only available for “Priority 1” emergency cases.

Phone number: +49 (6172) 608 - 7877 For all other cases please contact the Service Desk. All services described are solely provided outside the regular working hours effective in Germany (Hessen).

QUALITY PARAMETERS

Service times:	Workdays: 18:00 - 08:00 CET, weekends and public polidays*  (prior to the next business day): 00:00-24:00 CET
Information to Reporting Person (outside regular service times):	After 4 hours** at the latest
Information to Reporting Person (within regular service times):	After 2 hours** at the latest

* The workday and public holidays referred to are effective in Germany and Hessen

** Provided that the agreed communication channels (e.g Lotus Notes ) are available

PROVISIONS BY FNC

·Availability of supporting staff

·“Best effort” concerning finding solutions or provisional solutions for “Priority 1” emergency cases

·Request/contact acceptance via emergency phone number

OPERATIONS

·FNC is responsible for defining and determining the priority of an emergency

·Fault analysis, prioritization and classification, assignment

·Escalation management (if necessary)

·All “Prio 1” emergency cases reported by the customer shall be accepted by FNC and documented in a ticketing system

·Providing ad-hoc assistance or workarounds

·Information to Reporting Person after solving the problem and status information during the problem resolution process

43

FNC Emergency Support

Support for IT systems that are critical for business
outside the standard support times

USER / CUSTOMER PARTICIPATION

·User shall report “Priority 1” emergency cases only to the responsible emergency service help desk. The emergency service help desk has to be contacted via the stipulated an communicated channel (e.g. telephone number). FNC cannot ensure proper processing of requests and problem reports if these were submitted to other FNC staff members.

·The customer and FNC shall collaborate in all stages of the process and shall be responsible for supporting FNC in its efforts to provide the service to the following extent:

·appoint an appropriate number of competent staff for communication and problem resolution.

·provide FNC with all reasonable and necessary information and documentation.

·responsible for reaching timely internal consensus and decisions required for the performance of services under this service description.

·In case that joint actions have been agreed upon, the customer shall be responsible for its own efforts — supported by FNC - to independently prepare, perform and analyze the actions to be contributed by the customer.

·make applications available only to those staff members who have been appropriately trained.

·ensure compliance with the policies, implemented for the use of the applications, on the part of the “customer´s” staff.

OUT OF SCOPE

·Faults that do not match “Priority 1”

·User administration

INFRASTRUCTURE

·Active Call Distribution system (ACD)

·Ticketing tool

REPORTING

·Call and ticket statistics by request

44

Email Plus with User Support

Reliable worldwide email communication and scheduling

Contact Person: Gianpietro Alpiani | Availability: Rhine-Main Area                                       Material No.: I000051

SERVICE COMPONENT DESCRIPTION

With the service component “Email Plus with User Support” you obtain a highly available platform - based on Lotus Notes - for your internal and external communication. In addition to sending emails and having a 300 MB mailbox, you can also do scheduling and use the chat function for quick arrangements. The mailbox is limited to 300 MB and can be enhanced, if required, for an additional charge. Attachments of up to 50 MB can be sent with each email. FNC´s top priority is the security of your data. That is why your data is backed up by the FNC Data Center at regular intervals. Furthermore, while sending and receiving messages, the entire unencrypted mail traffic is automatically checked for viruses and spam.

In addition to its communication infrastructure with Lotus Domino servers, certificate servers and directories, FNC is the worldwide administrator of the Fresenius email domains (e.g. @Fresenius.com) and the Domino Lightweight Directory Access Protocol (LDAP) directory services. Numerous extensions (see Optional Extensions) are available to supplement this service.

QUALITY PARAMETERS

Operating times:	24/7
Maintenance window:	A maintenance window is not stipulated, necessary work will be announced
Availability in % per month:	99*

* Based on a three month average

FUNCTIONALITIES

·Platform: Lotus Notes (the standard is 300 MB per mailbox)

·Interfaces to Domino servers

·Maximum size of email incl. attachments 50 MB

·Automatic antivirus monitoring of unencrypted emails

·Automatic spam filtering

·Message encryption (Notes encryption) possible within the Fresenius network

·Instant messaging (chat)

·Scheduling

PROVISIONS BY FNC

·“Messaging Infrastructure” provided by FNC Data Center in Bad Homburg/Germany

DEPLOYMENT

·Client software is provided through central software distribution

·Client access data will be sent by interoffice mail (letter: “user name and password for DP systems”)

45

Email Plus with User Support

Reliable worldwide email communication and scheduling

OPERATIONS

·Administration of:

·Domino server software

·Master data of users, distribution lists

·Simple Mail Transfer Protocol (SMTP) server

·Global Domino administration service

·Mailbox recovery

·Recovery of deleted items

·Mailbox backup

·General systems monitoring

·Availability monitoring

·Capacity, utilisation and performance monitoring

·Service Level Reporting

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Mailbox size extension ( > 300 MB) possible for an additional charge

USER / CUSTOMER PARTICIPATION

·New Lotus Notes user account via IT request in the FNC intranet

OUT OF SCOPE

·Notes client licenses (separate compensation)

·Installation of client applications

·Creating team rooms or Notes databases (based on standard template)

·1st Level Support

46

Email Facility Connection Standard

Local platform for worldwide communication by
operating your own local email server

Contact Person: Gianpietro Alpiani | Availability: worldwide                                                    Material No.: I000036

SERVICE COMPONENT DESCRIPTION

With the service component “Email Facility Connection Standard” you obtain the key — based on Lotus Notes — for your daily worldwide email communication. FNC provides the server application (Notes Domino server) incl. server software licenses. The setup of the server software and the administration is also carried out by FNC via remote connection. The necessary server hardware shall be provided by you at your location in accordance with the specifications.

In addition to communicating by email, the Lotus Notes platform provides scheduling and chat functions as standard features. Attachments of up to 50 MB can be sent with each email. The particular size of the mailbox is limited to the local email server memory capacity. Automatic spam filtering protects you from unsolicited promotional emails and enhances security.

You provide the administration of the end users from a local site. This includes the installation of the client software onto the end devices as well as the local user administration. The local administrator is the first point of contact for the users. FNC supports the local administrator and provides 2nd and 3rd Level Support.

The Lotus Notes client licenses incur license fees.

Extensions are available for the service component “Email Facility Connection Standard” (see Optional Extensions).

QUALITY PARAMETERS

Operating times:	24/7
Availability:	The customer´s own responsibility

FUNCTIONALITIES

·Platform: Lotus Notes (mailbox size depends on local memory)

·Message encryption (Notes encryption) possible within the Fresenius network

·Data backup on local server

·Interfaces

(e.g. LDAP, POP, SMTP, MAPI, IMAP...)

·Maximum size of e-mail incl. attachments 50 MB

·      Automatic spam filtering

·      Scheduling

PROVISIONS BY FNC

·Licenses for Domino server

·Domino server software

DEPLOYMENT

·Installation of Domino server software via remote connection

·Installation of Domino server software patches and hot fixes via remote connection

47

Email Facility Connection Standard

Local platform for worldwide communication by
operating your own local email server

OPERATIONS

·General systems administration for Domino server software via remote support

·Administration of SMTP server

·Global Domino administration service

·Server software maintenance via remote connection

INCIDENT MANAGEMENT & SUPPORT

·2nd Level / 3rd Level Support for Domino server software via remote connection

·2nd Level and 3rd Level Support for local 1st Levels

OPTIONAL EXTENSIONS

·Web interface (Lotus iNotes)

·Automatic antivirus monitoring for unencrypted e-mails

·Mailbox archiving

·Installation of new releases for server application

·Creating team rooms or Notes databases (based on standard template)

USER / CUSTOMER PARTICIPATION

·Functioning local infrastructure for e-mail server

·Deployment / administration of e-mail server according to specifications

·Installation of client application

·Administration of user-, distribution lists (FNC provides self service for user administration)

·Recovery of team rooms and/or Notes databases

·Backup and restore

·Mailbox recovery

·Recovery of deleted items

·Web-Interface (Lotus iNotes)

OUT OF SCOPE

·Infrastructure for hardware housing

·Email server hardware

·Hardware and storage backup

·Local hardware maintenance

·License for Notes client access

·Installation and configuration of application software backup and restore

48

Email Facility Connection Plus

Local email server for worldwide communication
provided and operated by FNC

Contact Person: Gianpietro Alpiani | Availability: worldwide                                                    Material No.:  I000051

SERVICE COMPONENT DESCRIPTION

With the service component “Email Facility Connection Plus” you obtain the key - based on Lotus Notes – to your daily worldwide communication. FNC provides the necessary email server incl. server software licenses. The setup and administration of the server is carried out via remote connection by FNC.

In addition to communicating by email, the Lotus Notes platform provides scheduling and chat functions as standard features. Attachments of up to 50 MB can be sent with each email. The particular size of the mailbox is limited to the local email server memory capacity. Automatic spam filtering protects you from unsolicited promotional emails and enhances security.

You provide the administration of the end users from a local site. This includes the installation of the client software onto the end devices. The local administrator is the first point of contact for the users. FNC supports the local administrator and provides 2nd Level and 3rd Level Support. Moreover, FNC actively monitors the availability of the local email server. The Lotus Notes client licenses incur license fees.

Numerous extensions are available for the service component “email facility connection plus” (see Optional Extensions).

QUALITY PARAMETERS

Operating times:	24/7
Request handling:	1 week lead time
Availability in % per month:*	99**

* The operability of the local infrastructure has to be ensured.

** Based on a three month average

FUNCTIONALITIES

·Platform: Lotus Notes (mailbox size depends on local memory)

·Message encryption (Notes encryption) possible within the Fresenius network

·Data backup on local server

·Interfaces (LDAP, POP, SMTP, MAPI, IMAP...)

·Maximum size of email incl.attachments 50 MB

·Automatic spam filtering

·Scheduling

PROVISIONS BY FNC

·Email server

·Server licenses: Domino

·Domino server software

DEPLOYMENT

·Installation and configuration of Domino server by local service provider

·Installation of releases, patches and hot fixes for server software

49

Email Facility Connection Plus

Local email server for worldwide communication
provided and operated by FNC

OPERATIONS

·Administration of:

·Domino server software via remote support

·Simple Mail Transfer Protocol (SMTP) server

·Global Domino administration service

Monitoring:

·General systems monitoring

·Availability monitoring

Maintenance of:

·Local hardware — provided by hardware suppliers

·Server software via remote connection by FNC

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support for Domino server via remote connection

·2nd and 3nd Level Support for local 1st Levels (local Notes administrators)

OPTIONAL EXTENSIONS

·Web interface (Lotus iNotes)

·Automatic antivirus monitoring for unencrypted emails

·Mailbox archiving

·Creating team rooms or Notes databases

·Mailbox extention ( > 300 MB) in steps of 50 MB

USER / CUSTOMER PARTICIPATION

·Installation of client application

·Administration of user-, distribution lists (Fresenius Netcare provides self service for user administration)

·Recovery of team rooms and/or Notes databases

·Backup and restore

·Mailbox recovery

·Recovery of deleted items

·Web-Interface (Lotus iNotes)

OUT OF SCOPE

·Infrastructure for hardware housing

·Lotus Notes client access licenses (separate compensation)

·1st Level Support

50

Email Web Solution Basic

Web-based worldwide email communication and scheduling

Contact Person: Gianpietro Alpiani | Availability: Worldwide                                                   Material No.: I000173

SERVICE COMPONENT DESCRIPTION

With the service component “Email Web Solution”, you obtain a highly available web platform for your internal and external email communication. The maximum size of the users’ mailbox is 100MB. Attachments of up to 5 MB can be sent with each email. Since the Web Client is opened in the Internet Explorer or Firefox, Lotus Notes Client does not have to be installed on your personal computer. However, to start the Web Client, an internet connection is required. FNC´s top priority is the security of your data. That is why your data is backed up by the FNC Data Center at regular intervals. Furthermore, while sending and receiving messages, the entire unencrypted email traffic is automatically checked for viruses and spam.

In addition to its communication infrastructure with Lotus Domino servers, certificate servers and directories, FNC is the worldwide administrator of the Fresenius email domains (e.g. @Fresenius. com) and the Domino Lightweight Directory Access Protocol (LDAP) directory services. There are no additional extensions available for Lotus Notes Web Client. Extensions are possible by switching to the Email Web Solution EXTENDED service, which includes Calendaring and PIM service, instant messaging (chat) and rich presence, and possible connection of authorized mobile devices (service extension).

QUALITY PARAMETERS

Operating times:	24/7
Maintenance window:	Necessary maintenance work will be announced
Availability in % per month:	99*

* based on a tree-month average

FUNCTIONALITIES

·Platform: Browser or other mail clients (no Lotus Notes Client)

·100 MB mailbox

·Web interface (Notes DWA)

·Maximum size of email 5 MB

·Automatic antivirus monitoring of unencrypted e-mails

·Automatic spam filtering

·Instant messaging (chat)

·Scheduling

PROVISIONS BY FNC

·“Messaging Infrastructure” provided by FNC Data Center in Bad Homburg/Germany

DEPLOYMENT

·Installation of new releases, patches, hot fixes for Web Mail server software

OPERATIONS

·Administration server software (Domino)

·User administration

·Backup and restore

·Mailbox recovery

·Recovery of deleted items

·Web access (Notes DWA)

·Global Mail User Directory administration service

·Routing of international mail traffic (Hub)

51

Email Web Solution Basic

Web-based worldwide email communication and scheduling

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support for Web Mail server software

·2nd and 3rd Level Support for local 1st Levels (local Notes administrators)

USER / CUSTOMER PARTICIPATION

·Request for new Web Mail Client shall be filed with local Lotus Notes administrator and forwarded to 2nd Level Support

·Local Lotus Notes administrator provides 1st Level Support

OUT OF SCOPE

·Lotus Notes client applications

·Message encryption within the Fresenius network

·Fax server and gateways

·Access to team rooms or Notes databases (based on standard template)

52

Email Web Solution Extended

Web-based worldwide email communication and scheduling

Contact Person: Gianpietro Alpiani | Availability: worldwide Material No.: I000305

SERVICE COMPONENT DESCRIPTION

With the service component “Email Web Solution Extended”, you obtain a highly available web platform — based on Lotus iNotes - for your internal and external email communication. In addition to sending/ receiving emails and having a 100 MB mailbox, you can also do calendar and scheduling, instant messaging (chat) and rich presence, and connect your mailbox to an authorized mobile device (service extension). Attachments of up to 50 MB can be sent with each email.

Since the Web Client is opened in the Internet Explorer or Firefox, Lotus Notes Client does not have to be installed on your personal computer. However, to start the Web Client, an internet connection is required. FNC´s top priority is the security of your data. That is why your data is backed up by the FNC Data Center at regular intervals. Furthermore, while sending and receiving messages, the entire unencrypted email traffic is automatically checked for viruses and spam.

In addition to its communication infrastructure with Lotus Domino servers, certificate servers and directories, FNC is the worldwide administrator of the Fresenius email domains (e.g. @Fresenius. com) and the Domino Lightweight Directory Access Protocol (LDAP) directory services. As mentioned above, in addition to the service provided by the Email Web Solution basic, with this EXTENED option you will get those additional services:  Calendaring and PIM service, instant messaging (chat) and rich presence, and possible connection of authorized mobile devices (service extension). No further additional extensions are available for Lotus Notes Web Client.

QUALITY PARAMETERS

Operating times:	24/7
Maintenance window:	Necessary maintenance work will be announced
Availability in % per month:	99*

* based on a tree-month average

FUNCTIONALITIES

·Platform: Browser or other mail clients (no Lotus Notes Client)

·100 MB mailbox

·Web interface (Notes DWA)

·Maximum size of e-mail 50 MB

·Automatic antivirus monitoring of unencrypted e-mails

·Automatic spam filtering

·Instant messaging (chat)

·Calendar and Scheduling

PROVISIONS BY FNC

·“Messaging Infrastructure” provided by FNC Data Center in Bad Homburg/Germany

·Notes Web Client licenses (Lotus iNotes)

DEPLOYMENT

·Installation of new releases, patches, hot fixes for Domino server software

53

OPERATIONS

·Administration server software (Domino)

·User administration

·Backup and restore

·Mailbox recovery

·Recovery of deleted items

·Webmail-Access (Lotus iNotes)

·Global Domino administration service

·Routing of international mail traffic (Hub)

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support for Web Mail server software

·2nd and 3rd Level Support for local 1st Levels (local Notes administrators)

USER / CUSTOMER PARTICIPATION

·Request for new Web Mail Client shall be filed with IT Administrator and forwarded to 2nd Level Support

·Local IT administrator provides 1st Level Support

OUT OF SCOPE

·Lotus Notes client applications

·Encryption of messages within Fresenius network

·Fax server and gateways

·Creation of team rooms or Notes databases (based on standard template)

54

Mobile Email for BlackBerrys

Reliable worldwide BlackBerry communication

Contact Person: Gianpietro Alpiani | Availability: worldwide Material No.: I000172

SERVICE COMPONENT DESCRIPTION

With the service component “Mobile Email for BlackBerrys” you connect your BlackBerry to your Fresenius Lotus Notes mailbox via a mobile network. Emails, appointments and, if applicable, contacts are automatically synchronized between your Lotus Notes mailbox and your BlackBerry at the push of a button, and they are checked for viruses. Data can only be stored in the Fresenius Lotus Notes mailboxes. This makes it unnecessary to add special services concerning the backup, storage or recovery of data.

On-site support for the user is provided by a local Notes administrator who, if required, is assisted by FNC. FNC provides 2nd and 3rd Level Support in cooperation with the designated local administrator (1st Level).

Note:

The BlackBerry device and the data plan required by the mobile provider are not included in this service component. Your BlackBerry has to be protected locally by a password. In case of a hardware loss, FNC shall be notified immediately.

Any new contract has to be approved by the board of directors in charge or a representative appointed by the board of directors.

QUALITY PARAMETERS

Operating times:	24/7
Maintenance window:	Sunday 08:00 – 09:00 CET worldwide
Service times:	06:00 – 18:00 CET Service Desk
On-call service times (Server):	Monday - Friday 18:00 – 22:00 CET Saturday/Sunday + public holidays 09:00 – 19:00 CET

FUNCTIONALITIES

·Virus protection on server

·Encryption: strong

·Synchronization of:

· Mobile Mail with Lotus Notes

· Calendar

· Contacts, if applicable

PROVISIONS BY FNC

·“Mobile Messaging Infrastructure” provided by FNC Data Center in Bad Homburg/Germany

OPERATIONS

·Planning and defining global filtering rules

·Defining client policies (e.g. password rules)

·User service component consultation and selection

·Service component accessories consultation and selection (e.g. hands-free equipment)

·General systems monitoring

·User documentation of systems and operations

·Messaging server

·Software maintenance and daily data backup

55

INCIDENT MANAGEMENT & SUPPORT

· 2nd and 3rd Level Support for local hotline / service desks

·  Ticket processing

·  Incident isolation

·  Remote incident resolution, where possible

·  Feedback to local 1st Level Support

·  Escalation management

·  Support for local administrator re. setup/configuration

USER / CUSTOMER PARTICIPATION

·Ordering BlackBerry with corresponding requirements

·Complying with authorization procedure

·Ensuring security policy compliance

·Appointing/contacting key user and/or local administrator

·BlackBerry administration (e.g. client activation, re-generating master key, data deletion,…)

·Activation via Wireless Enterprise or BlackBerry Desktop Manager USB

·BlackBerry user administration

·User support re. setup/configuration by the local administrator

OUT OF SCOPE

·BlackBerrys and regional telecommunications contract

·Preparation and distribution of devices (e.g. inserting the SIM card)

·No support for non-BlackBerry devices (e.g. Nokia)

56

Software Packaging and Deployment

Target-oriented distribution and maintenance of the
software products used with FNC

Contact Person: Lothar Gützkow | Availability: worldwide Material No.: -

SERVICE COMPONENT DESCRIPTION

With the service component “Software Packaging and Deployment” you can install, update and de- install your software on your user’s clients via mass rollout in a reliable and secure manner.

As far as standard software is concerned, FNC automatically makes sure that all software - that is provided by the Fresenius Group and required by the user - is available. Securing the running business by maintaining and distributing the software is also part of the service component “Basic IT Operation Package”.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 08:00 - 18:00 CET
Maintenance window in hours per week:	4

FUNCTIONALITIES

Rollout method:

·Push — for necessary security updates of applications

·Pull — for newly released applications and updates

·Offline - via CD or DVD dispatch only for SAPGUI

·User- or client-based

Special features:

·Language- or country-specific packaging possible (currently only for GER and UK)

·Distribution of software for terminal server (Citrix)

·Distribution for the use of Citrix to mobile or other clients

·Automatic de-installation possible in case of security-related relevance

·Maintaining and updating the operating system and software packages

PROVISIONS BY FNC

·Software depot and Windows server update service

DEPLOYMENT

·Deployment and maintenance of infrastructure for software distribution

·Maintaining and updating the distribution software

·Installation and configuration of client and user profiles (provided by the technician during an exchange of devices or move)

·Release installation distribution software

·Installation of patches, updates for distribution software

57

OPERATIONS

·Software life cycle management

·Implementing current security standards

·System maintenance

·Software packaging, creating scripts

·Testing standard software, incl. updates, patches, service packs for standard software

·Creating master images, CDs, DVDs

·Distribution of templates, policies, virus patterns

·Activation of software package with software subject to licensing

·Availability monitoring

·Capacity, utilisation and performance monitoring

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Testing of software, incl. updates, patches, service packs for software

·Offline rollout via CD or DVD dispatch for further applications (non-SAP)

USER / CUSTOMER PARTICIPATION

·In case of software subject to licensing, ordering the license with IT procurement

·Retrieving the software from the software depot after activation by user

·In case of individual software, the customer ensures compatibility with standard applications

·Clients have to be connected to the central software distribution (exception: for selected software, the rollout can be carried out via CD/DVD)

OUT OF SCOPE

·Distribution to servers

·On-site installation

·Short user instructions

·User training sessions and consultations

·Group training sessions for users

AVAILABILITY

·Distribution of application via software depot only for activated locations

·Activation of additional locations worldwide for software depot possible by arrangement (within the Fresenius Global Network)

·Dispatch of CD and DVD worldwide (only possible for selected software)

·Terminal server (Citrix) worldwide (Citrix Client is required)

·Windows server update service for activated locations

58

Terminal Server

Terminal servers enable a hardware-independent, reliable virtual
working environment

Contact Person: Lothar Gützkow | Availability: worldwide Material No.: I000252

SERVICE COMPONENT DESCRIPTION

With the service component “Terminal Server” you can open application programs on a central server and use them, assisted by a graphic user interface, with your own computer, via the Fresenius network. Terminal servers provide the following advantages:

·New software rollouts do not have to be installed on every single client

·The application software is operated centrally and runs independent of the hardware

·The processing power is rendered centrally and not on local computers; performance problems do not occur

·High security standard since the applications are centrally operated and the data remains in the Data Center.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Maintenance window in hours per week:	24 (outside the service times)
Availability in % pro Monat:	98*

* Based on a three month average

FUNCTIONALITIES

·Deployment of basic applications without software licenses (e.g. SAPGUI (current version), Kipdips, Applix, Office products)

·Farm concept (quick response to customer requirements)

·Deployment of applications via Citrix (terminal server software) for mobile end devices

PROVISIONS BY FNC

·Citrix Server

·Operating system software

DEPLOYMENT

·Client provided via software depot or via mail and/or File Transfer Protocol (FTP) download

·Installation of releases and updates for client applications (software depot or via email with FTP link)

59

OPERATIONS

·Concept design of standard system configurations

·Capacity planning

·Implementation of current security standards (access rights control, virus protection, security patches)

·General systems administration and parametrization

·Hardware maintenance (i.e. incident isolation/resolution or repair/ replacement of hardware, incl. spare parts stockkeeping)

·Performance analyses and tuning measures

·Deletion of expired sessions

·Administration active directory

·Pro-active updating of standard software (update / patches)

·Availability monitoring

·Capacity, utilisation and performance monitoring

·Comprehensive virus protection for Citrix and the installed applications

·Creating and maintaining the user documentation

·Increasing and decreasing system capacities

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Quantity adjustments for a high number of users

·Deployment of individual Citrix-capable applications

·Patching and/or updating individual software

USER / CUSTOMER PARTICIPATION

·BANF/ e-mail with request and cost unit for new user to FNC

·Installing Citrix Client

OUT OF SCOPE

·Software licenses for applications offered

60

E-Fax

Send and receive fax messages directly via email

Contact Person: Gerhard Rettenbacher | Availability: Rhine-Main-Area Material No.: I000033

SERVICE COMPONENT DESCRIPTION

With the service component “E-Fax” you can send and receive fax messages directly via your Lotus Notes Client. The “E-Fax Connector” accepts faxes for you around the clock in our Data Center in Bad Homburg/Germany — without a fax machine or a computer that is permanently switched on. You — as the fax recipient — do not accrue any additional telephone fees. The sender of a fax message only pays the valid telephone rate.

Performance features:

·Sending faxes from Lotus Notes

·Integrating and sending of Word, Excel, PPT, PDF and TIF files

·Receiving faxes

·Fax-on-demand

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times in hours per week:	Monday through Friday (except public holidays) 08:00 — 17:00 CET
Maintenance window in hours per week:	10
Processing time for standard change:	Next business day
Availability in % per month:	99*

* Based on a three month average

FUNCTIONALITIES

·Sending and receiving faxes from Lotus Notes

·Sending e-mail attachments from Lotus Notes via fax

·Integrating Word, Excel, PPT, PDF and TIF files

·Fax-on-demand

PROVISIONS BY FNC

·Infrastructure provided by FNC Data Center in Bad Homburg/Germany

·Redundant infrastructure to enable high availability of service

USER / CUSTOMER PARTICIPATION

·Completing and sending the IT request “Request for LAN and Notes access” in the FNC intranet

OPERATIONS

·Planning and designing the standard systems configurations

·Maintaining and further developing the technology (incl. hardware replacement, if necessary)

·Implementing current security standards

·User administration

·Patch management and providing new releases of servers

·General systems monitoring

·Capacity, utilisation and performance monitoring

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

DEPLOYMENT

·Installation and activation of fax service

61

Network Printer Access

Staff members have the possibility to access printers in the Fresenius network system

Contact Person: Ralf Ehrenborg | Availability: Rhine-Main-Area Material No.: I000284

SERVICE COMPONENT DESCRIPTION

The network printer service enables Fresenius staff members or external staff engaged by Fresenius to have access to printers in the Fresenius network system. The service ensures the timely integration (wiring, setup and print queue assignment) of the printers and operation via the existing print server.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times per week:	Monday through Friday (except public holidays) 08:00 - 16:30 CET
Availability in % per month:	98*

* Based on a three month average

FUNCTIONALITIES

·Administration of print queue by FNC

·Printing via the Fresenius network

PROVISIONS BY FNC

·Print server (planning and operating)

·Network connection

OPERATIONS

·Monitoring

·General operations control

·Life cycle management

·Infrastructure maintenance (Hardware and Software)

·Monitoring the active network components

·User support

·Replacement of outdated infrastructure within the scope of life cycle management (for printservers)

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Printer setup and configuration

·Connection / configuration of multifunction devices

USER / CUSTOMER PARTICIPATION

·Procuring network printer via FNC procurement

·Completing printer management form (shall be sent by email)

·Scheduling date and place for installation and/or connection, if necessary

·Alternatively, opening a ticket for installation at service desk

OUT OF SCOPE

·Setting up and configuring (separate order)

·Client hardware (printer)

·Travelling to on-site assignments (expenses)

·Consumables

62

Internet Access Basic

Internet access via the Fresenius network

Contact Person: Gerhard Rettenbacher | Availability: worldwide Material No.: I000048

SERVICE COMPONENT DESCRIPTION

With the service component “Internet Access” you obtain internet access via browser and File Transfer Protocol Client. The authorization for access is provided using the browser via a password query. If access is performed via other applications, these have to support a communication interface and a proxy authentication. Accessing unwanted or risky websites is automatically prevented. The traffic fees for usage are invoiced per MB.

In the FNC intranet you will find the IT request for internet access as well as information concerning the rules that have to be observed within the Fresenius Group for surfing the internet.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Maintenance window in hours per week:	10 Saturday 16:00 — 20:00 CET, Sunday 08:00 — 14:00 CET or after advance notice
Availability in % per month*:	97*

* Guaranteed from the time of switching from the internet service provider to FNC

FUNCTIONALITIES

·Connection to several internet providers (high availability)

·Web caching

·Content and URL filtering

·User authentication

·User-based activation of the internet access

·Firewalling

PROVISIONS BY FNC

·Connection to the Internet Service Provider (ISP) for Bad Homburg / Germany included; other locations are responsible for their own ISP access

DEPLOYMENT

·Data transmission volume (20 MB internet traffic per month & user)

·Deployment of proxy

OPERATIONS

·Capacity and performance planning

·Implementation of current security standards (e.g. for internet browser, firewall,…)

·High availability concept

·ISP management / negotiations

·Infrastructure maintenance (required central hardware and software)

·Automatic update of URL filter rule

·General systems monitoring

·ISP connection(s) monitoring

·Individual and traffic invoicing on the user level

·Adjusting to technical standards

·Testing

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

63

OPTIONAL EXTENSIONS

·Automatic antivirus filtering

USER / CUSTOMER PARTICIPATION

·Requesting deployment via online forms

·Complying with the company internet policy (security / user policy)

·Using the enabled browser (Internet Explorer and Firefox)

OUT OF SCOPE

·Client hardware (modem, ISDN card, DSL router)

·Internet fees

·Telephone dial-in (analog/ISDN)

·GPRS / UMTS /DSL connection

·Virus protection and content checking

64

VPN Connect Full Access

Internet access via Fresenius network

Contact Person: Gerhard Rettenbacher | Availability: worldwide Material No.: I000171

SERVICE COMPONENT DESCRIPTION

The service “VPN Connect Full Access” enables you to access Fresenius resources on the go from your own computer. The data transmission is encrypted via the internet. FNC provides an accessing software, which needs to be installed on your computer. A personal certificate - that has to be created when installing - is used for authentication.

In principle, all Fresenius programs/applications are executable via the VPN connection. Since this service component runs — for security reasons — in a protected area of the central Data Center, activation in the firewall is necessary for special applications. Please specify the application in the IT request. Standard applications, such as Lotus Notes, SAP or file server access, for example, are generally activated.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Montag bis Freitag (außer an Feiertagen) 06:00-18:00Uhr
Maintenance window in hours per week:	10 (Samstag 16:00 — 20:00 MEZ, Sonntag 08:00 — 14:00 MEZ oder nach Ankündigung)
Availability in % per month*:	98*

* Based on a three month average

FUNCTIONALITIES

·Encryption algorithms: strong (e.g. 3DES, AES)

·Authentication via software certificate

·Central firewalling

·Simultaneous access to the company network for all clients

PROVISIONS BY FNC

·VPN client software

·central Fresenius internet access

DEPLOYMENT

·Deployment of client software by central sortware allocation center (if possible) or via email with link

·Activation of the clien software via remote access

OPERATIONS

·Implementation of current security standards

·Administration

·General systems administration and parametrization

·Life cycle management

·Certificate management (creation / blocking)

·Maintenance infrastructure (hardware and software)

·Monitoring of active central network components

·Monitoring the security specifications for central IT services

·Performing (security) audits for central components

·Monitoring of central infrastrukture

·Replacement of outdated infrastructure within the scope of life cycle management

·Deployment of patches and new releases

65

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Installation on site by technician (separate compensation)

USER / CUSTOMER PARTICIPATION

·The user needs internet access to enable communication with the Fresenius VPN gateways; the corresponding VPN protocols have to be activated in the user´s firewall

·Requesting the service via FNC intranet request

·Compliance to the FNC Security Policy (see FNC Intranet)

·In the event a third party is engaged: an agreement is required concerning the obligation to ensure compliance with security requirements, especially so that the network or the systems are not attacked and information is not spied upon

OUT OF SCOPEOUT OF SCOPE

·Client hardware (modem, ISDN card, DSL router)

·Internet fees with provider

·Telephone dial-in (analog/ISDN)

·GPRS / UMTS fees

·DSL connection

·Virus protection and content checking

·Installation of client software (client software is available at the software depot)

66

VPN Connect Basic Application

Staff members can — while on the go — access internal resources
from the company computer via VPN and a certificate

Contact Person: Gerhard Rettenbacher | Availability: worldwide Material No.: I000228

SERVICE COMPONENT DESCRIPTION

The service component “VPN connect Basic Application” enables you (as a Fresenius staff member), while travelling or working from your home office, to access internal Fresenius resources from your own Fresenius computer. Using web VPN with certificate is recommended for Fresenius staff members who only want to use email, SAP and intranet while on the go. The data is transmitted in encrypted form. The user has to register only once with the Web VPN service. In doing so, a browser certificate is generated which entitles the user to access the service.

The Web VPN service provides the following applications:

· Internal websites — special software is not required for this

· SAP (via SAPGUI)

· Lotus Notes

As far as SAP and Lotus Notes are concerned, a software client has to be loaded and started from the home page of the service. Only the Windows operating system in FNC Support is supported. Accessing other (or via other) applications, such as terminal or file service etc., is not possible with this service component.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Maintenance window in hours per week:	10 Saturday 16:00 - 20:00 CET Sunday 08:00 - 14:00 CET or by arrangement
Availability in % per month:	98*

* Based on a three month average

FUNCTIONALITIES

·Encryption algorithms: strong (e.g. 3DES, AES)

·Supported access technologies: SSL-VPN

·Authentication via software certificate

·Central firewalling

·Simultaneous access to the company network for all clients

PROVISIONS BY FNC

·Certificate

·VPN tunnel software for client

·Central Fresenius internet access

DEPLOYMENT

·Certificate activation (enrolment)

·Tunnel software provided by browser

67

OPERATIONS

·Implementation of current security standards

·General systems administration and parametrization

·Certificate generation / certificate management

·Certificate revocation

·Infrastructure maintenance

·Monitoring the active network components

·Monitoring the security specifications for central IT services

·Performing (security) audits for central components

·Deployment of patches and new releases for infrastructure

·Replacement of outdated infrastructure within the scope of life cycle management

·Monitoring the central infrastructure

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

USER / CUSTOMER PARTICIPATION

·The user needs internet access to enable communication with the Fresenius VPN gateways; the corresponding VPN protocols have to be activated in the user´s firewall

·In the event a third party is engaged: an agreement is required concerning the obligation to ensure compliance with security requirements, especially so that the network or the systems are not attacked and information is not spied upon

·Requesting the service via FNC intranet request

·Installation of the certificate that has been sent

OUT OF SCOPE

·Client hardware (modem, ISDN card, DSL router)

·Internet fees

·Telephone dial-in fees (analog/ISDN)

·GPRS / UMTS / DSL connection

·Virus protection and content checking

·Accessing other applications, such as terminal or file service etc., is not possible with this service component

68

VPN WEB Connect

Staff members can — from external locations - access internal
 websites and applications via VPN (password protected)

Contact Person: Gerhard Rettenbacher | Availability: worldwide Material No.: I000227

SERVICE COMPONENT DESCRIPTION

The service “VPN WEB Connect” enables Fresenius staff members or external staff engaged by Fresenius to have access to internal Fresenius resources. Using web VPN with Token is recommended for access from external computers, for instance from an internet café or from external laptops. The data is transmitted in encrypted form.

The user has to log in to a website via browser. A special device, called Token, determines the password that needs to be entered in the browser. The Token measures 6 x 3.5 x 0.9 centimeters.

With this service component you can access the following applications:

·Internal websites — special software is not required for this

·SAP (via SAPGUI)

·Lotus Notes

As far as SAP and Lotus Notes are concerned, a minor software client has to be loaded and started from the home page of the service. Only the current version of the Windows operating system is supported.

Accessing other (or via other) applications, such as terminal or file service etc., is not possible with this service component.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Maintenance window in hours per week:	10 Saturday 16:00 — 20:00 CET, Sunday 08:00 — 14:00 CET or by arrangement
Availability in % per month*:	98*

* Based on a three month average

FUNCTIONALITIES

·Encryption algorithms: strong (e.g. 3DES, AES)

·Supported access technologies: SSL-VPN

·Authentication via user name and one-time password (Token or other)

·Central firewalling (application layer inspection)

·Simultaneous access to

PROVISIONS BY FNC

·Keytoken

·Replacement Token by request

·Tunnel software for client

·Central Fresenius internet access

DEPLOYMENT

·Deployment of VPN tunnel software via browser

·Keytoken shall be sent

69

OPERATIONS

·Implementation of current security standards

·General systems administration and parametrization

·Life cycle management

·Maintenance of central hardware and software

·Central infrastructure monitoring

·Monitoring the security specifications for central IT services

·Performing (security) audits for central components

·Hardware and Keytoken maintenance

·Replacement of outdated infrastructure within the scope of life cycle management

·Deployment of patches and new releases for infrastructure

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

USER / CUSTOMER PARTICIPATION

·The user needs internet access to enable communication with the Fresenius VPN gateways; the corresponding VPN protocols have to be activated in the user´s firewall

·Requesting the service via FNC intranet request

·In the event a third party is engaged: an agreement is required concerning the obligation to ensure compliance with security requirements, especially so that the network or the systems are not attacked and information is not spied upon

·Returning the Token after the service has ended

·Requesting a replacement Token

OUT OF SCOPE

·Client hardware (modem, ISDN card, DSL router)

·Internet fees

·Telephone dial-in (analog/ISDN)

·GPRS / UMTS fees

·Virus protection and content checking

·Accessing other applications, such as terminal or file service etc., is not possible with this service component

70

Home Office Basic

Access to Fresenius resources from the
home office via a VPN router

Contact Person: Gerhard Rettenbacher | Availability: Germany Material No.: I000202

SERVICE COMPONENT DESCRIPTION

With the service component “Home Office Basic” you can access the Fresenius network with your documents and data from your own computer in the home office. The data is transmitted in encrypted form via the internet. The connection to the Fresenius network is automatically provided via router. Therefore, separate VPN software is not required.

However, a DSL connection by Fresenius is needed. A connection to the Fresenius network via a private DSL connection is not possible! Regarding this service component “Home Office Basic”, all maintenance and support work that is carried out on the DSL router shall be separately invoiced according to time and effort.

In principle, all Fresenius programs/applications are executable from the home office. Since this service component runs — for security reasons — in a protected area of the central Data Center, activation in the firewall is necessary for special applications. Please specify the application you want to access from your home office in the IT request. Standard applications, such as Lotus Notes, SAP or file server access, for example, are generally activated.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Maintenance window in hours per week:	10
Availability in % per month*:	98*

* Based on a three month average

FUNCTIONALITIES

·Encryption algorithms: strong (e.g. 3DES, AES)

·3 GB traffic volume

·Central internet access via FNC

·Central firewalling (application layer inspection)

·Redundant VPN access gateways

·Simultaneous access to company network for all clients

PROVISIONS BY FNC

·DSL router

DEPLOYMENT

·Installation and configuration of router via remote connection

OPERATIONS

·Implementation of current Fresenius security standards

·General systems administration and parametrization

·Life cycle management

·Infrastructure maintenance (hardware and software)

·Monitoring the security specifications for central IT services

·Performing (security) audits for central components

71

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·On-site installation

·Deployment of patches

·Deployment of new releases

·Deployment of the installation of new releases, incl. required re-configuration

OUT OF SCOPE

·Hardware maintenance of router

·Replacement of outdated infrastructure within the scope of life cycle management

·Software maintenance of router

·Internet fees of the user

·Telephone dial-in (analog/ISDN)

·GPRS / UMTS function / fees

·DSL connection

·Life cycle management

·Central monitoring of the active decentralized network components

72

Home Office Comfort

Access to Fresenius resources from the home office
via a VPN router with W-LAN

Contact Person: Gerhard Rettenbacher Material No.: I000213

SERVICE COMPONENT DESCRIPTION

With the service component “Home Office Comfort” you can access the Fresenius network with your data and documents from your own computer in the home office. The data is transmitted in encrypted form via the internet. The connection to the Fresenius network is automatically controlled via router with W-LAN function. Therefore, separate VPN software is not required. However, a DSL connection by Fresenius is necessary. Access to the Fresenius network via a private DSL connection is not possible. In case the DSLconnection fails, it can alternatively be established to Fresenius via ISDN. The service component “Home Office Comfort” contains all maintenance and support work that can be carried out on the DSL router via remote connection. If required, a service technician will provide on-site support subject to separate compensation.

In principle, all Fresenius programs/applications are executable from the home office. Since this service component runs — for security reasons — in a protected area of the central Data Center, activation in the firewall is necessary for special applications. Please specify in the IT request the applications you want to access from your home office. Standard applications, such as Lotus Notes, SAP or file server access, for example, are generally activated.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Maintenance window in hours per week:	10
Availability in % per month*:	98*

* Based on a three month average

FUNCTIONALITIES

·Encryption algorithms “strong” (e.g. 3DES, AES)

·Central firewalling (application layer inspection)

·3 GB traffic volume

·Central internet access via FNC

·Redundant VPN access gateways

·Simultaneous access to company network for all clients

PROVISIONS BY FNC

·DSL router with W-LAN

·ISDN backup connection (optional)

DEPLOYMENT

·Pre-configuration of active components (e.g. router)

·Deployment of patches and new releases,incl. required reconfiguration via remote connection

73

OPERATIONS

·Implementation of current Fresenius security standards

·General systems administration and parametrization

·Life cycle management

·Certificate generation

·Certificate management

·Certificate revocation

·Infrastructure maintenance (hardware and software)

·Monitoring the security specifications for central IT services

·Performing (security) audits for central components

·Hardware maintenance for provided router with W-LAN

·Replacement of outdated infrastructure within the scope of life cycle management

·Monitoring the central infrastructure

·Software maintenance for provided router with W-LAN

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·ISDN backup connection

·Plus package (ISDN + 2GB traffic volume)

·On-site installation

OUT OF SCOPE

·Internet fees of the user

·Telephone dial-in (analog/ISDN)

·GPRS / UMTS function / fees

·DSL connection

·Central monitoring of the active decentralized network components

74

Voice Telephone

Digital telephone connection with a wide range
of business functions

Contact Person: Gerhard Rettenbacher | Availability: Rhine-Main Area Material No.: I000075

SERVICE COMPONENT DESCRIPTION

A reliable communication infrastructure lays the foundation for a large corporate group with many subsidiaries. With the service component “Voice Telephone” FNC offers the connection to the central Fresenius telephone system and provides you with a standard IP telephone. The IP telephones offer practical functions, such as: call forwarding, call rerouting, conference calls and many more. FNC assigns the telephone numbers, sets up the telephones for you and ensures smooth operation.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Availability in % per month*:	99*

* Based on a three month average

FUNCTIONALITIES

·Forwarding is programable (possible provisions are: time frame, reachability, busy)

·Conference call with max. 8 participants

·Call pickup, call groups, pickup groups

·Re-routing among locations

·Manager / secretary station

·Free distribution of all extension numbers to end devices

PROVISIONS BY FNC

·Voice end device: standard IP telephone

·Pool of replacement end devices for replacing devices outside the manufacturer´s maintenance

·Connecting to the central Fresenius telephone system

DEPLOYMENT

·On-site installation, configuration and integration of the telephone

·Setup of telephone connection

·Putting end device into service

·Installation of release patches and updates for end devices

·Disassembly and disposal of end devices, if applicable

OPERATIONS

·Designing the high availability concept

·Administration of telephone numbers

·Negotiations and management with telecommunication service providers (carrier management)

·General systems monitoring

·Maintenance of central components

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

75

OPTIONAL EXTENSIONS

·Interfaces with applications

·Automatic Call Distribution (ACD) — call distribution linear, cyclical or broadcast

·Hotline function: automatic connection dial-up to defined end devices

USER / CUSTOMER PARTICIPATION

·Sending IT request for a new telephone line to FNC

OUT OF SCOPE

·Fees for external telephone calls

·Voice mailbox for each subscriber

76

Voice Mailbox

Voice mailbox for existing landline connections

Contact Person: Gerhard Rettenbacher | Availability: Rhine-Main Area Material No.: I000075

SERVICE COMPONENT DESCRIPTION

With the service component “Voice Mailbox” you receive a voice mailbox functionality for your existing telephone connection. Recorded calls are retrievable via a telephone message box. As an option, you can receive the recorded calls as a sound file via email.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Availability in % per month*:	99*

* Based on a three month average

FUNCTIONALITIES

·Answering machine and voice mailbox

DEPLOYMENT

·Mailbox configuration by FNC

OPERATIONS

·General systems monitoring

·Availability monitoring

·Installation of releases, patches, updates for the voice mailbox system

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Voice-to-mail

USER / CUSTOMER PARTICIPATION

·IT request application

77

Fax Connection

Connection to the Fresenius fax infrastructure

Contact Person: Gerhard Rettenbacher | Availability: Rhine-Main Area Material No.: I000075

SERVICE COMPONENT DESCRIPTION

With FNC’s service component “Fax Connection”, you receive a connection for your fax machine. The fax connection is provided and operated by FNC. Order the fax end device at the FNC IT procurement. Our on-site technicians will gladly help you to get started or aid in the analysis of errors.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Availability in % per month*:	99*

* Based on a three month average

FUNCTIONALITIES

·Redirection of fax to other connections or locations can be established by the telephone switchboard

PROVISIONS BY FNC

·Connection for fax machines

DEPLOYMENT

·Installation of mailbox by FNC

OPERATIONS

·Implementation of current security standards

·General systems monitoring

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Upgrade and retooling of hardware components of end device

·Moving of single device

·Dismantling and - if need be - disposal of hardware

USER / CUSTOMER PARTICIPATION

·Request a new fax connection via FNC intranet

·Order end device through FNC IT

OUT OF SCOPE

·Fax machine (purchase via FNC IT procurement)

The following services are - as far as there is a service contract - provided by the supplier of the end device:

· Installation, configuration, integration hardware

· Initial operation

· Maintanence end devices

· Support end devices

78

Mobile Phones and Data Connections

Fresenius offers staff members standard mobile
 phones for commercial use

Contact Person: Jürgen Schulz | Availability: Rhine-Main Area Material No.: -

SERVICE COMPONENT DESCRIPTION

A reliable communication infrastructure lays the foundation for a large corporate group with many subsidiaries. With the service component “Mobile Phones and Data Connections” FNC offers maximum flexibility and provides you with mobile phones (cell phones), smartphones, and hardware for data transmission from the range of services in the intranet. The mobile phones offer practical functions, such as: call forwarding, call rerouting, hands-free equipment, mailbox service and many more. FNC guarantees extensive service for standardized devices and ensures smooth operation.

QUALITY PARAMETERS

Guaranteed service times in hours per week:	Monday through Friday (except public holidays) 06:00 - 17:00 CET
Term of mobile phone contract:	24 months

PROVISIONS BY FNC

·Voice end devices (subsidized mobile phone / smartphone every 24 months)

·Subsidized data transmission hardware (e.g. UMTS stick, PDA) every 24 months

DEPLOYMENT

·Delivery of phone and contract data by postal mail

·Disposal of end devices

·Devices on loan

OPERATIONS

·Negotiations and management with telecommunication service providers (carrier management)

·De-activation of SIM cards

·Ordering replacement SIM cards

·SIM activation (PIN/PUK)

·Repair of defective end devices / accessories

·Contract data management

·Warranty processing

·On-Site stockkeeping of blank SIMs (for quick deployment of replacement cards)

·Stockkeeping of replacement / pool devices

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

79

OPTIONAL EXTENSIONS

·Hands-free equipment for motor vehicles

·Dual SIM card

·Data flat rate for internet usage

·Fixed data volume for internet usage

·International option

·Fixed quotas of call volume, group-internal

USER / CUSTOMER PARTICIPATION

·Sending BANF for new phone to FNC

·Adhering to approval workflow (FME intranet approval tool (only for BlackBerry))

·Requesting new mobile phone after 24 months (observing mobile phone guideline)

OUT OF SCOPE

·Standard support of non-enabled devices

REPORTING

·Call itemization (optional)

·Billing information by postal mail

·Reporting according to organizational unit, cost unit, etc. by request

80

Audio Conferencing

Initiating external conference calls

Contact Person: Andreas Schaubert | Availability: worldwide Material No.: I000262

SERVICE COMPONENT DESCRIPTION

With the service component “Audio Conferencing” you can have conference calls worldwide with up to 60 participants. FNC provides the platform with telephone numbers and a conference management function. Should you have conference calls on a frequent or regular basis, you can request a permanent dial-in number. If necessary, an operator supports and monitors (optional) your conference call. FNC also supports — via an external service provider - audio conferences with up to 90 participants, as an option.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Maintenance window in hours per week:	Depending on necessity, outside the service times
Availability in % per month:	99*

* Based on a three month average

FUNCTIONALITIES

·Reserving the audio conference via email or Lotus Notes database (shall be set up at your location, by request, if needed regularly)

·Permanent setup of a dial-in number (by request)

·Conference management function for participants (among group of participants)

·Central dial-in number for audio conference

·Toll-free dial-in (USA)

PROVISIONS BY FNC

·Central audio conferencing server

OPERATIONS

·General systems administration (e.g. configuration of dial-in numbers)

·Availability monitoring of dial-in numbers

·Capacity and utilisation monitoring

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Monitoring the conference connection via operator

·Audio conference with more than 60 participants

USER / CUSTOMER PARTICIPATION

·Reserving the audio conference via e-mail or Lotus Notes database

·If needed, requesting the permanent setup of a dial-in number

OUT OF SCOPE

·Applicable telephone fees

81

Room Video Conferencing

Video conferencing for spoken and visual communication in
meeting rooms

Contact Person: Andreas Schaubert | Availability: worldwide Material No.: I000262

SERVICE COMPONENT DESCRIPTION

With the service component “Room Video Conferencing” you can do video conferencing with internal and/or external colleagues and/or business partners in meeting rooms that are equipped with video conferencing systems. FNC will gladly support you in setting up a video conference room with regard to a video conferencing system, the equipment plan and a media control system for your location. As far as video conferencing is concerned, additional participants can dial-in and join the video communication via an audio link. If required, an operator monitors the connection.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET

FUNCTIONALITIES

·Reserving the video conference via email or Lotus Notes database

·Worldwide video conferences possible via the global Fresenius network

·Encryption of the connection is possible when the end devices support the standard AES128 Media Encryption and DH1024 Key Exchange

·Camera control with zooming and focusing on the participants

·Video conferences with external companies

PROVISIONS BY FNC

·Central video conferencing server

OPERATIONS

·Availability monitoring of video conferencing server

·Capacity and utilisation monitoring

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Preparation of the video conference by FNC

·Monitoring the connection by an operator

·Setting up and checking the quality of the video connection

USER / CUSTOMER PARTICIPATION

·Requesting a new video conference via Lotus Notes database (blank form, time frame, booking information, cost unit, company) or per email

·Room has to be reserved / booked

OUT OF SCOPE

·Room for video conferences

·Video conferencing equipment

·Dial-in costs (e.g. ISDN)

82

Desktop Video Conferencing

Video conferencing for spoken and visual communication
 via your own computer

Contact Person: Andreas Schaubert | Availability: worldwide Material No.: I000261

SERVICE COMPONENT DESCRIPTION

With the service component “Desktop Video Conferencing” by FNC you cannot only hear the persons you are talking to, but also see them. For this service you need a computer — connected to the Fresenius network - with a webcam and a headset. FNC provides you with the required conferencing software so that you can verbally and visually communicate with your business partners worldwide via video conferencing. In addition to a point-to-point connection between 2 conference participants, a video conference with several participants can be set up as an option.

QUALITY PARAMETERS

Operating times:	24/7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET
Maintenance window in hours per week:	10

FUNCTIONALITIES

·Setting up a point-to-point connection via the global Fresenius network with the aid of address books

·Encryption of the connection is possible when the end devices support the standard AES128 Media Encryption and DH1024 Key Exchange

PROVISIONS BY FNC

·Central videoconferencing server

·Client software with license

·Application documentation and quick tips

·Address book of all participants

DEPLOYMENT

·Client software is provided via an email link

OPERATIONS

·General systems administration (e.g. configuration of user data)

·Installation of application, release patches, hot fixes

·Availability monitoring of video conferencing server

·Capacity and utilisation monitoring

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

83

OPTIONAL EXTENSIONS

·Multi-point connection via the global network or ISDN

·Reserving a multi-point conference via email or Notes database with FNC

·Central instruction and management of the conference

·Software / hardware configuration by FNC technicians

USER / CUSTOMER PARTICIPATION

·Hardware has to be procured by the customer (order requirements forwarded to FNC IT procurement)

·IT request with name and cost unit of the user via email to National Telecommunication

·Installation of the required Client software and hardware by the user; support by an FNC technician is possible subject to separate compensation

OUT OF SCOPE

·Required user hardware: e.g. webcam, headset with microphone (newer notebooks may already have an integrated webcam and microphone)

·Applicable fees for ISDN connections

84

Output Management Internal

Receiving large printing tasks for central
processing and distribution

Contact Person: Christian Scheerer | Availability: Rhine-Main Area Material No.: I000049

SERVICE COMPONENT DESCRIPTION

With the service component “Output Management Internal” you can print large internal printing tasks via a central system (e.g. SAP). The service component includes the subsequent collective distribution of the printed products to the output recipient via interoffice mail (Rhine-Main area).

QUALITY PARAMETERS

Operating times:	5x7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET

PROVISIONS BY FNC

·Black/white laser printer

·Expendable items (toner and paper)

OPERATIONS

·Production planning andscheduling

·Post-processing (separating, tearing, ...)

·Mailing via interoffice mail (Rhine-Main area)

·Printer monitoring

·Output production monitoring

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Expendable items (pre-printed paper)

USER / CUSTOMER PARTICIPATION

·SAP has to be configured for mass printing

·Template for the printing paper has to be defined

·Recipient for output needs to be specified

·Coordinating the time schedule and/or delivery date

OUT OF SCOPE

·Transporting executed printing orders outside the Rhine-Main area

·Mail sorting

·Enveloping

·Franking

85

Output Management External

Organizing printing tasks worldwide via an
external service provider

Contact Person: Werner Wagner | Availability: worldwide Material No.: I000047

SERVICE COMPONENT DESCRIPTION

With the service component “Output Management External” you can have your invoices, that are generated in SAP every day, sent to your customers worldwide via an external service provider. The external service provider prints the invoices and envelopes them in a postage- and cost-optimized manner. In this way, you save on mailing expenses and a quick and smooth process is ensured.

QUALITY PARAMETERS

Operating times:	5x7
Guaranteed service times:	Monday through Friday (except public holidays) 06:00 - 18:00 CET

OPERATIONS

·Production planning and scheduling

·Post-processing (separating, tearing, ...)

·Mail sorting, enveloping, franking

·Mailing worldwide(for international mailing separate postal charges apply)

·Consolidating mailings (mailings are pre-sorted)

·Printer monitoring

·Output production monitoring

·Issuing output status reports

INCIDENT MANAGEMENT & SUPPORT

·2nd and 3rd Level Support

OPTIONAL EXTENSIONS

·Expendable items (paper and pre-printed paper)

USER / CUSTOMER PARTICIPATION

·SAP has to be configured for mass printing

·Template for the printing paper has to be defined

·Coordinating the time schedule and/or delivery date

86

One-time License Fee

SAP ERP 6.0 and SAP Maintenance

Contact Person: Service Desk | Availability: worldwide

SERVICE COMPONENT DESCRIPTION

(Material groups: 96111129, 96111130)

One-time license fee for the usage of standard SAP systems including archiving, user and SAP GUI creation on your PC. Software maintenance of software providers (SAP).

SAP MAINTENANCE FEE:

mySAP Business Suite:

Material No.	Description	For named user and year
I000115	SAP Maintenance Professional User	€	345,96

87

CHARGING

Licenses:

Based on period comparisons (actual number of users vs. licenses purchased) in coordination with the respective customers.

SAP Maintenance:

Monthly charging based on registered users.

Remark

In case of Professional and Limited Professional Users, IXOS is included.

Travel expenses for the set-up of SAP GUIs outside the area of Friedberg - Bad Homburg - Darmstadt will be charged to the customer.

Other license types are provided on request.

88

SAP Usage

Contact Person: Service Desk | Availability: worldwide Material No.: I000159

SERVICE COMPONENT DESCRIPTION

(Material Group: 96111112)

The following services are covered by this annex:

·Ensuring system availability (e.g. 98%)

·Hardware for development, test and production incl. disks, archive, exchange of components, etc.

·Backup and external storage of backup

·Archiving Data

·Technical release changes and hot packages

·SAP GUI - Management

·Support of SAP ERP 6.0 printing

·Monitoring of System

·Reorganization of Data

·Improvement of response time

·Planning of further Hardware requirements

·Provision of Hardware and Software

·Housing Costs — Power, Floor space, Air Cond.

·Maintenance of data center Hardware / Software

QUALITY PARAMETERS

Technical Hotline:	Monday through Friday (except public holidays) 08:00-18:00 CET
Availability in % per month:	98*

*based on a three month average

OPERATIONS

The following price conditions are applied for the SAP Usage average:

·Usage in hours by average rate € 28,94

89

SAP Support

Contact Person: Service Desk

SERVICE COMPONENT DESCRIPTION

(Materialgruppe: 96111136)

Fresenius’ business operations are primarily supported by SAP. In order to give you the best possible support with questions revolving around SAP, FNC runs an extensive SAP support organization.

For the support of the SAP users FNC provides a certain capacity per user including the following services:

·Hotline / Maintenance

·Petty Requests (< 2h)

·Customer advice

·Test of release-changes/hot-packages

·Release-changes

·Hot-packages

·Check of new or changed programs

·Transports in productive systems

·Quality and performance improvement

·Monitoring productive systems

·Tuning activities (SAP-programs and -jobs)

·Quality Management as basis for progressive validation of GxP relevant processes

·Support for the validation of GxP relevant processes

90

SAP Project capacity for
 application development

Contact Person: Service Desk Material No.: I000004

SERVICE COMPONENT DESCRIPTION

(Material Group: 96111114)

Fresenius Netcare will take over the complete handling of a project. It will provide a limited contingent for the use of externals. Therefore, a certain capacity are planned within the SLA.

From overall concept to draft for programming

·Project definition for further functional improvements

·User support in determining the benefits resulting from a project and assistance with the approval procedure

·Checking of effects upon the data processing centre and the network

·Hardware requirements

·Software requirements

·Demands on the network

·Checking of standard software

·If applicable, selection of development tools

Realisation

·Co-ordination with customer

·Programming

·Design and realisation of a training concept

·Offer for support

Work place costs for application developers

·Terminal devices (PC, Printer, etc.)

·Processor resources

·Network resources

·Consumptive material

·Rentals

·Office equipment

·Travel expenses between the Fresenius locations in Rhein Main Area (Germany)

·All other travel expenses will be charged out additionally

·Market observation

·Education

Administration / co-ordination of externals

·Checking the necessity of the assignment

·Selection of the appropriate partner

·Negotiations, incl. contract

·Assignment planning and co-ordination

·Approval of dp-technical features

·Factual checking of the invoices

·Instruction to effect payment

91

CONDITIONS

The following price conditions are applied :

Price

·€ 980.00 per person day (8 h) resp. € 122.50 per hour

Charging

·Order of customer based on an offer made by Fresenius Netcare

·Offers and charging are made using one of three methods:

Fixed price

·Realisation of defined requirements at an agreed price and date

Upper price limit

·Agreement of an upper price limit which may not be exceeded

·Charging according to services rendered on the basis of man days

According to expenditures

·Charging according to services rendered on the basis of man days

·Foreseeable exceeding of offer in case of fixed price or upper price limit, for example due to additional requirements:

·  Information to customer, giving reasons

·  After approval by the customer the realisation will be effected

Remarks

If the capacity is not exploited, the customer is NOT charged at this time, although the capacity was be kept ready. Should the estimated expenditure in the offer be exceeded, the customer will be informed and reasons will be given before the costs are incurred. Only after written approval by the customer will the cost be effected. Since agreed projects have priority, additional requirements will have an effect upon the period of realisation. Rights on software: The customer shall receive simple, non exclusive use rights of the software developed within a project. The assignment of external services/consultants is co-ordinated between the customer and Fresenius Netcare. Fresenius Netcare co-ordinates the assignment and checks the factual correctness of the invoices.

92

Electronic Data Interchange

Contact Person: Service Desk Material No.: I000083

SERVICE COMPONENT DESCRIPTION

(Materialgruppe: 96111123, Material I000083)

Processing of IDocs e.g. for:

·electronically sent orders, invoices, deliveries, price conditions, goods movements as well as

·electronically received orders, invoices, and master data (e.g. customers, materials, …).

OPERATION

·Monitoring and optimising of all components

·Monitoring of processing of messages.

·Clarification of problems with all parties involved, suppliers, customers, clearing house, external network partners

·Minor developments

CONDITIONS

The following price conditions are applied:

Price

·€ 0,28 per IDoc position

Charging

Monthly according to number of IDoc positions / invoices

93

IT Training

Contact Person: Service Desk

SERVICE COMPONENT DESCRIPTION

(Materialgruppe: 96111117, 96111135)

The training unit co-ordinates all training sessions offered by FNC.

Training sessions offered

·See training catalogue

Administration

·Generation of a training offer

·Planning of the training sessions, incl. registration and room planning

·Obtaining and checking of external trainers

·Co-ordination of external trainers

Resources

·Training by own and external trainers

Costs assumed

·Room costs, incl. additional expenses

·Equipment, PCs, printers, servers

·Processor resources for SAP R/3

·Training material

·External trainers

Trainings with external training agencies (special agreements possible)

CONDITIONS

The following price conditions are applied:

I000060	Training MS Access	€	560
I000063	Single training	€	810
I000064	Training for departments - 1 day	€	990
I000062	Training room rental 2	€	320
I000068	Training room rental 3	€	370
I000058	Workshop 1	€	560
I000059	Workshop 2	€	520

Charging

Charging after attendance of training to the cost centre stated on the registration form.

94

SAP Travel Management

Carry out all economic processes of travelling

Contact Person: Goesta Kühn | Availability: Germany

SERVICE COMPONENT DESCRIPTION

The service component SAP Travel Management allows you to carry out all economic processes of travelling from travel authorization request and travel expense report to securely and efficiently handing over travel expenses to other functional areas of the company. Travel management accompanies all settlement processes of travel with holistic functionality and integrates them into the circle of accounting and payment. This comprises travel authorization request as well as accounting of travel costs according to the company guideline U4. Travel authorization requests and travel expense reports will be entered exclusively via the respective company portal. Further information can be found in the SAP Portal SLA.

QUALITY PARAMETERS

Betriebszeiten:	24/7
Garantierte Servicezeiten:	Montag bis Donnerstag (außer an Feiertagen) 09:00 - 17:00 Uhr
Wartungsfenster in Stunden:	LCP Einspielung 4x im Jahr EHP Einspielung 1x im Jahr Systemanpassung bei gesetzlichen Änderungen
Verfügbarkeit in % pro Monat:	98*

* Bezogen auf einen Dreimonatsduchschnitt

FUNCTIONALITIES

·Workflow-based approval of travel authorization request

·Workflow-based approval of travel expense reports

·Workflow-based approval of monthly travel expense reports

·Email notification

·Workflow-based approval of permanent travel authorization requests

·Replacement regulations

·Email forwarding

PROVISIONS BY FNC

·Operation travel management in P13

·P13 hosting in data center Bad Homburg

·Backup systems

·Archiving systems

·Interface to FI / CO

·Travel management module

DEPLOYMENT

·User creation via SAP user administration for travel management (User authorizations must be requested via SAP data responsible according to the respective organization and process.)

·Deletion or blocking of users in P13

95

OPERATIONS

·Conception of standard system configurations according to the company guideline (U4) (customizing not included)

·Realize current security standards

·Client connection (access via SAP portal, make Dynpros for portal usage available)

·Backup concept

·Archiving concept (by means of P13)

·Job preparation and planning (e.g. booking, charging)

·Interfaces FI/CO

·User concept

·Module maintenance

·General system administration and parameterization

·System administration and parameterization of low-level software

·Maintenance of system environment

·Renew integration environment every four weeks

·Printer administration

·Administration of interfaces to FI/CO

·Error correction of approval workflow (according to effort if not based on system error)

·General system monitoring

·Supervision, availability

·Capacity, load and performance monitoring

INCIDENT MANAGEMENT & SUPPORT

·Support of travel management is charged according to effort

·The HR hotline is the contact for travel management

OPTIONAL EXTENSIONS

·Setting up functions: „divisional secretary”, „board approval process”

USER / CUSTOMER PARTICIPATION

·Request a user incl. function via data responsible in charge

·Verification of master data within organization management by responsibles to be named by businesses

·Acceptance of ordered system modifications

OUT OF SCOPE

·Smartphone connection

·SAP P13 user

·SAP portal user needs to be requested separately

·Training

·Consultancy for new implementations or special solutions

·Data management (corrections and error removal, master data maintenance, ...)

96

Online Learning Center

Contact Person: Service Desk Material No.: I000258

SERVICE COMPONENT DESCRIPTION

FNC offers a learning platform (Online Learning Center), with which online training courses can be managed and executed via internet. In order to implement the personal design of platform, course catalogue, and news section, separate domains can be created.

Using the learning platform

·Presence training can be booked by every user. The booking of online courses requires a paid for account

Creating a new domain

·Creating an individual web address (sub-domain)

·Creating roles for key users

·Individualization of ‘Look & Feel’ in accordance with corporate design

User support

·Processing registrations, passwords, contact queries, and help requests

·Training (and supporting) key users in their functional role

Administrative services

·Registering new users

·Creating new roles

·Creating new categories and courses

Technological services

·Continuous updating and customization of software applications

·Maintaining the servers infrastructure (backup plan, security patches, etc.)

Course-hosting and development services

·Creating online-courses (software simulations, tutorials, etc.)

·Imbedding externally acquired online-courses

Incoming costs

·Server

·Software licenses

CONDITIONS

Using the learning platform for online-training (unlike for booked presence schooling) requires a paid for user account, either on an annual basis (€ 55 per user) or based on a total of 5000 course-logins per quarter.

97

Price

Using the platform (selection of invoicing model)

a)on an annual basis € 44 per user

b)on login basis (5000 logins valid for 3 or 6 months) € 5.200 or €10.400

Creating a new domain

Creating a new domain (including web address and key user roles)	€	4500
Customizing ‘Look & Feel’ in accordance with corporate design	invoice at cost

User support

Processing registrations, passwords, contact queries, and help requests	€	960
Customizing ‘Look & Feel’ in accordance with corporate design	invoice at cost

Verwaltungsservices

Registering new users (according to list)	€	200
Creatin new roles	€	200
Creating new course (including categories)	€	200

Technologische Dienstleistungen

Continuous updating and customization of software applications (entailed in 2.1.1.)	(incl. in 2.1.1)
Imbedding externally acquired online-courses	(incl. in 2.1.1)

Kurs-Hosting und Entwicklungsservices

Creating online-courses (software simulations, tutorials, etc.)	special agreement
Imbedding externally acquired online-courses	(incl. in 2.1.1)

Charging

Using the platform is charged based on chosen invoicing model

a)On annual basis invoiced once a year

b)On login basis invoiced after expiration of agreed runtime (3 or 6 months)

All other services are invoiced after agreement.

98

Fresenius Netcare GmbH

Else-Kröner Straße 1

61352Bad Homburg v.d.H.

T: +49 6172 608 - 0

E: service@fresenius-netcare.com

I: www.fresenius-netcare.com

Content Responsibility

Hermann Luckhardt

Director IT Service Management

T: +49 6172 608 - 2654

F: +49 6172 608 39 - 2654

E: hermann.luckhardt@fresenius-netcare.com

PRICE LIST 2013

Summary of Standard Services, Prices and Charging Conditions

This summary covers standard services only.

Individual services / conditions as per separate agreements.

For more details see our descriptions

Version 1.4

Service components new	Material Number	Prices	Charging conditions
Network and Telecommunication Services
LAN
Basic IT Operation Package	I000284	58,00 €	network printer per month
Infrastructure services Maintenance R/3 printer	I000019	48.30€ 115.50€	month C-Itoh 5000 month C-Itoh 1000
WAN
Fresenius global network	I000238		Actual line and hardware costs; individual prices
Internet & Intranet
Internet Access Base	I000048	4,00 €	Actual number of Internet user by month base fee incl. 20 MB traffic
Internet Access Volume	I000081	0,14 € 27,75 €	for each MB above 20 MB Maximum user / month
VPN
VPN Connect full access	I000171	23,75 €	per device and month plus volume
VPN WEB connect	I000227	21,00 €	per user / month
VPN Connect Basic Application	I000228	14,00 €	per user / month
VPN including router	I000230	120,00 €	per device and month plus volume
RAS Dial in / Dial in Equant Only for ongoing bookings / no new orders	I000055	30,00 €	per user / month
Homeoffice Basic	I000202	67,00 €	per user / month
Homeoffice Comfort	I000213	90,00 €	per user / month
VOICE & FAX
Voice Telephone / fax	I000075	21,50 €	Actual device by month
Paging system freeset	I000079	35,00 €	Actual device by month
Telephone cost	I000080	0,013 €	per unit
Mobile rent Mobile Phone	I000xxx	3,00 €	per week plus units
Conferencing Services
Desktop Video Conferencing	I000261	19,70 € 100,00 €	per month one time
Audio / Room Conferencing	I000262		Up to System, in/out, Video/Audio

101

Service components new	Material Number	Prices	Charging conditions
Hosting Services
Output
Output management internal	I000049	0,067 €	per page
Output management external	I000047	0,65 € — 1,58 €	per invoice
Output management external	I000071	0,65 € — 1,58 €	per invoice
Output management external	I000072	0,69 € — 1,58 €	per invoice
Application Management
SAP
SAP USAGE
SAP usage average	I000159	28,94 €	Real usage by average rate per h
SAP SUPPORT
SAP support professional user	I000114	2.452,00 €	Actual number of users per year
SAP support limited professional user	I000052	934,00 €	Actual numbers of users per year
SAP support Travel Management ESS	I000201	1,00 €	Number of travels
SAP supports EBP user support	I000175	61,00 €	Actual numbers of users per year, additional
SAP LICENSES
SAP licenses professional user	I000021	1.580,00 €	New, additional users one-time
SAP licenses limited professional user	I000021	900,00 €	New, additional users one-time
SAP licenses employee user	I000021	102,50 €	New, additional users one-time
BW reporting only user	I000021	58,00 €	New, additional users one-time
ESS user	I000021	44,50 €	New, additional users one-time
Engines (additional functions) due to special metrics on request
SAP MAINTENANCE FOR LICENSES
SAP professional standard user	I000115	345,96 €	per named user and year
SAP limited professional user	I000192	197,04 €	per named user and year
SAP employee user	I000198	22,44 €	per named user and year
BW reporting only user	I000221	12,72 €	per named user and year
ESS user	I000193	9,72 €	per named user and year
Maintenance for engines based on license volume
EDI orders	I000083	0,28 €	per order position / delivery item / outgoing invoice item

102

Service components new	Material Number	Prices	Charging conditions
Non SAP Appications
Online learning center	I000258		lump sum based on separate agreement
	End User Service
Client Backup	I000222	11,80 €	per device and month
Terminalserver	I000252	19,50 €	per user and month
Harddrive protection Software-Engineering	I000269	4,85 €	per device and month
Basic IT Operation Package	I000045	85,00 €	per month
Clients
First Installation Service	I000203	84,00 €	Charging according to separate orders by h for PC service
IT Equipment Moving Service	I000204	84,00 €	Charging according to separate orders by h for PC service
Onsite Support	I000205	84,00 €	Charging according to separate orders by h for PC service
Onsite Support Borkenberg	I000217	84,00 €	Charging according to separate orders by h for PC service
Onsite Support Friedberg	I000208	84,00 €	Charging according to separate orders by h for PC service
Computer Pick-up Service	I000211	84,00 €	Charging according to separate orders by h for PC service
Onsite Support VIP	I000206	105,00 €	Charging according to separate orders by h
Board Disposition	I000207	105,00 €	Charging according to separate orders by h
IS Purchasing	I000084	23,63 €	per order position
IS Purchasing SRM Bundles	I000285	50,00 €	per order

103

Service components new	Material Number	Prices	Charging conditions
	Service Desk
Messaging
E-Mail facility connection plus	I000051	9,50 €	Actual numbers of users by month
Email facility connection standard	I000036	7,53 €	Actual number of users by month
Lotus Notes license	I000054	47,25 €	New users: one time fee
Email Web Solution	I000173	2,50 €	Actual number of users by month
Email Web Solution extended	I000305	3,50 €	Actual number of users by month
Mailbox Volume extension	I000087	3,88 €	per month and user for each 50 MB mail box exceeding the free part of 300 MB.
Additional disk space on central server	I000277	0,14 €	per month for each allocated 10 MB increment per user.
Mobile Email for Blackberrys	I000172	13,75 €	Actual number of devices by month
E-Fax	I000033	4,00 €	Actual number of devices by month
Training
Training MS Access	I000060	560,00 €	Price according to pricing list cost per unit / person
Single training	I000063	810,00 €	Price according to pricing list cost per unit / person
Training for departments — 1 day	I000064	990,00 €	Price according to pricing list cost per unit / person
Training room rental 2	I000062	320,00 €	Price according to pricing list cost per unit / person
Training room rental 3	I000068	370,00 €	Price according to pricing list cost per unit / person
Workshop 1	I000058	560,00 €	Price according to pricing list cost per unit / person
Workshop 2	I000059	520,00 €	Price according to pricing list cost per unit / person
Workshop 3	I000069	540,00 €	Price according to pricing list cost per unit / person
Workshop 4	I000070	300,00 €	Price according to pricing list cost per unit / person
Training cancel. fee 100%	I000073		Up to the training ordered
Training cancel. fee 75%	I000074		Up to the training ordered
Project
Projects	I000004	980,00 € 122,50 €	Charging according to separate orders. Rate is per day / per hour for internal personnel.

104

SIGNATURES

Bad Homburg, 4.6.13		Bad Homburg, 08.05.2013
Fresenius Medical Care AG & Co. KGaA represented by its General Partner Fresenius Medical Care Management AG, represented by		Fresenius Netcare GmbH represented by
By:	/s/ Thomas Dimt	By:	/s/ Jurgen Kunze
	Thomas Dimt		Jürgen Kunze
	Executive Vice President		Vice Chairman
	Commercial Services EMEALA
By:	/s/ Klaus Grimm	By:	/s/ Ralf Ehrenborg
	Klaus Grimm		Ralf Ehrenborg
	Vice President IT Coordination EMEALA		Senior Vice President

105

Service Agreement SAP

to the General Agreement 2013

between

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„FME”)

and

Fresenius Netcare GmbH

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„NETCARE”)

Status	:	22.01.2013
Last printed	:	1/22/2013 6:09:00 PM
Version	:	1.0

1

Version

This Section ensures tracking of changes and thereby enhances the quality of the document. Each change has to be documented up to the final version. The next subversion will start from beginning.

New releases as a result of major reviews of the Service model will cause a higher number before the dot. Therefore all Service descriptions have the same release number at a certain time, starting with 1.x after initial release.

Updated versions as a result of general maintenance work will cause a higher number behind the dot, starting with .01, continuing with .02, .03 and so on.

This document may be updated regularly by the Service Management Units of the Parties. Changes to this document require the approval of the Steering Committee.

Vers.	Change	Section	Created by/ When	Reviewed by/ When	Approved by / When
1.0	Creation of the document	all	FNC-ITSM / 04.10.2012	FME-ITC / 11.10.2012	Steering Committee / 26.10.2012

Index

1.	Preamble			4
2.	NETCARE’s Responsibilities and Services			4
	2.1	Operating Services		5
		2.1.1	SAP Base Administration & Support	5
		2.1.2	Data center	7
		2.1.3	Network within the DC EK1 and D20	7
		2.1.4	Hardware	8
		2.1.5	Software License	8
		2.1.6	Disk Space	8
		2.1.7	Backup	8
		2.1.8	Printing	8
		2.1.9	Component BC	9
		2.1.10	Monitoring	10
		2.1.11	Storage Systems/Data storage	10
		2.1.12	Archiving of Records	10
		2.1.13	Maintenance Contracts	10
		2.1.14	Availability	10
		2.1.15	Response Time	11

2

		2.1.16	Operating Times and Contractual Service Times	11
		2.1.17	Responsibility for the Data / Permissions	11
	2.2	SAP Application Services		12
		2.2.1	Application monitoring	14
		2.2.2	SAP Application Transport	14
		2.2.3	User Administration	15
		2.2.4	Batch Job Processing	15
		2.2.5	Application Maintenance and Update	16
		2.2.6	GxP and SOX compliance	16
	2.3	SAP Support		16
		2.3.1	Service Levels	18
		2.3.2	Reporting	18
		2.3.3	Ticket and Call Management	19
		2.3.4	Priorities	19
		2.3.5	Escalation Processes	21
	2.4	SAP License		21
		2.4.1	SAP License Administration	22
		2.4.2	Repurchase	23
		2.4.3	Maintenance	23
3.	FME’s Responsibilities			23
	3.1	Licenses		23
	3.2	Responsibility for the Data / Permissions		23
	3.1	Super Users		23
4.	Joint Tasks			23
	4.1	Procedures in Case of Malfunctions		23
	4.2	Tuning		24
	4.3	Record Archiving		24
	4.4	Network Connection		24
5.	Remuneration			24
	5.1	SAP Operation, Application Services & Support Fees		24
	5.2	Invoicing of SAP Licenses and Maintenance		25
	5.3	Benchmark		25
	5.4	inSITE: Service and Price Review		25
6.	Term and Termination			25
7.	Attachment 1: Definitions			27

3

1.   Preamble

NETCARE operates and maintains the Fresenius Group’s SAP Systems for several Group companies. FME is using these Systems and procures the associated SAP services.

Subject to the terms and conditions of this Service Agreement SAP (“Service Agreement”), the General Agreement, the Annexes and the Standard Service Agreement, FME procures IT Services from NETCARE.

NETCARE’s SAP Service provision to FME is defined in three layers:

·Service Agreement SAP

·SAP Service Level Agreements

·SAP Price List

This Service Agreement shall provide general provisions and service standards on the respective SAP Services stipulated hereunder and attached to this Service Agreement as specific SAP Service Level Agreements. Furthermore this Service Agreement shall also apply for additional SAP Functions or Modules which have to be licensed separately and shall therefore be covered by separate SAP Service Level Agreements.

The SAP Service Level Agreements define specific SAP Services, provide detailed provisions on Individual Services and describe deviations from the service standards defined in this Service Agreement.

The SAP Price List contains an overview of all SAP Service Level Agreements and explicitly governs remuneration details and penalties if applicable.

In cases of contradictions the respective SAP Service Level Agreements shall supersede the terms and conditions in this Service Agreement as well as the SAP Price List.

The Parties differentiate between Shared SAP Services and Dedicated SAP Services. Such SAP services shall be typically defined based on System Families in SAP Service Level Agreements. Notwithstanding the Parties may agree on SAP services based on specific Systems and Applications in supplementary SAP Service Level Agreements.

2.   NETCARE’s Responsibilities and Services

NETCARE’s SAP service provision to FME comprises the following services:

·Operating Services

·Application Services

4

·Support Services

·SAP License.

2.1   Operating Services

Purpose of the services rendered hereunder is to provide and operate the infrastructure of the data center, comprising hardware, operating system, software required for the operation of the operating system, data bases, SAP base component (BC) and other SAP Applications as defined in the respective Service Level Agreements. The services shall extend to the Point of Delivery. The transfer after the Point of Delivery to FME locations is not governed by this Service Agreement.

NETCARE’s data center, where the infrastructure for FME is provided, shall be basis for the operating services rendered hereunder. In the following, the general responsibilities of the Parties and the services for the operation by NETCARE shall be defined.

2.1.1   SAP Base Administration & Support

The following table contains the Standard SAP Base Administration & Support parameters delivered by NETCARE.

These parameters apply for the majority of the productive SAP Systems. Any deviations of these service parameters will be defined in the respective SAP Service Level Agreement.

SAP Base Operation Service Items	Standards
Deployment
Install	charged separately (T&M)
Adds, Changes
SAP-Upgrades (technical implementation)	Included: max. one implementation of Enhancement Package or Support Package per year
Implement JAVA Support packages	n.a.
Installation of DBMS patches, updates (technical implementation)	Included
Installation of OS patches, updates (technical implementation)	Included
Implement new SAP kernel patches	Included
Uninstall	not included
Operation
Planning

5

SAP Base Operation Service Items	Standards
Planning of periodically scheduled technical SAP jobs	Included
Define naming conventions and System planning	Included
Planning and coordination of maintenance windows and downtime	Included
Administration
Start / stop System	Included
Basis performance tuning and optimization	Included
Transport management System setup	Included
System log analysis	Included
SAP Basis dump analysis	Included
SAP Connect administration	Included
SAP Logon group administration	Included
SAP Spool System administration	Included
SAP Router and Service connection administration	Included
SAPNet (OSS) access administration	Included
SAP System user administration (standard user SAP*, DDIC, etc.)	Included
Maintain SAP System profile parameters	Included
Basis operation of SAP clients	Included
Investigate and fix technical errors	Included
Printer administration and error handling in SAP and operating system	Included
Data Management
Set up, copy and remove SAP clients	optionally included (on request)
Create System copies	included: according to the System Lifecycle Management processes
Monitoring
General Systems monitoring	Included
Availability monitoring	Included
Capacity, utilization and performance monitoring	Included
Monitor standard System batch jobs	Included
Monitor update processes	Included

6

SAP Base Operation Service Items	Standards
Check basis related ABAP dumps	Included
Monitor SAP Connect	Included
Reporting
Documentation of Systems and operation	Included
System utilization and performance reports	Included
Service Level Reporting	Included published on Intranet

2.1.2   Data center

NETCARE shall provide the premises for the Systems, comprising the rooms determined therefore in the locations with the Fresenius names EK1 (Else-Kröner-Str. 1) and D20 (Daimlerstr. 20) in Bad Homburg, Germany including all costs for media, including electricity without limitation, air conditioning etc. At the time of execution of this Service Agreement, such rooms are:

Location	Function
EK1	Data Center (DC EK1)
D20	Data Center (DC D20)
D20	Data Backup Location (DC D20)

All rooms feature air condition, UPS, fire protection system and access to an emergency power unit (Diesel). Additionally, DC EK1 also features redundant UPSs with respective redundant UPS batteries. All premises are integrated in the access control system of Fresenius Group.

2.1.3   Network within the DC EK1 and D20

The computers are connected to the existing network infrastructure of DC EK1 and DC D20 comprising connection to the network of SAP AG for using the support services and for sending error notices to SAP AG. The network is technically optimized and is secured against the Internet and other external networks by a firewall. NETCARE is monitoring

7

advisories and security alerts of hard- and software vendors and shall implement relevant advisories within reasonable time.

2.1.4   Hardware

Within its discretion, NETCARE will acquire, install, and operate hardware and system software.  The SAP Systems use a shared server farm distributed across two data centers. This allows the option to move a system to another server within or across data centers. Management of the infrastructure, in particular installation, start, stop, update of hardware, and of the operating system and of the software required for the operation of the operating system shall be in the responsibility of NETCARE.

2.1.5   Software License

NETCARE, at her sole cost, shall provide the number and the extent of licenses required for the operating of the Systems.  This shall include SAP licenses required for the operating and required by NETCARE representatives. Excluded shall be SAP and data base licenses for FME’s Named Users and products which shall be defined in section 2.4.

2.1.6   Disk Space

Data shall be stored on the central storage systems in the DC EK1 and D20. All disk systems shall be designed with redundant controllers and shall be connected via redundant switches / glass fiber. NETCARE shall be responsible for the management of the disk infrastructure, in particular regarding optimization of access and growth.

2.1.7   Backup

Data backup shall be stored on the backup systems in place. Generally, backups shall be performed automatically without human intervention. The backup infrastructure shall be installed in a building separated from data processing. Data shall be stored on the media provided by NETCARE and such media shall remain in the tape library / backup disk systems.

Data base logs shall be saved in different NETCARE locations within reasonable time (5 min.) but within 8 hours latest, after having been filed.

2.1.8   Printing

NETCARE shall define printer queues on the level of the operating systems and the BC. NETCARE shall also be responsible for the management of print jobs up to the print server. Transfer of print jobs to FME locations is not governed by this Service Agreement

8

SAP. Interferences, e.g. deletion of print jobs in Systems, shall be performed subject to the provision of FME and within reasonable time.

2.1.9   Component BC

NETCARE shall be responsible for the component BC. Such responsibility shall include installation, configuration, start/stop etc. of data bases and instances. In order to meet the agreed upon services levels under this Service Agreement SAP, NETCARE shall perform all tasks required by the operation of the Applications.

NETCARE shall solely be responsible among others for the following tasks:

·      Data base management required to achieve defined performance indicators

·Installation, extension of table spaces

·      Management of redo segments, undo-spaces, log-files

·      Data base reorganization

·Unlimited technical installation of hot packages/support packages according to SAP recommendation and/or request of the application development group

NETCARE shall be responsible for the technical execution among others for the following tasks if FME or NETCARE’s Development respectively reasonably require NETCARE to perform such services from time to time:

·Pro-active installation of notes issued by SAP in BC

·Performing “Early Watch” sessions and installation of notes in BC

·Configuration of ALE and RFC connections

·Installation/definition of printer drivers/processing tasks in the Systems

·Performing archiving processes after consultation with the responsible FME Operation Unit and providing such archived data on FME’s request.

·Performing basis-jobs, e.g. spool reorganization, job-log reorganization

·Technical performance of transport subject to the provision of NETCARE’s Development.

9

·System copy/client copy on demand at least once a quarter. If necessary system copies should be approved by the respective IT governance and validation committees.

·Technical implementation with respect to the System (such as support, security and enhancement packages as well as error corrections) as part of the Application maintenance and update as defined in Section 2.2.5.

2.1.10   Monitoring

NETCARE shall monitor in its sole responsibility the entire infrastructure required by the performance under this Service Agreement SAP online and continuously during the agreed service times. Monitoring includes among others the control of disk spaces, system availability, backup infrastructure, critical database and other system performance parameters.

2.1.11   Storage Systems/Data storage

In general, NETCARE shall use storage systems with redundant controllers which shall have redundant connections to the servers.

2.1.12   Archiving of Records

If applicable, records shall be archived on the archive available at NETCARE’s DC EK1 on archiving systems. Such data shall be stored on media which shall be purchased by NETCARE. Such data shall be available as a record item in the productive part of a System for the last sixteen calendar months. Thereafter, the archived records shall be stored in a PBS-system and according to the statutory storage provisions.

2.1.13   Maintenance Contracts

NETCARE, at its sole expense, shall enter into hardware and software maintenance contracts for the components required for providing the services. The number and scope of such maintenance contracts shall be in line with the duties of a prudent business man.

2.1.14   Availability

In general the Availability of the productive Systems shall be at least 99% if not otherwise defined in the respective SAP Service Level Agreement.

Availability = (Factual Service Time + excused non-availability + agreed non-availability) / Scheduled Service Time.

10

2.1.15   Response Time

NETCARE shall provide a Response Time of all dialog steps in the productive System at the Point of Delivery as defined in the respective Service Level Agreements. Investments required for the achievement of such Response Times shall be at NETCARE’s sole expense and fully covered by the fee payable by FME. NETCARE shall report the Response Time of the previous calendar month and Availability before the fifth working day of each month on the Intranet.

NETCARE shall permanently monitor the operation of the Applications. Performance of the Applications shall be frequently controlled; problematic functions and jobs run by FME’s users shall be discussed with the responsible process owner or if not defined with FME respectively in order to optimize Response Times of the Applications.

For the period after implementation of new functionalities, in particular ABAP programs developed by NETCARE, a grace period shall be agreed upon between the Parties.

2.1.16   Operating Times and Contractual Service Times

In general, the productive SAP Systems shall be available 7x24h minus the agreed upon maintenance times on Saturday, 16:00 until 20:00 CET, Sunday, 08:00 until 14:00 CET.

If not otherwise agreed in the respective SAP Service Level Agreement the Contractual Service Times for the productive SAP Systems shall be Monday through Friday, 06:00 to 18:00 CET. During this timeframe, SAP system administration is guaranteed.

Maintenance work in the maintenance periods may be delivered by NETCARE on short notice. In this case, NETCARE shall notify FME of planned maintenance services immediately. Maintenance periods shall only be used if reasonably required.

If maintenance works, such as works on the central power line, are required outside of the maintenance periods, and which particularly may materially affect the Availability or the Response Time of the Systems, NETCARE shall consult with FME. Time required by this maintenance work shall be deemed as down time.

NETCARE hereby offers enhanced Contractual Service Time at the end of each quarter and on weekends for FME’s weekend production against separate remuneration.

2.1.17   Responsibility for the Data / Permissions

NETCARE shall be responsible for the availability and security of the data.

11

2.2   SAP Application Services

Purpose of the services rendered hereunder is to provide and operate the Applications including but not limited to application monitoring, user administration, application maintenance and batch job processing. All services described below are provided during regular local business hours, with the exclusion of local holidays.

The following table contains the Standard SAP Application operation parameters delivered by NETCARE. These parameters apply for the majority of the productive SAP Systems. Discrepancies of the service parameters will be defined in the SAP Service Level Agreement.

SAP Application Operation Service Items	Standards
Deployment
Adds, Changes
Installation of SAP software releases	Included max. one implementation of Enhancement Package or Support Package per year
Installation of SAP patches and hot fixes	included
Perform corrections and transports Change & Transport System (CTS)	included
Provision of SAP UI	included
Corrective Change
Maintenance (Customizing)	included
Maintenance (Code related)	included
Maintenance Data Objects	included
Interface adjustments (corrections and troubleshooting)	included
System Testing	included
Operation
Planning
Maintain SAP client concept (Mandantenkonzept)	included
Administration
Archive link administration	included
Handle CTS requests	included
Application Operation
Interface control and administration	included
Analyse and clean up update terminations	included
Analyse and clean up lock entries	included
Check for Application related ABAP dumps	included

12

SAP Application Operation Service Items	Standards
Troubleshoot and restart Application batch jobs	included
Analysis of Early Watch reports	included
Application performance analysis and tuning	included
Problem analysis	included
Specific Application related tasks
Administer and run batch input sessions	included
Analyse faulty batch input sessions	included
Reorganize processed batch input sessions	included
Supervision of ALE-based interfaces	included
Administration of other Application related interface types	included
Monitoring and administration of other communication components	included
Data load management	included
Monitor upload jobs incl. restart	included
Monitoring
Monitor SAP batch processing	included
Monitor workflows	included
Early watch reports	included
Application-Support
Support & Information
User information for Application	included
Support for warnings & alerts	included
Technical issues, such as printer connections	included
Business process-related issues	included
Application-specific user support	included
Administration User profile
User profiles and roles	included
Maintain authorization profiles	included
Maintain activity groups	included
Other
Other Services
Certification (ISO, ITIL, etc.)	Included ISO9001
GxP compliance	charged separately (T&M)
SOX	charged separately (T&M)

13

There might be an additional remuneration on time & material (T&M) base for specific SAP Application Services as described in the SAP Price List and SAP Service Level Agreements.

The responsibility for customizing and development of Applications shall solely be assigned to NETCARE. Such Services shall be handled as a separate project to be agreed between the Parties according to the regulations outlined in the General Agreement and MSD.

2.2.1   Application monitoring

NETCARE shall permanently monitor the operations of the Applications for Incidents. Performance of the Applications shall be frequently controlled; problematic functions and jobs run by FME’s users shall be discussed within the Service Management Units respectively in order to optimize response time of the Applications.

2.2.2   SAP Application Transport

NETCARE shall be solely responsible for performing and supervising Application Transports from the development System to the integration System and the productive System, for all reasons including maintenance, error correction, new implementation or change of already implemented programs and configurations.

For specific Systems such Application Transports shall be controlled by Solution Manager Change Request Management (ChaRM) and can be done within Maintenance Cycles. The applicability of these Maintenance Cycles shall be defined in the respective SAP Service Level Agreement. Only urgent corrections and simple customizing can be excluded from Maintenance Cycles. An extension of the Maintenance Cycle procedure to other Systems can be agreed between the Parties.

The GoLive of these Maintenance Cycles takes place every 2 months according to the calendar mutually agreed between the Parties on a yearly base and published on NETCARE’s Intranet.

However, according to the standards of SAP, Application development in the productive parts of the Systems shall be avoided were possible. NETCARE, therefore, shall not engage independently without FME’s approval and commissioning Application development for FME specific Applications. Upon FME’s request, NETCARE shall grant to employees of FME, which may be nominated by FME IT Coordination Department and the number of which shall not exceed five, reading privileges for customizing.

14

2.2.3   User Administration

NETCARE is responsible for providing a user management concept and services for all Systems and Applications managed by NETCARE.

NETCARE takes care of all technical steps related to the user administration. This service comprises, based on FME request:

·creation of new users

·blocking of obsolete users and

·allocation of user authorizations and access rights on request.

This service has to be performed as outlined herein after receiving the request from authorized staff of FME.

NETCARE shall provide support and maintenance for the Application for user management. Several core functionalities will be provided as listed below:

·automatic assignments of access rights to the user (on request and after approval)

·role management

·maintain information workflow and stages

·management of controlled temporary access rights

·support for fulfillment of regulatory requirements

NETCARE shall provide technical, organizational and compliance guidelines and policies for user management.

2.2.4   Batch Job Processing

NETCARE is responsible for troubleshooting and restarting of application batch jobs. Should a system downtime occur within non-attended operating time and not be noticed until start of regular business hours, then the Second or Third Level Support shall prioritize the business-relevant batch jobs and enable processing of such batch jobs and monitor them closely.

15

2.2.5   Application Maintenance and Update

Application maintenance shall be in NET CARE’s sole responsibility. Application maintenance shall include Application customizing and programming. In frequent intervals, it is required to install so called support-, security- and enhancement packages and error corrections. NETCARE shall be responsible for scheduling of such activity and NETCARE shall reach an agreement with the respective IT governance and validation committees upon such scheduling and performing release changes. FME shall be permanently represented in such committees.

The current SAP UI software package will be provided by NETCARE to the responsible local PC support units. It remains in the responsibility of the local PC support units to install the SAP UI. If NETCARE provides these local PC support services the installation will be provided free of charge as part of the release change, if not otherwise agreed in the local Service Agreement. Client licenses mandatory required by a new SAP UI installation (for instance EXCEL) shall be provided by FME. On request and a separate remuneration SAP UI installation also for locations may be provided.

2.2.6   GxP and SOX compliance

NETCARE shall maintain quality management which shall be responsible within NETCARE for compliance with the GxP regulations in course of implementation of all GxP relevant Applications and/or processes and subsequent support services (error corrections, support-, security-, enhancement packages). Furthermore, NETCARE shall assist FME in-the validation of GxP relevant processes in collaboration with the respective IT governance and validation committees.

2.3   SAP Support

The primary goal of such Support Services rendered by NETCARE shall be to restore the availability and / or quality of service operations as fast as possible and to minimize the adverse impact on business operations in case of malfunctions, Incidents, problems and failures of the productive Applications and / or the productive Systems. Furthermore the SAP support shall comprise brief consulting on handling issues other than assistance with Incidents of the Applications by the First Level Support. Execution of Petty Requests shall also be part of the contractual services and compensation for such shall be fully paid up by the support fee. However longer consulting services e.g. in terms of training shall not be comprised.

16

NETCARE provides SAP support to FME based on a decentralized support concept that considers the local conditions and/or specific requirements. This support concept comprises the local SAP Service Desks (First Level Support) and if necessary the involvement of further specialists by NETCARE in order to resolve the Incidents and achieve the mutually agreed Service Levels (Second and Third Level Support). The service times and contact information of the SAP Service Desks shall be defined in the Standard Service Agreement and published on NETCARE’s Intranet. The service times and contact information will be revised and agreed between the Parties on a yearly base. This enables the user to choose the right point of contact for the specific region/location. All Incidents reported to NETCARE are registered in a ticketing system.

In general First Level Support is available for all SAP users in local language. It is possible that in some countries, the First Level Support may not be provided by NETCARE in local language. In such cases the Parties shall agree on FME providing local Super-Users being able to communicate in local language and to channel any issues towards the NETCARE First Level Support. In such cases the number of Super- Users shall be limited to two users which have to be named to the NETCARE First Level Support.

The following table shows the main characteristics of the SAP support:

SAP Support Service Items	Standards
Incident Management & Support
First Level Support	included
Second Level Support
Process tickets from First Level Support	included
Respond to technical questions on Application Modules	included
Use OSS access (enter notes etc.)	included
Feedback to first level support	included
Escalation to third level support	included
Third Level Support	included
Process tickets from Second Level Support	included
Feedback to First Level Support	included
Reporting
Service Level Reporting	Included using SAP BW

17

2.3.1   Service Levels

NETCARE guarantees the following Service Levels:

a)minimum attainability 75/35 (Minimum Attainability):

Minimum Attainability is achieved as far as

·75 % of all incoming calls are picked up over a period of 3 months average and

·75 % of the picked up calls have been received within 35 seconds over a period of 3 months average.

b)Minimum Solution Rate

Minimum solution rate is achieved as far as

·80% of the calls received and entered as tickets within one month shall be solved within 30 days. The measurement shall be performed at the end of the next month.

2.3.2   Reporting

NETCARE´s SAP Service Desk provides reports including:

·agreed Service Levels

·the number of calls

·the overall number of Incidents per SAP Module.

The Reporting shall be generated based on SAP BW and will be rendered as a PowerPoint presentation on NETCARE’s Intranet.

Due to the fact that the existing setup of the Automatic Call Distribution Telephone- System (ACD) is not able to document the attainability specific for FME users, for the time being, the measurement of all incoming calls (Fresenius total) shall be used as basis for the calculation of the performance.

The figures guaranteed under 2.3.1 shall be valid for all NETCARE support locations, but will be only measured where an ACD is implemented. In case of a general system problem (i.e. SAP downtime) the respective calls made during this time-range will be excluded in the measurement-statistic. FME shall be informed on such exclusions detailing the respective general system problem and time-range.

18

2.3.3   Ticket and Call Management

In general FME users shall address all inquiries, Incidents, etc. to the First Level Support. NETCARE cannot secure proper processing of requests and problem reports which may have been submitted to other NETCARE staff.

Requests and problem reports shall be registered and categorized. NETCARE shall register the information received, such as name of the FME employee, date and time of registration, short text and description, category of request, priority, etc. If the registering NETCARE staff is unable to solve the problem, the problem shall be submitted to competent staff of the Second Level Support.

If reasonably necessary, NETCARE shall notify the requesting FME user after a problem has been solved.

2.3.4   Priorities

After receipt of the problem ticket, the processing First Level Support shall prioritize such ticket. All received tickets shall be processed according to the priority of the ticket. The following priorities shall apply (for the avoidance of doubt, the requirements in each priority hereunder shall be cumulative only if explicitly indicated by the use of the word “and”):

Priority 1: Critical

·A service in its entirety or an important part of a service is not available and processes important or critical to the FME’s businesses cannot be used or are materially affected by an incident.

·Service levels of FME’s business services are violated or such violation is very probable.

·It is very likely that business relations between FME and its business partners will be disrupted.

·A material number of staff cannot perform their assigned duties or are materially affected in performing their permanent duties.

·FME has no immediate alternative in order to perform the affected business process.

Priority 2: High

·A material function of an application is not available and no workaround is available for an immediate solution.

19

·Frequently used business processes are affected by the incident and a service level violation of FME’s business services is probable.

·It is likely that business relations between FME and its business partners will be affected.

·Numerous staff may be frequently affected in performing their temporarily assigned duties or a single staff cannot perform his/her permanently assigned duties.

·This priority is applicable, e.g., if order registration and commissioning is affected.

·For the avoidance of doubt, events more critical than the ones defined under Priority 2 shall be exclusively governed by Priority 1.

Priority 3: Medium

·An application is not complying with specifications and/or a workaround for a Priority 1 or Priority 2 incident is available.

·The effect on business process is of non-material nature.

·Violations of Service Levels are of non-material nature or not likely.

·Effects on business relationships between FME and its business partners are non- material.

·Staff is affected in performing their duties only occasionally or they may perform other duties during incident solution.

·Priority 3 shall apply, e.g., if procurement orders, booking of cost accounts except for the purpose of month end closing and invoicing review is affected.

Priority 4: Low

·An incident not or minimally affecting business processes.

·There is no direct effect on business relationships between FME and its business partners.

·The incident may cause an inconvenience to single employees. E.g., incidents may affect reporting, headlines are not formatted, sums and selections are not correct.

20

2.3.5   Escalation Processes

Based on the priority of the requests/reports, NETCARE shall use the following internal escalation processes in general:

·      Priority 1:

A problem report shall be processed immediately after receipt. The first preliminary status report to FME shall be due within one hour. FME shall be kept constantly informed on the progress until submission of the final status report. The recipients of the problem reports are defined in Attachment 3.

·      Priority 2:

If no solution or workaround has been found for a problem within four hours after receipt, a specialist or the Second Level Support shall be entrusted with a problem solution. The first status report to FME shall be due after one hour.

·      Priority 3:

If no problem solution or workaround is perceived by the First Level Support 24 hours after receipt, a specialist or the Second Level Support shall be entrusted with a problem solution. The first status report to FME shall be due after 24 hours.

·      Priority 4:

Since no critical problem demanding immediate action has been reported, Second and Third Level Support will not be involved automatically. Only in case that the First Level Support fails to reach a problem solution independently the Second or Third Level Support shall be involved. The first status report shall be due after seven days.

2.4   SAP License

The contractual relationship between the company SAP and the Fresenius G roup is solely administered by NETCARE.

For the benefit of FME, NETCARE shall be responsible for the negotiation, all contractual obligations and the purchase of SAP licenses. NETCARE shall balance and represent all FME requirements and shall always be obliged to negotiate in best effort for FME. FME shall have access to the SAP licenses required for the contractual operations under the same scope as has been granted by SAP AG to NETCARE.

21

NETCARE is responsible towards SAP AG that all contractual obligations between SAP AG and FME are fulfilled. Therefore, NETCARE takes care that FME buys sufficient SAP licenses from NETCARE.

2.4.1   SAP License Administration

NETCARE shall perform the SAP license administration and verify on quarterly basis whether FME has sufficient SAP licenses or not. NETCARE checks all new SAP users registered on the System, all required licenses and all obsolete SAP-users disabled in the System. Before selling and invoicing SAP licenses, the quantity has to be discussed between NETCARE and FME on a yearly basis. Goal of this discussion should be to keep the number of SAP licenses as low as possible and to share SAP licenses within the Fresenius group for cost saving purposes. The license verification shall include the following main tasks:

·The user volume will be calculated based on the number of SAP maintenance units of all productive systems.

·NETCARE shall allocate the limited professional user licenses wherever possible according to the SAP licensing guidelines.

·The identified inventory of licenses will be reported by NETCARE to FME on a quarterly basis.

·Once a year NETCARE performs a license inventory comparing the current license volume with the baseline of the previous year.

·The result of the license inventory will be reported by NETCARE to FME and mutually discussed between the Service Management Units.

·Licenses which have been newly procured will be charged to the respective entity.

·Licenses which are not used are reported by NETCARE to the respective FME entity and NETCARE offers the repurchase of such licenses as outlined later in this Section.

If the number of SAP users exceeds the number of SAP licenses acquired, NETCARE shall offer the according number of SAP licenses to FME based on the Price List. As far as the number of SAP licenses bought exceeds the number of SAP users, FME may sell the SAP licenses back to NETCARE. NETCARE shall be obliged to take these SAP licenses back as far as there is a demand in other Fresenius group companies in buying

22

new SAP licenses. According to SAP AG license rules SAP licenses are transferable between FME SAP users.

2.4.2   Repurchase

NETCARE shall pay to FME for each SAP license repurchased 90% of the current price as outlined in the Price List, regardless of the book value. A credit for repurchase shall be granted once a year accordingly.

2.4.3   Maintenance

A maintenance fee is due for named SAP users and products.

3.FME’s Responsibilities

3.1   Licenses

FME shall be obligated to order sufficient licenses and pay the respective maintenance fees required for named users and products necessary for the Applications and data bases from NETCARE. Detailed description can be found in the Price List.

3.2   Responsibility for the Data / Permissions

FME shall solely be responsible for the accuracy of the data and of the master data.

3.1   Super Users

FME shall ensure that at least the following prerequisites have to be fulfilled by the Super Users:

·      Very good understanding of the business-environment and the processes

·      Well trained in the SAP-functionality

·      Super Users will be commonly agreed between NETCARE and FME. NETCARE will not unreasonably withhold consent.

4.Joint Tasks

4.1   Procedures in Case of Malfunctions

NETCARE shall be responsible for the immediate elimination of any malfunctions and System lockups. FME shall support NETCARE by providing:

·         Description of the problem

·         Support in identifying possible test data

·         User specification of desired changes

23

·         End user tests for fixes and changes

Any elimination of malfunctions or System lockups shall be free of charge for FME. Insufficient support by FME shall not entitle NETCARE to claim for any reduction of service qualities or for any increase of service prices.

4.2   Tuning

Besides the growth of a data base, the specific use of an Application materially influences the response performance. FME shall support the tuning, in that FME users shall collaborate with the Operation Units of NETCARE.

NETCARE shall be responsible for all tuning activities such as analysis of the data base and the installation of indices.

4.3   Record Archiving

FME and NETCARE shall jointly develop a concept for the archiving and reorganizing the data base, in order to limit the growth of such data base and to influence the response performance positively.

In that joint development, NETCARE shall be responsible for configuring the Application, the implementation of the batch jobs required by the Application, and shall perform the technical part of the archiving.

4.4   Network Connection

The distribution of the contractual services via WAN into the LAN of FME locations shall be governed by a separate Service Agreement.

5.Remuneration

5.1   SAP Operation, Application Services & Support Fees

Hereunder the most common pricing principles applied to the SAP System Families are defined.

Applicable types of remuneration can be:

·      Consumption based pricing shall be calculated upon the amount of usage.

·      User based on number of Named User

·      Lump sum based pricing

The type of remuneration is defined in the respective SAP Price List.

24

5.2   Invoicing of SAP Licenses and Maintenance

NETCARE shall invoice FME the one time SAP license fee according to Section 2.4, per additional SAP license after agreement with FME IT Coordination Department on a yearly basis. Maintenance fees can be found in the Price List. For maintenance, NETCARE shall invoice monthly the 12th part of the annual maintenance fee.

5.3   Benchmark

Due to the fact that the inSITE Program rollout is going to take place until 2016, the Parties agreed not to request a benchmarking evaluation before 2017.

5.4   inSITE: Service and Price Review

The Parties shall evaluate the impact of the inSITE Program to the service provisioning as stipulated hereunder and shall be obligated to adjust the terms and conditions of this Service Agreement SAP and the respective Service Level Agreements.

6.Term and Termination

The term of this Service Agreement (the “Term”) shall commence on January 1, 2013 and shall extend to December 31, 2017. Thereafter, the Service Agreement shall automatically renew by another period of five years unless one Party terminates the agreement by giving six months prior written notice to the end of the term. From then on the Service Agreement will be extended automatically for successive one year periods unless one of the parties terminates this Service Agreement by giving 6 months prior written notice to the expiration of the then current term. The duration of the respective SAP Service Level Agreements may vary and is defined within these Agreements.

FME shall be entitled to terminate this Service Agreement for cause if

·NETCARE fails to reach the Availability or the Minimum Attainability three times a year (360 days).

·If NETCARE unreasonably withholds consent to the shut-down of modified Applications.

·If NETCARE rejects FME’s request to substitute SAP software against adequate remuneration by other, technically superior software solutions.

·If NETCARE fails to comply with the data security standards imposed by laws and regulations and the Fresenius Network Security Guideline in the applica- ble version and FME suffers substantial damage thereby.

25

Bad Homburg,		Bad Homburg, 08.05.2013
Fresenius Medical Care AG & Co. KGaA represented by its General Partner Fresenius Medical Care Management AG, represented by		Fresenius Netcare GmbH represented by
By:	/s/ Rice Powell	By:	/s/ Klaus Kieren
	Rice Powell Global Chief Executive Officer and Chairman of Management Board		Klaus Kieren Chairman
By:	/s/ Dr. Emanuele Gatti	By:	/s/ Jurgen Kunze
	Dr. Emanuele Gatti CEO Europe, Latin America, Middle East and Africa Global Chief Strategist		Jürgen Kunze Vice Chairman

Attachments to this Service Agreement:

Attachment 1: Definitions

26

7.   Attachment 1: Definitions

Active user	Active users are named users which have accessed the respective SAP System during the last 12 months.
Agreed Non-Availability	Time of non-availability, calculated in hours, in the Contractual Service Time, aggregated through the Averaging Period, when the Application was not available at the Point of Delivery and on which the Parties, after mutual consultation have agreed in writing, e. g. for maintenance, transports or upgrades.
Application	An Application is defined as FME specifically customized SAP software including Modules, SAP Functions and Modifications rendered and installed on a System. Applications under this Service Agreement shall as well comprise specific SAP products, e.g. BO, BW, SCM, SEM and CRM.
Application Transport	Performing transports of program developments in the System Family by the workbench.
Archiving	Records shall be archived on the archive systems available at NETCARE’s DC EK1 and D20. Such data shall be stored on media which shall be purchased by NETCARE. Such data shall be available as a record item in the productive part of a System for the last sixteen calendar months. Thereafter, the archived records shall be stored in the PBS-system and according to the statutory storage provisions.
Availability	Factual Service Time plus Excused Non-Availability plus Agreed Non-Availability divided by Scheduled Service Time measured in percent with two decimals. Availability shall be calculated for each productive System separately
Averaging Period	Period for determination of the contractual availability. Such period shall comprise the calendar month at issue and the previous two calendar months.
Contractual Service Time	Time specified by days and hours, for which NETCARE is obliged to provide the usability of the Application at the Point of Delivery.

27

CPU — Hour	Synthetic unit measuring the resource consumption of an SAP System. SAP ERP generates single statistic records for each transaction comprising, among others, the database service time and the CPU time used on the application server for the transaction at issue. Such records are handed over to user exit Z_USEREXIT_WORKLOAD and are thereafter fed into the ac- counting application SLAM by reply Deutschland AG, (Geschäftseinheit Syskoplan reply). The CPU-Hour is computed taking into account the database service time and the spent CPU time. The CPU hour is stan- dardized on a CPU performance of 2003. Different CPU speeds of hardware elements shall be equalized according to the relative Application performance. Such equalization is required if hardware elements are exchanged. The equalization factors for the CPU speed are in relation to the SPEC CPU figures, officially published by SPEC (www.spec.org) for the server or CPU type at issue.
Dedicated SAP Service	Means a SAP Service provided dedicated and solely for FME by NETCARE.
Development / CCBP	NETCARE divisions / employees responsible for the Application development and customizing.
Excused Non-Availability	Time of non-availability, calculated in hours, in the Contractual Service Time, averaged through the Averaging Period, when the Application was not available at the Point of Delivery for reasons outside of the control and responsibility of NETCARE, e. g. Force Majeure.
Factual Service Time	Time, calculated in hours, in the Contractual Service Time, aggregated over the Averaging Period, when the Application is available to users at the Point of Delivery. The Application is available, when a log on is possible.
Fresenius Group	The Fresenius Group includes all legal entities directly and indirectly owned by Fresenius SE, whether by majority or not.

28

GxP and SOX Regulations	These are good practices laws and regulations imposed on FME’s field of business.
inSITE Program	Harmonization of business processes and standardization of information flows are crucial for FME’s future growth. The inSITE Program counts on the deployment of the SAP software in all 40 EMEALA countries until 2016 in order to achieve growth targets in the region.
Modules	A SAP System is divided into Modules such as BC, FI, CO, HR, IM, MM, WM, PP, PS, LO, QM and SD, which maps business process of that particular department or business unit.
Modification	Modifications are all changes or own NETCARE developments which are implemented in the SAP source code and which are not SAP standard.
Named user	The definition of a Named User shall be according to the SAP licensing rules. A Named User is counted only once although the Named User may be registered in more than one of the Systems.
Petty Requests	Requests for customizing activities which require less than two hours of efforts in each case.
Planned Downtime	Time of non-availability, calculated in hours, in the Contractual Service Time, aggregated through the Averaging Period, when the Application was not available at the Point of Delivery and on which the Parties, after mutual consultation have agreed in writing, e. g. for maintenance, transports or upgrades and also the maintenance cycle.
Point of Delivery	Point of Delivery shall mean the interface on the side of the data center of the local area network at the location EK1/D20.
Print Server	Dedicated server, to which the SAP-Systems deliver print jobs (point of delivery for print jobs).

29

Response Time	Response Time shall mean the average response time of an Application minus the time required by the network and SAP-UI (generated as ø response time in transaction STO3 in release ERP 6.0), as determined at the Point of Delivery and averaged over a week (week means Monday through Friday).
SAP Functions	Function modules are procedures that are defined in special ABAP programs only, so-called function groups, but can be called from all ABAP programs. Function groups act as containers for function modules that logically belong together. One example of an additional SAP Function is MDGM (Master Data Governance Model). MDGM enables central governance of master data – from initial creation in SAP Business Suite applications through delivery to other solutions. This SAP Function has to be licensed separately.
SAP User	FME SAP users, according to the definition of the pricelist “Summary of Standard Services, Prices and Charging Conditions” published on the intranet.
Scheduled Service Time	Aggregated Contractual Service Time in the Averaging Period.
Shared SAP Services	Means a SAP Service provided not dedicated and not solely for FME by NETCARE but also to other divisions of the Fresenius Group.
System	A System is defined as the hardware and operating software needed for the installation of one Application.
System Family	In general a System Family contains all Systems registered under one SAP Installation number (11, 12, 13....). One System Family contains the following Systems: · productive System (P) · development System (C) · integration System (I)

30

	· test System for dedicated projects (K) Typically the System Family consists of all four Systems, but the number may vary.
Super-User	Super-Users being able to communicate in local language and to channel any issues towards the NETCARE first level. The following prerequisites have to be fulfilled by the Super-Users: ·      very good understanding of the business environment and the processes ·      well trained in the SAP functionality
Unplanned Downtime	Time of non-availability, calculated in hours, in the Contractual Service Time, averaged through the Averaging Period, when the Application was not available at the Point of Delivery.

31

SAP Service Level Agreement

X11 ERP EMEA

to the General Agreement / Service Agreement SAP

between

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„FME”)

and

Fresenius Netcare GmbH

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„NETCARE”)

Current status	:	22.01.2013
Last printed	:	1/22/2013 4:22:00 PM
Version	:	1.0

1

Version

This Section ensures tracking of changes and thereby enhances the quality of the document. Each change has to be documented up to the final version. The next subversion will start from beginning.

New releases as a result of major reviews of the Service model will cause a higher number before the dot. Therefore all Service descriptions have the same release number at a certain time, starting with 1.x after initial release.

Updated versions as a result of general maintenance work will cause a higher number behind the dot, starting with .01, continuing with .02, .03 and so on.

This document may be updated regularly by the Service Management Units of the Parties. Changes to this document require the approval of the Steering Committee.

Vers.	Change	Section	Created by/ When	Reviewed by/ When	Approved by / When
1.0	Creation of the document	all	FNC-ITSM / 04.10.2012	FME-ITC / 11.10.2012	Steering Committee / 26.10.2012

Index

1.	Description	3
2.	Operating Services	3
3.	SAP Application Services and SAP Support	4
4.	Term and Termination	4
5.	Signatures	5

2

1.  Description

System Family X11 ERP EMEA

The SAP ERP System Family X11 is the shared SAP System Family for Fresenius Medical Care, Fresenius Kabi and Fresenius SE for Europe, Middle East and Africa (EMEA).

In focus are the end-to-end processes using Modules like:

·      Finance

·      Controlling

·      Materials Management

·      Production Planning and Control

·      Plant Maintenance

·      Quality Management

·      Sales and Distribution

P11 allows the computerized handling of a variety of tasks within a business enterprise. P11 is configured and customized according to the needs of FME’s business. P11 is closely connected to the ELVIS warehouse management system P12, but also enabled for other warehouse management systems like SAP Warehouse Management. P11 has also integration into the majority of the other Fresenius SAP Systems by using in most cases SAP-PI operated interfaces.

If not otherwise agreed in this Service Level Agreement the Services with respect to this System Family shall be provided as defined in the Service Agreement SAP.

2.  Operating Services

System Family	X11 ERP EMEA
System Landscape	P11 (Production)
	C11 (Development)
	I11 (Integration)
	K11 (Test-System for dedicated projects)
Shared / Dedicated SAP Service	Shared
Operating Services per System
P11
Operating Time	included
Contractual Service Time	included
Availability (only valid for productive System)	included

3

System Family	X11 ERP EMEA
Server Hardware	Shared Server Farm
SAPS	n.a.
Memory	n.a.
Storage	Mirrored across 2 data center
Backup	Daily backup; with retention period of 8 weeks
Databases	DB2
Response Time at Point of Delivery	1,4 sec in 90% of transactions
Maintenance times	included
C11, I11, K11
Server Hardware	Shared Server Farm
SAPS	n.a.
Memory	n.a.
Storage	Non-mirrored
Backup	Daily(C); Weekly (I, K); retention period of 8 weeks
Databases	DB2

3.  SAP Application Services and SAP Support

SAP Application Services and SAP Support
Applicability of Maintenance Cycles
Maintenance Cycles	included
Policies / Security
ICFR / SOX relevant	Yes
GxP (Validation) relevant	Yes

4.   Term and Termination

The term of this SAP Service Level Agreement (the “Term”) shall commence on January 1, 2013 and shall extend to December 31, 2017. Thereafter, the SAP Service Level Agreement shall automatically renew by another period of five years unless one Party terminates the agreement by giving six months prior written notice to the end of the term. From then on the SAP Service Level Agreement will be extended automatically for successive one year periods unless one of the parties terminates this SAP Service Level Agreement by giving 6 months prior written notice to the expiration of the then current term.

4

5.   Signatures

Bad Homburg,		Bad Homburg, 08.05.2013
Fresenius Medical Care AG & Co. KGaA represented by its General Partner Fresenius Medical Care Management AG, represented by		Fresenius Netcare GmbH represented by
By:	/s/ Rice Powell	By:	/s/ Klaus Kieren
	Rice Powell		Klaus Kieren
	Global Chief Executive Officer and Chairman of the Management Board		Chairman
By:	/s/ Dr. Emanuele Gatti	By:	/s/ Jurgen Kunze
	Dr. Emanuele Gatti		Jürgen Kunze
	CEO Europe, Latin America, Middle East and Africa Global Chief Strategist		Vice Chairman

5

SAP Service Level Agreement

X12 ELVIS

to the General Agreement / Service Agreement SAP

between

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„FME”)

and

Fresenius Netcare GmbH

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„NETCARE”)

Current status	:	22.01.2013
Last printed	:	1/22/2013 4:17:00 PM
Version	:	1.0

1

Version

This Section ensures tracking of changes and thereby enhances the quality of the document. Each change has to be documented up to the final version. The next subversion will start from beginning.

New releases as a result of major reviews of the Service model will cause a higher number before the dot. Therefore all Service descriptions have the same release number at a certain time, starting with 1.x after initial release.

Updated versions as a result of general maintenance work will cause a higher number behind the dot, starting with .01, continuing with .02, .03 and so on.

This document may be updated regularly by the Service Management Units of the Parties. Changes to this document require the approval of the Steering Committee.

Vers.	Change	Section	Created by/ When	Reviewed by/ When	Approved by / When
1.0	Creation of the document	all	FNC-ITSM / 04.10.2012	FME-ITC / 11.10.2012	Steering Committee / 26.10.2012

Index

1.	Description	2
2.	Operating Services	3
3.	SAP Application Services and SAP Support	3
4.	Term and Termination	4
5.	Signatures	5

1.  Description

System Family X12 ELVIS

ELVIS (acronym for Eigenentwickeltes Lagerverwaltungs- und Informationssystem) is a warehouse management and information system developed by NETCARE to complement the SAP ERP System environment by comprehensive warehouse management functionalities.

If not otherwise agreed in this Service Level Agreement the Services with respect to this System Family shall be provided as defined in the Service Agreement SAP.

2

2.   Operating Services

System Family	X12 ELVIS
System Landscape	P12 (Production)
	C12 (Development)
	I12 (Integration)
	K12 (Test-System for dedicated projects)
Shared / Dedicated SAP Service	Shared
Operating Services per System
P12
Operating Time	included
Contractual Service Time	included
Availability (only valid for productive System)	included
Server Hardware	Shared Server Farm
SAPS	n.a.
Memory	n.a.
Storage	Mirrored across 2 data center
Backup	Daily backup; with retention period of 8 weeks
Databases	DB2
Response Time at Point of Delivery	1,4 sec in 90% of transactions
Maintenance times	included
C12, I12, K12
Server Hardware	Shared Server Farm
SAPS	n.a.
Memory	n.a.
Storage	Non-mirrored
Backup	Daily(C); Weekly (I, K); retention period of 8 weeks
Databases	DB2

3.   SAP Application Services and SAP Support

SAP Application Services and SAP Support
Applicability of Maintenance Cycles
Maintenance Cycles	included
Policies / Security
ICFR / SOX relevant	Yes
GxP (Validation) relevant	Yes

3

4.   Term and Termination

The term of this SAP Service Level Agreement (the “Term”) shall commence on January 1, 2013 and shall extend to December 31, 2017. Thereafter, the SAP Service Level Agreement shall automatically renew by another period of five years unless one Party terminates the agreement by giving six months prior written notice to the end of the term. From then on the SAP Service Level Agreement will be extended automatically for successive one year periods unless one of the parties terminates this SAP Service Level Agreement by giving 6 months prior written notice to the expiration of the then current term.

4

5.   Signatures

Bad Homburg,		Bad Homburg, 08.05.2013
Fresenius Medical Care AG & Co. KGaA represented by its General Partner Fresenius Medical Care Management AG represented by		Fresenius Netcare GmbH represented by
By:	/s/ Rice Powell	By:	/s/ Klaus Kieren
	Rice Powell		Klaus Kieren
	Global Chief Executive Officer and Chairman of the Management Board		Chairman
By:	/s/ Dr. Emanuele Gatti	By:	/s/ Jurgen Kunze
	Dr. Emanuele Gatti		Jürgen Kunze
	CEO Europe, Latin America, Middle East and Africa Global Chief Strategist		Vice Chairman

5

SAP Service Level Agreement

X13 HCM

to the General Agreement / Service Agreement SAP

between

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„FME”)

and

Fresenius Netcare GmbH

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„NETCARE”)

Current status	:	22.01.2013
Last printed	:	1/22/2013 4:19:00 PM
Version	:	1.0

1

Version

This Section ensures tracking of changes and thereby enhances the quality of the document. Each change has to be documented up to the final version. The next subversion will start from beginning.

New releases as a result of major reviews of the Service model will cause a higher number before the dot. Therefore all Service descriptions have the same release number at a certain time, starting with 1.x after initial release.

Updated versions as a result of general maintenance work will cause a higher number behind the dot, starting with .01, continuing with .02, .03 and so on.

This document may be updated regularly by the Service Management Units of the Parties. Changes to this document require the approval of the Steering Committee.

Vers.	Change	Section	Created by/ When	Reviewed by/ When	Approved by / When
1.0	Creation of the document	all	FNC-ITSM / 04.10.2012	FME-ITC / 11.10.2012	Steering Committee / 26.10.2012

Index
1.	Description	2
2.	Operating Services	3
3.	SAP Application Services and SAP Support	4
4.	Out-of-Scope Services	4
5.	Term and Termination	4
6.	Signatures	5

1.  Description

System Family X13 HCM

Human Resource Management System provides the Application bases which enables further optional Services in the area of human resource management including but not limited to: Payroll Service, Cost Planning, Time Management.

2

The Human Resource Management System is fully integrated with several other SAP Systems (finance, controlling, etc.).

If not otherwise agreed in this Service Level Agreement the Services with respect to this System Family shall be provided as defined in the Service Agreement SAP.

2.  Operating Services

System Family	X13 HCM
System Landscape	P13 (Production)
	C13 (Development)
	I13 (Integration)
	K13 (Test-System for dedicated projects)
Shared / Dedicated SAP Service	Shared
Operating Services per System
P13
Operating Time	included
Contractual Service Time	included
Availability (only valid for productive System)	included
Server Hardware	Shared Server Farm
SAPS	n.a.
Memory	n.a.
Storage	Mirrored across 2 data center
Backup	Daily backup; with retention period of 8 weeks
Databases	DB2
Response Time at Point of Delivery	1,4 sec in 90% of transactions
Maintenance times	included
C13, I13, K13
Server Hardware	Shared Server Farm
SAPS	n.a.
Memory	n.a.
Storage	Non-mirrored
Backup	Daily(C); Weekly (I, K); retention period of 8 weeks
Databases	DB2

3

3.  SAP Application Services and SAP Support

SAP Application Services and SAP Support
Applicability of Maintenance Cycles
Maintenance Cycles	n.a.
Policies / Security
ICFR / SOX relevant	Yes
GxP (Validation) relevant	Yes

4.  Out-of-Scope Services

The following HCM Services are not in scope of this Service Level Agreement:

·      HCM Personnel Cost Planning

·      HCM Time Management

·      HCM Personnel Allocation Planning

·      HCM XTIME

·      HCM Payroll

·      HCM Payroll Clinics

·      HCM Learning Management

5.  Term and Termination

The term of this SAP Service Level Agreement (the “Term”) shall commence on January 1, 2013 and shall extend to December 31, 2017. Thereafter, the SAP Service Level Agreement shall automatically renew by another period of five years unless one Party terminates the agreement by giving six months prior written notice to the end of the term. From then on the SAP Service Level Agreement will be extended automatically for successive one year periods unless one of the parties terminates this SAP Service Level Agreement by giving 6 months prior written notice to the expiration of the then current term.

4

6.  Signatures

Bad Homburg,		Bad Homburg, 08.05.2013
Fresenius Medical Care AG & Co. KGaA represented by its General Partner		Fresenius Netcare GmbH represented by
Fresenius Medical Care Management AG, represented by
By:	/s/ Rice Powell	By:	/s/ Klaus Kieren
	Rice Powell		Klaus Kieren
	Global Chief Executive Officer and Chairman of the Management Board		Chairman
By:	/s/ Dr. Emanuele Gatti	By:	/s/ Jurgen Kunze
	Dr. Emanuele Gatti		Jürgen Kunze
	CEO Europe, Latin America, Middle East and Africa Global Chief Strategist		Vice Chairman

5

SAP Service Level Agreement

X22 ERP LA

to the General Agreement / Service Agreement SAP

between

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„FME”)

and

Fresenius Netcare GmbH

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„NETCARE”)

Status	:	22.01.2013
Last printed	:	1/22/2013 5:23:00 PM
Version	:	1.0

1

Version

This Section ensures tracking of changes and thereby enhances the quality of the document. Each change has to be documented up to the final version. The next subversion will start from beginning.

New releases as a result of major reviews of the Service model will cause a higher number before the dot. Therefore all Service descriptions have the same release number at a certain time, starting with 1.x after initial release.

Updated versions as a result of general maintenance work will cause a higher number behind the dot, starting with .01, continuing with .02, .03 and so on.

This  document  may be  updated  regularly by the  Service  Management  Units  of  the Parties. Changes to this document require the approval of the Steering Committee.

Vers.	Change	Section	Created by/ When	Reviewed by/ When	Approved by / When
1.0	Creation of the document	all	FNC-ITSM / 04.10.2012	FME-ITC / 11.10.2012	Steering Committee / 26.10.2012

Index

1.	Description	2
2.	Operating Services	3
3.	SAP Application Services and SAP Support	4
4.	Term and Termination	4
5.	Signatures	5

1.  Description

System Family X22 ERP LA

The SAP ERP System P22 is the shared SAP System for Fresenius Medical Care and Fresenius Kabi for Latin America (LA).

In focus are the end-to-end processes using Modules like:

·Finance

·Controlling

·Materials Management

2

·Production Planning and Control

·Plant Maintenance

·Quality Management

·Sales and Distribution

P22 allows the computerized handling of a variety of tasks within a business enterprise. P22 is configured and customized according to the needs of FME’s business. P22 uses integrated warehouse management functionality. P22 has also integration to other Fresenius SAP Systems by using in most cases SAP-PI operated interfaces.

If not otherwise agreed in this Service Level Agreement the Services with respect to this System Family shall be provided as defined in the Service Agreement SAP.

2.  Operating Services

System Family	X22 ERP LA
System Landscape	P22 (Production) C22 (Development) I22 (Integration) K22 (Test-System for dedicated projects)
Shared / Dedicated SAP Service	Shared
Operating Services per System
P22
Operating Time	Included
Contractual Service Time	The Contractual Service Times for the Latin America System Family shall be Monday through Friday 09:00 to 01:00 (of the following day) CET.
Availability (only valid for productive System)	Included
Server Hardware	Shared Server Farm
SAPS	n.a.
Memory	n.a.
Storage	Mirrored across 2 data center
Backup	Daily backup; with retention period of 8 weeks
Databases	DB2
Response Time at Point of Delivery	1,4 sec in 90% of transactions
Maintenance times	The Latin America System Family shall be available 7x24h minus the agreed upon maintenance times on Saturday, 08:00 until 12:00 and 22:00 to 02:00 CET, Sunday, 08:00 until 14:00 and 14:00 to 20:00 CET.
C22, I22, K22
Server Hardware	Shared Server Farm
SAPS	n.a.

3

System Family	X22 ERP LA
Memory	n.a.
Storage	Non-mirrored
Backup	Daily(C); Weekly (I, K); retention period of 8 weeks
Databases	DB2

3.  SAP Application Services and SAP Support

SAP Application Services and SAP Support
Applicability of Maintenance Cycles
Maintenance Cycles	n.a.
Policies / Security
ICFR / SOX relevant	Yes
GxP (Validation) relevant	Yes

4.  Term and Termination

The term of this SAP Service Level Agreement (the “Term”) shall commence on January 1, 2013 and shall extend to December 31, 2017. Thereafter, the SAP Service Level Agreement shall automatically renew by another period of five years unless one Party terminates the agreement by giving six months prior written notice to the end of the term. From then on the SAP Service Level Agreement will be extended automatically for successive one year periods unless one of the parties terminates this SAP Service Level Agreement by giving 6 months prior written notice to the expiration of the then current term.

4

5.  Signatures

Bad Homburg,		Bad Homburg, 08.05.2013
Fresenius Medical Care AG & Co. KGaA represented by its General Partner Fresenius Medical Care Management AG, represented by		Fresenius Netcare GmbH represented by
By:	/s/ Rice Powell	By:	/s/ Klaus Kieren
	Rice Powell		Klaus Kieren
	Global Chief Executive Officer and Chairman of the Management Board		Chairman
By:	/s/ Dr. Emanuele Gatti	By:	/s/ Jurgen Kunze
	Dr. Emanuele Gatti		Jürgen Kunze
	CEO Europe, Latin America, Middle East and Africa Global Chief Strategist		Vice Chairman

5

SAP Service Level Agreement

X29 SEM

to the General Agreement / Service Agreement SAP

between

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„FME”)

and

Fresenius Netcare GmbH

Else-Kröner-Straße 1

D-61352 Bad Homburg

(„NETCARE”)

Current status	:	22.01.2013
Last printed	:	1/22/2013 4:28:00 PM
Version	:	1.0

1

Version

This Section ensures tracking of changes and thereby enhances the quality of the document. Each change has to be documented up to the final version. The next subversion will start from beginning.

New releases as a result of major reviews of the Service model will cause a higher number before the dot. Therefore all Service descriptions have the same release number at a certain time, starting with 1.x after initial release.

Updated versions as a result of general maintenance work will cause a higher number behind the dot, starting with .01, continuing with .02, .03 and so on.

This document may be updated regularly by the Service Management Units of the Parties. Changes to this document require the approval of the Steering Committee.

Vers.	Change	Section	Created by/ When	Reviewed by/ When	Approved by / When
1.0	Creation of the document	all	FNC-ITSM / 04.10.2012	FME-ITC / 11.10.2012	Steering Committee / 26.10.2012

Index

1. Description	2
2. Operating Services	3
3. SAP Application Services and SAP Support	4
4. Term and Termination	5
5. Signatures	6

1.Description

System Family X29 Strategic Enterprise Management

This Application supports legal and management consolidation processes in large enterprises, based on various GAAPs, like local GAAPs, US GAAP and IFRS.

FME is using the SEM component BCS which is specifically customized for the needs of FME. This component will be used for legal and management consolidation, reporting and planning. (“SEM-BCS”).

If not otherwise agreed in this Service Level Agreement the Services with respect to this System Family shall be provided as defined in the Service Agreement SAP.

2

2.Operating Services

System Family	X29 SEM
System Landscape	P29 (Production) C29 (Development) I29 (Integration) K29 (Test-System for dedicated projects)
Shared / Dedicated SAP Service	Shared
Operating Services per System
P29
Operating Time	included
Contractual Service Time	included
Extended Contractual Service Time	The Extended Contractual Service Times shall apply to the closing phases described in Extended Service Schedule. The Extended Service shall not exceed 50 days per year.
Availability	included
Server Hardware	Shared Server Farm
SAPS	n.a.
Memory	n.a.
Storage	Mirrored across 2 data center
Backup	Daily backup; with retention period of 8 weeks
Databases	DB2
Maintenance times	included
C29, I29, K29
Server Hardware	Shared Server Farm
SAPS	n.a.
Memory	n.a.
Storage	Non-mirrored
Backup	Daily(C); Weekly (I, K); retention period of 8 weeks
Databases	DB2

The Response Time shall be measured and monitored by NETCARE on a regular monthly basis. Without FME’s request required, NETCARE shall report such measured Response Time of the previous calendar month before the fifth working day to FME.

In case the determined KPIs will be exceeded significantly by the regular measured Response Time NETCARE shall immediately perform a root cause analysis, shall discuss the results of such analysis with FME and shall undertake to optimize the performance of the Systems if reasonable necessary.

3

In any case such optimization of the performance will require changes of the System (e.g. new hardware or significant hardware extensions) FME and NETCARE will mutually decide about the realization of such changes by separate Agreement.

For the determination of the KPI’s and the measurement of the Response Time the reports and also the selections of the parameters as defined in hereunder

NETCARE and FME agree to evaluate biannually the performance of the Application based on the measured Response Time. On basis of this evaluation both Parties may agree jointly on new KPIs to grant a continuous improvement of the performance of the Application.

For the period after implementation of new functionalities, in particular ABAPprograms developed by NETCARE, a grace period shall be agreed upon between the parties.

Reports and selected parameters for the determination of KPIs:

FBCSM PL BY COUNTRY 2009 NEVV

FBCSM MF PLANUNG_V2

FBCSLDC INVENTORYAFF F3

FBCSLCF CHANGE IN INVENTORIES

FBCSMCTFL PL GM SGA ACT

FBCSMCTFL SU HDPDSALES FLASH

3.SAP Application Services and SAP Support

SAP Application Services and SAP Support
Applicability of Maintenance Cycles
Maintenance Cycles	n.a.
Policies / Security
ICFR / SOX relevant	Yes
GxP (Validation) relevant	No
Support-Services: (Production)
Reaction Times	· During the closing phases: without undue delay · During preclosing phases: two hours · all other days: one business day The Application Support is based on the limited capacities of the SEM-Support-Group and priorities.

4

Furthermore NETCARE hereby offers Application Support on weekends upon FME’s request against separate remuneration. The request will have to be confirmed by FME latest on Thursday 04.00 pm to get effective for the following weekend. The reaction time for such Application Support shall be one hour.

4.Term and Termination

The term of this SAP Service Level Agreement (the “Term”) shall commence on January 1, 2013. The Term shall be one year and shall expire on December 31, 2013. Thereafter, this SAP Service Level Agreement shall automatically extend by one year renewal periods, unless one of the parties terminates the agreement by giving six months prior written notice.

5

5.Signatures
Bad Homburg,		Bad Homburg, 08.05.2013
Fresenius Medical Care AG & Co. KGaA represented by its General Partner Fresenius Medical Care Management AG, represented by		Fresenius Netcare GmbH represented by
By:	/s/ Rice Powell	By:	/s/ Klaus Kieren
	Rice Powell		Klaus Kieren
	Global Chief Executive Officer and Chairman of the Management Board		Chairman
By:	/s/ Dr. Emanuele Gatti	By:	/s/ Jurgen Kunze
	Dr. Emanuele Gatti		Jürgen Kunze
	CEO Europe, Latin America, Middle East and Africa Global Chief Strategist		Vice Chairman

6

SAP Price List for Fresenius Medical Care

to the Service Agrement SAP

between

Fresenius Medical Care AG & Co. KGaA

and

Fresenius Netcare GmbH

General Agreement 2013

SAP Price List for Fresenius Medical Care

Price Overview 2013

System Family	X11 ERP EMEA	X12 Elvis	X13 HCM
Duration	01.01.2013 - 31.12.2017 and (if not terminated according to Sec. 4 of the respective SLA) 01.01.2018 - 31.12.2013	01.01.2013 - 31.12.2017 and (if not terminated according to Sec. 4 of the respective SLA) 01.01.2018 - 31.12.2013	01.01.2013 - 31.12.2017 and (if not terminated according to Sec. 5 of the respective SLA) 01.01.2018 - 31.12.2013
Support Services remuneration:	Base 2013 (see next worksheet: SAP Remuneration 2013-2022)	Base 2013 (see next worksheet: SAP Remuneration 2013-2022)	Base 2013 (see next worksheet: SAP Remuneration 2013-2022)
named User based	Yes	Yes	No
supported User type:	n.a.	n.a.	n.a.
User fee [per year]	n.a.	n.a.	n.a.
SAP Support Professional [per year]	2.452,00 €	2.452,00 €	2.452,00 €
SAP Support limited Professional [per year]	934,00 €	934,00 €	934,00 €
SAP Support SRM [per year]	n.a.	n.a.	n.a.
SAP Support light (Latin America only) [per year]	n.a.	n.a.	n.a.
SAP Support Base [per year]	n.a.	953,00 €	n.a.
SAP Support Handheld [per year]	934,00 €	934,00 €	934,00 €
SAP Support Elvis Mobile [per year]	n.a.	953,00 €	n.a.
time and material base [per year]	n.a.	n.a.	Yes, partly (Incidents on T&M base)
7*24 global support fee [per year]	n.a.	n.a.	n.a.
lump sum [per year]	n.a.	n.a.	n.a.
SAP Maintenance [per year]	User based licensing as described in the Service Agreement SAP and priced in the FME Price List	User based licensing as described in the Service Agreement SAP and priced in the FME Price List	User based licensing as described in the Service Agreement SAP and priced in the FME Price List
Stipulation for Application Upgrade	Included max. one implementation of Enhancement Package or Support Package per year. Annual contingent of 0,2 person days per user for EHP Upgrades is already considered in the Support remuneration. The real EHP Upgrade effort will be balanced within this contingent. Reimbursement may happen if no EHP Upgrade takes place or the assumed contingent is not fully needed.	Included max. one implementation of Enhancement Package or Support Package per year. Annual contingent of 0,2 person days per user for EHP Upgrades is already considered in the Support remuneration. The real EHP Upgrade effort will be balanced within this contingent. Reimbursement may happen if no EHP Upgrade takes place or the assumed contingent is not fully needed.	EHP Upgrade: charged separately (T&M) Support Package (max 4/year) : included Legal change Packages: not part of this Service
DataCenter Services remuneration:
named User based	Synthetic measuring of CPU usage	Synthetic measuring of CPU usage	Synthetic measuring of CPU usage
CPU Usage [EUR per hour]	28,94 € (see next worksheet: SAP Remuneration 2013-2022)	28,94 € (see next worksheet: SAP Remuneration 2013-2022)	28,94 € (see next worksheet: SAP Remuneration 2013-2022)
lump sum [EUR per year]	n.a.	n.a.	n.a.
User based [EUR per user and year]	n.a.	n.a.	n.a.
Increase of Storage [EUR per 10 GB / year]	n.a.	n.a.	n.a.
Technical Basis Support	n.a.	n.a.	n.a.
Additional price information regarding DataCenter Services for the inSITE Program, not yet covered by the SAP Service Level Agreements under the Annex SAP
Systems	E11 (ERP Template DEV) 13.080 €	J12 (ELVIS Template TEST) 27.840,- €
	J11 (ERP Template TEST) 70.440,- €
	X11 (New GL) 50.040,- €
	S11 (Sandbox) 13.080,- €
	M11 (TREX E11) 5.760,- €
	N11 (TREX J11) 5.760,- €
	O11 (TREX K11) 5.760,- €
	U11 (TREX C11) 5.760,- €
	V11 (TREX I11) 5.760,- €
	W11 (TREX P11) 5.760,- €
	L11 (ERP Training)
Penalty: (productive System)
System Operation	(99% - Availability) * 5 * fees paid for CPU- usage in the month at question (* = multiplied by)	(99% - Availability) * 5 * fees paid for CPU-usage in the month at question (* = multiplied by)	(99% - Availability) * 5 * fees paid for CPU-usage in the month at question (* = multiplied by)
	Such credit shall not exceed 15 % of the monthly fees payable to NETCARE for CPU consumption. FME shall be entitled to set-off credits against future payments.	Such credit shall not exceed 15 % of the monthly fees payable to NETCARE for CPU consumption. FME shall be entitled to set-off credits against future payments.	Such credit shall not exceed 15 % of the monthly fees payable to NETCARE for CPU consumption. FME shall be entitled to set-off credits against future payments.
Support Operation	For each full percentage-point below the 75% level, 1 % of the respective charge for SAP- Support shall be deducted based on the month and the users within the scope of measurement (to be defined in detail by the Steering Committee). Excluded are time frames with priority 1 system failures.	For each full percentage-point below the 75% level, 1 % of the respective charge for SAP-Support shall be deducted based on the month and the users within the scope of measurement (to be defined in detail by the Steering Committee). Excluded are time frames with priority 1 system failures.	For each full percentage-point below the 75% level, 1 % of the respective charge for SAP- Support shall be deducted based on the month and the users within the scope of measurement (to be defined in detail by the Steering Committee). Excluded are time frames with priority 1 system failures.
	The total reduction will be limited to 15 % of the monthly contractual fees payable	The total reduction will be limited to 15 % of the monthly contractual fees payable	The total reduction will be limited to 15 % of the monthly contractual fees payable

1

SAP Price List for Fresenius Medical Care

Price Overview 2013

System Family	X22 ERP LA	X29 SEM
Duration	01.01.2013 - 31.12.2017 and (if not terminated according to Sec. 4 of the respective SLA) 01.01.2018 - 31.12.2013	01.01.2013 - 31.12.2013
Support Services remuneration:	Base 2013 (see next worksheet: SAP Remuneration 2013-2022)	Base 2013
named User based	Yes	Yes
supported User type:	n.a.	n.a.
User fee [per year]	n.a.	n.a.
SAP Support Professional [per year]	1.909,00 €	n.a.
SAP Support limited Professional [per year]	934,00 €	n.a.
SAP Support SRM [per year]	n.a.	n.a.
SAP Support light (Latin America only) [per year]	636,00 €	n.a.
SAP Support Base [per year]	n.a.	n.a.
SAP Support Handheld [per year]	934,00 €	n.a.
SAP Support Elvis Mobile [per year]	n.a.	n.a.
time and material base [per year]	n.a.	n.a.
7*24 global support fee [per year]	n.a.	n.a.
lump sum [per year]	n.a.	158.728,68 €
SAP Maintenance [per year]	User based licensing as described in the Service Agreement SAP and priced in the FME Price List
Stipulation for Application Upgrade	Included max. one implementation of Enhancement Package or Support Package per year. Annual contingent of 0,2 person days per user for EHP Upgrades is already considered in the Support remuneration. The real EHP Upgrade effort will be balanced within this contingent. Reimbursement may happen if no EHP Upgrade takes place or the assumed contingent is not fully needed.	Included max. one implementation of Enhancement Package or Support Package per year
DataCenter Services remuneration:
named User based	Synthetic measuring of CPU usage	n.a.
CPU Usage [EUR per hour]	28,94 € (see next worksheet: SAP Remuneration 2013-2022)	n.a.
lump sum [EUR per year]	n.a.	46.475,04 €
User based [EUR per user and year]	n.a.	n.a.
Increase of Storage [EUR per 10 GB / year]	n.a.	n.a.
Technical Basis Support	n.a.	n.a.
Additional price information regarding DataCenter Services for the inSITE Program, not yet covered by the SAP Service Level Agreements under the Annex SAP
Systems
Penalty:(productiveSystem)
System Operation	(99% - Availability) * 5 * fees paid for CPU-usage in the month at question (* = multiplied by)	(99% - Availability) * 5 * fees paid for CPU-usage in the month at question (* = multiplied by)
	Such credit shall not exceed 15 % of the monthly fees payable to NETCARE for CPU consumption. FME shall be entitled to set-off credits against future payments.	Such credit shall not exceed 30 % of the monthly fees payable to NETCARE for CPU consumption. FME shall be entitled to set-off credits against future payments.
Support Operation	For each full percentage-point below the 75% level, 1 % of the respective charge for SAP-Support shall be deducted based on the month and the users within the scope of measurement (to be defined in detail by the Steering Committee).  Excluded are time frames with priority 1 system failures.	If the SEM Support Group fails to comply with the reaction times specified, NETCARE shall pay EUR 1000,00 € to FME as penalty for each case, however, not more than 3000,00 € per calendar month.
	The total reduction will be limited to 15 % of the monthly contractual fees payable

2

SAP Price List for Fresenius Medical Care

Price Overview 2013-2022

CPU Usage:

SAP productive System: P11, P12, P13, P22

Year	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
€ per CPU/h	28,94 €	28,07 €	27,23 €	26,41 €	25,62 €	24,85 €	24,10 €	23,38 €	22,68 €	22,00 €

Usertypes - Application Support Fee: P11, P12, P13

Usertype / Year	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
SAP Support Professional	2.452,00 €	2.501,00 €	2.551,00 €	2.602,00 €	2.654,00 €	2.654,00 €	2.654,00 €	2.707,00 €	2.761,00 €	2.817,00 €
SAP Support limited Professional	934,00 €	953,00 €	972,00 €	992,00 €	1.011,00 €	1.011,00 €	1.011,00 €	1.032,00 €	1.052,00 €	1.073,00 €
SAP Support EBP	61,00 €	62,00 €	64,00 €	65,00 €	66,00 €	66,00 €	66,00 €	68,00 €	69,00 €	70,00 €
SAP Support LIGHT	636,00 €	649,00 €	662,00 €	675,00 €	689,00 €	689,00 €	689,00 €	703,00 €	717,00 €	731,00 €
SAP Support Base	953,00 €	972,00 €	992,00 €	1.011,00 €	1.032,00 €	1.032,00 €	1.032,00 €	1.052,00 €	1.073,00 €	1.095,00 €
SAP Support Handheld	934,00 €	953,00 €	972,00 €	992,00 €	1.011,00 €	1.011,00 €	1.011,00 €	1.032,00 €	1.052,00 €	1.073,00 €
SAP Support Elvis Mobile	953,00 €	972,00 €	992,00 €	1.011,00 €	1.032,00 €	1.032,00 €	1.032,00 €	1.052,00 €	1.073,00 €	1.095,00 €

Usertypes - Application Support Fee: P22 (and also valid for P11-migrated Latin America users)

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
SAP Support Professional	1.909,00 €	1.947,00 €	1.986,00 €	2.026,00 €	2.066,00 €	2.108,00 €	2.150,00 €	2.193,00 €	2.237,00 €	2.281,00 €
SAP Support limited Professional	636,00 €	649,00 €	662,00 €	675,00 €	688,00 €	702,00 €	716,00 €	731,00 €	745,00 €	760,00 €
SAP Support Handheld	934,00 €	953,00 €	972,00 €	991,00 €	1.011,00 €	1.031,00 €	1.052,00 €	1.073,00 €	1.094,00 €	1.116,00 €

3

XML

Noncontrolling Interests Subject to Put Provisions

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Noncontrolling Interests Subject to Put Provisions

9. Noncontrolling Interests Subject to Put Provisions

The Company has potential obligations to purchase the noncontrollinginterests held by third parties in certain of its consolidated subsidiaries. These obligations are in the form of put provisions and are exercisable at the third-party owners' discretion within specified periods as outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase all or part of third-party owners' noncontrolling interests at the appraised fair value at the time of exercise. The methodology the Company uses to estimate the fair values of the noncontrolling interest subject to put provisions assumes the greater of net book value or a multiple of earnings, based on historical earnings, the development stage of the underlying business and other factors. The estimated fair values of the noncontrolling interests subject to these put provisions can also fluctuate and the implicit multiple of earnings at which these noncontrolling interest obligations may ultimately be settled could vary significantly from our current estimates depending upon market conditions.

AtJune 30, 2013 and December 31, 2012, the Company's potential obligations under these put options were $541,347and $523,260, respectively, of which, at June 30, 2013, $208,239were exercisable. No put options were exercised during the first six months of 2013.

Following is a roll forward of noncontrolling interests subject to put provisions for the six months ended June 30, 2013 and the year ended December 31, 2012:

	June 30, 2013		December 31, 2012
Beginning balance as of January 1,	$	523,260	$	410,491
Contributions to noncontrolling interests		(56,330)		(114,536)
Purchase/ sale of noncontrolling interests		10,515		134,643
Contributions from noncontrolling interests		4,909		16,565
Changes in fair value of noncontrolling interests		10,333		(18,880)
Net income		48,812		94,718
Other comprehensive income (loss)		(152)		259
Ending balance as of June 30, 2013 and December 31, 2012	$	541,347	$	523,260

XML

Other Comprehensive Income - Rollforward (Details) (USD $) In Thousands, unless otherwise specified	6 Months Ended		12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012	Dec. 31, 2011
Balance			$ (489,244)	$ (482,719)
Other comprehensive income (loss) before reclassifications	(122,460)	(64,797)
AOCI reclassifications	17,851	10,208
Other comprehensive income loss net of taxes	(104,609)	(54,589)
Ending Balance OCI	(593,853)	(537,308)
Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges [Member]
Balance			(138,341)	(136,221)
Other comprehensive income (loss) before reclassifications	4,902	(17,181)
AOCI reclassifications	9,974	4,892
Other comprehensive income loss net of taxes	14,876	(12,289)
Ending Balance OCI	(123,465)	(148,510)
Accumulate benefit plans adjustment [Member]
Balance			(179,423)	(111,215)
AOCI reclassifications	7,877	5,316
Other comprehensive income loss net of taxes	7,877	5,316
Ending Balance OCI	(171,546)	(105,899)
Accumulated translation adjustments (Domain) [Member]
Balance			(174,349)	(238,331)
Other comprehensive income (loss) before reclassifications	(125,044)	(47,702)
Other comprehensive income loss net of taxes	(125,044)	(47,702)
Ending Balance OCI	(299,393)	(286,033)
Total, before non-controlling interests
Balance			(492,113)	(485,767)
Other comprehensive income (loss) before reclassifications	(120,142)	(64,883)
AOCI reclassifications	17,851	10,208
Other comprehensive income loss net of taxes	(102,291)	(54,675)
Ending Balance OCI	(594,404)	(540,442)
Noncontrolling interests not subject to put provisions [Member]
Balance			2,869	3,048
Other comprehensive income (loss) before reclassifications	(2,318)	86
Other comprehensive income loss net of taxes	(2,318)	86
Ending Balance OCI	$ 551	$ 3,134

XML

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 585,857	$ 688,040
Trade accounts receivable less allowance for doubtful accounts of $318,989 in 2013 and $328,893 in 2012	3,031,167	3,019,424
Accounts receivable from related parties	190,868	137,809
Inventories	1,055,099	1,036,809
Prepaid expenses and other current assets	994,777	937,761
Deferred tax asset, current	292,033	307,613
Total current assets	6,149,801	6,127,456
Property, plant and equipment, net	2,935,140	2,940,603
Intangible assets	681,264	710,116
Goodwill	11,468,599	11,421,889
Deferred tax asset, non-current	135,631	133,753
Equity Method Investments	617,430	637,373
Other assets	340,482	354,808
Total assets	22,328,347	22,325,998
Current liabilities:
Accounts payable	493,947	622,294
Accounts payable to related parties	199,285	123,350
Accrued expenses and other current liabilities	1,831,164	1,787,471
Short-term borrowings and other financial liabilities	115,322	117,850
Short-term borrowings from related parties	59,364	3,973
Current portion of long-term debt and capital lease obligations	514,118	334,747
Income tax payable, current	154,938	150,003
Deferred tax liability, current	37,409	30,303
Total current liabilities	3,405,547	3,169,991
Total long-term debt less current maturities	7,657,012	7,785,740
Other liabilities	324,338	294,569
Pension liabilities	432,060	423,361
Income tax payable, non-current	205,438	201,642
Deferred tax liability, non-current	652,612	664,001
Long term debt from related parties		56,174
Total liabilities	12,677,007	12,595,478
Noncontrolling interests subject to put provisions	541,347	523,260
Company shareholders' equity:
Preferred stock, no par value, 1.00 Euro nominal value, 7,066,522 shares authorized, 3,973,333 issued and outstanding as of December 31, 2012 (see note 7)	0	4,462
Common stock, no par value, 1.00 Euro nominal value, 392,462,972 shares authorized, 307,579,315 issued and 303,998,508 outstanding	380,510	374,915
Treasury Stock	248,889	0
Additional paid-in capital	3,548,973	3,491,581
Retained earnings	5,755,550	5,563,661
Accumulated other comprehensive (loss)	(594,404)	(492,113)
Total Company shareholders' equity	8,841,740	8,942,506
Minority interest	268,253	264,754
Total equity	9,109,993	9,207,260
Total liabilities and equity	$ 22,328,347	$ 22,325,998

XML

Acquisition of Liberty Dialysis Holdings- Pro Forma

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Acquisition Of Liberty Dialysis Holding [TextBlock]

Pro Forma Financial Information

The following financial information, on a pro forma basis, reflects the consolidated results of operations as if the Liberty Acquisition and the divestitures described above had been consummated on January 1, 2011. The pro forma information includes adjustments primarily for elimination of the investment gain and the gain from the retirement of debt. The pro-forma financial information is not necessarily indicative of the results of operations as it would have been had the transactions been consummated on January 1, 2011.

		For the three months ended June 30,			For the six months ended June 30,
		2012			2012
Net revenue		$	3,420,560	$	6,782,198
Net income attributable to shareholders of FMC-AG & Co. KGaA			266,093		529,400
Income per ordinary share
	Basic	$	0.87	$	1.74
	Fully diluted	$	0.87	$	1.73

XML

Supplemental Condensed Combining Information

3 Months Ended

6 Months Ended

Mar. 31, 2012

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Supplemental Condensed Combining Information

		For the six months ended June 30, 2012
		Issuer		Guarantors						Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
		FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH
Net Income		$	2,162	$	659,835	$	11,130	$	420,710	$	724,342	$	(1,099,181)	$	718,998
	Gain (loss) related to cash flow hedges		-		(5,916)		(9)		11,725		2,442		-		8,242
	Actuarial gain (loss) on defined benefit pension plans		-		15		186		8,536		6		-		8,743
	Gain (loss) related to foreign currency translation		-		26,112		18,886		-		(94,106)		1,492		(47,616)
	Income tax (expense) benefit related to components of other comprehensive income		-		3,427		(51)		(7,993)		(19,341)		-		(23,958)
Other comprehensive income (loss), net of tax			-		23,638		19,012		12,268		(110,999)		1,492		(54,589)
Total comprehensive income		$	2,162	$	683,473	$	30,142	$	432,978	$	613,343	$	(1,097,689)	$	664,409
	Comprehensive income attributable to noncontrolling interests		-		-		-		-		-		59,249		59,249
Comprehensive income attributable to shareholders of FMC-AG & Co. KGaA		$	2,162	$	683,473	$	30,142	$	432,978	$	613,343	$	(1,156,938)	$	605,160

16. Supplemental Condensed Combining Information

FMC Finance III, a former wholly-owned subsidiary of the Company, issued 6⅞% Senior Notes due 2017 in July 2007. On June 20, 2011, Fresenius Medical Care US Finance, Inc. (“US Finance”) acquired substantially all of the assets of FMC Finance III and assumed its obligations, including the 6⅞% Senior Notes and the related indenture. The 6⅞% senior notes are fully and unconditionally guaranteed, jointly and severally on a senior basis, by the Company and by D-GmbH and FMCH (“the Guarantor Subsidiaries”). The 6⅞% Senior Notes and related guarantees were issued in an exchange offer registered under the Securities Act of 1933. The financial statements in this report present the financial condition, results of operations and cash flows of the Company, on a consolidated basis at June 30, 2013 and December 31, 2012 and for the six-monthperiods ended June 30, 2013 and 2012. The following combining financial information for the Company is atJune 30, 2013 and December 31, 2012 and for the six-monthperiods ended June 30, 2013 and 2012, segregated between FMC US Finance as issuer, the Company, the Guarantor Subsidiaries, and the Company's other businesses (the “Non-Guarantor Subsidiaries”). For purposes of the condensed combining information, the Company and the Guarantor Subsidiaries carry their investments under the equity method. Other (income) expense includes income (loss) related to investments in consolidated subsidiaries recorded under the equity method for purposes of the condensed combining information. In addition, other (income) expense includes income and losses from profit and loss transfer agreements as well as dividends received.

		For the six months ended June 30, 2013
		Issuer		Guarantors
		FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH		Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
Net revenue		$	-	$	-	$	1,006,662	$	-	$	7,664,410	$	(1,594,636)	$	7,076,436
Cost of revenue			-		-		663,055		-		5,719,837		(1,574,347)		4,808,545
	Gross profit		-		-		343,607		-		1,944,573		(20,289)		2,267,891
Operating expenses (income):
	Selling, general and administrative (1)		-		40,547		106,983		(55,685)		1,057,633		19,568		1,169,046
	Research and development		-		-		36,549		-		24,912		(168)		61,293
Operating (loss) income			-		(40,547)		200,075		55,685		862,028		(39,689)		1,037,552
Other (income) expense:
	Interest, net		(3,417)		95,049		3,804		87,078		24,349		417		207,280
	Other, net		-		(615,001)		164,333		(383,157)		-		833,825		-
Income (loss) before income taxes			3,417		479,405		31,938		351,764		837,679		(873,931)		830,272
	Income tax expense (benefit)		1,240		(8,618)		37,248		(12,385)		285,430		(30,301)		272,614
Net Income (loss)			2,177		488,023		(5,310)		364,149		552,249		(843,630)		557,658
Net Income attributable to noncontrolling interests			-		-		-		-		-		69,635		69,635
Net income (loss) attributable to shareholders of FMC-AG & Co. KGaA		$	2,177	$	488,023	$	(5,310)	$	364,149	$	552,249	$	(913,265)	$	488,023
(1) Selling, general and administrative is presented net of Gain on Sale of dialysis clinics and net of income from equity method investees.

		For the six months ended June 30, 2012
		Issuer		Guarantors
		FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH		Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
Net revenue		$	-	$	-	$	928,262	$	-	$	7,183,245	$	(1,434,779)	$	6,676,728
Cost of revenue			-		-		587,675		-		5,317,223		(1,424,553)		4,480,345
	Gross profit		-		-		340,587		-		1,866,022		(10,226)		2,196,383
Operating expenses (income):
	Selling, general and administrative (1)		-		5,066		104,788		68,031		836,598		34,649		1,049,132
	Research and development		-		-		34,134		-		21,326		-		55,460
Operating (loss) income			-		(5,066)		201,665		(68,031)		1,008,098		(44,875)		1,091,791
Other (income) expense:
	Investment gain		-		-		-		-		(139,600)		-		(139,600)
	Interest, net		(3,412)		103,541		1,741		72,356		28,849		-		203,075
	Other, net		-		(817,512)		130,561		(505,714)		-		1,192,665		-
Income (loss) before income taxes			3,412		708,905		69,363		365,327		1,118,849		(1,237,540)		1,028,316
	Income tax expense (benefit)		1,250		49,070		58,233		(55,383)		394,507		(138,359)		309,318
Net Income (loss)			2,162		659,835		11,130		420,710		724,342		(1,099,181)		718,998
Net Income attributable to noncontrolling interests			-		-		-		-		-		59,163		59,163
Net income (loss) attributable to shareholders of FMC-AG & Co. KGaA		$	2,162	$	659,835	$	11,130	$	420,710	$	724,342	$	(1,158,344)	$	659,835
(1) Selling, general and administrative is presented net of Gain on Sale of dialysis clinics and net of income from equity method investees.

		For the six months ended June 30, 2013
		Issuer		Guarantors						Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
		FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH
Net Income		$	2,177	$	488,023	$	(5,310)	$	364,149	$	552,249	$	(843,630)	$	557,658
	Gain (loss) related to cash flow hedges		-		14,431		-		-		5,459		-		19,890
	Actuarial gain (loss) on defined benefit pension plans		-		65		1,267		11,335		110		-		12,777
	Gain (loss) related to foreign currency translation		-		27,707		(6,535)		-		(154,567)		6,033		(127,362)
	Income tax (expense) benefit related to components of other comprehensive income		-		(4,162)		(369)		(4,472)		(911)		-		(9,914)
Other comprehensive income (loss), net of tax			-		38,041		(5,637)		6,863		(149,909)		6,033		(104,609)
Total comprehensive income		$	2,177	$	526,064	$	(10,947)	$	371,012	$	402,340	$	(837,597)	$	453,049
	Comprehensive income attributable to noncontrolling interests		-		-		-		-		-		67,317		67,317
Comprehensive income attributable to shareholders of FMC-AG & Co. KGaA		$	2,177	$	526,064	$	(10,947)	$	371,012	$	402,340	$	(904,914)	$	385,732

			At June 30, 2013
			Issuer		Guarantors						Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
			FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH
Current assets:
	Cash and cash equivalents		$	1	$	4,932	$	595	$	-	$	550,768	$	29,561	$	585,857
	Trade accounts receivable, less allowance for doubtful accounts			-		-		178,405		-		2,852,762		-		3,031,167
	Accounts receivable from related parties			1,269,703		1,816,703		1,647,943		1,665,304		4,471,651		(10,680,436)		190,868
	Inventories			-		-		293,332		-		898,209		(136,442)		1,055,099
	Prepaid expenses and other current assets			-		104,662		46,298		67		842,973		777		994,777
	Deferred taxes			-		-		-		-		291,134		899		292,033
		Total current assets		1,269,704		1,926,297		2,166,573		1,665,371		9,907,497		(10,785,641)		6,149,801
Property, plant and equipment, net				-		540		215,429		-		2,839,566		(120,395)		2,935,140
Intangible assets				-		690		72,003		-		608,636		(65)		681,264
Goodwill				-		-		54,374		-		11,414,225		-		11,468,599
Deferred taxes				-		69,036		7,645		-		123,080		(64,130)		135,631
Other assets and notes receivables (1)				-		12,780,039		28,056		12,140,029		5,998,848		(29,989,060)		957,912
	Total assets		$	1,269,704	$	14,776,602	$	2,544,080	$	13,805,400	$	30,891,852	$	(40,959,291)	$	22,328,347
Current liabilities:
	Accounts payable		$	-	$	659	$	36,248	$	-	$	457,040	$	-	$	493,947
	Accounts payable to related parties			-		2,064,018		730,076		1,597,911		6,525,218		(10,717,938)		199,285
	Accrued expenses and other current liabilities			29,771		45,648		133,908		3,262		1,618,116		459		1,831,164
	Short-term borrowings			-		42		-		-		115,280		-		115,322
	Short-term borrowings from related parties			-		-		-		-		59,364		-		59,364
	Current portion of long-term debt and capital lease obligations			-		280,629		-		200,000		33,489		-		514,118
	Income tax payable			-		103,521		-		-		41,548		9,869		154,938
	Deferred taxes			-		4,820		9,638		-		63,487		(40,536)		37,409
		Total current liabilities		29,771		2,499,337		909,870		1,801,173		8,913,542		(10,748,146)		3,405,547
Long term debt and capital lease obligations, less current portion				1,169,932		207,763		-		2,501,512		6,993,976		(3,216,171)		7,657,012
Long term borrowings from related parties				-		3,185,549		651,161		2,006,006		7,433		(5,850,149)		-
Other liabilities				-		5,775		13,340		11,830		261,047		32,346		324,338
Pension liabilities				-		9,464		208,554		-		214,042		-		432,060
Income tax payable				2,633		26,974		-		-		42,109		133,722		205,438
Deferred taxes				-		-		-		-		680,438		(27,826)		652,612
		Total liabilities		1,202,336		5,934,862		1,782,925		6,320,521		17,112,587		(19,676,224)		12,677,007
Noncontrolling interests subject to put provisions				-		-		-		-		541,347		-		541,347
Total FMC-AG & Co. KGaA shareholders' equity				67,368		8,841,740		761,155		7,484,879		12,969,665		(21,283,067)		8,841,740
Noncontrolling interests not subject to put provisions				-		-		-		-		268,253		-		268,253
Total equity				67,368		8,841,740		761,155		7,484,879		13,237,918		(21,283,067)		9,109,993
	Total liabilities and equity		$	1,269,704	$	14,776,602	$	2,544,080	$	13,805,400	$	30,891,852	$	(40,959,291)	$	22,328,347
(1) Other Assets and notes receivables are presented net of investment in equity method investees.

			At December 31, 2012
			Issuer		Guarantors						Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
			FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH
Current assets:
	Cash and cash equivalents		$	1	$	78	$	501	$	-	$	686,457	$	1,003	$	688,040
	Trade accounts receivable, less allowance for doubtful accounts			-		-		170,627		-		2,848,797		-		3,019,424
	Accounts receivable from related parties			1,269,471		2,257,445		1,449,317		3,562,953		4,398,630		(12,800,007)		137,809
	Inventories			-		-		271,039		-		885,613		(119,843)		1,036,809
	Prepaid expenses and other current assets			-		72,022		27,693		167		837,152		727		937,761
	Deferred taxes			-		-		-		-		311,280		(3,667)		307,613
		Total current assets		1,269,472		2,329,545		1,919,177		3,563,120		9,967,929		(12,921,787)		6,127,456
Property, plant and equipment, net				-		611		206,873		-		2,856,000		(122,881)		2,940,603
Intangible assets				-		584		67,874		-		641,714		(56)		710,116
Goodwill				-		-		54,848		-		11,367,041		-		11,421,889
Deferred taxes				-		51,111		10,123		-		131,452		(58,933)		133,753
Other assets and notes receivables (1)				-		12,675,998		650,255		11,766,104		(4,751,531)		(19,348,645)		992,181
	Total assets		$	1,269,472	$	15,057,849	$	2,909,150	$	15,329,224	$	20,212,605	$	(32,452,302)	$	22,325,998
Current liabilities:
	Accounts payable		$	-	$	1,935	$	41,114	$	-	$	579,245	$	-	$	622,294
	Accounts payable to related parties			-		2,234,205		491,525		1,598,852		8,663,240		(12,864,472)		123,350
	Accrued expenses and other current liabilities			29,771		27,530		102,728		3,157		1,611,997		12,288		1,787,471
	Short-term borrowings			-		38		-		-		117,812		-		117,850
	Short-term borrowings from related parties			-		-		-		-		3,973		-		3,973
	Current portion of long-term debt and capital lease obligations			-		207,160		-		100,000		27,587		-		334,747
	Income tax payable			-		130,636		-		-		19,367		-		150,003
	Deferred taxes			-		1,622		8,126		-		61,774		(41,219)		30,303
		Total current liabilities		29,771		2,603,126		643,493		1,702,009		11,084,995		(12,893,403)		3,169,991
Long term debt and capital lease obligations, less current portion				1,172,397		285,049		-		2,559,340		7,020,190		(3,251,236)		7,785,740
Long term borrowings from related parties				-		3,212,455		657,284		2,019,925		64,530		(5,898,020)		56,174
Other liabilities				-		6,696		12,679		110,637		130,634		33,923		294,569
Pension liabilities				-		7,753		202,219		-		213,389		-		423,361
Income tax payable				2,113		264		-		-		52,684		146,581		201,642
Deferred taxes				-		-		-		-		685,158		(21,157)		664,001
		Total liabilities		1,204,281		6,115,343		1,515,675		6,391,911		19,251,580		(21,883,312)		12,595,478
Noncontrolling interests subject to put provisions				-		-		-		-		523,260		-		523,260
Total FMC-AG & Co. KGaA shareholders' equity				65,191		8,942,506		1,393,475		8,937,313		173,011		(10,568,990)		8,942,506
Noncontrolling interests not subject to put provisions				-		-		-		-		264,754		-		264,754
Total equity				65,191		8,942,506		1,393,475		8,937,313		437,765		(10,568,990)		9,207,260
	Total liabilities and equity		$	1,269,472	$	15,057,849	$	2,909,150	$	15,329,224	$	20,212,605	$	(32,452,302)	$	22,325,998
(1) Other Assets and notes receivables are presented net of investment in equity method investees.

				For the six months ended June 30, 2013
				Issuer		Guarantors
				FMC US Finance		FMC - AG & Co. KGaA		D-GmbH			FMCH	Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
Operating Activities:
	Net income (loss)			$	2,177	$	488,023	$	(5,310)	$	364,149	$	552,249	$	(843,630)	$	557,658
	Adjustments to reconcile net income to net cash provided by (used in) operating activities:
	Equity affiliate income				-		(331,592)		-		(383,157)		-		714,749		-
		Depreciation and amortization			-		330		24,691		-		305,236		(15,103)		315,154
		Change in deferred taxes, net			-		(19,248)		3,651		-		18,363		(9,336)		(6,570)
		(Gain) loss on sale of fixed assets and investments			-		(12)		(153)		-		(6,089)		-		(6,254)
		Compensation expense related to stock options			-		12,777		-		-		-		-		12,777
		Cash inflow (outflow) from hedging			-		(4,028)		-		-		-		-		(4,028)
		Investments in equity method investees, net			-		22,691		-		-		(7,940)		-		14,751
	Changes in assets and liabilities, net of amounts from businesses acquired:
		Trade accounts receivable, net			-		-		(11,574)		-		(51,000)		-		(62,574)
		Inventories			-		-		(24,736)		-		(29,542)		20,013		(34,265)
		Prepaid expenses and other current and non-current assets			-		10,768		(17,389)		(53,403)		60,215		28,585		28,776
		Accounts receivable from / payable to related parties			(410)		286,966		68,660		57,847		(462,322)		70,579		21,320
		Accounts payable, accrued expenses and other current and non-current liabilities			-		10,171		38,199		106		(53,631)		(3,854)		(9,009)
		Income tax payable			520		729		-		(12,385)		(1,376)		25,313		12,801
			Net cash provided by (used in) operating activities		2,287		477,575		76,039		(26,843)		324,163		(12,684)		840,537
Investing Activities:
	Purchases of property, plant and equipment				-		(45)		(39,394)		-		(311,089)		16,886		(333,642)
	Proceeds from sale of property, plant and equipment				-		17		271		-		14,508		-		14,796
	Disbursement of loans to related parties				-		45,738		-		28,419		-		(74,157)		-
	Acquisitions and investments, net of cash acquired, and purchases of intangible assets				-		(23,076)		(1,943)		-		(100,883)		24,093		(101,809)
	Proceeds from divestitures				-		-		-		-		17,824		-		17,824
			Net cash provided by (used in) investing activities		-		22,634		(41,066)		28,419		(379,640)		(33,178)		(402,831)
Financing Activities:
	Short-term borrowings, net				-		4		(34,873)		-		35,808		-		939
	Long-term debt and capital lease obligations, net				(2,287)		354		-		1,730,386		(1,769,326)		74,157		33,284
	Increase (decrease) of accounts receivable securitization program				-		-		-		-		23,000		-		23,000
	Proceeds from exercise of stock options				-		32,210		-		-		3,932		-		36,142
	Purchase of treasury stock				-		(230,654)		-		-		-		-		(230,654)
	Dividends paid				-		(296,134)		-		-		(1,665)		1,665		(296,134)
	Capital increase (decrease)				-		-		-		(1,731,962)		1,733,364		(1,402)		-
	Distributions to noncontrolling interest				-		-		-		-		(117,855)		-		(117,855)
	Contributions from noncontrolling interest				-		-		-		-		27,157		-		27,157
			Net cash provided by (used in) financing activities		(2,287)		(494,220)		(34,873)		(1,576)		(65,585)		74,420		(524,121)
Effect of exchange rate changes on cash and cash equivalents					-		(1,135)		(6)		-		(14,627)		-		(15,768)
Cash and Cash Equivalents:
Net increase (decrease) in cash and cash equivalents					-		4,854		94		-		(135,689)		28,558		(102,183)
Cash and cash equivalents at beginning of period					1		78		501		-		686,457		1,003		688,040
Cash and cash equivalents at end of period				$	1	$	4,932	$	595	$	-	$	550,768	$	29,561	$	585,857

				For the six months ended June 30, 2012
				Issuer		Guarantors						Non-Guarantor Subsidiaries
				FMC US Finance		FMC - AG & Co. KGaA		D-GmbH			FMCH				Combining Adjustment			Combined Total
Operating Activities:
	Net income (loss)			$	2,162	$	659,835	$	11,130	$	420,710	$	724,342	$	(1,099,181)	$	718,998
	Adjustments to reconcile net income to net cash provided by (used in) operating activities:
	Equity affiliate income				-		(532,403)		-		(505,714)		-		1,038,117		-
		Depreciation and amortization			-		221		23,540		-		284,698		(14,208)		294,251
		Change in deferred taxes, net			-		14,485		5,121		-		48,162		(2,834)		64,934
		(Gain) loss on sale of fixed assets and investments			-		(40)		20		-		(32,954)		-		(32,974)
		Investment (gain)			-		-		-		-		(139,600)		-		(139,600)
		Compensation expense related to stock options			-		12,949		-		-		-		-		12,949
		Cash outflow from hedging			-		1,334		-		-		(15,408)		-		(14,074)
		Investments in equity method investees, net			-		36,785		-		-		(7,806)		-		28,979
	Changes in assets and liabilities, net of amounts from businesses acquired:
		Trade accounts receivable, net			-		-		(13,554)		-		1,056		-		(12,498)
		Inventories			-		-		(52,595)		-		(19,998)		7,772		(64,821)
		Prepaid expenses and other current and non-current assets			-		120,331		(21,321)		73,363		(47,295)		(820)		124,258
		Accounts receivable from / payable to related parties			(4,127)		(241,016)		66,759		70,910		36,203		52,513		(18,758)
		Accounts payable, accrued expenses and other current and non-current liabilities			-		(812)		35,310		3,822		(19,087)		(1,905)		17,328
		Income tax payable			252		(11,026)		-		(55,383)		54,560		(35,415)		(47,012)
			Net cash provided by (used in) operating activities		(1,713)		60,643		54,410		7,708		866,873		(55,961)		931,960
Investing Activities:
	Purchases of property, plant and equipment				-		(361)		(31,912)		-		(262,701)		17,551		(277,423)
	Proceeds from sale of property, plant and equipment				-		40		147		-		3,477		-		3,664
	Disbursement of loans to related parties				-		(45,917)		82		513,595		-		(467,760)		-
	Acquisitions and investments, net of cash acquired, and purchases of intangible assets				-		(1,627,403)		(488)		-		(1,747,201)		1,626,913		(1,748,179)
	Proceeds from divestitures				-		45		-		-		228,206		(45)		228,206
			Net cash provided by (used in) investing activities		-		(1,673,596)		(32,171)		513,595		(1,778,219)		1,176,659		(1,793,732)
Financing Activities:
	Short-term borrowings, net				-		9,306		(21,944)		-		27,972		-		15,334
	Long-term debt and capital lease obligations, net				1,713		1,943,267		-		(521,303)		(418,270)		467,760		1,473,167
	Increase (decrease) of accounts receivable securitization program				-		-		-		-		(82,500)		-		(82,500)
	Proceeds from exercise of stock options				-		19,471		-		-		3,277		-		22,748
	Dividends paid				-		(271,733)		-		-		-		-		(271,733)
	Capital increase (decrease)				-		-		-		-		1,590,083		(1,590,083)		-
	Distributions to noncontrolling interest				-		-		-		-		(79,334)		-		(79,334)
	Contributions from noncontrolling interest				-		-		-		-		11,763		-		11,763
			Net cash provided by (used in) financing activities		1,713		1,700,311		(21,944)		(521,303)		1,052,991		(1,122,323)		1,089,445
Effect of exchange rate changes on cash and cash equivalents					-		1,065		(12)		-		(8,640)		-		(7,587)
Cash and Cash Equivalents:
Net increase (decrease) in cash and cash equivalents					-		88,423		283		-		133,005		(1,625)		220,086
Cash and cash equivalents at beginning of period					1		2		144		-		457,145		-		457,292
Cash and cash equivalents at end of period				$	1	$	88,425	$	427	$	-	$	590,150	$	(1,625)	$	677,378

XML

Supplementary Cash Flow Information (Details) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Supplementary cash flow information:
Cash paid for interest	$ 191,259	$ 155,263
Cash paid for income taxes, net of tax refund	225,740	229,128
Cash inflow for income taxes from stock option exercises	3,933	3,277
Supplemental disclosures of cash flow information, details for acquisitions:
Assets acquired	(130,864)	(2,337,691)
Liabilities assumed	17,173	226,377
Noncontrolling interest	5,570	95,418
Notes assumed in connection with acquisition	11,683	15,102
Noncontrolling Interest Subject To Put Provisions	15,320	87,201
Cash Paid	(81,118)	(1,913,593)
Less cash acquired in acquisition	5,139	170,301
Net cash paid for acquisitions	(75,979)	(1,743,292)
CashPaidForInvestments	(22,894)	(390)
Cash Paid For Intangible Assets	(2,936)	(4,497)
Cash Paid For Acquisitions And Investments Net Of Cash Acquired And Purchases Of Intangible Assets	$ (101,809)	$ (1,748,179)

XML

Patient Service Revenue

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Patient Service Revenue Text Block 1 [Text Block]

10. Sources of Revenue

Below is a table showing the sources of our U.S. patient service revenue (net of contractual allowance and discounts but before patient service bad debt provision), included in the Company's dialysis care revenue, for thesix months ended June 30, 2013 and 2012. Outside of the U.S., the Company does not recognize patient service revenue at the time the services are rendered without assessing the patient's ability to pay. Accordingly, the additional disclosure requirements introduced with ASU 2011-07 only apply to the U.S. patient service revenue.

	For the six months ended June 30,
		2013		2012
Medicare ESRD program	$	2,131,095	$	1,926,433
Private/alternative payors		1,865,556		1,775,378
Medicaid and other government sources		186,059		194,154
Hospitals		209,517		201,709
Total patient service revenue	$	4,392,227	$	4,097,674

XML

Patient Service Revenue (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Jun. 30, 2012
Patient Service Revenue By Payor [Line Items]
Patient Service Revenue by Payor	$ 4,392,227	$ 4,097,674
Medicare ESRD program
Patient Service Revenue By Payor [Line Items]
Patient Service Revenue by Payor	2,131,095	1,926,433
Hospitals
Patient Service Revenue By Payor [Line Items]
Patient Service Revenue by Payor	209,517	201,709
Private
Patient Service Revenue By Payor [Line Items]
Patient Service Revenue by Payor	1,865,556	1,775,378
Medicaid and other government sources
Patient Service Revenue By Payor [Line Items]
Patient Service Revenue by Payor	$ 186,059	$ 194,154

XML

Supplemental Condensed Combining Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012	Dec. 31, 2011
Consolidated Statements of Income
Net revenue	$ 3,612,515	$ 3,427,973	$ 7,076,436	$ 6,676,728
Cost of revenues	2,454,142	2,301,099	4,808,545	4,480,345
Gross profit	1,158,373	1,126,874	2,267,891	2,196,383
Selling, general and administrative			1,169,046	1,049,132
Research and development	30,921	26,938	61,293	55,460
Operating income	544,239	588,825	1,037,552	1,091,791
Other (income) expense:
Interest, net			207,280	203,075
Gain on the sale of dialysis clinics	(7,727)	(24,647)	(8,800)
Income before income taxes	441,188	497,545	830,272	1,028,316
Income tax expense	143,613	172,241	272,614	309,318
Net Income	297,575	325,304	557,658	718,998
Other comprehensive income loss derivatives qualifying as hedges before tax	3,993	12,525	19,890	8,242
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax	6,385	4,370	12,777	8,743
Other comprehensive income loss foreign currency transaction and translation adjustment before tax	(59,174)	(168,412)	(127,362)	(47,616)
Other comprehensive income loss tax	(3,232)	(4,977)	(9,914)	(23,958)
Less: Net income attributable to noncontrolling interests	35,051	35,967	69,635	59,163
Income attributable to the Company	262,524	289,337	488,023	659,835
Current assets:
Cash and cash equivalents	585,857	677,378	585,857	677,378	688,040	457,292
Trade accounts receivable less allowance for doubtful accounts of $318,989 in 2013 and $328,893 in 2012	3,031,167		3,031,167		3,019,424
Accounts receivable from related parties	190,868		190,868		137,809
Inventories	1,055,099		1,055,099		1,036,809
Prepaid expenses and other current assets	994,777		994,777		937,761
Deferred tax asset, current	292,033		292,033		307,613
Total current assets	6,149,801		6,149,801		6,127,456
Property, plant and equipment, net	2,935,140		2,935,140		2,940,603
Intangible assets	681,264		681,264		710,116
Goodwill	11,468,599		11,468,599		11,421,889
Deferred tax asset, non-current	135,631		135,631		133,753
Total assets	22,328,347		22,328,347		22,325,998
Current liabilities:
Accounts payable	493,947		493,947		622,294
Accounts payable to related parties	199,285		199,285		123,350
Accrued expenses and other current liabilities	1,831,164		1,831,164		1,787,471
Short-term borrowings and other financial liabilities	115,322		115,322		117,850
Short Term Borrowings Due To Related Parties Current Acquisitions	59,364		59,364		3,973
Current portion of long-term debt and capital lease obligations	514,118		514,118		334,747
Income tax payable, current	154,938		154,938		150,003
Deferred tax liability, current	37,409		37,409		30,303
Total current liabilities	3,405,547		3,405,547		3,169,991
Total long-term debt less current maturities	7,657,012		7,657,012		7,785,740
Other liabilities	324,338		324,338		294,569
Pension liabilities	432,060		432,060		423,361
Income tax payable, non-current	205,438		205,438		201,642
Deferred tax liability, non-current	652,612		652,612		664,001
Total liabilities	12,677,007		12,677,007		12,595,478
Noncontrolling interests subject to put provisions	541,347		541,347		523,260
Company shareholders' equity	8,841,740		8,841,740		8,942,506
Minority interest	268,253		268,253		264,754
Total equity	9,109,993		9,109,993		9,207,260	8,061,017
Total liabilities and equity	22,328,347		22,328,347		22,325,998
Consolidated Statements of Comprehensive Income
Net Income	297,575	325,304	557,658	718,998
Other comprehensive income loss derivatives qualifying as hedges before tax	3,993	12,525	19,890	8,242
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax	6,385	4,370	12,777	8,743
Other comprehensive income loss foreign currency transaction and translation adjustment before tax	(59,174)	(168,412)	(127,362)	(47,616)
Other comprehensive income loss tax	(3,232)	(4,977)	(9,914)	(23,958)
Other comprehensive income (loss), net of tax	(52,028)	(156,494)	(104,609)	(54,589)
Total comprehensive income	245,547	168,810	453,049	664,409
Comprehensive income attributable to noncontrolling interests	(34,715)	(35,212)	(67,317)	(59,249)
Comprehensive income attributable to the Company	210,832	133,598	385,732	605,160
FMCH [Member]
Other (income) expense:
Income attributable to the Company			364,149
Issuers [Member] | FMCH [Member]
Other (income) expense:
Interest, net				72,356
Issuers [Member] | FMC US Finance [Member]
Consolidated Statements of Income
Selling, general and administrative				0
Operating income				0
Other (income) expense:
Interest, net			(3,417)	(3,412)
Income before income taxes			3,417	3,412
Income tax expense			1,240	1,250
Net Income			2,177	2,162
Income attributable to the Company			2,177	2,162
Current assets:
Cash and cash equivalents	1	1	1	1	1
Accounts receivable from related parties	1,269,703		1,269,703		1,269,471
Total current assets	1,269,704		1,269,704		1,269,472
Total assets	1,269,704		1,269,704		1,269,472
Current liabilities:
Accounts payable to related parties					0
Accrued expenses and other current liabilities	29,771		29,771		29,771
Income tax payable, current					0
Total current liabilities	29,771		29,771		29,771
Total long-term debt less current maturities	1,169,932		1,169,932		1,172,397
Income tax payable, non-current	2,633		2,633
Total liabilities	1,202,336		1,202,336		1,204,281
Company shareholders' equity	67,368		67,368		65,191
Total equity	67,368		67,368		65,191
Total liabilities and equity	1,269,704		1,269,704		1,269,472
Consolidated Statements of Comprehensive Income
Net Income			2,177	2,162
Total comprehensive income			2,177
Comprehensive income attributable to the Company			2,177
Guarantors [Member] | Total FMC-AG and Co. KGaA [Member]
Consolidated Statements of Income
Selling, general and administrative			40,547	5,066
Operating income			(40,547)	(5,066)
Other (income) expense:
Interest, net			95,049	103,541
Other, net			(615,001)	(817,512)
Income before income taxes			479,405	708,905
Income tax expense			(8,618)	49,070
Net Income			488,023	659,835
Other comprehensive income loss derivatives qualifying as hedges before tax			14,431	(5,916)
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax			65	15
Other comprehensive income loss foreign currency transaction and translation adjustment before tax			27,707	26,112
Other comprehensive income loss tax			(4,162)	3,427
Income attributable to the Company			488,023	659,835
Current assets:
Cash and cash equivalents	4,932	88,425	4,932	88,425	78	2
Accounts receivable from related parties	1,816,703		1,816,703		2,257,445
Prepaid expenses and other current assets	104,662		104,662		72,022
Deferred tax asset, current					0
Total current assets	1,926,297		1,926,297		2,329,545
Property, plant and equipment, net	540		540		611
Intangible assets	690		690		584
Deferred tax asset, non-current	69,036		69,036		51,111
Other assets	12,780,039		12,780,039		12,675,998
Total assets	14,776,602		14,776,602		15,057,849
Current liabilities:
Accounts payable	659		659		1,935
Accounts payable to related parties	2,064,018		2,064,018		2,234,205
Accrued expenses and other current liabilities	45,648		45,648		27,530
Short-term borrowings and other financial liabilities	42		42		38
Current portion of long-term debt and capital lease obligations	280,629		280,629		207,160
Income tax payable, current	103,521		103,521		130,636
Total current liabilities	2,499,337		2,499,337		2,603,126
Total long-term debt less current maturities	207,763		207,763		285,049
Long term borrowings from related parties	3,185,549		3,185,549		3,212,455
Other liabilities	5,775		5,775		6,696
Pension liabilities	9,464		9,464		7,753
Income tax payable, non-current	26,974		26,974		264
Total liabilities	5,934,862		5,934,862		6,115,343
Company shareholders' equity	8,841,740		8,841,740		8,942,506
Total equity	8,841,740		8,841,740		8,942,506
Total liabilities and equity	14,776,602		14,776,602		15,057,849
Consolidated Statements of Comprehensive Income
Net Income			488,023	659,835
Other comprehensive income loss derivatives qualifying as hedges before tax			14,431	(5,916)
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax			65	15
Other comprehensive income loss foreign currency transaction and translation adjustment before tax			27,707	26,112
Other comprehensive income loss tax			(4,162)	3,427
Other comprehensive income (loss), net of tax			38,041	23,638
Total comprehensive income			526,064	683,473
Comprehensive income attributable to the Company			526,064	683,473
Guarantors [Member] | D GmbH [Member]
Consolidated Statements of Income
Net revenue			1,006,662	928,262
Cost of revenues			663,055	587,675
Gross profit			343,607	340,587
Selling, general and administrative			106,983	104,788
Research and development			36,549	34,134
Operating income			200,075	201,665
Other (income) expense:
Interest, net			3,804	1,741
Other, net			164,333	130,561
Income before income taxes			31,938	69,363
Income tax expense			37,248	58,233
Net Income			(5,310)	11,130
Other comprehensive income loss derivatives qualifying as hedges before tax				(9)
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax			1,267	186
Other comprehensive income loss foreign currency transaction and translation adjustment before tax			(6,535)	18,886
Other comprehensive income loss tax			(369)	(51)
Income attributable to the Company			(5,310)	11,130
Current assets:
Cash and cash equivalents	595	427	595	427	501	144
Trade accounts receivable less allowance for doubtful accounts of $318,989 in 2013 and $328,893 in 2012	178,405		178,405		170,627
Accounts receivable from related parties	1,647,943		1,647,943		1,449,317
Inventories	293,332		293,332		271,039
Prepaid expenses and other current assets	46,298		46,298		27,693
Total current assets	2,166,573		2,166,573		1,919,177
Property, plant and equipment, net	215,429		215,429		206,873
Intangible assets	72,003		72,003		67,874
Goodwill	54,374		54,374		54,848
Deferred tax asset, non-current	7,645		7,645		10,123
Other assets	28,056		28,056		650,255
Total assets	2,544,080		2,544,080		2,909,150
Current liabilities:
Accounts payable	36,248		36,248		41,114
Accounts payable to related parties	730,076		730,076		491,525
Accrued expenses and other current liabilities	133,908		133,908		102,728
Deferred tax liability, current	9,638		9,638		8,126
Total current liabilities	909,870		909,870		643,493
Long term borrowings from related parties	651,161		651,161		657,284
Other liabilities	13,340		13,340		12,679
Pension liabilities	208,554		208,554		202,219
Total liabilities	1,782,925		1,782,925		1,515,675
Company shareholders' equity	761,155		761,155		1,393,475
Total equity	761,155		761,155		1,393,475
Total liabilities and equity	2,544,080		2,544,080		2,909,150
Consolidated Statements of Comprehensive Income
Net Income			(5,310)	11,130
Other comprehensive income loss derivatives qualifying as hedges before tax				(9)
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax			1,267	186
Other comprehensive income loss foreign currency transaction and translation adjustment before tax			(6,535)	18,886
Other comprehensive income loss tax			(369)	(51)
Other comprehensive income (loss), net of tax			(5,637)	19,012
Total comprehensive income			(10,947)	30,142
Comprehensive income attributable to the Company			(10,947)	30,142
Guarantors [Member] | FMCH [Member]
Consolidated Statements of Income
Selling, general and administrative			(55,685)	68,031
Operating income			55,685	(68,031)
Other (income) expense:
Interest, net			87,078
Other, net			(383,157)	(505,714)
Income before income taxes			351,764	365,327
Income tax expense			(12,385)	(55,383)
Net Income			364,149	420,710
Other comprehensive income loss derivatives qualifying as hedges before tax				11,725
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax			11,335	8,536
Other comprehensive income loss tax			(4,472)	(7,993)
Income attributable to the Company				420,710
Current assets:
Accounts receivable from related parties	1,665,304		1,665,304		3,562,953
Prepaid expenses and other current assets	67		67		167
Total current assets	1,665,371		1,665,371		3,563,120
Other assets	12,140,029		12,140,029		11,766,104
Total assets	13,805,400		13,805,400		15,329,224
Current liabilities:
Accounts payable to related parties	1,597,911		1,597,911		1,598,852
Accrued expenses and other current liabilities	3,262		3,262		3,157
Current portion of long-term debt and capital lease obligations	200,000		200,000		100,000
Total current liabilities	1,801,173		1,801,173		1,702,009
Total long-term debt less current maturities					2,559,340
Long term borrowings from related parties	2,006,006		2,006,006		2,019,925
Other liabilities					110,637
Total liabilities	6,320,521		6,320,521		6,391,911
Company shareholders' equity	7,484,879		7,484,879		8,937,313
Total equity	7,484,879		7,484,879		8,937,313
Total liabilities and equity	13,805,400		13,805,400		15,329,224
Consolidated Statements of Comprehensive Income
Net Income			364,149	420,710
Other comprehensive income loss derivatives qualifying as hedges before tax				11,725
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax			11,335	8,536
Other comprehensive income loss tax			(4,472)	(7,993)
Other comprehensive income (loss), net of tax			6,863	12,268
Total comprehensive income			371,012	432,978
Comprehensive income attributable to the Company			371,012	432,978
Non Guarantor Subsidiaries [Member]
Consolidated Statements of Income
Net revenue			7,664,410	7,183,245
Cost of revenues			5,719,837	5,317,223
Gross profit			1,944,573	1,866,022
Selling, general and administrative			1,057,633	836,598
Research and development			24,912	21,326
Operating income			862,028	1,008,098
Other (income) expense:
Interest, net			24,349	28,849
Gain on the sale of dialysis clinics			0
Income before income taxes			837,679	1,118,849
Income tax expense			285,430	394,507
Net Income			552,249	724,342
Other comprehensive income loss derivatives qualifying as hedges before tax			5,459	2,442
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax			110	6
Other comprehensive income loss foreign currency transaction and translation adjustment before tax			(154,567)	(94,106)
Other comprehensive income loss tax			(911)	(19,341)
Income attributable to the Company			552,249	724,342
Current assets:
Cash and cash equivalents	550,768	590,150	550,768	590,150	686,457	457,145
Trade accounts receivable less allowance for doubtful accounts of $318,989 in 2013 and $328,893 in 2012	2,852,762		2,852,762		2,848,797
Accounts receivable from related parties	4,471,651		4,471,651		4,398,630
Inventories	898,209		898,209		885,613
Prepaid expenses and other current assets	842,973		842,973		837,152
Deferred tax asset, current	291,134		291,134		311,280
Total current assets	9,907,497		9,907,497		9,967,929
Property, plant and equipment, net	2,839,566		2,839,566		2,856,000
Intangible assets	608,636		608,636		641,714
Goodwill	11,414,225		11,414,225		11,367,041
Deferred tax asset, non-current	123,080		123,080		131,452
Other assets	5,998,848		5,998,848		(4,751,531)
Total assets	30,891,852		30,891,852		20,212,605
Current liabilities:
Accounts payable	457,040		457,040		579,245
Accounts payable to related parties	6,525,218		6,525,218		8,663,240
Accrued expenses and other current liabilities	1,618,116		1,618,116		1,611,997
Short-term borrowings and other financial liabilities	115,280		115,280		117,812
Short Term Borrowings Due To Related Parties Current Acquisitions	59,364		59,364		3,973
Current portion of long-term debt and capital lease obligations	33,489		33,489		27,587
Income tax payable, current	41,548		41,548		19,367
Deferred tax liability, current	63,487		63,487		61,774
Total current liabilities	8,913,542		8,913,542		11,084,995
Total long-term debt less current maturities	6,993,976		6,993,976		7,020,190
Long term borrowings from related parties	7,433		7,433		64,530
Other liabilities	261,047		261,047		130,634
Pension liabilities	214,042		214,042		213,389
Income tax payable, non-current	42,109		42,109		52,684
Deferred tax liability, non-current	680,438		680,438		685,158
Total liabilities	17,112,587		17,112,587		19,251,580
Noncontrolling interests subject to put provisions	541,347		541,347		523,260
Company shareholders' equity	12,969,665		12,969,665		173,011
Minority interest	268,253		268,253		264,754
Total equity	13,237,918		13,237,918		437,765
Total liabilities and equity	30,891,852		30,891,852		20,212,605
Consolidated Statements of Comprehensive Income
Net Income			552,249	724,342
Other comprehensive income loss derivatives qualifying as hedges before tax			5,459	2,442
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax			110	6
Other comprehensive income loss foreign currency transaction and translation adjustment before tax			(154,567)	(94,106)
Other comprehensive income loss tax			(911)	(19,341)
Other comprehensive income (loss), net of tax			(149,909)	(110,999)
Total comprehensive income			402,340	613,343
Comprehensive income attributable to the Company			402,340	613,343
Combining Adjustment [Member]
Consolidated Statements of Income
Net revenue			(1,594,636)	(1,434,779)
Cost of revenues			(1,574,347)	(1,424,553)
Gross profit			(20,289)	(10,226)
Selling, general and administrative			19,568	34,649
Operating income			(39,689)	(44,875)
Other (income) expense:
Interest, net			417	0
Other, net			833,825	1,192,665
Income before income taxes			(873,931)	(1,237,540)
Income tax expense			(30,301)	(138,359)
Net Income			(843,630)	(1,099,181)
Other comprehensive income loss foreign currency transaction and translation adjustment before tax			6,033	1,492
Less: Net income attributable to noncontrolling interests			69,635	59,163
Income attributable to the Company			(913,265)	(1,158,344)
Current assets:
Cash and cash equivalents	29,561		29,561			0
Accounts receivable from related parties	(10,680,436)		(10,680,436)		(12,800,007)
Inventories	(136,442)		(136,442)		(119,843)
Prepaid expenses and other current assets	777		777		727
Deferred tax asset, current	899		899		(3,667)
Total current assets	(10,785,641)		(10,785,641)		(12,921,787)
Property, plant and equipment, net	(120,395)		(120,395)		(122,881)
Deferred tax asset, non-current	(64,130)		(64,130)		(58,933)
Other assets	(29,989,060)		(29,989,060)		(19,348,645)
Total assets	(40,959,291)		(40,959,291)		(32,452,302)
Current liabilities:
Accounts payable to related parties	(10,717,938)		(10,717,938)		(12,864,472)
Accrued expenses and other current liabilities	459		459		12,288
Short Term Borrowings Due To Related Parties Current Acquisitions	0		0		0
Income tax payable, current	9,869		9,869
Deferred tax liability, current	(40,536)		(40,536)		(41,219)
Total current liabilities	(10,748,146)		(10,748,146)		(12,893,403)
Total long-term debt less current maturities	(3,216,171)		(3,216,171)		(3,251,236)
Long term borrowings from related parties	(5,850,149)		(5,850,149)		(5,898,020)
Other liabilities	32,346		32,346		33,923
Income tax payable, non-current	133,722		133,722		146,581
Deferred tax liability, non-current	(27,826)		(27,826)		(21,157)
Total liabilities	(19,676,224)		(19,676,224)		(21,883,312)
Company shareholders' equity	(21,283,067)		(21,283,067)		(10,568,990)
Total equity	(21,283,067)		(21,283,067)		(10,568,990)
Total liabilities and equity	(40,959,291)		(40,959,291)		(32,452,302)
Consolidated Statements of Comprehensive Income
Net Income			(843,630)	(1,099,181)
Other comprehensive income loss foreign currency transaction and translation adjustment before tax			6,033	1,492
Other comprehensive income (loss), net of tax			6,033	1,492
Total comprehensive income			(837,597)	(1,097,689)
Comprehensive income attributable to noncontrolling interests			(67,317)	(59,249)
Comprehensive income attributable to the Company			$ (904,914)	$ (1,156,938)

XML

Supplemental Condensed Combining Information (Tables)

3 Months Ended

6 Months Ended

Mar. 31, 2012

Jun. 30, 2013

Supplemental Condensed Combining Information (Tables) [Abstract]

Income statement information segregated by issuers and guarantors

		For the six months ended June 30, 2013
		Issuer		Guarantors
		FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH		Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
Net revenue		$	-	$	-	$	1,006,662	$	-	$	7,664,410	$	(1,594,636)	$	7,076,436
Cost of revenue			-		-		663,055		-		5,719,837		(1,574,347)		4,808,545
	Gross profit		-		-		343,607		-		1,944,573		(20,289)		2,267,891
Operating expenses (income):
	Selling, general and administrative (1)		-		40,547		106,983		(55,685)		1,057,633		19,568		1,169,046
	Research and development		-		-		36,549		-		24,912		(168)		61,293
Operating (loss) income			-		(40,547)		200,075		55,685		862,028		(39,689)		1,037,552
Other (income) expense:
	Interest, net		(3,417)		95,049		3,804		87,078		24,349		417		207,280
	Other, net		-		(615,001)		164,333		(383,157)		-		833,825		-
Income (loss) before income taxes			3,417		479,405		31,938		351,764		837,679		(873,931)		830,272
	Income tax expense (benefit)		1,240		(8,618)		37,248		(12,385)		285,430		(30,301)		272,614
Net Income (loss)			2,177		488,023		(5,310)		364,149		552,249		(843,630)		557,658
Net Income attributable to noncontrolling interests			-		-		-		-		-		69,635		69,635
Net income (loss) attributable to shareholders of FMC-AG & Co. KGaA		$	2,177	$	488,023	$	(5,310)	$	364,149	$	552,249	$	(913,265)	$	488,023
(1) Selling, general and administrative is presented net of Gain on Sale of dialysis clinics and net of income from equity method investees.

		For the six months ended June 30, 2012
		Issuer		Guarantors
		FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH		Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
Net revenue		$	-	$	-	$	928,262	$	-	$	7,183,245	$	(1,434,779)	$	6,676,728
Cost of revenue			-		-		587,675		-		5,317,223		(1,424,553)		4,480,345
	Gross profit		-		-		340,587		-		1,866,022		(10,226)		2,196,383
Operating expenses (income):
	Selling, general and administrative (1)		-		5,066		104,788		68,031		836,598		34,649		1,049,132
	Research and development		-		-		34,134		-		21,326		-		55,460
Operating (loss) income			-		(5,066)		201,665		(68,031)		1,008,098		(44,875)		1,091,791
Other (income) expense:
	Investment gain		-		-		-		-		(139,600)		-		(139,600)
	Interest, net		(3,412)		103,541		1,741		72,356		28,849		-		203,075
	Other, net		-		(817,512)		130,561		(505,714)		-		1,192,665		-
Income (loss) before income taxes			3,412		708,905		69,363		365,327		1,118,849		(1,237,540)		1,028,316
	Income tax expense (benefit)		1,250		49,070		58,233		(55,383)		394,507		(138,359)		309,318
Net Income (loss)			2,162		659,835		11,130		420,710		724,342		(1,099,181)		718,998
Net Income attributable to noncontrolling interests			-		-		-		-		-		59,163		59,163
Net income (loss) attributable to shareholders of FMC-AG & Co. KGaA		$	2,162	$	659,835	$	11,130	$	420,710	$	724,342	$	(1,158,344)	$	659,835
(1) Selling, general and administrative is presented net of Gain on Sale of dialysis clinics and net of income from equity method investees.

Balance sheet information segregated by issuers and guarantors

			At June 30, 2013
			Issuer		Guarantors						Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
			FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH
Current assets:
	Cash and cash equivalents		$	1	$	4,932	$	595	$	-	$	550,768	$	29,561	$	585,857
	Trade accounts receivable, less allowance for doubtful accounts			-		-		178,405		-		2,852,762		-		3,031,167
	Accounts receivable from related parties			1,269,703		1,816,703		1,647,943		1,665,304		4,471,651		(10,680,436)		190,868
	Inventories			-		-		293,332		-		898,209		(136,442)		1,055,099
	Prepaid expenses and other current assets			-		104,662		46,298		67		842,973		777		994,777
	Deferred taxes			-		-		-		-		291,134		899		292,033
		Total current assets		1,269,704		1,926,297		2,166,573		1,665,371		9,907,497		(10,785,641)		6,149,801
Property, plant and equipment, net				-		540		215,429		-		2,839,566		(120,395)		2,935,140
Intangible assets				-		690		72,003		-		608,636		(65)		681,264
Goodwill				-		-		54,374		-		11,414,225		-		11,468,599
Deferred taxes				-		69,036		7,645		-		123,080		(64,130)		135,631
Other assets and notes receivables (1)				-		12,780,039		28,056		12,140,029		5,998,848		(29,989,060)		957,912
	Total assets		$	1,269,704	$	14,776,602	$	2,544,080	$	13,805,400	$	30,891,852	$	(40,959,291)	$	22,328,347
Current liabilities:
	Accounts payable		$	-	$	659	$	36,248	$	-	$	457,040	$	-	$	493,947
	Accounts payable to related parties			-		2,064,018		730,076		1,597,911		6,525,218		(10,717,938)		199,285
	Accrued expenses and other current liabilities			29,771		45,648		133,908		3,262		1,618,116		459		1,831,164
	Short-term borrowings			-		42		-		-		115,280		-		115,322
	Short-term borrowings from related parties			-		-		-		-		59,364		-		59,364
	Current portion of long-term debt and capital lease obligations			-		280,629		-		200,000		33,489		-		514,118
	Income tax payable			-		103,521		-		-		41,548		9,869		154,938
	Deferred taxes			-		4,820		9,638		-		63,487		(40,536)		37,409
		Total current liabilities		29,771		2,499,337		909,870		1,801,173		8,913,542		(10,748,146)		3,405,547
Long term debt and capital lease obligations, less current portion				1,169,932		207,763		-		2,501,512		6,993,976		(3,216,171)		7,657,012
Long term borrowings from related parties				-		3,185,549		651,161		2,006,006		7,433		(5,850,149)		-
Other liabilities				-		5,775		13,340		11,830		261,047		32,346		324,338
Pension liabilities				-		9,464		208,554		-		214,042		-		432,060
Income tax payable				2,633		26,974		-		-		42,109		133,722		205,438
Deferred taxes				-		-		-		-		680,438		(27,826)		652,612
		Total liabilities		1,202,336		5,934,862		1,782,925		6,320,521		17,112,587		(19,676,224)		12,677,007
Noncontrolling interests subject to put provisions				-		-		-		-		541,347		-		541,347
Total FMC-AG & Co. KGaA shareholders' equity				67,368		8,841,740		761,155		7,484,879		12,969,665		(21,283,067)		8,841,740
Noncontrolling interests not subject to put provisions				-		-		-		-		268,253		-		268,253
Total equity				67,368		8,841,740		761,155		7,484,879		13,237,918		(21,283,067)		9,109,993
	Total liabilities and equity		$	1,269,704	$	14,776,602	$	2,544,080	$	13,805,400	$	30,891,852	$	(40,959,291)	$	22,328,347
(1) Other Assets and notes receivables are presented net of investment in equity method investees.

			At December 31, 2012
			Issuer		Guarantors						Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
			FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH
Current assets:
	Cash and cash equivalents		$	1	$	78	$	501	$	-	$	686,457	$	1,003	$	688,040
	Trade accounts receivable, less allowance for doubtful accounts			-		-		170,627		-		2,848,797		-		3,019,424
	Accounts receivable from related parties			1,269,471		2,257,445		1,449,317		3,562,953		4,398,630		(12,800,007)		137,809
	Inventories			-		-		271,039		-		885,613		(119,843)		1,036,809
	Prepaid expenses and other current assets			-		72,022		27,693		167		837,152		727		937,761
	Deferred taxes			-		-		-		-		311,280		(3,667)		307,613
		Total current assets		1,269,472		2,329,545		1,919,177		3,563,120		9,967,929		(12,921,787)		6,127,456
Property, plant and equipment, net				-		611		206,873		-		2,856,000		(122,881)		2,940,603
Intangible assets				-		584		67,874		-		641,714		(56)		710,116
Goodwill				-		-		54,848		-		11,367,041		-		11,421,889
Deferred taxes				-		51,111		10,123		-		131,452		(58,933)		133,753
Other assets and notes receivables (1)				-		12,675,998		650,255		11,766,104		(4,751,531)		(19,348,645)		992,181
	Total assets		$	1,269,472	$	15,057,849	$	2,909,150	$	15,329,224	$	20,212,605	$	(32,452,302)	$	22,325,998
Current liabilities:
	Accounts payable		$	-	$	1,935	$	41,114	$	-	$	579,245	$	-	$	622,294
	Accounts payable to related parties			-		2,234,205		491,525		1,598,852		8,663,240		(12,864,472)		123,350
	Accrued expenses and other current liabilities			29,771		27,530		102,728		3,157		1,611,997		12,288		1,787,471
	Short-term borrowings			-		38		-		-		117,812		-		117,850
	Short-term borrowings from related parties			-		-		-		-		3,973		-		3,973
	Current portion of long-term debt and capital lease obligations			-		207,160		-		100,000		27,587		-		334,747
	Income tax payable			-		130,636		-		-		19,367		-		150,003
	Deferred taxes			-		1,622		8,126		-		61,774		(41,219)		30,303
		Total current liabilities		29,771		2,603,126		643,493		1,702,009		11,084,995		(12,893,403)		3,169,991
Long term debt and capital lease obligations, less current portion				1,172,397		285,049		-		2,559,340		7,020,190		(3,251,236)		7,785,740
Long term borrowings from related parties				-		3,212,455		657,284		2,019,925		64,530		(5,898,020)		56,174
Other liabilities				-		6,696		12,679		110,637		130,634		33,923		294,569
Pension liabilities				-		7,753		202,219		-		213,389		-		423,361
Income tax payable				2,113		264		-		-		52,684		146,581		201,642
Deferred taxes				-		-		-		-		685,158		(21,157)		664,001
		Total liabilities		1,204,281		6,115,343		1,515,675		6,391,911		19,251,580		(21,883,312)		12,595,478
Noncontrolling interests subject to put provisions				-		-		-		-		523,260		-		523,260
Total FMC-AG & Co. KGaA shareholders' equity				65,191		8,942,506		1,393,475		8,937,313		173,011		(10,568,990)		8,942,506
Noncontrolling interests not subject to put provisions				-		-		-		-		264,754		-		264,754
Total equity				65,191		8,942,506		1,393,475		8,937,313		437,765		(10,568,990)		9,207,260
	Total liabilities and equity		$	1,269,472	$	15,057,849	$	2,909,150	$	15,329,224	$	20,212,605	$	(32,452,302)	$	22,325,998
(1) Other Assets and notes receivables are presented net of investment in equity method investees.

Statement of cash flows information segregated by issuers and guarantors

				For the six months ended June 30, 2013
				Issuer		Guarantors
				FMC US Finance		FMC - AG & Co. KGaA		D-GmbH			FMCH	Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
Operating Activities:
	Net income (loss)			$	2,177	$	488,023	$	(5,310)	$	364,149	$	552,249	$	(843,630)	$	557,658
	Adjustments to reconcile net income to net cash provided by (used in) operating activities:
	Equity affiliate income				-		(331,592)		-		(383,157)		-		714,749		-
		Depreciation and amortization			-		330		24,691		-		305,236		(15,103)		315,154
		Change in deferred taxes, net			-		(19,248)		3,651		-		18,363		(9,336)		(6,570)
		(Gain) loss on sale of fixed assets and investments			-		(12)		(153)		-		(6,089)		-		(6,254)
		Compensation expense related to stock options			-		12,777		-		-		-		-		12,777
		Cash inflow (outflow) from hedging			-		(4,028)		-		-		-		-		(4,028)
		Investments in equity method investees, net			-		22,691		-		-		(7,940)		-		14,751
	Changes in assets and liabilities, net of amounts from businesses acquired:
		Trade accounts receivable, net			-		-		(11,574)		-		(51,000)		-		(62,574)
		Inventories			-		-		(24,736)		-		(29,542)		20,013		(34,265)
		Prepaid expenses and other current and non-current assets			-		10,768		(17,389)		(53,403)		60,215		28,585		28,776
		Accounts receivable from / payable to related parties			(410)		286,966		68,660		57,847		(462,322)		70,579		21,320
		Accounts payable, accrued expenses and other current and non-current liabilities			-		10,171		38,199		106		(53,631)		(3,854)		(9,009)
		Income tax payable			520		729		-		(12,385)		(1,376)		25,313		12,801
			Net cash provided by (used in) operating activities		2,287		477,575		76,039		(26,843)		324,163		(12,684)		840,537
Investing Activities:
	Purchases of property, plant and equipment				-		(45)		(39,394)		-		(311,089)		16,886		(333,642)
	Proceeds from sale of property, plant and equipment				-		17		271		-		14,508		-		14,796
	Disbursement of loans to related parties				-		45,738		-		28,419		-		(74,157)		-
	Acquisitions and investments, net of cash acquired, and purchases of intangible assets				-		(23,076)		(1,943)		-		(100,883)		24,093		(101,809)
	Proceeds from divestitures				-		-		-		-		17,824		-		17,824
			Net cash provided by (used in) investing activities		-		22,634		(41,066)		28,419		(379,640)		(33,178)		(402,831)
Financing Activities:
	Short-term borrowings, net				-		4		(34,873)		-		35,808		-		939
	Long-term debt and capital lease obligations, net				(2,287)		354		-		1,730,386		(1,769,326)		74,157		33,284
	Increase (decrease) of accounts receivable securitization program				-		-		-		-		23,000		-		23,000
	Proceeds from exercise of stock options				-		32,210		-		-		3,932		-		36,142
	Purchase of treasury stock				-		(230,654)		-		-		-		-		(230,654)
	Dividends paid				-		(296,134)		-		-		(1,665)		1,665		(296,134)
	Capital increase (decrease)				-		-		-		(1,731,962)		1,733,364		(1,402)		-
	Distributions to noncontrolling interest				-		-		-		-		(117,855)		-		(117,855)
	Contributions from noncontrolling interest				-		-		-		-		27,157		-		27,157
			Net cash provided by (used in) financing activities		(2,287)		(494,220)		(34,873)		(1,576)		(65,585)		74,420		(524,121)
Effect of exchange rate changes on cash and cash equivalents					-		(1,135)		(6)		-		(14,627)		-		(15,768)
Cash and Cash Equivalents:
Net increase (decrease) in cash and cash equivalents					-		4,854		94		-		(135,689)		28,558		(102,183)
Cash and cash equivalents at beginning of period					1		78		501		-		686,457		1,003		688,040
Cash and cash equivalents at end of period				$	1	$	4,932	$	595	$	-	$	550,768	$	29,561	$	585,857

				For the six months ended June 30, 2012
				Issuer		Guarantors						Non-Guarantor Subsidiaries
				FMC US Finance		FMC - AG & Co. KGaA		D-GmbH			FMCH				Combining Adjustment			Combined Total
Operating Activities:
	Net income (loss)			$	2,162	$	659,835	$	11,130	$	420,710	$	724,342	$	(1,099,181)	$	718,998
	Adjustments to reconcile net income to net cash provided by (used in) operating activities:
	Equity affiliate income				-		(532,403)		-		(505,714)		-		1,038,117		-
		Depreciation and amortization			-		221		23,540		-		284,698		(14,208)		294,251
		Change in deferred taxes, net			-		14,485		5,121		-		48,162		(2,834)		64,934
		(Gain) loss on sale of fixed assets and investments			-		(40)		20		-		(32,954)		-		(32,974)
		Investment (gain)			-		-		-		-		(139,600)		-		(139,600)
		Compensation expense related to stock options			-		12,949		-		-		-		-		12,949
		Cash outflow from hedging			-		1,334		-		-		(15,408)		-		(14,074)
		Investments in equity method investees, net			-		36,785		-		-		(7,806)		-		28,979
	Changes in assets and liabilities, net of amounts from businesses acquired:
		Trade accounts receivable, net			-		-		(13,554)		-		1,056		-		(12,498)
		Inventories			-		-		(52,595)		-		(19,998)		7,772		(64,821)
		Prepaid expenses and other current and non-current assets			-		120,331		(21,321)		73,363		(47,295)		(820)		124,258
		Accounts receivable from / payable to related parties			(4,127)		(241,016)		66,759		70,910		36,203		52,513		(18,758)
		Accounts payable, accrued expenses and other current and non-current liabilities			-		(812)		35,310		3,822		(19,087)		(1,905)		17,328
		Income tax payable			252		(11,026)		-		(55,383)		54,560		(35,415)		(47,012)
			Net cash provided by (used in) operating activities		(1,713)		60,643		54,410		7,708		866,873		(55,961)		931,960
Investing Activities:
	Purchases of property, plant and equipment				-		(361)		(31,912)		-		(262,701)		17,551		(277,423)
	Proceeds from sale of property, plant and equipment				-		40		147		-		3,477		-		3,664
	Disbursement of loans to related parties				-		(45,917)		82		513,595		-		(467,760)		-
	Acquisitions and investments, net of cash acquired, and purchases of intangible assets				-		(1,627,403)		(488)		-		(1,747,201)		1,626,913		(1,748,179)
	Proceeds from divestitures				-		45		-		-		228,206		(45)		228,206
			Net cash provided by (used in) investing activities		-		(1,673,596)		(32,171)		513,595		(1,778,219)		1,176,659		(1,793,732)
Financing Activities:
	Short-term borrowings, net				-		9,306		(21,944)		-		27,972		-		15,334
	Long-term debt and capital lease obligations, net				1,713		1,943,267		-		(521,303)		(418,270)		467,760		1,473,167
	Increase (decrease) of accounts receivable securitization program				-		-		-		-		(82,500)		-		(82,500)
	Proceeds from exercise of stock options				-		19,471		-		-		3,277		-		22,748
	Dividends paid				-		(271,733)		-		-		-		-		(271,733)
	Capital increase (decrease)				-		-		-		-		1,590,083		(1,590,083)		-
	Distributions to noncontrolling interest				-		-		-		-		(79,334)		-		(79,334)
	Contributions from noncontrolling interest				-		-		-		-		11,763		-		11,763
			Net cash provided by (used in) financing activities		1,713		1,700,311		(21,944)		(521,303)		1,052,991		(1,122,323)		1,089,445
Effect of exchange rate changes on cash and cash equivalents					-		1,065		(12)		-		(8,640)		-		(7,587)
Cash and Cash Equivalents:
Net increase (decrease) in cash and cash equivalents					-		88,423		283		-		133,005		(1,625)		220,086
Cash and cash equivalents at beginning of period					1		2		144		-		457,145		-		457,292
Cash and cash equivalents at end of period				$	1	$	88,425	$	427	$	-	$	590,150	$	(1,625)	$	677,378

Other comprehensive income statement segregated by issuers and guarantors

		For the six months ended June 30, 2012
		Issuer		Guarantors						Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
		FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH
Net Income		$	2,162	$	659,835	$	11,130	$	420,710	$	724,342	$	(1,099,181)	$	718,998
	Gain (loss) related to cash flow hedges		-		(5,916)		(9)		11,725		2,442		-		8,242
	Actuarial gain (loss) on defined benefit pension plans		-		15		186		8,536		6		-		8,743
	Gain (loss) related to foreign currency translation		-		26,112		18,886		-		(94,106)		1,492		(47,616)
	Income tax (expense) benefit related to components of other comprehensive income		-		3,427		(51)		(7,993)		(19,341)		-		(23,958)
Other comprehensive income (loss), net of tax			-		23,638		19,012		12,268		(110,999)		1,492		(54,589)
Total comprehensive income		$	2,162	$	683,473	$	30,142	$	432,978	$	613,343	$	(1,097,689)	$	664,409
	Comprehensive income attributable to noncontrolling interests		-		-		-		-		-		59,249		59,249
Comprehensive income attributable to shareholders of FMC-AG & Co. KGaA		$	2,162	$	683,473	$	30,142	$	432,978	$	613,343	$	(1,156,938)	$	605,160

		For the six months ended June 30, 2013
		Issuer		Guarantors						Non-Guarantor Subsidiaries		Combining Adjustment		Combined Total
		FMC US Finance		FMC - AG & Co. KGaA		D-GmbH		FMCH
Net Income		$	2,177	$	488,023	$	(5,310)	$	364,149	$	552,249	$	(843,630)	$	557,658
	Gain (loss) related to cash flow hedges		-		14,431		-		-		5,459		-		19,890
	Actuarial gain (loss) on defined benefit pension plans		-		65		1,267		11,335		110		-		12,777
	Gain (loss) related to foreign currency translation		-		27,707		(6,535)		-		(154,567)		6,033		(127,362)
	Income tax (expense) benefit related to components of other comprehensive income		-		(4,162)		(369)		(4,472)		(911)		-		(9,914)
Other comprehensive income (loss), net of tax			-		38,041		(5,637)		6,863		(149,909)		6,033		(104,609)
Total comprehensive income		$	2,177	$	526,064	$	(10,947)	$	371,012	$	402,340	$	(837,597)	$	453,049
	Comprehensive income attributable to noncontrolling interests		-		-		-		-		-		67,317		67,317
Comprehensive income attributable to shareholders of FMC-AG & Co. KGaA		$	2,177	$	526,064	$	(10,947)	$	371,012	$	402,340	$	(904,914)	$	385,732

XML

Inventories (Tables)

6 Months Ended

Jun. 30, 2013

Inventories (Tables) [Abstract]

Inventory Disclosure Tables [Text Block]

			June 30, 2013		December 31, 2012
Finished goods		$	644,376	$	627,338
Raw materials and purchased components			179,242		171,373
Health care supplies			143,233		154,840
Work in process			88,248		83,258
	Inventories	$	1,055,099	$	1,036,809

XML

Acquisition of Liberty Dialysis Holdings - Pro Forma (Tables)

6 Months Ended

Jun. 30, 2013

Pro Forma (Tables) [Abstract]

Pro Forma Tabular Disclosures [Table Text Block]

		For the three months ended June 30,			For the six months ended June 30,
		2012			2012
Net revenue		$	3,420,560	$	6,782,198
Net income attributable to shareholders of FMC-AG & Co. KGaA			266,093		529,400
Income per ordinary share
	Basic	$	0.87	$	1.74
	Fully diluted	$	0.87	$	1.73

XML

Employee Benefit Plans (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Components Of Net Periodic Benefit Cost [Abstract]
Service cost	$ 3,818	$ 2,645	$ 7,669	$ 5,337
Interest cost	6,735	6,446	13,495	12,938
Expected return on plan assets	(3,400)	(3,825)	(6,800)	(7,650)
Amortization of unrealized losses	6,385	4,370	12,777	8,743
Net periodic benefit costs	$ 13,538	$ 9,636	$ 27,141	$ 19,368

XML

Financial Instrument (Tables)

6 Months Ended

Jun. 30, 2013

Financial Instruments (Tables) [Abstract]

Non-Derivative Financial Instruments

				June 30,			December 31,
				2013			2012
		Fair Value		Carrying	Fair		Carrying	Fair
		Hierarchy		Amount	Value		Amount	Value
Assets
	Cash and cash equivalents	1	$	585,857	585,857	$	688,040	688,040
	Accounts Receivable	2		3,222,035	3,222,035		3,157,233	3,157,233
Liabilities
	Accounts payable	2		693,232	693,232		745,644	745,644
	Short-term borrowings	2		174,686	174,686		121,823	121,823
	Long term debt, excluding 2012 Credit Agreement, Euro Notes and Senior Notes	2		563,986	563,986		721,928	721,928
	2012 Credit Agreement	2		2,832,312	2,828,542		2,659,340	2,652,840
	Senior Notes	2		4,730,687	5,075,954		4,743,442	5,296,325
	Euro Notes	2		44,145	45,407		51,951	54,574
Noncontrolling interests subject to put provisions		3		541,347	541,347		523,260	523,260

Derivative Financial Instruments Valuation

			June 30, 2013				December 31, 2012
				Assets(2)		Liabilities(2)		Assets(2)		Liabilities(2)
Derivatives in cash flow hedging relationships (1)
	Current
		Foreign exchange contracts		8,109		(1,566)		7,839		(7,510)
	Non-current
		Foreign exchange contracts		-		-		942		(187)
		Interest rate contracts		-		(4,246)		-		(6,221)
Total			$	8,109	$	(5,812)	$	8,781	$	(13,918)
Derivatives not designated as hedging instruments (1)
	Current
		Foreign exchange contracts		12,361		(6,217)		23,396		(19,068)
	Non-current
		Foreign exchange contracts		1,098		(1,227)		132		(292)
Total			$	13,459	$	(7,444)	$	23,528	$	(19,360)
	(1) At June 30, 2013 and December 31, 2012, the valuation of the Company's derivatives was determined using Significant Other Observable Inputs (Level 2) in accordance with the fair value hierarchy levels established in U.S. GAAP.
	(2) Derivative instruments are marked to market each reporting period resulting in carrying amounts being equal to fair values at the reporting date.

Effect of Derivatives on the Consolidated Financial Statements

The Effect of Derivatives on the Consolidated Financial Statements
		Amount of Gain or (Loss) Recognized in OCI on Derivatives			Location of (Gain) or Loss Reclassified from AOCI in Income			Amount of (Gain) or Loss Reclassified from AOCI in Income
Derivatives in Cash Flow Hedging Relationships
		(Effective Portion) for the six months ended June 30,							(Effective Portion) for the six months ended June 30,
		2013		2012	(Effective Portion)			2013			2012
Interest rate contracts	$	3,585	$	(4,913)	Interest income/expense		$	13,094		$	10,527
Foreign exchange contracts		1,962		8,883	Costs of Revenue			514			(7,261)
Foreign exchange contracts					Interest income/expense			735			1,006
	$	5,547	$	3,970			$	14,343		$	4,272
Derivatives not Designated as Hedging Instruments				Amount of (Gain) or Loss Recognized in Income on Derivatives for the six months ended June 30,
		Location of (Gain) or Loss Recognized in Income on Derivative
				2013		2012
Foreign exchange contracts		Selling, general and administrative expense	$	(42,102)	$	(1,458)
Foreign exchange contracts		Interest income/expense		3,397		3,066
			$	(38,705)	$	1,608

XML

Acquisition of Liberty Dialysis Holdings - Pro Forma (Details) (USD $) In Thousands, unless otherwise specified	6 Months Ended	3 Months Ended
	Jun. 30, 2012	Jun. 30, 2012 LibertyAcquisitionProForma [Member]
Pro Forma [Line Items]
Pro forma net revenue	$ 6,782,198	$ 3,420,560
Pro forma net income attributable to the shareholders of FMC-AG & co. KGaA	$ 529,400	$ 266,093
Basic	1.74	0.87
Fully diluted	1.73	0.87

XML

Commitments and Contingencies (Details) (Insurance Claims [Member], USD $) In Thousands, unless otherwise specified	Mar. 31, 2013
Insurance Claims [Member]
Loss Contingencies [Line Items]
Loss Contingency Accrual Carrying Value Current	$ 115,000

XML

Employee Benefit Plans (Tables)

6 Months Ended

Jun. 30, 2013

Employee Benefit Plans (Tables) [Abstract]

Schedule of the components of net periodic benefit cost

	Three months ended June 30,				Six months ended June 30,
	2013		2012		2013		2012
Components of net periodic benefit cost:
Service cost	$	3,818	$	2,645	$	7,669	$	5,337
Interest cost		6,735		6,446		13,495		12,938
Expected return on plan assets		(3,400)		(3,825)		(6,800)		(7,650)
Amortization of unrealized losses		6,385		4,370		12,777		8,743
Net periodic benefit costs	$	13,538	$	9,636	$	27,141	$	19,368

XML

Short-term Borrowings and Other Financial Liabilities and Short-term Borrowings from Related Parties (Details) (USD $) In Thousands, unless otherwise specified			6 Months Ended
	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2013 Fresenius SE [Member]	Jun. 30, 2013 General Partner [Member]
Short Term Borrowings Other Financial Liabilities And Short Term Borrowings From Related Parties (Details) [Abstract]
Borrowings under lines of credit	$ 115,322	$ 117,850
Related Party Transaction [Line Items]
Related Party Transaction Rate			1.492%	2.132%
Short-term borrowings and other financial liabilities	115,322	117,850
Short Term Borrowings Due To Related Parties Current Acquisitions	59,364	3,973
Short-term borrowings, Other financial liabilities and Short-term borrowings from related parties	$ 174,686	$ 121,823

XML

Acquisition of Liberty Dialysis Holdings (Tables)

6 Months Ended

Jun. 30, 2013

Business Acquisition, Date of Acquisition [Abstract]

Acquisition [Text Block]

Assets held for sale		$	164,068
Trade accounts receivable			149,219
Other current assets			17,458
Deferred tax assets			14,932
Property, plant and equipment			168,335
Intangible assets and other assets			84,556
Goodwill			2,003,465
Accounts payable, accrued expenses and other current liabilities			(105,403)
Income tax payable and deferred taxes			(33,597)
Short-term borrowings, other financial liabilities, long-term debt and capital lease obligations			(72,101)
Other liabilities			(39,923)
Noncontrolling interests (subject and not subject to put provisions)			(169,651)
Total acquisition cost		$	2,181,358
Less non-cash contributions at fair value
	Investment at acquisition date		(201,915)
	Long-term Notes Receivable		(282,784)
Total non-cash items		$	(484,699)
Net Cash paid		$	1,696,659

XML

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Operating Activities:
Net Income	$ 557,658	$ 718,998
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	315,154	294,251
Change in deferred taxes, net	(6,570)	64,934
(Gain) loss on sale of fixed assets	2,546	1,004
Stock Option Compensation Expense	12,777	12,949
Cash outflow from hedging	(4,028)	(14,074)
Investment gain	0	139,600
Dividend income from equity method investees	14,751	28,979
Changes in assets and liabilities, net of amounts from businesses acquired:
Trade accounts receivable, net	(62,574)	(12,498)
Inventories, net	(34,265)	(64,821)
Prepaid expenses, other current and non-current assets	28,776	124,258
Accounts receivable, related parties	(56,774)	(101,405)
Accounts payable, related parties	78,094	82,647
Accounts payable, accrued expenses and other current and non-current liabilities	(9,009)	17,328
Income tax payable	12,801	(47,012)
Net cash provided by (used in) operating activities	840,537	931,960
Investing Activities:
Purchases of property, plant and equipment	(333,642)	(277,423)
Proceeds from sale of property, plant and equipment	14,796	3,664
Acquisitions and investments, net of cash acquired, and net purchases of intangible assets	(101,809)	(1,748,179)
Proceeds from divestitures	17,824	228,206
Net cash (used in) provided by investing activities	(402,831)	(1,793,732)
Financing Activities:
Proceeds from short-term borrowings and other financial liabilities	64,703	57,332
Repayments of short-term borrowings and other financial liabilities	(62,148)	(67,162)
Proceeds from short-term borrowings from related parties	4,203	38,907
Repayments of short-term borrowings from related parties	(5,819)	(13,743)
Proceeds from long-term debt and capital lease obligations (net of debt issuance costs and other hedging costs of $156,406 in 2012)	203,080	2,028,913
Repayments of long-term debt and capital lease obligations	(169,796)	(555,746)
Increase (decrease) of accounts receivable securitization program	23,000	(82,500)
Proceeds from exercise of stock options	36,142	22,748
Payment of dividends [N]	(296,134)	(271,733)
Purchase of treasury stock	(230,654)	0
Distributions to Noncontrolling interests	(117,855)	(79,334)
Contributions from noncontrolling interests	27,157	11,763
Cash provided by (used in) financing activities	(524,121)	1,089,445
Effect of exchange rate changes on cash and cash equivalents	(15,768)	(7,587)
Cash and Cash Equivalents:
Net (decrease) in cash and cash equivalents	(102,183)	220,086
Cash and cash equivalents at beginning of period	688,040	457,292
Cash and cash equivalents at end of period	$ 585,857	$ 677,378

XML

The Company, Basis of Presentation, Healthcare Reform and Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

The Company and Basis of Presentation

1. The Company and Basis of Presentation

The Company

Fresenius Medical Care AG & Co. KGaA (“FMC-AG & Co. KGaA” or the “Company”), a German partnership limited by shares (Kommanditgesellschaft auf Aktien), is the world's largest kidney dialysis company, operating in both the field of dialysis care and the field of dialysis products for the treatment of end-stage renal disease (“ESRD”). The Company's dialysis care business, in addition to providing dialysis treatments, includes pharmacy services and vascular access surgery services (together, the “Expanded Services”). The Company's dialysis products business includes manufacturing and distributing products and equipment for the treatment of ESRD.The Company's dialysis business is vertically integrated, providing dialysis treatment at dialysis clinics it owns or operates and supplying these clinics with a broad range of products. In addition, the Company sells dialysis products to other dialysis service providers. Fresenius Medical Care Holdings, Inc. (“FMCH”), locatedin the United States and our largest subsidiary also provides laboratory testing services, and inpatient dialysis services as well as other services under contract to hospitals.

In these unaudited consolidated financial statements, “FMC-AG & Co. KGaA,” or the “Company,” “we,” “us” or “our” refers to the Company or the Company and its subsidiaries on a consolidated basis, as the context requires. The term “North America Segment” refers to the North America operating segment. The term “International Segment” refers to the combined Europe, Middle East, Africa and Latin America (“EMEALA”)operating segment and Asia-Pacific operating segment.

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

The consolidated financial statements at June 30, 2013 and for the three and sixmonths ended June 30, 2013 and 2012 contained in this report are unaudited and should be read in conjunction with the consolidated financial statements contained in the Company's 2012 Annual Report on Form 20-F. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Such financial statements reflect all adjustments that, in the opinion of management, are necessary for a fair presentation of the results of the periods presented. All such adjustments are of a normal recurring nature.

The accounting policies applied in the accompanying consolidated financial statements are the same as those applied in the consolidated financial statements at and for the year ended December 31, 2012, contained in the Company's 2012 Annual Report on Form 20-F.

The results of operations for the three and six-month periods ended June 30, 2013 are not necessarily indicative of the results of operations for the year ending December 31, 2013.

XML

Related Party Transactions

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Related Party Transactions

3. Related Party Transactions

The Company's parent, Fresenius SE & Co. KGaA (“Fresenius SE”), a German partnership limited by shares, owns 100% of the share capital of Fresenius Medical Care Management AG, the Company's general partner (“General Partner”). Fresenius SE, the Company's largest shareholder, owns approximately 31.0% of the Company's voting shares atJune 30, 2013, excludingthe shares purchased through the share buyback program as they are not considered to be outstanding, voting shares (see Note 7, Earnings Per Share).

a)Service and Lease Agreements

The Company is party to service agreements with Fresenius SE and certain of its affiliates (collectively the “Fresenius SE Companies”) to receive services, including, but not limited to: administrative services, management information services, employee benefit administration, insurance, information technology services, tax services and treasury management services. In 2013, the Company entered into a new information technology services agreement for the next five years, expiring in 2018, which hasan automatic continuationfor an additional 5 year period with short-term continuations thereafter unless either party terminates the agreement as of the end of the then-current term.The Company has complied with all corporate governance procedures for this agreement (for information on corporate governance, see Item 16G, “Corporate Governance” in our Annual Report on Form 20-F for the year ended December 31, 2012). During the six-monthended June 30, 2013 and 2012, amounts charged by Fresenius SE to the Company under the terms of these agreements were $57,253and $38,418, respectively. The Company also provides certain services to the Fresenius SE Companies, including research and development, central purchasing and warehousing. The Company charged $3,387and $3,184for services rendered to the Fresenius SE Companies during the first six months of 2013 and 2012 respectively.

Under real estate operating lease agreements entered into with the Fresenius SE Companies, which are leases for the corporate headquarters in Bad Homburg, Germany and production sites in Schweinfurt and St. Wendel, Germany, the Company paid the Fresenius SE Companies $13,317 and $12,660during thesix months ended June 30, 2013 and 2012, respectively. The majority of the leases expire in 2016 and contain renewal options.

The Company's Articles of Association provide that the General Partner shall be reimbursed for any and all expenses in connection with management of the Company's business, including remuneration of the members of the General Partner's supervisory board and the General Partner's management board. The aggregate amount reimbursed to the General Partner was $9,136and $6,453, respectively, for its management services during thesix monthsended June 30, 2013 and 2012.

b)Products

For the first six months of 2013 and 2012, the Company sold products to the Fresenius SE Companies for $15,598and $12,646,respectively. During the same periods, the Company made purchases from the Fresenius SE Companies in the amount of $22,066and $24,488, respectively.

In addition to the purchases noted above, the Company currently purchases heparin supplied by Fresenius Kabi USA, Inc. (“Kabi USA”), through an independent group purchasing organization (“GPO”). Kabi USA is wholly-owned by Fresenius Kabi AG, a wholly-owned subsidiary of Fresenius SE. The Company has no direct supply agreement with Kabi USA and does not submit purchase orders directly to Kabi USA. During the six-monthended June 30, 2013 and 2012, FMCH, a 100% owned subsidiary of the Company and its principal North American subsidiary, acquired approximately $8,864 and $8,565, respectively, of heparin from Kabi USA, through the GPO contract, which was negotiated by the GPO at arm's length on behalf of all members of the GPO.

c)Financing Provided by and to Fresenius SE and the General Partner

The Company receives short-term financing from and provides short-term financing to Fresenius SE. The Company also utilizes Fresenius SE's cash management system for the settlement of certain intercompany receivables and payables with its subsidiaries and other related parties.

At June 30, 2013, the Company provided a loan to Fresenius SE of €22,600 ($29,561 at June 30, 2013) at an interest rate of 1.371%, due and paid on July 2, 2013.

On August 19, 2009, the Company borrowed €1,500 ($1,962 at June 30, 2013) from the General Partner at 1.335%. The loan repayment has been extended periodically and is currently due August 20, 2013 at an interest rate of 2.132%.

At June 30, 2013, the Company had a Chinese Yuan Renminbi (“CNY”) loan of 352,313 ($57,402 at June 30, 2013) outstanding with a subsidiary of Fresenius SE at an interest rate of 6.1% and a maturity date of May 23, 2014.

d) Other

The Company, at June 30, 2013, had a receivable from Fresenius SE in the amount of €4,791 ($6,267 at June 30, 2013) resulting from being a party to a German trade tax group agreement with Fresenius SE for the fiscal years 1997-2001.

XML

Acquisition of Liberty Dialysis Holdings

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Acquisition of Liberty Dialysis Holdings [Text Block]

2. Acquisition of Liberty Dialysis Holdings, Inc.

On February 28, 2012, the Company acquired 100% of the equity of Liberty Dialysis Holdings, Inc. (“LD Holdings”), the owner of Liberty Dialysis and owner of a 51% stake in Renal Advantage Partners, LLC (the “Liberty Acquisition”). The Company accounted for this transaction as a business combination and finalized the acquisition accounting on February 28, 2013.

Total consideration for the Liberty Acquisition was $2,181,358, consisting of $1,696,659cash, net of cash acquired and$484,699non-cash consideration. Accounting standards for business combinations require previously held equity interests to be fair valued at the time of the acquisition with the difference to book value to be recognized as a gain or loss in income. Prior to the Liberty Acquisition, the Company had a 49% equity investment in Renal Advantage Partners, LLC, the fair value of which, $201,915,was included as part of the non-cash consideration. The fair value was determined based on the discounted cash flow method, utilizing a discount rate of approximately 13%. In addition to the Company's investment, it also had a loan receivable from Renal Advantage Partners, LLC of $279,793, at a fair value of $282,784, which was retired as part of the transaction.

The following table summarizes the final fair values of assets acquired and liabilities assumed at the date of the acquisition. Any adjustments to acquisition accounting from December 31, 2012 until finalization, net of related income tax effects, were recorded with a corresponding adjustment to goodwill:

Assets held for sale		$	164,068
Trade accounts receivable			149,219
Other current assets			17,458
Deferred tax assets			14,932
Property, plant and equipment			168,335
Intangible assets and other assets			84,556
Goodwill			2,003,465
Accounts payable, accrued expenses and other current liabilities			(105,403)
Income tax payable and deferred taxes			(33,597)
Short-term borrowings, other financial liabilities, long-term debt and capital lease obligations			(72,101)
Other liabilities			(39,923)
Noncontrolling interests (subject and not subject to put provisions)			(169,651)
Total acquisition cost		$	2,181,358
Less non-cash contributions at fair value
	Investment at acquisition date		(201,915)
	Long-term Notes Receivable		(282,784)
Total non-cash items		$	(484,699)
Net Cash paid		$	1,696,659

The amortizable intangible assets acquired in this acquisition have weighted average useful lives of 6-8 years.

Goodwill in the amount of $2,003,465 was acquired as part of the Liberty Acquisition and was allocated to the North America Segment. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Goodwill arises principally due to the fair value placed on an estimated stream of future cash flows versus building a similar franchise. Of the goodwill recognized in this acquisition, approximately $436,000 is expected to be deductible for tax purposes and amortized over a 15 year period.

The noncontrolling interests acquired as part of the acquisition are stated at fair value based upon contractual multiples typically utilized by the Company for such arrangements as well as the Company's overall experience

The fair valuation of the Company's investment at the time of the Liberty Acquisition resulted in a non-taxable gain of$139,600. The retirement of the loan receivable resulted in a benefit of $8,501.

Divestitures

In connection with the Federal Trade Commission's consent order relating to the Liberty Acquisition, the Company agreed to divest a total of 62 renal dialysis centers. 61 clinics were soldby the end of the second quarter of 2012, 24 of which wereFMC-AG & Co. KGaA clinics which generated a gain of $33,490. This gain was subsequently finalized in the amount of $33,455 during the period ended December 31, 2012 and included in the Consolidated Statements of Income.In the second quarter of 2013, the remaining clinic was sold for a gain of$7,705. The 38 clinics acquired and subsequently sold were categorized as Assets held for sale in the table above at the time of the Liberty Acquisition.

XML

Related Party Transactions (Details) In Thousands, unless otherwise specified	6 Months Ended		6 Months Ended
	Jun. 30, 2013 USD ($)	Dec. 31, 2012 USD ($)	Jun. 30, 2013 Fresenius SE [Member] USD ($)	Jun. 30, 2013 Fresenius SE [Member] EUR (€)	Jun. 30, 2013 Fresenius SE [Member] Services Provided By Related Party [Member] USD ($)	Jun. 30, 2012 Fresenius SE [Member] Services Provided By Related Party [Member] USD ($)	Jun. 30, 2013 Fresenius SE [Member] Services Provided To Related Party [Member] USD ($)	Jun. 30, 2012 Fresenius SE [Member] Services Provided To Related Party [Member] USD ($)	Jun. 30, 2013 Fresenius SE [Member] Operating Lease Agreements [Member] USD ($)	Jun. 30, 2012 Fresenius SE [Member] Operating Lease Agreements [Member] USD ($)	Jun. 30, 2013 Fresenius SE [Member] Sales To Related Party [Member] USD ($)	Jun. 30, 2012 Fresenius SE [Member] Sales To Related Party [Member] USD ($)	Jun. 30, 2013 Fresenius SE [Member] Purchases From Related Party [Member] USD ($)	Jun. 30, 2012 Fresenius SE [Member] Purchases From Related Party [Member] USD ($)	Jun. 30, 2013 Fresenius SE [Member] Taxes Receivable [Member] USD ($)	Jun. 30, 2013 Fresenius SE [Member] Taxes Receivable [Member] EUR (€)	Jun. 30, 2013 General Partner [Member] USD ($)	Jun. 30, 2013 General Partner [Member] EUR (€)	Jun. 30, 2013 General Partner [Member] Services Provided By Related Party [Member] USD ($)	Jun. 30, 2012 General Partner [Member] Services Provided By Related Party [Member] USD ($)	Jun. 30, 2013 APP Inc [Member] Purchases From Related Party [Member] USD ($)	Jun. 30, 2012 APP Inc [Member] Purchases From Related Party [Member] USD ($)	Jun. 30, 2013 Equity Method Investees [Member] Sales To Related Party [Member] USD ($)	Jun. 30, 2013 Fresenius SE Subsidiary [Member] USD ($)
Related Party Transactions [Line Items]
FSE ownership percentage	30.30%
Amount of transaction					$ 57,253	$ 38,418	$ 3,387	$ 3,184	$ 13,317	$ 12,660	$ 15,598	$ 12,646	$ 22,066	$ 24,488	$ 6,108	€ 4,770			$ 9,136	$ 6,453	$ 8,864	$ 8,565	$ 655
Due to related parties	$ 199,285	$ 123,350	$ 4,098	€ 3,200													$ 1,921	€ 1,500						$ 57,496
Interest rate			1.492%	1.492%													2.132%	2.132%						6.10%
Date of repayment	May 23, 2014		Apr. 30, 2012	Apr. 30, 2012													Aug. 20, 2013	Aug. 20, 2013						Apr. 14, 2013

XML

Short-term Borrowings, Other Finanacial Liabilties and Short-term Borrowings from Related Parties (Tables)

6 Months Ended

Jun. 30, 2013

Short Term Debt (Tables) [Abstract]

Schedule of Short-term debt

	June 30, 2013		December 31, 2012
Borrowings under lines of credit	$	115,322	$	117,850
Short-term borrowings from related parties (see Note 3.c.)		59,364		3,973
Short-term borrowings and Short-term borrowings from related parties	$	174,686	$	121,823

XML

Noncontrolling Interests Subject To Put Provisions (Tables)

6 Months Ended

Jun. 30, 2013

Noncontrolling Interests Subject To Put Provisions (Tables) [Abstract]

Noncontrolling Interests Subject to Put Provisions

9. Noncontrolling Interests Subject to Put Provisions

The Company has potential obligations to purchase the noncontrollinginterests held by third parties in certain of its consolidated subsidiaries. These obligations are in the form of put provisions and are exercisable at the third-party owners' discretion within specified periods as outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase all or part of third-party owners' noncontrolling interests at the appraised fair value at the time of exercise. The methodology the Company uses to estimate the fair values of the noncontrolling interest subject to put provisions assumes the greater of net book value or a multiple of earnings, based on historical earnings, the development stage of the underlying business and other factors. The estimated fair values of the noncontrolling interests subject to these put provisions can also fluctuate and the implicit multiple of earnings at which these noncontrolling interest obligations may ultimately be settled could vary significantly from our current estimates depending upon market conditions.

AtJune 30, 2013 and December 31, 2012, the Company's potential obligations under these put options were $541,347and $523,260, respectively, of which, at June 30, 2013, $208,239were exercisable. No put options were exercised during the first six months of 2013.

Following is a roll forward of noncontrolling interests subject to put provisions for the six months ended June 30, 2013 and the year ended December 31, 2012:

	June 30, 2013		December 31, 2012
Beginning balance as of January 1,	$	523,260	$	410,491
Contributions to noncontrolling interests		(56,330)		(114,536)
Purchase/ sale of noncontrolling interests		10,515		134,643
Contributions from noncontrolling interests		4,909		16,565
Changes in fair value of noncontrolling interests		10,333		(18,880)
Net income		48,812		94,718
Other comprehensive income (loss)		(152)		259
Ending balance as of June 30, 2013 and December 31, 2012	$	541,347	$	523,260

XML

Supplementary Cash Flow Information (Tables)

3 Months Ended

Mar. 31, 2013

Supplementary Cash Flow Information (Tables) [Abstract]

Schedule of supplemental Cash Flow information

		Six months ended June 30,
		2013		2012
Supplementary cash flow information:
	Cash paid for interest	$	191,259	$	155,263
	Cash paid for income taxes (1)	$	225,740	$	229,128
	Cash inflow for income taxes from stock option exercises	$	3,933	$	3,277
Supplemental disclosures of cash flow information:
	Details for acquisitions:
	Assets acquired	$	(130,864)	$	(2,337,691)
	Liabilities assumed		17,173		226,377
	Noncontrolling interest subject to put provisions		15,320		87,201
	Noncontrolling interest		5,570		95,418
	Obligations assumed in connection with acquisition		11,683		15,102
	Cash paid		(81,118)		(1,913,593)
	Less cash acquired		5,139		170,301
	Net cash paid for acquisitions		(75,979)		(1,743,292)
	Cash paid for investments		(22,894)		(390)
	Cash paid for intangible assets		(2,936)		(4,497)
	Total cash paid for acquisitions and investments, net of cash acquired, and purchases of intangible assets	$	(101,809)	$	(1,748,179)
	(1) Net of tax refund.

XML

Business Segment Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Entity-Wide Information, Revenue from External Customer [Line Items]
Net revenue from external customers	$ 3,612,515	$ 3,427,973	$ 7,076,436	$ 6,676,728
Segment depreciation and amortization	(158,801)	(150,877)	(315,154)	(294,251)
Operating income	544,239	588,825	1,037,552	1,091,791
Income from equity method investees	4,416	3,858	9,224	9,355
Segment assets	22,328,347		22,328,347		22,325,998
thereof investment in equity method investees	617,430		617,430		637,373
Capital expenditures, acquisitions and investments	215,880	198,382	435,451	2,025,602
Segment Total [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Net revenue from external customers	3,603,569	3,419,594	7,059,471	6,660,267
Inter - segment revenue	1,771	3,088		6,540
Segment revenue	3,605,340	3,422,682	7,062,317	6,666,807
Segment depreciation and amortization	(126,909)	(122,027)	(252,322)	(236,970)
Operating income	602,770	638,307	1,155,430	1,181,052
Income from equity method investees	3,699	8,400	8,903	11,449
Segment assets	20,066,557	19,484,012	20,066,557	19,484,012
thereof investment in equity method investees	622,620	606,330	622,620	606,330
Capital expenditures, acquisitions and investments	174,123	162,397	369,157	1,961,864
North America [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Net revenue from external customers	2,375,247	2,248,692	4,662,497	4,353,276
Inter - segment revenue	1,771	3,088	2,846	6,540
Segment revenue	2,377,018	2,251,780	4,665,343	4,359,816
Segment depreciation and amortization	(81,208)	(79,113)	(161,368)	(151,129)
Operating income	393,806	431,084	762,659	778,917
Income from equity method investees	3,646	8,338	7,935	11,320
Segment assets	14,094,573	13,788,169	14,094,573	13,788,169
thereof investment in equity method investees	247,277	246,161	247,277	246,161
Capital expenditures, acquisitions and investments	107,948	101,463	220,280	1,862,044
Exclusion of non-cash acquisitions			6,000
International [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Net revenue from external customers	1,228,322	1,170,902	2,396,974	2,306,991
Inter - segment revenue			2,846
Segment revenue	1,228,322	1,170,902	2,396,974	2,306,991
Segment depreciation and amortization	(45,701)	(42,914)	(90,954)	(85,841)
Operating income	208,964	207,223	392,771	402,135
Income from equity method investees	53	62	968	129
Segment assets	5,971,985	5,695,843	5,971,985	5,695,843
thereof investment in equity method investees	375,343	360,169	375,343	360,169
Capital expenditures, acquisitions and investments	66,175	60,934	148,877	99,820
Exclusion of non-cash acquisitions			1,731	8,884
Corporate1 [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Net revenue from external customers	8,946	8,379	16,965	16,461
Inter - segment revenue	(1,771)	(3,088)	(2,846)	(6,540)
Segment revenue	7,175	5,291	14,119	9,921
Segment depreciation and amortization	(31,892)	(28,850)	(62,832)	(57,281)
Operating income	(58,531)	(49,482)	(117,878)	(89,261)
Income from equity method investees	717	(4,542)	321	(2,094)
Segment assets	2,261,790	2,260,398	2,261,790	2,260,398
thereof investment in equity method investees	(5,190)	(2,714)	(5,190)	(2,714)
Capital expenditures, acquisitions and investments	41,757	35,985	66,294	63,738
Exclusion of non-cash acquisitions				$ 2,125

XML

Financial Instruments (Details) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2012	Dec. 31, 2011
Assets:
Cash and cash equivalents	$ 585,857	$ 688,040	$ 677,378	$ 457,292
Liabilities:
Short-term borrowings	115,322	117,850
Short-term borrowings from related parties	59,364	3,973
Noncontrolling interests subject to put provisions	541,347	523,260
Notional amount of foreign currency cash flow hedge derivatives	201,150	611,488
Notional amount of interest rate derivatives	1,344,019	1,574,667
Amount estimated to be transferred in the future from accumulated OCI into earnings	974
The time period estimated for the anticipated transfer of interest expense into earnings	12 months
Derivative assets subject to master netting agreements	16,854	32,044
Derivative liabilities subject to master netting agreements	9,631	19,193
Derivative net assets subject to master netting agreements	11,937	20,773
Derivative net liabiltiies subject to master netting agreements	4,714	7,922
Euro Notes [Member]
Liabilities:
Senior Long Term Notes	44,145	51,951
Senior Notes [Member]
Liabilities:
Senior Long Term Notes	4,730,687	4,743,442
Carrying Reported Amount Fair Value Disclosure [Member]
Assets:
Cash and cash equivalents	585,857	688,040
Accounts receivable	3,222,035	3,157,233
Liabilities:
Accounts Payable	693,232	745,644
Short-term borrowings	174,686	121,823
Long term debt, excluding Amended 2006 Senior Credit Agreement, Euro Notes and Senior Notes	563,986	721,928
Senior Credit Agreement	2,832,312	2,659,340
Noncontrolling interests subject to put provisions	541,347	523,260
Carrying Reported Amount Fair Value Disclosure [Member] | Euro Notes [Member]
Liabilities:
Senior Long Term Notes	44,145	51,951
Carrying Reported Amount Fair Value Disclosure [Member] | Senior Notes [Member]
Liabilities:
Senior Long Term Notes	4,730,687	4,743,442
Portion At Fair Value Fair Value Disclosure [Member]
Assets:
Cash and cash equivalents	585,857	688,040
Accounts receivable	3,222,035	3,157,233
Liabilities:
Accounts Payable	693,232	745,644
Short-term borrowings	174,686	121,823
Long term debt, excluding Amended 2006 Senior Credit Agreement, Euro Notes and Senior Notes	563,986	721,928
Senior Credit Agreement	2,828,542	2,652,840
Noncontrolling interests subject to put provisions	541,347	523,260
Portion At Fair Value Fair Value Disclosure [Member] | Euro Notes [Member]
Liabilities:
Senior Long Term Notes	45,407	54,574
Portion At Fair Value Fair Value Disclosure [Member] | Senior Notes [Member]
Liabilities:
Senior Long Term Notes	$ 5,075,954	$ 5,296,325

XML

Earnings Per Share (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Numerators:
Income attributable to the Company	$ 262,524,000	$ 289,337,000	$ 488,023,000	$ 659,835,000
Less: Dividend preference on Preference shares		25,000		51,000
Income available to all classes of shares	262,524,000	289,312,000	488,023,000	659,784,000
Denominators:
Weighted average number of ordinary shares outstanding	302,409,369	300,415,725	302,590,288	300,310,425
Weighted average number of preference shares outstanding	3,842,900	3,966,600	3,907,756	3,966,301
Total weighted average shares outstanding	306,252,269	304,382,325	306,498,044	304,276,726
Potentially dilutive Ordinary shares	1,362,863	2,405,628	1,247,741	2,372,829
Potentially dilutive Preference shares	0	18,019	0	18,145
Total weighted average Ordinary shares outstanding assuming dilution	303,772,232	302,821,353	303,838,029	302,683,254
Total weighted average Preference shares outstanding assuming dilution	3,842,900	3,984,619	3,907,756	3,984,446
Basic income per Ordinary share	0.86	0.95	1.59	2.17
Fully diluted income per Ordinary share	$ 0.85	$ 0.94	$ 1.59	$ 2.15

XML

Consolidated Statements of Comprehensive Income (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Consolidated Statements of Comprehensive Income
Net Income	$ 297,575	$ 325,304	$ 557,658	$ 718,998
Other comprehensive income loss derivatives qualifying as hedges before tax	3,993	12,525	19,890	8,242
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax	6,385	4,370	12,777	8,743
Other comprehensive income loss foreign currency transaction and translation adjustment before tax	(59,174)	(168,412)	(127,362)	(47,616)
Other comprehensive income loss tax	(3,232)	(4,977)	(9,914)	(23,958)
Other comprehensive income (loss), net of tax	(52,028)	(156,494)	(104,609)	(54,589)
Total comprehensive income	245,547	168,810	453,049	664,409
Comprehensive income attributable to Noncontrolling interests	34,715	35,212	67,317	59,249
Comprehensive income attributable to the Company	$ 210,832	$ 133,598	$ 385,732	$ 605,160

XML

Long-term Debt and Capital Lease Obligations

3 Months Ended

6 Months Ended

Mar. 31, 2013

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Long-term Debt and Capital Lease Obligations

	Maximum Amount Available June 30, 2013				Balance Outstanding June 30, 2013
Revolving Credit USD	$	600,000	$	600,000	$	101,512	$	101,512
Revolving Credit EUR	€	500,000	$	654,000	€	100,000	$	130,800
Term Loan A	$	2,600,000	$	2,600,000	$	2,600,000	$	2,600,000
			$	3,854,000			$	2,832,312
	Maximum Amount Available December 31, 2012				Balance Outstanding December 31, 2012
Revolving Credit USD	$	600,000	$	600,000	$	59,340	$	59,340
Revolving Credit EUR	€	500,000	$	659,700	€	-	$	-
Term Loan A	$	2,600,000	$	2,600,000	$	2,600,000	$	2,600,000
			$	3,859,700			$	2,659,340

6. Long-Term Debt and Capital Lease Obligations and Long-Term Debt from Related Parties

AtJune 30, 2013 and December 31, 2012, long-term debt and capital lease obligations and long-term debt from related parties consisted of the following:

	June 30, 2013		December 31, 2012
2012 Credit Agreement	$	2,832,312	$	2,659,340
Senior Notes		4,730,687		4,743,442
Euro Notes		44,145		51,951
European Investment Bank Agreements		231,926		324,334
Accounts receivable facility		185,000		162,000
Capital lease obligations		13,772		15,618
Other		133,288		163,802
Long-term debt and capital lease obligations		8,171,130		8,120,487
Less current maturities		(514,118)		(334,747)
Long-term debt and capital lease obligations, less current portion		7,657,012		7,785,740
Long-term debt from related parties		-		56,174
Long-term debt and capital lease obligations and long-term debt from related parties	$	7,657,012	$	7,841,914

2012 Credit Agreement

The following table shows the available and outstanding amounts under the 2012 Credit Agreement at June 30, 2013and at December 31, 2012:

In addition, atJune 30, 2013 and December 31, 2012, the Company had letters of credit outstanding in the amount of $ 11,065 and $ 77,188 , respectively, under the revolving credit facility, which are not included above as part of the balance outstanding, but reduce the available borrowings under the revolving credit facility.

Accounts Receivable Facility Letters of Credit

The Company also had letters of credit outstanding under the accounts receivable facility in the amount of $ 65,622 as of June 30, 2013. These letters of credit are not included above as part of the balance outstanding atJune 30, 2013;however,they reduce available borrowings under the accounts receivable facility.

XML

Consolidated Balance Sheets (Parentheticals) (USD $) In Thousands, except Share data, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Consolidated Balance Sheets
Trade accounts receivable allowance for doubtful accounts	$ 318,989	$ 328,893
Preferred stock authorized	7,066,522
Preferred stock issued	3,973,333
Preferred stock outstanding	3,973,333
Common stock authorized	385,396,450
Common stock issued	302,843,085
Common stock outstanding	302,843,085

XML

Supplemental Condensed Combining Information (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Operating Activities:
Net Income	$ 297,575	$ 325,304	$ 557,658	$ 718,998
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			315,154	294,251
Change in deferred taxes, net			(6,570)	64,934
(Gain) loss on sale of fixed assets and investments			(6,254)	(32,974)
Stock Option Compensation Expense			12,777	12,949
Cash outflow from hedging			(4,028)	(14,074)
Investment gain	0	12,915	0	139,600
Dividend income from equity method investees			14,751	28,979
Changes in assets and liabilities, net of amounts from businesses acquired:
Trade accounts receivable, net			(62,574)	(12,498)
Inventories, net			(34,265)	(64,821)
Prepaid expenses, other current and non-current assets			28,776	124,258
Accounts receivable from/payable to related parties			21,320	(18,758)
Accounts payable, accrued expenses and other current and non-current liabilities			(9,009)	17,328
Income tax payable			12,801	(47,012)
Net cash provided by (used in) operating activities			840,537	931,960
Investing Activities:
Purchases of property, plant and equipment			(333,642)	(277,423)
Proceeds from sale of property, plant and equipment			14,796	3,664
Disbursements of loans to related parties				0
Acquisitions and investments, net of cash acquired, and net purchases of intangible assets			(101,809)	(1,748,179)
Proceeds from divestitures			17,824	228,206
Net cash (used in) provided by investing activities			(402,831)	(1,793,732)
Financing Activities:
Short-term borrowings, net			939	15,334
Long-term debt and capital lease obligations, net			33,284	1,473,167
Increase (decrease) of accounts receivable securitization program			23,000	(82,500)
Proceeds from exercise of stock options			36,142	22,748
Payment of dividends [N]			(296,134)	(271,733)
Capital (decrease) increase				0
Distributions to noncontrolling interests			117,855	79,334
Contributions from noncontrolling interests			27,157	11,763
Treasury Stock Purchased			230,654	0
Net cash (used in) provided by financing activities			(524,121)	1,089,445
Effect of exchange rate changes on cash and cash equivalents			(15,768)	(7,587)
Cash and Cash Equivalents:
(decrease) in cash and cash equivalents			(102,183)	220,086
Cash and cash equivalents at beginning of period			688,040	457,292
Cash and cash equivalents at end of period	585,857	677,378	585,857	677,378
Issuers [Member]
Changes in assets and liabilities, net of amounts from businesses acquired:
Net cash provided by (used in) operating activities			2,287
Issuers [Member] | Total FMC-AG and Co. KGaA [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Income Loss From Equity Method Investments Net Of Dividends Or Distributions				(532,403)
Issuers [Member] | FMC US Finance [Member]
Operating Activities:
Net Income			2,177	2,162
Changes in assets and liabilities, net of amounts from businesses acquired:
Accounts receivable from/payable to related parties			(410)	(4,127)
Accounts payable, accrued expenses and other current and non-current liabilities				0
Income tax payable			520	252
Net cash provided by (used in) operating activities				(1,713)
Financing Activities:
Long-term debt and capital lease obligations, net			(2,287)	1,713
Capital (decrease) increase				0
Net cash (used in) provided by financing activities			(2,287)	1,713
Cash and Cash Equivalents:
(decrease) in cash and cash equivalents				0
Cash and cash equivalents at beginning of period			1
Cash and cash equivalents at end of period	1	1	1	1
Guarantors [Member] | Total FMC-AG and Co. KGaA [Member]
Operating Activities:
Net Income			488,023	659,835
Adjustments to reconcile net income to net cash provided by operating activities:
Income Loss From Equity Method Investments Net Of Dividends Or Distributions			(331,592)
Depreciation and amortization			330	221
Change in deferred taxes, net			(19,248)	14,485
(Gain) loss on sale of fixed assets and investments			(12)	(40)
Stock Option Compensation Expense			12,777	12,949
Cash outflow from hedging			(4,028)	(1,334)
Dividend income from equity method investees			(22,691)	(36,785)
Changes in assets and liabilities, net of amounts from businesses acquired:
Prepaid expenses, other current and non-current assets			10,768	120,331
Accounts receivable from/payable to related parties			286,966	(241,016)
Accounts payable, accrued expenses and other current and non-current liabilities			10,171	(812)
Income tax payable			729	(11,026)
Net cash provided by (used in) operating activities			477,575	60,643
Investing Activities:
Purchases of property, plant and equipment			(45)	(361)
Proceeds from sale of property, plant and equipment			17
Disbursements of loans to related parties			45,738	(45,917)
Acquisitions and investments, net of cash acquired, and net purchases of intangible assets			(23,076)	(1,627,403)
Proceeds from divestitures			0
Net cash (used in) provided by investing activities			22,634	(1,673,596)
Financing Activities:
Short-term borrowings, net			4	9,306
Long-term debt and capital lease obligations, net			354	1,943,267
Proceeds from exercise of stock options			32,210	19,471
Payment of dividends [N]			(296,134)	(271,733)
Treasury Stock Purchased			(230,654)
Net cash (used in) provided by financing activities			(494,220)	1,700,311
Effect of exchange rate changes on cash and cash equivalents			(1,135)	1,065
Cash and Cash Equivalents:
(decrease) in cash and cash equivalents			4,854	88,423
Cash and cash equivalents at beginning of period			78	2
Cash and cash equivalents at end of period	4,932	88,425	4,932	88,425
Guarantors [Member] | D GmbH [Member]
Operating Activities:
Net Income			(5,310)	11,130
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			24,691	23,540
Change in deferred taxes, net			3,651	5,121
(Gain) loss on sale of fixed assets and investments			(153)	20
Changes in assets and liabilities, net of amounts from businesses acquired:
Trade accounts receivable, net			(11,574)	(13,554)
Inventories, net			(24,736)	(52,595)
Prepaid expenses, other current and non-current assets			(17,389)	(21,321)
Accounts receivable from/payable to related parties			68,660	66,759
Accounts payable, accrued expenses and other current and non-current liabilities			38,199	35,310
Net cash provided by (used in) operating activities			76,039	54,410
Investing Activities:
Purchases of property, plant and equipment			(39,394)	(31,912)
Proceeds from sale of property, plant and equipment			271	147
Disbursements of loans to related parties			0	82
Acquisitions and investments, net of cash acquired, and net purchases of intangible assets			(1,943)	(488)
Net cash (used in) provided by investing activities			(41,066)	(32,171)
Financing Activities:
Short-term borrowings, net			(34,873)	(21,944)
Net cash (used in) provided by financing activities			(34,873)	(21,944)
Effect of exchange rate changes on cash and cash equivalents			(6)	(12)
Cash and Cash Equivalents:
(decrease) in cash and cash equivalents			94	283
Cash and cash equivalents at beginning of period			501	144
Cash and cash equivalents at end of period	595	427	595	427
Guarantors [Member] | FMCH [Member]
Operating Activities:
Net Income			364,149	420,710
Adjustments to reconcile net income to net cash provided by operating activities:
Income Loss From Equity Method Investments Net Of Dividends Or Distributions			(383,157)	(505,714)
Depreciation and amortization				0
Changes in assets and liabilities, net of amounts from businesses acquired:
Prepaid expenses, other current and non-current assets			(53,403)	73,363
Accounts receivable from/payable to related parties			57,847	70,910
Accounts payable, accrued expenses and other current and non-current liabilities			106	3,822
Income tax payable			(12,385)	(55,383)
Net cash provided by (used in) operating activities			(26,843)	7,708
Investing Activities:
Disbursements of loans to related parties			28,419	513,595
Net cash (used in) provided by investing activities			28,419	513,595
Financing Activities:
Short-term borrowings, net				0
Long-term debt and capital lease obligations, net			1,730,386	(521,303)
Capital (decrease) increase			(1,731,962)	0
Net cash (used in) provided by financing activities			(1,576)	(521,303)
Non Guarantor Subsidiaries [Member]
Operating Activities:
Net Income			552,249	724,342
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			305,236	284,698
Change in deferred taxes, net			18,363	48,162
(Gain) loss on sale of fixed assets and investments			(6,089)	(32,954)
Cash outflow from hedging				15,408
Dividend income from equity method investees			7,940	7,806
Changes in assets and liabilities, net of amounts from businesses acquired:
Trade accounts receivable, net			(51,000)	1,056
Inventories, net			(29,542)	(19,998)
Prepaid expenses, other current and non-current assets			60,215	(47,295)
Accounts receivable from/payable to related parties			(462,322)	36,203
Accounts payable, accrued expenses and other current and non-current liabilities			(53,631)	(19,087)
Income tax payable			(1,376)	54,560
Net cash provided by (used in) operating activities			324,163	866,873
Investing Activities:
Purchases of property, plant and equipment			(311,089)	(262,701)
Proceeds from sale of property, plant and equipment			14,508	3,477
Acquisitions and investments, net of cash acquired, and net purchases of intangible assets			(100,883)	(1,747,201)
Proceeds from divestitures			17,824
Net cash (used in) provided by investing activities			(379,640)	(1,778,219)
Financing Activities:
Short-term borrowings, net			35,808	27,972
Long-term debt and capital lease obligations, net			(1,769,326)	(418,270)
Increase (decrease) of accounts receivable securitization program			23,000	(82,500)
Proceeds from exercise of stock options			3,932	3,277
Payment of dividends [N]			(1,665)	0
Capital (decrease) increase			1,733,364	1,590,083
Distributions to noncontrolling interests			117,855	(79,334)
Contributions from noncontrolling interests			27,157	11,763
Net cash (used in) provided by financing activities			(65,585)	1,052,991
Effect of exchange rate changes on cash and cash equivalents			(14,627)	(8,640)
Cash and Cash Equivalents:
(decrease) in cash and cash equivalents			(135,689)	133,005
Cash and cash equivalents at beginning of period			686,457	457,145
Cash and cash equivalents at end of period	550,768	590,150	550,768	590,150
Combining Adjustment [Member]
Operating Activities:
Net Income			(843,630)	(1,099,181)
Adjustments to reconcile net income to net cash provided by operating activities:
Income Loss From Equity Method Investments Net Of Dividends Or Distributions			714,749	1,038,117
Depreciation and amortization			(15,103)	(14,208)
Change in deferred taxes, net			(9,336)	(2,834)
Changes in assets and liabilities, net of amounts from businesses acquired:
Inventories, net			20,013	7,772
Prepaid expenses, other current and non-current assets			28,585	(820)
Accounts receivable from/payable to related parties			70,579	52,513
Accounts payable, accrued expenses and other current and non-current liabilities			(3,854)	(1,905)
Income tax payable			25,313	(35,415)
Net cash provided by (used in) operating activities			(12,684)	(55,961)
Investing Activities:
Purchases of property, plant and equipment			16,886	17,551
Disbursements of loans to related parties			(74,157)	(467,760)
Acquisitions and investments, net of cash acquired, and net purchases of intangible assets			24,093	1,626,913
Net cash (used in) provided by investing activities			(33,178)	1,176,659
Financing Activities:
Long-term debt and capital lease obligations, net			74,157	467,760
Payment of dividends [N]			1,665	0
Capital (decrease) increase			(1,402)	(1,590,083)
Net cash (used in) provided by financing activities			74,420	(1,122,323)
Effect of exchange rate changes on cash and cash equivalents				0
Cash and Cash Equivalents:
(decrease) in cash and cash equivalents			28,558	(1,625)
Cash and cash equivalents at beginning of period				0
Cash and cash equivalents at end of period	$ 29,561		$ 29,561

XML

Consolidated Statements of Income (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Net revenue:
Dialysis Care Revenue	$ 2,811,244,000	$ 2,675,422,000	$ 5,553,179,000	$ 5,219,481,000
Valuation Allowances and Reserves, Adjustments	67,798,000	70,303,000	131,547,000	137,162,000
Net Dialysis care revenue	2,743,446,000	2,605,119,000	5,421,632,000	5,082,319,000
Dialysis Products Revenue	869,069,000	822,854,000	1,654,804,000	1,594,409,000
Net revenue	3,612,515,000	3,427,973,000	7,076,436,000	6,676,728,000
Costs of revenue:
Dialysis Care Cost of Revenue	2,057,342,000	1,913,947,000	4,041,566,000	3,745,073,000
Dialysis Products Cost of Revenue	396,800,000	387,152,000	766,979,000	735,272,000
Cost of revenues	2,454,142,000	2,301,099,000	4,808,545,000	4,480,345,000
Gross profit	1,158,373,000	1,126,874,000	2,267,891,000	2,196,383,000
Operating expenses:
Selling, general and administrative	595,356,000	539,616,000	1,187,070,000	1,092,448,000
Research and development	30,921,000	26,938,000	61,293,000	55,460,000
Income from equity method investees	(4,416,000)	(3,858,000)	(9,224,000)	(9,355,000)
Gain on the sale of dialysis clinics	7,727,000	24,647,000	8,800,000
Operating income	544,239,000	588,825,000	1,037,552,000	1,091,791,000
Other (income) expense:
Interest income	(6,653,000)	(12,496,000)	(17,242,000)	(32,802,000)
Interest expense	109,704,000	116,691,000	224,522,000	235,877,000
Investment gain	0	12,915,000	0	139,600,000
Income before income taxes	441,188,000	497,545,000	830,272,000	1,028,316,000
Income tax expense	143,613,000	172,241,000	272,614,000	309,318,000
Net Income	297,575,000	325,304,000	557,658,000	718,998,000
Less: Net income attributable to noncontrolling interests	35,051,000	35,967,000	69,635,000	59,163,000
Net Income attributable to the Company	262,524,000	289,337,000	488,023,000	659,835,000
Earning Per Share Diluted	$ 0.85	$ 0.94	$ 1.59	$ 2.15

XML

Financial Instruments (Details 1) (Significant Observable Inputs (Level 2), USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Designated As Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Assets	$ 8,109	$ 8,781
Liabilities	(5,812)	(13,918)
Nondesignated as Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Assets	13,459	23,528
Liabilities	(7,444)	(19,360)
Foreign Exchange Contract Current [Member] | Designated As Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Assets	8,109	7,839
Liabilities	(1,566)	(7,510)
Foreign Exchange Contract Current [Member] | Nondesignated as Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Assets	12,361	23,396
Liabilities	(6,217)	(19,068)
Foreign Exchange Contract Non Current [Member] | Designated As Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Assets	0	942
Liabilities		(187)
Foreign Exchange Contract Non Current [Member] | Nondesignated as Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Assets	1,098	132
Liabilities	(1,227)	(292)
Interest Rate Contract Non Current Dollar [Member] | Designated As Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Liabilities	$ (4,246)	$ (6,221)

XML

Long-term Debt and Capital Lease Obligations (Tables)

3 Months Ended

6 Months Ended

Mar. 31, 2013

Jun. 30, 2013

Long Term Debt and Capital Lease Obligations (Tables) [Abstract]

Schedule of long-term debt

	June 30, 2013		December 31, 2012
2012 Credit Agreement	$	2,832,312	$	2,659,340
Senior Notes		4,730,687		4,743,442
Euro Notes		44,145		51,951
European Investment Bank Agreements		231,926		324,334
Accounts receivable facility		185,000		162,000
Capital lease obligations		13,772		15,618
Other		133,288		163,802
Long-term debt and capital lease obligations		8,171,130		8,120,487
Less current maturities		(514,118)		(334,747)
Long-term debt and capital lease obligations, less current portion		7,657,012		7,785,740
Long-term debt from related parties		-		56,174
Long-term debt and capital lease obligations and long-term debt from related parties	$	7,657,012	$	7,841,914

2006 Senior Credit Agreement Table

	Maximum Amount Available June 30, 2013				Balance Outstanding June 30, 2013
Revolving Credit USD	$	600,000	$	600,000	$	101,512	$	101,512
Revolving Credit EUR	€	500,000	$	654,000	€	100,000	$	130,800
Term Loan A	$	2,600,000	$	2,600,000	$	2,600,000	$	2,600,000
			$	3,854,000			$	2,832,312
	Maximum Amount Available December 31, 2012				Balance Outstanding December 31, 2012
Revolving Credit USD	$	600,000	$	600,000	$	59,340	$	59,340
Revolving Credit EUR	€	500,000	$	659,700	€	-	$	-
Term Loan A	$	2,600,000	$	2,600,000	$	2,600,000	$	2,600,000
			$	3,859,700			$	2,659,340

XML

Supplementary Cash Flow Information

3 Months Ended

6 Months Ended

Mar. 31, 2013

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Cash Flow Supplemental Disclosures [Text Block]

		Six months ended June 30,
		2013		2012
Supplementary cash flow information:
	Cash paid for interest	$	191,259	$	155,263
	Cash paid for income taxes (1)	$	225,740	$	229,128
	Cash inflow for income taxes from stock option exercises	$	3,933	$	3,277
Supplemental disclosures of cash flow information:
	Details for acquisitions:
	Assets acquired	$	(130,864)	$	(2,337,691)
	Liabilities assumed		17,173		226,377
	Noncontrolling interest subject to put provisions		15,320		87,201
	Noncontrolling interest		5,570		95,418
	Obligations assumed in connection with acquisition		11,683		15,102
	Cash paid		(81,118)		(1,913,593)
	Less cash acquired		5,139		170,301
	Net cash paid for acquisitions		(75,979)		(1,743,292)
	Cash paid for investments		(22,894)		(390)
	Cash paid for intangible assets		(2,936)		(4,497)
	Total cash paid for acquisitions and investments, net of cash acquired, and purchases of intangible assets	$	(101,809)	$	(1,748,179)
	(1) Net of tax refund.

15. Supplementary Cash Flow Information

The following additional information is provided with respect to the consolidated statements of cash flows:

XML

Long-term Debt and Capital Lease Obligations (Details) (USD $) In Thousands, unless otherwise specified				3 Months Ended	12 Months Ended																3 Months Ended
	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2013 Amended 2006 Senior Credit Agreement [Member]	Mar. 31, 2013 Senior Credit Agreement 2012 Member [Member]	Dec. 31, 2012 Senior Credit Agreement 2012 Member [Member]	Dec. 31, 2012	Jun. 30, 2013 RevolvingCreditEUR [Member]	Dec. 31, 2012 RevolvingCreditEUR [Member]	Jun. 30, 2013 Long Term Debt [Member]	Dec. 31, 2012 Long Term Debt [Member]	Dec. 31, 2012 Amended 2006 Senior Credit Agreement [Member]	Jun. 30, 2013 Term Loan [Member] TermLoanA2012 [Member]	Dec. 31, 2012 Term Loan [Member] TermLoanA2012 [Member]	Jun. 30, 2013 Revolving Credit Facility [Member]	Jun. 30, 2013 Senior Notes [Member]	Dec. 31, 2012 Senior Notes [Member]	Jun. 30, 2013 Euro Notes [Member]	Dec. 31, 2012 Euro Notes [Member]	Jun. 30, 2013 EIB Agreements [Member]	Dec. 31, 2012 EIB Agreements [Member]	Mar. 31, 2013 Accounts Receivable Facility [Member]
Debt Instrument [Line Items]
Senior Credit Agreement			$ 2,832,312								$ 2,659,340
Senior Long Term Notes															4,730,687	4,743,442	44,145	51,951	231,926	324,334
Capital lease obligations	13,772	15,618
Other	133,288	163,802
Long-term debt and capital lease obligations	8,171,130	8,120,487
Less current maturities	514,118	334,747
Total long-term debt less current maturities	7,657,012	7,785,740
Revolving credit maximum amount available	3,854,000	3,859,700				600,000		659,700				2,600,000	2,600,000	600,000
Revolving credit balance outstanding	2,832,312	2,659,340				59,340						2,600,000	2,600,000	101,512
Maximum amount available							654,000
Balance outstanding							130,800
Line of credit outstanding which reduces available borrowings under the revolving credit facility				11,065	77,188																65,622
Accounts receivable facility									$ 185,000	$ 162,000

XML

Other Comprehensive Income - Reclassifications (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Other comprehensive income derivatives qualifying as hedges net of tax period increase decrease abstract
Interest rate contracts			$ 13,094	$ 10,527
Foreign exchange contracts cost of revenue			514	(7,261)
Foreign exchange contracts interest			735	1,006
Total before tax			14,343	4,272
Tax expense or benefit			(4,369)	620
Net of tax			9,974	4,892
Other comprehensive income defined benefit plans adjustment net of tax period increase decrease abstract
Other comprehensive income loss pension and other post retirement benefit plans net unamortized gain loss arising during period before tax	6,385	4,370	12,777	8,743
Total before tax			12,777	8,743
Benefit plans tax expense			(4,900)	(3,427)
Benefit plans net of tax			7,877	5,316
Total reclassifications for the period			$ 17,851	$ 10,208

XML

Acquisition of Liberty Dialysis Holdings (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Business Acquisition [Line Items]
Trade accounts receivable	$ 3,031,167		$ 3,031,167		$ 3,019,424
Other current assets	994,777		994,777		937,761
Goodwill	11,468,599		11,468,599		11,421,889
Income tax payable, current	154,938		154,938		150,003
Short Term Borrowings Due To Related Parties Current Acquisitions	59,364		59,364		3,973
Cash Paid	(81,118)	(1,913,593)	(81,118)	(1,913,593)
Revenue	3,612,515	3,427,973	7,076,436	6,676,728
Operating income	544,239	588,825	1,037,552	1,091,791
Liberty Dialysis Holdings [Member]
Business Acquisition [Line Items]
Other current assets	164,068		164,068
Trade accounts receivable	149,219		149,219
Other current assets	17,458		17,458
Deferred Tax Asset	14,932		14,932
Property, plant and equipment	168,335		168,335
Intangible assets and other assets	84,556		84,556
Goodwill	2,003,465		2,003,465
Accounts payable, accrued expenses and other current liabilities	(105,403)		(105,403)
Income tax payable, current	(33,597)		(33,597)
Short Term Borrowings Due To Related Parties Current Acquisitions	(72,101)		(72,101)
Other Liabilities	(39,923)		(39,923)
Noncontrolling interests (subject and not subject to put provisions)	(169,651)		(169,651)
Total acquisition cost	2,181,358		2,181,358
Investment at acquisition date	(201,915)		(201,915)
Long Term Note Receivable Acquisitions	(282,784)		(282,784)
Total non-cash items	(484,699)		(484,699)
Cash Paid	$ 1,696,659		$ 1,696,659

XML

Other Comprehensive Income (Tables)

6 Months Ended

Jun. 30, 2013

Other Comprehensive Income (Tables) [Abstract]

Other Comprehensive Income Rollforward [Text Block]

		Gain (Loss) related to cash flow hedges		Actuarial gain (loss) on defined benefit pension plans		Gain (loss) related to foreign-currency translation		Total, before non-controlling interests		Non-controlling interests		Total
Balance at December 31, 2011		$	(136,221)	$	(111,215)	$	(238,331)	$	(485,767)	$	3,048	$	(482,719)
	Other comprehensive income (loss) before reclassifications		(17,181)		-		(47,702)		(64,883)		86		(64,797)
	Amounts reclassified from accumulated other comprehensive income (loss) (1)		4,892		5,316		-		10,208		-		10,208
Other comprehensive income (loss) after reclassifications			(12,289)		5,316		(47,702)		(54,675)		86		(54,589)
Balance at June 30, 2012		$	(148,510)	$	(105,899)	$	(286,033)	$	(540,442)	$	3,134	$	(537,308)
Balance at December 31, 2012		$	(138,341)	$	(179,423)	$	(174,349)	$	(492,113)	$	2,869	$	(489,244)
	Other comprehensive income (loss) before reclassifications		4,902		-		(125,044)		(120,142)		(2,318)		(122,460)
	Amounts reclassified from accumulated other comprehensive income (loss) (1)		9,974		7,877		-		17,851		-		17,851
Other comprehensive income (loss) after reclassifications			14,876		7,877		(125,044)		(102,291)		(2,318)		(104,609)
Balance at June 30, 2013		$	(123,465)	$	(171,546)	$	(299,393)	$	(594,404)	$	551	$	(593,853)
(1) See separate table below for details about these reclassifications.

Other Comprehensive Income Reclassifications [Text Block]

Details about Accumulated Other Comprehensive Income (Loss) ("AOCI") Components		Amount of (Gain) Loss reclassified from AOCI in Income				Location of (Gain) Loss reclassified from AOCI in Income
		For the six months ended June 30,
		2013		2012
(Gain) Loss related to cash flow hedges
	Interest rate contracts	$	13,094	$	10,527	Interest income/expense
	Foreign exchange contracts		514		(7,261)	Costs of Revenue
	Foreign exchange contracts		735		1,006	Interest income/expense
			14,343		4,272	Total before tax
			(4,369)		620	Tax expense or benefit
		$	9,974	$	4,892	Net of tax
Actuarial (Gain) Loss on defined benefit pension plans
	Amortization of unrealized (gain) /loss		12,777		8,743	(1)
			12,777		8,743	Total before tax
			(4,900)		(3,427)	Tax expense or benefit
		$	7,877	$	5,316	Net of tax
Total reclassifications for the period		$	17,851	$	10,208	Net of tax
(1) Included in the computation of net periodic pension cost (see Note 8 for additional details).

XML

Business Segment Information (Tables)

3 Months Ended

Mar. 31, 2013

Business Segment Information (Tables) [Abstract]

Schedule of segment reporting information by segment

				North America Segment		International Segment		Segment Total		Corporate		Total
Three months ended June 30, 2013
	Net revenue external customers		$	2,375,247	$	1,228,322	$	3,603,569	$	8,946	$	3,612,515
	Inter - segment revenue			1,771		-		1,771		(1,771)		-
	Revenue			2,377,018		1,228,322		3,605,340		7,175		3,612,515
	Depreciation and amortization			(81,208)		(45,701)		(126,909)		(31,892)		(158,801)
	Operating income			393,806		208,964		602,770		(58,531)		544,239
	Income (loss) from equity method investees			3,646		53		3,699		717		4,416
	Capital expenditures, acquisitions and investments			107,948		66,175		174,123		41,757		215,880
Three months ended June 30, 2012
	Net revenue external customers		$	2,248,692	$	1,170,902	$	3,419,594	$	8,379	$	3,427,973
	Inter - segment revenue			3,088		-		3,088		(3,088)		-
	Revenue			2,251,780		1,170,902		3,422,682		5,291		3,427,973
	Depreciation and amortization			(79,113)		(42,914)		(122,027)		(28,850)		(150,877)
	Operating income			431,084		207,223		638,307		(49,482)		588,825
	Income (loss) from equity method investees			8,338		62		8,400		(4,542)		3,858
	Capital expenditures, acquisitions and investments			101,463		60,934		162,397		35,985		198,382
Six months ended June 30, 2013
	Net revenue external customers		$	4,662,497	$	2,396,974	$	7,059,471	$	16,965	$	7,076,436
	Inter - segment revenue			2,846		-		2,846		(2,846)		-
	Revenue			4,665,343		2,396,974		7,062,317		14,119		7,076,436
	Depreciation and amortization			(161,368)		(90,954)		(252,322)		(62,832)		(315,154)
	Operating Income			762,659		392,771		1,155,430		(117,878)		1,037,552
	Income (loss) from equity method investees			7,935		968		8,903		321		9,224
	Segment assets			14,094,573		5,971,985		20,066,557		2,261,790		22,328,347
		thereof investments in equity method investees		247,277		375,343		622,620		(5,190)		617,430
	Capital expenditures, acquisitions and investments(1)			220,280		148,877		369,157		66,294		435,451
Six months ended June 30, 2012
	Net revenue external customers		$	4,353,276	$	2,306,991	$	6,660,267	$	16,461	$	6,676,728
	Inter - segment revenue			6,540		-		6,540		(6,540)		-
	Revenue			4,359,816		2,306,991		6,666,807		9,921		6,676,728
	Depreciation and amortization			(151,129)		(85,841)		(236,970)		(57,281)		(294,251)
	Operating Income			778,917		402,135		1,181,052		(89,261)		1,091,791
	Income (loss) from equity method investees			11,320		129		11,449		(2,094)		9,355
	Segment assets			13,788,169		5,695,843		19,484,012		2,260,398		21,744,410
		thereof investments in equity method investees		246,161		360,169		606,330		(2,714)		603,616
	Capital expenditures, acquisitions and investments(2)			1,862,044		99,820		1,961,864		63,738		2,025,602
	(1) International acquisitions exclude $11,684 of non-cash acquisitions for 2013.
	(2) North America acquisitions exclude $496,386 of non-cash acquisitions and International acquisitions exclude $3,415 of non-cash acquisitions for 2012.

XML

Short-Term Borrowings and Other Financial Liabilities, and Short-Term Borrowings from Related Parties

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Short-Term Borrowings and Other Financial Liabilities, and Short-Term Borrowings from Related Parties

5. Short-Term Borrowings and Short-Term Borrowings from Related Parties

AtJune 30, 2013 and December 31, 2012, short-term borrowings and short-term borrowings from related parties consisted of the following:

	June 30, 2013		December 31, 2012
Borrowings under lines of credit	$	115,322	$	117,850
Short-term borrowings from related parties (see Note 3.c.)		59,364		3,973
Short-term borrowings and Short-term borrowings from related parties	$	174,686	$	121,823

XML

Earning Per Share (Tables)

6 Months Ended

Jun. 30, 2013

Earnings Per Share (Tables) [Abstract]

Schedule of Earning per Share

		For the three months ended June 30,				For the six months ended June 30,
		2013		2012		2013		2012
Numerators:
Net income attributable to shareholders of FMC-AG & Co. KGaA		$	262,524	$	289,337	$	488,023	$	659,835
less:
	Dividend preference on Preference shares		-		25		-		51
Income available to all classes of shares		$	262,524	$	289,312	$	488,023	$	659,784
Denominators:
Weighted average number of:
Ordinary shares outstanding			302,409,369		300,415,725		302,590,288		300,310,425
Preference shares outstanding			3,842,900		3,966,600		3,907,756		3,966,301
Total weighted average shares outstanding			306,252,269		304,382,325		306,498,044		304,276,726
Potentially dilutive Ordinary shares			1,362,863		2,405,628		1,247,741		2,372,829
Potentially dilutive Preference shares			-		18,019		-		18,145
Total weighted average Ordinary shares outstanding assuming dilution			303,772,232		302,821,353		303,838,029		302,683,254
Total weighted average Preference shares outstanding assuming dilution			3,842,900		3,984,619		3,907,756		3,984,446
Basic income per Ordinary share		$	0.86	$	0.95	$	1.59	$	2.17
Fully diluted income per Ordinary share		$	0.85	$	0.94	$	1.59	$	2.15

Period	Average price paid per share		Average price paid per share(1)		Total number of shares purchased as part of publicly announced plans or programs		Total Value of Shares Repurchased(4)		Total Value of Shares Repurchased(2), (4)			Maximum value of shares that may yet be purchased under plans or programs as of the end of the period(3)
		in €		in $				in €		in $		in €		in $
								in thousands
May 2013	€	52.96	$	68.48		1,078,255	€	57,107	$	73,842	€	327,910	$	426,480
June 2013	€	53.05	$	69.95		2,502,552	€	132,769	$	175,047	€	195,165	$	255,276
Total	€	53.03	$	69.51		3,580,807	€	189,876	$	248,889
(1) The dollar value is calculated using the daily exchange rate for the share repurchases made during the month.
(2) The value of the shares repurchased in Dollar is calculated using the total value of the shares purchased in Euro converted using the daily exchange rate for the transactions.
(3) The maximum Dollar value of the shares remaining is calculated using the maximum Euro value of shares that may yet be repurchased converted at the end of the month spot rate.
(4) This amount is inclusive of fees paid in the amount of approximately $53 (€ 41) for services rendered.

XML

Inventories (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Inventories (Details) [Abstract]
Raw materials and purchased components	$ 179,242	$ 171,373
Work in process	88,248	83,258
Finished goods	644,376	627,338
Health care supplies	143,233	154,840
Inventories	$ 1,055,099	$ 1,036,809

XML

Employee Benefit Plans

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Employee Benefit Plans

8. Employee Benefit Plans

The Company currently has two principal pension plans, one for German employees, the other covering employees in the United States, the latter of which was curtailed in 2002. Plan benefits are generally based on years of service and final salary. As there is no legal requirement in Germany to fund defined benefit plans, the Company's pension obligations in Germany are unfunded. Each year FMCH contributes to the plan covering United States employees at least the minimum required by the Employee Retirement Income Security Act of 1974, as amended.

The following table provides the calculations of net periodic benefit cost for the three- and six-monthsended June 30, 2013 and 2012, respectively.

	Three months ended June 30,				Six months ended June 30,
	2013		2012		2013		2012
Components of net periodic benefit cost:
Service cost	$	3,818	$	2,645	$	7,669	$	5,337
Interest cost		6,735		6,446		13,495		12,938
Expected return on plan assets		(3,400)		(3,825)		(6,800)		(7,650)
Amortization of unrealized losses		6,385		4,370		12,777		8,743
Net periodic benefit costs	$	13,538	$	9,636	$	27,141	$	19,368

XML

Inventories

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Inventories

4. Inventories

AtJune 30, 2013 and December 31, 2012, inventories consisted of the following:

			June 30, 2013		December 31, 2012
Finished goods		$	644,376	$	627,338
Raw materials and purchased components			179,242		171,373
Health care supplies			143,233		154,840
Work in process			88,248		83,258
	Inventories	$	1,055,099	$	1,036,809

XML

Consolidated Statements of Shareholders' Equity (USD $) In Thousands, except Share data, unless otherwise specified	Total	Preferred Stock, No par value [Member]	Common Stock, No par value [Member]	Treasury Stock Equity	Additional paid in capital [Member]	Retained earnings [Member]	Accumulated other comprehensive income (loss) [Member]	Total FMC-AG and Co. KGaA [Member]	Noncontrolling interests not subject to put provisions [Member]
Shareholders equity at Dec. 31, 2011	$ 8,061,017	$ 4,452	$ 371,649		$ 3,362,633	$ 4,648,585	$ (485,767)	$ 7,901,552
Shares issued at Dec. 31, 2011		3,965,691	300,164,922
Proceeds from exercise of options and related tax effects	113,786	10	3,266		110,510			113,786	159,465
Shares from exercise of options and related tax effects		7,642	2,574,836
Compensation expense related to stock options	26,476				26,476			26,476
Dividends paid	271,733					271,733		271,733
Minority interest increase from stock issuance	59,787				(26,918)			(26,918)	86,705
Minority interest decrease from distributions to noncontrolling interest holders	26,428								26,428
Changes in fair value of noncontrolling interests	18,880				18,880			18,880
Comprehensive income net of tax including portion attributable to noncontrolling interest abstract
Other comprehensive income loss net of tax period increase decrease less amounts attributable to noncontrolling interests subject to put provisions	(6,784)						(6,346)	(6,346)	(438)
Profit loss less amounts attributable to noncontrolling interests subject to put provisions	1,232,259					1,186,809		1,186,809	45,450
Comprehensive income net of tax including portion attributable to noncontrolling interest less amounts attributable to noncontrolling interests subject to put provisions	1,225,475							1,180,463	45,012
Shareholders equity at Dec. 31, 2012	9,207,260				3,491,581	5,563,661	(492,113)	8,942,506	264,754
Proceeds from exercise of options and related tax effects	35,839	3	1,130		34,706			35,839
Shares from exercise of options and related tax effects	2,200		864,024
Proceeds from conversion of preference shares	35,316	(4,465)	4,465		35,316			35,316
Preference share conversion		(3,975,533)	3,975,533
Compensation expense related to stock options	(12,777)				(12,777)			(12,777)
Dividends paid	296,134					296,134
treasury stock value	(248,889)			(3,580,807)
treasury stock shares				(248,889)
Minority interest increase from stock issuance	(10,111)				(15,074)			(15,074)	4,963
Minority interest decrease from distributions to noncontrolling interest holders	(20,121)							296,134	(20,121)
Changes in fair value of noncontrolling interests	(10,333)				(10,333)			(10,333)
Comprehensive income net of tax including portion attributable to noncontrolling interest abstract
Other comprehensive income loss net of tax period increase decrease less amounts attributable to noncontrolling interests subject to put provisions	(104,457)						(102,291)	(102,291)	(2,166)
Profit loss less amounts attributable to noncontrolling interests subject to put provisions	508,846					488,023		488,023	20,823
Comprehensive income net of tax including portion attributable to noncontrolling interest less amounts attributable to noncontrolling interests subject to put provisions	404,389							385,732	18,657
Shareholders equity at Jun. 30, 2013	$ 9,109,993	$ 0	$ 380,510	$ (248,889)	$ 3,548,973	$ 5,755,550	$ (594,404)	$ 8,841,740	$ 268,253
Shares issued at Jun. 30, 2013		0

XML

Financial Instruments (Details 2) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Designated As Hedging Instrument [Member]
Derivative Instruments Gain Loss [Line Items]
Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)	$ 5,547	$ 3,970
Amount of (Gain) or Loss Recognized in Income on Derivatives AOCI	14,343	4,272
Designated As Hedging Instrument [Member] | Interest Rate Contract [Member]
Derivative Instruments Gain Loss [Line Items]
Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)	3,585	(4,913)
Designated As Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivative Instruments Gain Loss [Line Items]
Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)	1,962	8,883
Nondesignated as Hedging Instrument [Member]
Derivative Instruments Gain Loss [Line Items]
Amount of (Gain) or Loss Recognized in Income on Derivatives	(38,705)	1,608
Interest Income Expense [Member] | Designated As Hedging Instrument [Member] | Interest Rate Contract [Member]
Derivative Instruments Gain Loss [Line Items]
Amount of (Gain) or Loss Recognized in Income on Derivatives AOCI	13,094	10,527
Interest Income Expense [Member] | Designated As Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivative Instruments Gain Loss [Line Items]
Amount of (Gain) or Loss Recognized in Income on Derivatives AOCI	735	1,006
Interest Income Expense [Member] | Nondesignated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivative Instruments Gain Loss [Line Items]
Amount of (Gain) or Loss Recognized in Income on Derivatives	3,397	3,066
Cost Of Sale [Member] | Designated As Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivative Instruments Gain Loss [Line Items]
Amount of (Gain) or Loss Recognized in Income on Derivatives AOCI	514	(7,261)
Selling, General and Administrative Expense [Member] | Nondesignated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivative Instruments Gain Loss [Line Items]
Amount of (Gain) or Loss Recognized in Income on Derivatives	$ (42,102)	$ (1,458)

XML

Noncontrolling Interests Subject to Put Provisions (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Noncontrolling Interests Subject To Put Provisions (Details) [Abstract]
Potential obligations under the put provisions	$ 541,347		$ 541,347		$ 523,260
Temporary Equity [Line Items]
Noncontrolling interests subject to put provisions beginning balance			523,260
Dividends paid			296,134		271,733
Minority interest increase from stock issuance			(10,111)		59,787
Minority interest decrease from distributions to noncontrolling interest holders			(20,121)		26,428
Changes in fair value of noncontrolling interests			(10,333)		18,880
Net Income	297,575	325,304	557,658	718,998
Other comprehensive income loss net of tax	(52,028)	(156,494)	(104,609)	(54,589)
Noncontrolling interests subject to put provisions ending balance	541,347		541,347		523,260
Put provisions exercisable	208,239		208,239
Noncontrolling interests subject to put provisions [Member]
Temporary Equity [Line Items]
Noncontrolling interests subject to put provisions beginning balance			410,491
Dividends paid			(56,330)		(114,536)
Minority interest increase from stock issuance			10,515		134,643
Minority interest decrease from distributions to noncontrolling interest holders			4,909		16,565
Changes in fair value of noncontrolling interests			10,333		(18,880)
Net Income			48,812		94,718
Other comprehensive income loss net of tax			(152)		259
Noncontrolling interests subject to put provisions ending balance					$ 410,491

XML

Patient Service Revenue (Tables)

6 Months Ended

Jun. 30, 2013

Patient Service Revenue by Payor (Abstract)

Patient Service Revenue [Text Block]

	For the six months ended June 30,
		2013		2012
Medicare ESRD program	$	2,131,095	$	1,926,433
Private/alternative payors		1,865,556		1,775,378
Medicaid and other government sources		186,059		194,154
Hospitals		209,517		201,709
Total patient service revenue	$	4,392,227	$	4,097,674

XML

Commitments and Contingencies

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Commitments and Contingencies

11. Commitments and Contingencies

Legal and Regulatory Matters

The Company is routinely involved in numerous claims, lawsuits, regulatory and tax audits, investigations and other legal matters arising, for the most part, in the ordinary course of its business of providing healthcare services and products. Legal matters that the Company currently deems to be material are described below. For the matters described below in which the Company believes a loss is both reasonably possible and estimable, an estimate of the loss or range of loss exposure is provided. For the other matters described below, the Company believes that the loss probability is remote and/or the loss or range of possible losses cannot be reasonably estimated at this time. The outcome of litigation and other legal matters is always difficult to predict accurately and outcomes that are not consistent with the Company's view of the merits can occur. The Company believes that it has valid defenses to the legal matters pending against it and is defending itself vigorously. Nevertheless, it is possible that the resolution of one or more of the legal matters currently pending or threatened could have a material adverse effect on its business, results of operations and financial condition.

Commercial Litigation

The Company was originally formed as a result of a series of transactions it completed pursuant to the Agreement and Plan of Reorganization dated as of February 4, 1996, by and between W.R. Grace & Co. and Fresenius SE (the "Merger"). At the time of the Merger, a W.R. Grace & Co. subsidiary known as W.R. Grace & Co.-Conn. had, and continues to have, significant liabilities arising out of product-liability related litigation (including asbestos-related actions), pre-Merger tax claims and other claims unrelated to National Medical Care, Inc. (“NMC”), which was W.R. Grace & Co.'s dialysis business prior to the Merger. In connection with the Merger, W.R. Grace & Co.-Conn. agreed to indemnify the Company, FMCH, and NMC against all liabilities of W.R. Grace & Co., whether relating to events occurring before or after the Merger, other than liabilities arising from or relating to NMC's operations. W.R. Grace & Co. and certain of its subsidiaries filed for reorganization under Chapter 11 of the U.S. Bankruptcy Code (the “Grace Chapter 11 Proceedings”) on April 2, 2001.

Prior to and after the commencement of the Grace Chapter 11 Proceedings, class action complaints were filed against W.R. Grace & Co. and FMCH by plaintiffs claiming to be creditors of W.R. Grace & Co.-Conn., and by the asbestos creditors' committees on behalf of the W.R. Grace & Co. bankruptcy estate in the Grace Chapter 11 Proceedings, alleging, among other things that the Merger was a fraudulent conveyance, violated the uniform fraudulent transfer act and constituted a conspiracy. All such cases have been stayed and transferred to or are pending before the U.S. District Court as part of the Grace Chapter 11 Proceedings.

In 2003, the Company reached agreement with the asbestos creditors' committees on behalf of the W.R. Grace & Co. bankruptcy estate and W.R. Grace & Co. in the matters pending in the Grace Chapter 11 Proceedings for the settlement of all fraudulent conveyance and tax claims against it and other claims related to the Company that arise out of the bankruptcy of W.R. Grace & Co. Under the terms of the settlement agreement as amended (the “Settlement Agreement”), fraudulent conveyance and other claims raised on behalf of asbestos claimants will be dismissed with prejudice and the Company will receive protection against existing and potential future W.R. Grace & Co. related claims, including fraudulent conveyance and asbestos claims, and indemnification against income tax claims related to the non-NMC members of the W.R. Grace & Co. consolidated tax group upon confirmation of a W.R. Grace & Co. bankruptcy reorganization plan that contains such provisions. Under the Settlement Agreement, the Company will pay a total of $115,000 without interest, which has previously been accrued and is included on the Company's Consolidated Balance Sheets, to the W.R. Grace & Co. bankruptcy estate, or as otherwise directed by the Court, upon plan confirmation. No admission of liability has been or will be made. While the Company believes this accrual reasonably estimates its currently anticipated costs related to the continued defense and resolution of this matter, no assurances can be given that its actual costs incurred will not exceed the amount of this accrual. The Settlement Agreement has been approved by the U.S. District Court. In January and February 2011, the U.S. Bankruptcy Court entered orders confirming the plan of reorganization and the confirmation orders were affirmed by the U.S. District Court on January 31, 2012. Multiple parties have appealed to the Third Circuit Court of Appeals and the plan of reorganization will not be implemented until the appeals are finally resolved.

Subsequent to the Merger, W.R. Grace & Co. was involved in a multi-step transaction involving Sealed Air Corporation (“Sealed Air,” formerly known as Grace Holding, Inc.). The Company is engaged in litigation with Sealed Air to confirm its entitlement to indemnification from Sealed Air for all losses and expenses incurred by the Company relating to pre-Merger tax liabilities and Merger-related claims. Under the Settlement Agreement, upon final confirmation of a plan of reorganization that satisfies the conditions of the Company's payment obligation, this litigation will be dismissed with prejudice.

On April 4, 2003, FMCH filed a suit in the U. S. District Court for the Northern District of California, styled Fresenius USA, Inc., et al., v. Baxter International Inc., et al., Case No. C 03-1431, seeking a declaratory judgment that FMCH does not infringe patents held by Baxter International Inc. and its subsidiaries and affiliates (“Baxter”), that the patents are invalid, and that Baxter is without right or authority to threaten or maintain suit against FMCH for alleged infringement of Baxter's patents. In general, the asserted patents concern the use of touch screen interfaces for hemodialysis machines. Baxter filed counterclaims against FMCH seeking more than $140,000 in monetary damages and injunctive relief, and alleging that FMCH willfully infringed on Baxter's patents. On July 17, 2006, the court entered judgment on a jury verdict in favor of FMCH finding all asserted claims of Baxter patents invalid as obvious and/or anticipated in light of prior art.

On February 13, 2007, the court granted Baxter's motion to set aside the jury's verdict in favor of FMCH and reinstated the patents and entered judgment of infringement. Following a trial on damages, the court entered judgment on November 6, 2007 in favor of Baxter on a jury award of $14,300. On April 4, 2008, the court denied Baxter's motion for a new trial, established a royalty payable to Baxter of 10% of the sales price for continuing sales of FMCH's 2008K hemodialysis machines and 7% of the sales price of related disposables, parts and service beginning November 7, 2007, and enjoined sales of the touchscreen-equipped 2008K machine effective January 1, 2009. The Company appealed the court's rulings to the United States Court of Appeals for the Federal Circuit (“Federal Circuit”). On September 10, 2009, the Federal Circuit reversed the district court's decision and determined that the asserted claims in two of the three patents at issue are invalid. As to the third patent, the Federal Circuit affirmed the district court's decision; however, the Court also vacated the injunction and award of damages. These issues were remanded to the District Court for reconsideration in light of the invalidity ruling on most of the claims. As a result, FMCH is no longer required to fund the court-approved escrow account set up to hold the royalty payments ordered by the district court. Funds of $70,000 were contributed to the escrow fund. Upon remand, the district court reduced the post verdict damages award to $10,000 and $61,000 of the escrowed funds was returned to FMCH. In the parallel reexamination of the last surviving patent, the U.S. Patent and Trademark Office (“USPTO”) and the Board of Patent Appeals and Interferences ruled that the remaining Baxter patent is invalid. On May 17, 2012 the Federal Circuit affirmed the USPTO's ruling and invalidated the final remaining Baxter patent. The Federal Circuit issued a mandate to the USPTO to cancel the claims of the last remaining asserted Baxter HD patent. Baxter appealed to the Federal Circuit claiming that approximately $20,000 of damages awarded to it by the District Court before the Federal Circuit affirmed the USPTO ruling constitutes a final judgment that may be collected. On July 2, 2013, the Federal Circuit denied Baxter's appeal and ordered the District Court to dismiss the case.

On August 27, 2012, Baxter filed suit in the U.S. District Court for the Northern District of Illinois, styled Baxter International Inc., et al., v. Fresenius Medical Care Holdings, Inc., Case No. 12-cv-06890, alleging that the Company's LibertyTM cycler infringes certain U.S. patents that were issued to Baxter between October 2010 and June 2012. The Company believes it has valid defenses to these claims, and will defend this litigation vigorously.

On April 5, 2013, the U.S. Judicial Panel on Multidistrict Litigation ordered that lawsuits filed in various federal courts alleging wrongful death and personal injury claims against FMCH and certain of its affiliates relating to FMCH's dialysate concentrate products NaturaLyte® and Granuflo® be transferred and consolidated for pretrial management purposes into a consolidated multidistrict litigation in the United States District Court for the District of Massachusetts, styled In Re: Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation, Case No. 2013-md-02428. These lawsuits allege generally that inadequate labeling and warnings for these products caused harm to patients. In addition, similar cases have been filed in other courts that will not be formally consolidated with the federal multidistrict litigation. FMCH believes that these lawsuits are without merit, and will defend them vigorously.

Other Litigation and Potential Exposures

On February 15, 2011, a qui tam relator's complaint under the False Claims Act against FMCH was unsealed by order of the United States District Court for the District of Massachusetts and served by the relator. The United States has not intervened in the case United States ex rel. Chris Drennen v. Fresenius Medical Care Holdings, Inc., 2009 Civ. 10179 (D. Mass.). The relator's complaint, which was first filed under seal in February 2009, alleges that the Company seeks and receives reimbursement from government payors for serum ferritin and hepatitis B laboratory tests that are medically unnecessary or not properly ordered by a physician. On March 6, 2011, the United States Attorney for the District of Massachusetts issued a Civil Investigative Demand seeking the production of documents related to the same laboratory tests that are the subject of the relator's complaint. FMCH has cooperated fully in responding to the Civil Investigative Demand, and will vigorously contest the relator's complaint.

On June 29, 2011, FMCH received a subpoena from the United States Attorney for the Eastern District of New York (“E.D.N.Y.”). On December 6, 2011, a single Company facility in New York received a subpoena from the Office of the Inspector General of the Department of Health and Human Services that was substantially similar to the one issued by the U.S. Attorney for the E.D.N.Y. These subpoenas are part of a criminal and civil investigation into relationships between retail pharmacies and outpatient dialysis facilities in the State of New York and into the reimbursement under government payor programs in New York for medications provided to patients with ESRD. Among the issues encompassed by the investigation is whether retail pharmacies may have provided or received compensation from the New York Medicaid program for pharmaceutical products that should be provided by the dialysis facilities in exchange for the New York Medicaid payment to the dialysis facilities. The Company has cooperated in the investigation.

Civil investigative demands were issued under the supervision of the United States Attorneys for Rhode Island and Connecticut to American Access Care LLC (AAC) and certain affiliated entities prior to the Company's acquisition of AAC in October 2011. In March 2012, a third subpoena was issued under the supervision of the United States Attorney for the Southern District of Florida (Miami). In May 2013, a fourth subpoena was served by the United States Attorney for the Eastern District of Virginia (Richmond). Also in May 2013, updated document productions were requested by the US Attorneys for Rhode Island and Connecticut. Although the subpoenas cover a wide range of documents and activities of AAC, the focus of the investigation is procedure coding and related billing practices and procedures. The Company has assumed responsibility for responding tothe subpoenas and is cooperating fully with the United States Attorneys.

The Company has received communications alleging certain conduct in certain countries outside the U.S. and Germany that may violate the U.S. Foreign Corrupt Practices Act (“FCPA”) or other anti-bribery laws.   In response to the allegations, the Audit and Corporate Governance Committee of the Company's Supervisory Board is conducting an internal review with the assistance of independent counsel retained for such purpose.  The Company voluntarily advised the U.S. Securities and Exchange Commission and the U.S. Department of Justice that allegations have been made and of the Company's internal review. The Company's independent counsel, in conjunction with the Company's Compliance department, have reviewed the Company's anti-corruption compliance program, including internal controls related to compliance with international anti-bribery laws, and appropriate enhancements are being implemented. The Company is fully committed to FCPA compliance. It cannot predict the final outcome of its review.

In December 2012 and January 2013, FMCH received subpoenas from the United States Attorneys for the District of Massachusetts and the Western District of Louisiana requesting production of a range of documents relating to products manufactured by FMCH, including the Granuflo® and Naturalyte® dialysate concentrate products. FMCH is cooperating fully in responding to these subpoenas.

The Company filed claims for refunds contesting the Internal Revenue Service's (“IRS”) disallowance of FMCH's civil settlement payment deductions taken by FMCH in prior year tax returns. As a result of a settlement agreement with the IRS, the Company received a partial refund in September 2008 of $37,000, inclusive of interest and preserved its right to pursue claims in the United States Courts for refunds of all other disallowed deductions, which totaled approximately $126,000. On December 22, 2008, the Company filed a complaint for complete refund in the United States District Court for the District of Massachusetts, styled as Fresenius Medical Care Holdings, Inc. v. United States. On August 15, 2012, a jury entered a verdict for FMCH granting additional deductions of $95,000. On May 31, 2013, the District Court entered final judgment for FMCH in the amount of $50,400. On July 18, 2013, the District Court denied the IRS's post trial motion seeking to set aside the verdict and judgment and closed the file. The IRS may appeal to the Court of Appeals for the First Circuit (Boston).

From time to time, the Company is a party to or may be threatened with other litigation or arbitration, claims or assessments arising in the ordinary course of its business. Management regularly analyzes current information including, as applicable, the Company's defenses and insurance coverage and, as necessary, provides accruals for probable liabilities for the eventual disposition of these matters.

The Company, like other healthcare providers, conducts its operations under intense government regulation and scrutiny. It must comply with regulations which relate to or govern the safety and efficacy of medical products and supplies, the marketing and distribution of such products, the operation of manufacturing facilities, laboratories and dialysis clinics, and environmental and occupational health and safety. With respect to its development, manufacture, marketing and distribution of medical products, if such compliance is not maintained, the Company could be subject to significant adverse regulatory actions by the FDA and comparable regulatory authorities outside the U.S. These regulatory actions could include warning letters or other enforcement notices from the FDA and/or comparable foreign regulatory authority, which may require the Company to expend significant time and resources in order to implement appropriate corrective actions. If warning letters or other enforcement notices are not addressed by the Company to the satisfaction of the FDA and/or comparable regulatory authorities outside the U.S., these regulatory authorities could take additional actions, including product recalls injunctions against the distribution of products or operation of manufacturing plants, civil penalties, seizures of the Company's products and/or criminal prosecution. The Company must also comply with the laws of the United States, including the federal Anti-Kickback Statute, the federal False Claims Act, the federal Stark Law andthe federal Foreign Corrupt Practices Act as well as other federal and state fraud and abuse laws. Applicable laws or regulations may be amended, or enforcement agencies or courts may make interpretations that differ from the Company's interpretations or the manner in which it conducts its business. Enforcement has become a high priority for the federal government and some states. In addition, the provisions of the False Claims Act authorizing payment of a portion of any recovery to the party bringing the suit encourage private plaintiffs to commence “qui tam” or “whistle blower” actions. In May 2009, the scope of the False Claims Act was expanded and additional protections for whistle blowers and procedural provisions to aid whistle blowers' ability to proceed in a False Claims Act case were added. By virtue of this regulatory environment, the Company's business activities and practices are subject to extensive review by regulatory authorities and private parties, and continuing audits, investigative demands, subpoenas, other inquiries, claims and litigation relating to the Company's compliance with applicable laws and regulations. The Company may not always be aware that an inquiry or action has begun, particularly in the case of “whistle blower” actions, which are initially filed under court seal.

The Company operates many facilities throughout the United States and other parts of the world. In such a decentralized system, it is often difficult to maintain the desired level of oversight and control over the thousands of individuals employed by many affiliated companies. The Company relies upon its management structure, regulatory and legal resources, and the effective operation of its compliance program to direct, manage and monitor the activities of these employees. On occasion, the Company may identify instances where employees or other agents deliberately, recklessly or inadvertently contravene the Company's policies or violate applicable law. The actions of such persons may subject the Company and its subsidiaries to liability under the Anti-Kickback Statute, the Stark Law, the False Claims Act and the Foreign Corrupt Practices Act, among other laws and comparable laws of other countries.

Physicians, hospitals and other participants in the healthcare industry are also subject to a large number of lawsuits alleging professional negligence, malpractice, product liability, worker's compensation or related claims, many of which involve large claims and significant defense costs. The Company has been and is currently subject to these suits due to the nature of its business and expects that those types of lawsuits may continue. Although the Company maintains insurance at a level which it believes to be prudent, it cannot assure that the coverage limits will be adequate or that insurance will cover all asserted claims. A successful claim against the Company or any of its subsidiaries in excess of insurance coverage could have a material adverse effect upon it and the results of its operations. Any claims, regardless of their merit or eventual outcome, could have a material adverse effect on the Company's reputation and business.

The Company has also had claims asserted against it and has had lawsuits filed against it relating to alleged patent infringements or businesses that it has acquired or divested. These claims and suits relate both to operation of the businesses and to the acquisition and divestiture transactions. The Company has, when appropriate, asserted its own claims, and claims for indemnification. A successful claim against the Company or any of its subsidiaries could have a material adverse effect upon its business, financial condition, and the results of its operations. Any claims, regardless of their merit or eventual outcome, could have a material adverse effect on the Company's reputation and business.

XML

Earnings Per Share

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Earnings Per Share

7. Earnings PerOrdinary Share

The following table contains reconciliations of the numerators and denominators of the basic and diluted earnings perordinary share computations for the three- and six-month ended June 30, 2013 and 2012:

		For the three months ended June 30,				For the six months ended June 30,
		2013		2012		2013		2012
Numerators:
Net income attributable to shareholders of FMC-AG & Co. KGaA		$	262,524	$	289,337	$	488,023	$	659,835
less:
	Dividend preference on Preference shares		-		25		-		51
Income available to all classes of shares		$	262,524	$	289,312	$	488,023	$	659,784
Denominators:
Weighted average number of:
Ordinary shares outstanding			302,409,369		300,415,725		302,590,288		300,310,425
Preference shares outstanding			3,842,900		3,966,600		3,907,756		3,966,301
Total weighted average shares outstanding			306,252,269		304,382,325		306,498,044		304,276,726
Potentially dilutive Ordinary shares			1,362,863		2,405,628		1,247,741		2,372,829
Potentially dilutive Preference shares			-		18,019		-		18,145
Total weighted average Ordinary shares outstanding assuming dilution			303,772,232		302,821,353		303,838,029		302,683,254
Total weighted average Preference shares outstanding assuming dilution			3,842,900		3,984,619		3,907,756		3,984,446
Basic income per Ordinary share		$	0.86	$	0.95	$	1.59	$	2.17
Fully diluted income per Ordinary share		$	0.85	$	0.94	$	1.59	$	2.15

On May 16, 2013, the Company held its Annual General Meeting and a separate Preference Shareholder Meeting during which resolutions on the conversion of the preference shares to ordinary shares were passed. The preference share conversion was affected on June 28, 2013 with 3,975,533 preference shares in the amount of€3,976 ($4,465)convertedon a 1:1 basis to ordinary shares. In addition, 32,006 options associated with the preference shares were converted for options associated with ordinary shares.

On July 5, 2013, the Company received a €27,000($35,316) premium from the largest preference shareholder for the conversion of their preference shares to ordinary shares. At June 30, 2013, this amount was recorded as ashort-term receivable with a corresponding increase recorded in equity.

Additionally, the Company announced the share buy-back program. The Company intends to repurchase ordinary shares in an aggregate value of up to €385,000 (approximately $500,000). This program is expected to run into the third quarter of 2013. At June 30, 2013, 3,580,807 shares were repurchased in the amount of €189,876 ($248,889). These shares are restricted treasury stock which means there are no associated dividends or voting rights. These treasury shares will be used to serve the sole purposes of either reducing the registered share capital of the Company by cancellation of the acquired shares, or fulfilling employee participation programs of the Company.

The following tabular disclosure provides the shares repurchased during the second quarter of 2013:

Period	Average price paid per share		Average price paid per share(1)		Total number of shares purchased as part of publicly announced plans or programs		Total Value of Shares Repurchased(4)		Total Value of Shares Repurchased(2), (4)			Maximum value of shares that may yet be purchased under plans or programs as of the end of the period(3)
		in €		in $				in €		in $		in €		in $
								in thousands
May 2013	€	52.96	$	68.48		1,078,255	€	57,107	$	73,842	€	327,910	$	426,480
June 2013	€	53.05	$	69.95		2,502,552	€	132,769	$	175,047	€	195,165	$	255,276
Total	€	53.03	$	69.51		3,580,807	€	189,876	$	248,889
(1) The dollar value is calculated using the daily exchange rate for the share repurchases made during the month.
(2) The value of the shares repurchased in Dollar is calculated using the total value of the shares purchased in Euro converted using the daily exchange rate for the transactions.
(3) The maximum Dollar value of the shares remaining is calculated using the maximum Euro value of shares that may yet be repurchased converted at the end of the month spot rate.
(4) This amount is inclusive of fees paid in the amount of approximately $53 (€ 41) for services rendered.

XML

Business Segment Information

3 Months Ended

6 Months Ended

Mar. 31, 2013

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Business Segment Information

				North America Segment		International Segment		Segment Total		Corporate		Total
Three months ended June 30, 2013
	Net revenue external customers		$	2,375,247	$	1,228,322	$	3,603,569	$	8,946	$	3,612,515
	Inter - segment revenue			1,771		-		1,771		(1,771)		-
	Revenue			2,377,018		1,228,322		3,605,340		7,175		3,612,515
	Depreciation and amortization			(81,208)		(45,701)		(126,909)		(31,892)		(158,801)
	Operating income			393,806		208,964		602,770		(58,531)		544,239
	Income (loss) from equity method investees			3,646		53		3,699		717		4,416
	Capital expenditures, acquisitions and investments			107,948		66,175		174,123		41,757		215,880
Three months ended June 30, 2012
	Net revenue external customers		$	2,248,692	$	1,170,902	$	3,419,594	$	8,379	$	3,427,973
	Inter - segment revenue			3,088		-		3,088		(3,088)		-
	Revenue			2,251,780		1,170,902		3,422,682		5,291		3,427,973
	Depreciation and amortization			(79,113)		(42,914)		(122,027)		(28,850)		(150,877)
	Operating income			431,084		207,223		638,307		(49,482)		588,825
	Income (loss) from equity method investees			8,338		62		8,400		(4,542)		3,858
	Capital expenditures, acquisitions and investments			101,463		60,934		162,397		35,985		198,382
Six months ended June 30, 2013
	Net revenue external customers		$	4,662,497	$	2,396,974	$	7,059,471	$	16,965	$	7,076,436
	Inter - segment revenue			2,846		-		2,846		(2,846)		-
	Revenue			4,665,343		2,396,974		7,062,317		14,119		7,076,436
	Depreciation and amortization			(161,368)		(90,954)		(252,322)		(62,832)		(315,154)
	Operating Income			762,659		392,771		1,155,430		(117,878)		1,037,552
	Income (loss) from equity method investees			7,935		968		8,903		321		9,224
	Segment assets			14,094,573		5,971,985		20,066,557		2,261,790		22,328,347
		thereof investments in equity method investees		247,277		375,343		622,620		(5,190)		617,430
	Capital expenditures, acquisitions and investments(1)			220,280		148,877		369,157		66,294		435,451
Six months ended June 30, 2012
	Net revenue external customers		$	4,353,276	$	2,306,991	$	6,660,267	$	16,461	$	6,676,728
	Inter - segment revenue			6,540		-		6,540		(6,540)		-
	Revenue			4,359,816		2,306,991		6,666,807		9,921		6,676,728
	Depreciation and amortization			(151,129)		(85,841)		(236,970)		(57,281)		(294,251)
	Operating Income			778,917		402,135		1,181,052		(89,261)		1,091,791
	Income (loss) from equity method investees			11,320		129		11,449		(2,094)		9,355
	Segment assets			13,788,169		5,695,843		19,484,012		2,260,398		21,744,410
		thereof investments in equity method investees		246,161		360,169		606,330		(2,714)		603,616
	Capital expenditures, acquisitions and investments(2)			1,862,044		99,820		1,961,864		63,738		2,025,602
	(1) International acquisitions exclude $11,684 of non-cash acquisitions for 2013.
	(2) North America acquisitions exclude $496,386 of non-cash acquisitions and International acquisitions exclude $3,415 of non-cash acquisitions for 2012.

14. Business Segment and Corporate Information

The Company has identified three operating segments, North America Segment, EMEALAand Asia Pacific, which were determined based upon how the Company manages its businesses. All segments are primarily engaged in providing dialysis care services and the distribution of products and equipment for the treatment of ESRD. The Company has aggregated EMEALA and the Asia Pacific operating segments as the “International Segment.” The segments are aggregated due to their similar economic characteristics. These characteristics include same services provided and same products sold, the same type patient population, similar methods of distribution of products and services and similar economic environments. The General Partner's management board member responsible for the profitability and cash flow of each segment's various businesses supervises the management of each operating segment. The accounting policies of the segments are the same as those the Company applies in preparing the consolidated financial statements under accounting principles generally accepted in the U.S. (“U.S. GAAP”).

Management evaluates each segment using a measure that reflects all of the segment's controllable revenues and expenses. With respect to the performance of business operations, management believes that the most appropriate measure in this regard is operating income which measures the Company's source of earnings. The Company does not include the investment gain resulting from the 2012 Liberty Acquisition nor income taxes as it believes these items to be outside the segments' control. Financing is a corporate function, which the Company's segments do not control. Therefore, the Company does not include interest expense relating to financing as a segment measurement. Similarly, the Company does not allocate “corporate costs,” which relate primarily to certain headquarters overhead charges, including accounting and finance, global research and development, etc., because the Company believes that these costs are also not within the control of the individual segments. Production of products, production asset management, quality management and procurement are centrally managed in Corporate by Global Manufacturing Operations. These corporate activities do not fulfill the definition of a segment. Products are transferred to the segments at cost; therefore no internal profit is generated. The associated internal revenues for the product transfers and their elimination are recorded as corporate activities. Capital expenditures for production are based on the expected demand of the segments and consolidated profitability considerations. In addition, certain revenues, investments and intangible assets, as well as any related expenses, are not allocated to a segment but are accounted for as “Corporate”.

Information pertaining to the Company's segments and its Corporate activities for the three- and six-monthperiods ended June 30, 2013 and 2012 is set forth below.

XML

Financial Instruments

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Financial Instruments

12. Financial Instruments

As a global supplier of dialysis services and products in more than 120 countries throughout the world, the Company is faced with a concentration of credit risks due to the nature of the reimbursement systems which are often provided by the governments of the countries in which the Company operates. Changes in reimbursement rates or the scope of coverage could have a material adverse effect on the Company's business, financial condition and results of operations and thus on its capacity to generate cash flow.

Non-derivative Financial Instruments

The following table presents the carrying amounts and fair values of the Company's non-derivative financial instruments at June 30, 2013, and December 31, 2012.

				June 30,			December 31,
				2013			2012
		Fair Value		Carrying	Fair		Carrying	Fair
		Hierarchy		Amount	Value		Amount	Value
Assets
	Cash and cash equivalents	1	$	585,857	585,857	$	688,040	688,040
	Accounts Receivable	2		3,222,035	3,222,035		3,157,233	3,157,233
Liabilities
	Accounts payable	2		693,232	693,232		745,644	745,644
	Short-term borrowings	2		174,686	174,686		121,823	121,823
	Long term debt, excluding 2012 Credit Agreement, Euro Notes and Senior Notes	2		563,986	563,986		721,928	721,928
	2012 Credit Agreement	2		2,832,312	2,828,542		2,659,340	2,652,840
	Senior Notes	2		4,730,687	5,075,954		4,743,442	5,296,325
	Euro Notes	2		44,145	45,407		51,951	54,574
Noncontrolling interests subject to put provisions		3		541,347	541,347		523,260	523,260

The carrying amounts in the table are included in the consolidated balance sheet under the indicated captions or in the case of long-term debt, in the captions shown in Note 6.

The significant methods and assumptions used in estimating the fair values of non-derivative financial instruments are as follows:

Cash and cash equivalents are stated at nominal value which equals the fair value.

Short-term financial instruments such as accounts receivable, accounts payable and short-term borrowings are valued at their carrying amounts, which are reasonable estimates of the fair value due to the relatively short period to maturity of these instruments.

The fair values of major long-term financial liabilities are calculated on the basis of market information. Instruments for which market quotes are available are measured using these quotes. The fair values of the other long-term financial liabilities are calculated at the present value of the respective future cash flows. To determine these present values, the prevailing interest rates and credit spreads for the Company as of the balance sheet date are used.

The valuation of noncontrolling interests subject to put provisions is determined using significant unobservable inputs.See Note 9 for a discussion of the Company's methodology for estimating the fair value of these noncontrolling interests subject to put obligations.

Currently, there is no indication that a decrease in the value of the Company's financing receivables is probable. Therefore, the allowances on credit losses of financing receivables are immaterial.

Derivative Financial Instruments

The Company is exposed to market risk from changes in foreign exchange rates and interest rates. In order to manage the risk of currency exchange rate and interest rate fluctuations, the Company enters into various hedging transactions by means of derivative instruments with highly rated financial institutions as authorized by the Company's General Partner. On a quarterly basis the Company performs an assessment of its counterparty credit risk. The Company currently considers this risk to be low. The Company's policy, which has been consistently followed, is that financial derivatives be used only for the purpose of hedging foreign currency and interest rate exposure.

In certain instances, the Company enters into derivative contracts that do not qualify for hedge accounting but are utilized for economic purposes (“economic hedges”). The Company does not use financial instruments for trading purposes.

The Company established guidelines for risk assessment procedures and controls for the use of financial instruments. They include a clear segregation of duties with regard to execution on one side and administration, accounting and controlling on the other.

To reduce the credit risk arising from derivatives the Company concluded Master Netting Agreements with banks. Through such agreements, positive and negative fair values of the derivative contracts could be offset against one another if a partner becomes insolvent. This offsetting is valid for transactions where the aggregate amount of obligations owed to and receivable from are not equal. If insolvency occurs, the party which owes the larger amountis obliged to pay the other party the difference between the amounts owed in the form of one net payment.

The Company elects not to offset the fair values of derivative financial instruments subject to master netting agreements in the statement of financial position.

At June 30, 2013 and December 31,2012, the Company had $16,854and $32,044of derivative financial assets subject to netting arrangements and $9,631 and $19,193of derivative financial liabilities subject to netting arrangements. Offsetting these derivative financial instruments would have resulted in net assets of $11,937 and $20,773as well as net liabilities of $4,714 and $7,922at June 30, 2013 and December 31,2012, respectively.

Foreign Exchange Risk Management

The Company conducts business on a global basis in various currencies, though a majority of its operations are in Germany and the United States. For financial reporting purposes, the Company has chosen the U.S. dollar as its reporting currency. Therefore, changes in the rate of exchange between the U.S. dollar and the local currencies in which the financial statements of the Company's international operations are maintained affect its results of operations and financial position as reported in its consolidated financial statements.

The Company's exposure to market risk for changes in foreign exchange rates relates to transactions such as sales and purchases. The Company has significant amounts of sales of products invoiced in euro from its European manufacturing facilities to its other international operations and, to a lesser extent, sales of products invoiced in other non-functional currencies. This exposes the subsidiaries to fluctuations in the rate of exchange between the euro and the currency in which their local operations are conducted. For the purpose of hedging existing and foreseeable foreign exchange transaction exposures the Company enters into foreign exchange forward contracts and, on a small scale, foreign exchange options. AtJune 30, 2013 the Company had no foreign exchange options.

Changes in the fair value of the effective portion of foreign exchange forward contracts designated and qualifying as cash flow hedges of forecasted product purchases and sales are reported in accumulated other comprehensive income (loss) (“AOCI”). Additionally, in connection with intercompany loans in foreign currency, the Company uses foreign exchange swaps thus assuring that no foreign exchange risks arise from those loans, which, if they qualify for cash flow hedge accounting, are also reported in AOCI. These amounts recorded in AOCI are subsequently reclassified into earnings as a component of cost of revenuesfor those contracts that hedge product purchases or as an adjustment of interest income/expense for those contracts that hedge loans, in the same period in which the hedged transaction affects earnings. The notional amounts of foreign exchange contracts in place that are designated and qualify as cash flow hedges totaled $201,150 and $611,488 at June 30,2013and December 31, 2012, respectively.

The Company also enters into derivative contracts for forecasted product purchases and sales and for intercompany loans in foreign currencies that do not qualify for hedge accounting but are utilized for economic hedges as defined above. In these cases, the change in value of the economic hedge is recorded in the income statement andusuallyoffsets the change in value recorded in the income statement for the underlying asset or liability. The notional amounts of economic hedges that do not qualify for hedge accounting totaled $1,344,019 and $1,574,667 at June 30,2013 and December 31,2012, respectively.

Interest Rate Risk Management

The Company enters into derivatives, particularly interest rate swaps and to a certain extent, interest rate options, to protect against the risk of rising interest rates. These interest rate derivatives are designated as cash flow hedges and have been entered into in order to effectively convert payments based on variable interest rates into payments at a fixed interest rate.The euro-denominated interest rate swaps expire in 2016 and have an interest rate of 1.73%. Interest payable and receivable under the swap agreements is accrued and recorded as an adjustment to interest expense.

AtJune 30, 2013 and December 31,2012, the notional amount of the euro-denominated interest rate swaps in place was €100,000 and €100,000 ($130,800 and $131,940 atJune 30, 2013 and December 31,2012, respectively).

Derivative Financial Instruments Valuation

The following table shows the carrying amounts of the Company'sderivatives at June 30, 2013 and December 31, 2012.

			June 30, 2013				December 31, 2012
				Assets(2)		Liabilities(2)		Assets(2)		Liabilities(2)
Derivatives in cash flow hedging relationships (1)
	Current
		Foreign exchange contracts		8,109		(1,566)		7,839		(7,510)
	Non-current
		Foreign exchange contracts		-		-		942		(187)
		Interest rate contracts		-		(4,246)		-		(6,221)
Total			$	8,109	$	(5,812)	$	8,781	$	(13,918)
Derivatives not designated as hedging instruments (1)
	Current
		Foreign exchange contracts		12,361		(6,217)		23,396		(19,068)
	Non-current
		Foreign exchange contracts		1,098		(1,227)		132		(292)
Total			$	13,459	$	(7,444)	$	23,528	$	(19,360)
	(1) At June 30, 2013 and December 31, 2012, the valuation of the Company's derivatives was determined using Significant Other Observable Inputs (Level 2) in accordance with the fair value hierarchy levels established in U.S. GAAP.
	(2) Derivative instruments are marked to market each reporting period resulting in carrying amounts being equal to fair values at the reporting date.

The carrying amounts for the current portion of derivatives indicated as assets in the table above are included in Prepaid expenses and other current assets in the Consolidated Balance Sheets while the current portion of those indicated as liabilities are included in Accrued expenses and other current liabilities. The non-current portions indicated as assets or liabilities are included in the Consolidated Balance Sheets in Other assets or Other liabilities, respectively.

The significant methods and assumptions used in estimating the fair values of derivative financial instruments are as follows:

The fair value of interest rate swaps is calculated by discounting the future cash flows on the basis of the market interest rates applicable for the remaining term of the contract at the balance sheet date. To determine the fair value of foreign exchange forward contracts, the contracted forward rate is compared to the current forward rate for the remaining term of the contract at the balance sheet date. The result is then discounted on the basis of the market interest rates prevailing at the balance sheet date for the applicable currency.

The Company includes its own credit risk for financial instruments deemed liabilities and counterparty-credit risks for financial instruments deemed assets when measuring the fair value of derivative financial instruments.

The Effect of Derivatives on the Consolidated Financial Statements
		Amount of Gain or (Loss) Recognized in OCI on Derivatives			Location of (Gain) or Loss Reclassified from AOCI in Income			Amount of (Gain) or Loss Reclassified from AOCI in Income
Derivatives in Cash Flow Hedging Relationships
		(Effective Portion) for the six months ended June 30,							(Effective Portion) for the six months ended June 30,
		2013		2012	(Effective Portion)			2013			2012
Interest rate contracts	$	3,585	$	(4,913)	Interest income/expense		$	13,094		$	10,527
Foreign exchange contracts		1,962		8,883	Costs of Revenue			514			(7,261)
Foreign exchange contracts					Interest income/expense			735			1,006
	$	5,547	$	3,970			$	14,343		$	4,272
Derivatives not Designated as Hedging Instruments				Amount of (Gain) or Loss Recognized in Income on Derivatives for the six months ended June 30,
		Location of (Gain) or Loss Recognized in Income on Derivative
				2013		2012
Foreign exchange contracts		Selling, general and administrative expense	$	(42,102)	$	(1,458)
Foreign exchange contracts		Interest income/expense		3,397		3,066
			$	(38,705)	$	1,608

For foreign exchange derivatives, the Company expects to recognize $974of losses deferred in AOCI at June 30, 2013, in earnings during the next twelve months.

The Company expects to incur additional interest expense of $19,787over the next twelve months which is currently deferred in AOCI. At June 30, 2013, this amount reflects the projected amortization of the settlement amount of the terminated swaps and the current fair value of the additional interest payments resulting fromthe remaining interest rate swap maturing in 2016.

AtJune 30, 2013, the Company had foreign exchange derivatives with maturities of up to 29 months and interest rate swaps with maturities of up to 40 months.

XML

Document and Entity Information (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended	6 Months Ended
	Mar. 31, 2013	Jun. 30, 2013
Document and Entity Information [Abstract]
Document period end date	Jun. 30, 2013
Amendment flag	false
Entity registrant name	FRESENIUS MEDICAL CARE AG & Co. KGaA
Entity current reporting status	Yes
Entity voluntary filers	Yes
Entity central index key	0001333141
Document type	6-K
Current fiscal year end date	--12-31
Entity filer category	Large Accelerated Filer
Entity well known seasoned issuer	Yes
Entity common stock shares outstanding	302,843,085
Entity public float	$ 17,790,161,435
Document Fiscal Year Focus	2013
Document Fiscal Period Focus		Q2

XML

Other Comprehensive Income

6 Months Ended

Jun. 30, 2013

Notes to Consolidated Financial Statements [Abstract]

Other Comprehensive Income

13. Other Comprehensive Income (Loss)

Changes in accumulated other comprehensive income (loss) by component for the six months ended June 30, 2013 and2012are as follows:

		Gain (Loss) related to cash flow hedges		Actuarial gain (loss) on defined benefit pension plans		Gain (loss) related to foreign-currency translation		Total, before non-controlling interests		Non-controlling interests		Total
Balance at December 31, 2011		$	(136,221)	$	(111,215)	$	(238,331)	$	(485,767)	$	3,048	$	(482,719)
	Other comprehensive income (loss) before reclassifications		(17,181)		-		(47,702)		(64,883)		86		(64,797)
	Amounts reclassified from accumulated other comprehensive income (loss) (1)		4,892		5,316		-		10,208		-		10,208
Other comprehensive income (loss) after reclassifications			(12,289)		5,316		(47,702)		(54,675)		86		(54,589)
Balance at June 30, 2012		$	(148,510)	$	(105,899)	$	(286,033)	$	(540,442)	$	3,134	$	(537,308)
Balance at December 31, 2012		$	(138,341)	$	(179,423)	$	(174,349)	$	(492,113)	$	2,869	$	(489,244)
	Other comprehensive income (loss) before reclassifications		4,902		-		(125,044)		(120,142)		(2,318)		(122,460)
	Amounts reclassified from accumulated other comprehensive income (loss) (1)		9,974		7,877		-		17,851		-		17,851
Other comprehensive income (loss) after reclassifications			14,876		7,877		(125,044)		(102,291)		(2,318)		(104,609)
Balance at June 30, 2013		$	(123,465)	$	(171,546)	$	(299,393)	$	(594,404)	$	551	$	(593,853)
(1) See separate table below for details about these reclassifications.

Reclassifications out of accumulated other comprehensive income (loss)for the six months ended June 30, 2013and2012are as follows:

Details about Accumulated Other Comprehensive Income (Loss) ("AOCI") Components		Amount of (Gain) Loss reclassified from AOCI in Income				Location of (Gain) Loss reclassified from AOCI in Income
		For the six months ended June 30,
		2013		2012
(Gain) Loss related to cash flow hedges
	Interest rate contracts	$	13,094	$	10,527	Interest income/expense
	Foreign exchange contracts		514		(7,261)	Costs of Revenue
	Foreign exchange contracts		735		1,006	Interest income/expense
			14,343		4,272	Total before tax
			(4,369)		620	Tax expense or benefit
		$	9,974	$	4,892	Net of tax
Actuarial (Gain) Loss on defined benefit pension plans
	Amortization of unrealized (gain) /loss		12,777		8,743	(1)
			12,777		8,743	Total before tax
			(4,900)		(3,427)	Tax expense or benefit
		$	7,877	$	5,316	Net of tax
Total reclassifications for the period		$	17,851	$	10,208	Net of tax
(1) Included in the computation of net periodic pension cost (see Note 8 for additional details).